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CARDI OL OGY
NONFATAL MYOCARDIAL INFARCTION OF WOMEN
E. BÖSZÖRMÉNYI, J . SZIGETI, L. MIKES, J . KISS, M. KÁRMÁN,
J . FEHÉR, MARGIT KOVÁCS
State Hospital fo r Cardiology, Balatonfiired, Hungary
(Received: May 28, 1989)
Five-hundred women admitted fo r re h a b ilita t io n  to  the State Hospital fo r Cardi­
ology 1 to  10 months a fte r  myocardial in fa rc tio n  v«re divided in to  two groups, v iz .  
group I  containing pa tien ts  less than 40 years o f age and group I I ,  in  which the pa­
t ie n ts  were older than 41 years. Forty-nine per cent o f the pa tients were b lu e -c o lla r, 
whereas 22% o f them were w h ite -co lla r workers; 16.5% had a high q u a lif ic a tio n , 28% 
were housewives or re t ire d .  The leading symptom a t admittance, tha t is  in  the post- 
in fa rc tio n  period, was angina pectoris (32% in  group I  and 73% in  group I I ) .  Heart 
fa ilu re ,  rhythm disturbance and hypertension occurred less frequently . The groups con­
siderably d iffe re d  from each other in  the frequency o f r is k  fac to rs . In  group I ,  
smoking (81%), use o f anticoncipients (41%) and hyperlipoproteinaemia (32%), while in  
group I I  hypertension (49%), smoking (45%), obesity  (43%) and hyperlipoproteinaemia 
(41%) were the main r is k  factors.
Keywords : Myocardial in fa rc tio n , r is k  fa c to rs , re h a b ilita t io n
In t r o d u c t io n
Coronary heart disease (CHD) is  the major cause of d is a b ility  and the 
leading cause of death of women, although women lag men in  incidence of CHD 
by 10 years /14 /. The advantage of women over men wanes with advancing age 
and is  p ra c tica lly  lo s t a fte r the menopause /1 4 /. On the other hand, myo­
card ia l in fa rc tion  (MI) in  young menstruating women occurs ra re ly  /1 1 /.
Abbreviations: CHD = coronary heart disease; Gr = group; p ts = patients
O ffp rin t requests should be sent to  E. Böszörményi, H-8231 Balatonfüred, Gyógy té r  2,
Hungary
Akadémiai Kiadó, Budapest
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The Framingham study has been in  continuous operation since 1948. 
Over 30 years of surveillance of 2873 women, 574 developed i n i t i a l  manifes­
ta tions  of CHD. There were 196 coronary fa ta l i t ie s  /14 /.
I t  is  a surprise that a large proportion of myocardial in fa rc tions  
(MI) remained unrecognized. Among women and men sustaining a f i r s t  MI 35% 
and 28%,respectively, went unrecognized /13 /.
The weight of evidence indicated that the r isk  of both nonfata l and 
fa ta l MI increases three to fou rfo ld  in  women who use high estrogen ora l 
contraceptives /1 4 /. Oral contraceptives alone, or especially combined with 
other r is k  factors, s ig n if ic a n tly  increase the incidence of MI /9 , 10, 12, 
18, 19, 24, 28, 30, 32, 33/.
Hypercholesterolaemia as a primary r is k  factor fo r CHD and myocardial 
in fa rc tio n  is  generally accepted in  the lite ra tu re  /6 /.
Elevated serum cholesterol le ve l is  considered by some investiga to rs 
a fu rthe r r isk  fac to r fo r  recurrent myocardial in fa rc tion  /7 , 31/, others 
disagree with th is , at least in  the male sex /20, 27/.
Wilhelmsen e t a l.  /35 / found tha t women with in fa rc tio n  had higher 
blood pressure values and higher tr ig ly c e r id e  levels, and smoked consider­
ably more than women in  the general population. A ll the same, the choles­
te ro l values were not s ig n if ic a n tly  higher in  the women w ith in fa rc tio n  
/3 5 /.
In th is  hospita l 3 to 4000 patients admitted fo r re h a b ilita tio n  a fte r 
MI are treated every year. In the la s t years, the number of myocardial in ­
fa rc tio n  has increased among our female patients.
This is  put in  evidence by the m odification of the men/women ra tio , 
which was 5.3:1 in  1977 and 3.9:1 in  1987. Considering the increasing number 
of women among our in fa rc t patien ts, we started a prospective study, try ing  
to  f in d  out the cha rac te ris tics , i f  there are any, of myocardial in fa rc tio n  
in  women.
P a t ie n ts  and Methods
We performed the complex inve s tig a tion  o f 500 women, admitted consecutively between 1 
January 1985 and 31 December 1987, fo r  re h a b ilita t io n  1-10 months (mean: 3.5 months) a fte r  MI.
In  the acute phase o f il ln e s s  the pa tien ts  had been treated in  various hosp ita ls  and 
c l in ic s  in  d iffe re n t towns o f Hungary. The diagnosis was done according to  the WHO c r i te r ia ,  
th a t is ,  the patients showed a t leas t two o f the three card ina l symptoms o f MI: 1) Long-last­
ing (more than 20 min) angina; 2) ECG m odifica tions ty p ic a l o f MI; 3) elevated plasma-enzyme 
le v e ls .
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No=500 age: 26 -90yea rs
Gr. I. 7 8p ts , 26-40 years, mean age: 34.8 years 
Gr. 11.422 p ts . 41-90yea rs , mean age: 54.8 years
F ig , 1, Age d is tr ib u t io n  o f the pa tients
Since we had no p o s s ib il ity  to  study th is  period o f M I, we have no data concerning 
acute-phase m orta lity  and symptoms.
The patients were d iv ided in to  two age groups: group I  inc lud ing  pa tients younger than 
40 years, and group I I  inc lud ing  patients o lde r than 41 years (F ig . 1 ).
We tr ie d  to evaluate the fo llow ing items:
I .  H istory
-  profession
-  heart complaints before MI 
-■ stress s itu a tio n s
I I .  C lin ic a l symptoms a t the admittance in  our hosp ita l
-  angina
-  congestive heart fa ilu re
-  hypertension
-  rhythm disturbances
-  s ite  of in fa rc t io n
I I I . Non-invasive inves tig a tion s
-  Bicycle ergometry
A l l  patients performed gradual b icyc le  exercise te s ts . Workload was increased in  a 
graded fashion from 30 W w ith  30 W increase every 3 min. The exercise was continued u n t i l  85% 
o f the maximal predicted heart rate was reached, or ischaemic changes occurred or anginal pain 
developed. ECG leads were arranged according to the CM^  system, w ith the reference electrode 
over the manubrium s te rn i,  an exploring e lectrode in  the V,. R, and another in  the V,. 
p o s it io n .
-  Phonomechanographv
We calculated the PEP/LVET ra t io .  Normal values in  our labora to ry: 0.34 +_ 0.03 Ratio 
above 0.37 was considered a sign of impaired le f t  ve n tric u la r function .
-  Radioisotope examinations with ^ In d iu m
We determined the:
62 2-  stroke volume index (stroke volume/m body surface): normal values Si 45 ml/m b .s .;
-  estimated e je c tio n  fra c tio n  (Van Dyke): normal values S  50%.
IV . Biochemical laboratory inves tiga tions
-  cho lestero l, normal values: <  6.4 mmol/1
-  s lig h t ly  elevated 6.5 -  6.6 mmol/1; elevated 2: 6.7 mmol/1
-  HOL cho les te ro l, normal values: 2  1.0 mmol/1
-  LDL cho leste ro l, normal values: < 4 . 0  mmol/1
-  T rig lyce rides, normal values: < 2 . 0  mmol/1
-  Type o f hyperlipoproteinaemia (HLP)
-  Uric acid, normal values: £ ; 350 mmol/1
V. Risk fa c to rs :
-  Positive fam ily  h is to ry
-  Smoking
-  Anticoncipients
-  Hypertension
-  Hyperlipoproteinaemia
-  Diabetes
-  Impaired glucose to lerance
-  Elevated u r ic  acid
-  Psychical stress
-  Obesity (Broca index i » l . l )
We evaluated the data o f Group I  and Group I I  pa tients  separately.
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R e s u lts
I .  H istory
- Profession: The m ajority of the patients (p ts) in  both groups were 
b lue -co lla r workers. In group I I ,  the number of re tire d  persons was con­
siderable. We included in  th is  group also a small number of housewives 
(F ig . 2).
-  Heart complaints before in fa rc tio n
The percentage of symptomfree patients before in fa rc tio n  was much 
higher in group I  than in  group I I .
. The younger patients had angina less frequently and arrhythmias more 
frequently than the o lder. None of them had heart fa ilu re  (F ig. 3).
-  Predisposing factors immediately before in fa rc tio n : 89, that is  
17.8%, of the 500 patients had stress s itua tions  several months or weeks 
before the in fa rc tio n  (group I :  22 = 28.2%; group I I :  67 pts = 15.8%).
Hard, long-lasting  or unusual physical a c t iv ity  was a predisposing 
fa c to r only in 68 cases (group I :  40 = 51.2%; group I I .  28 = 6.6%).
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W rite - Blue- House- Retired
co lla r co lla r w ives
workers w orkers
Gr. 1.
2 6 -  40yrs .
25 53 - - 78
Gr. II.
41-90yrs . 86 194 42 100 422
111 247 42 100 500
F ig . 2. Profession
П  Gr. I 78 pts. ^  Gr. 11 422 pts. ( )=No.of pa tien ts
F ig , ?. Cardiac complaints 1-5 years before the in fa rc tio n
I I . C lin ica l symptoms at admittance
In group I ,  only one-th ird  of the patients (25 = 32%) had angina and 
a few had heart fa ilu re  (7 pts = 8.9%) or arrhythmia (6 pts = 7.6%); and 
none had hypertension.
In group I I  the m ajority of the patients had angina (363 = 73%) or 
heart fa ilu re  (122 pts = 28.9%); only few had arrhythmia and hypertension 
before in fa rc tion  (Fig. 4).
873е/.
(363)
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Angina Heart Arrhythm ia Hyperten- 
fa ilure sion
32°/o
F ig , 4, C lin ic a l symptoms at admittance
S ite  o f the in fa rc tion
Only older patients had non-Q in fa rc tion  (69 = 16.2%) or double in ­
fa rc tio n  (20 pts = 4.6%). The m ajority of the young patients (33 = 42%) had 
a n te r io r , the majority of the older patients had in fe r io r  (138 = 32.6%) 
in fa rc t io n  (Fig. 5).
Non-invasive investigations
-  Bicycle exercise te s t . In both groups most patients had a good ex­
ercise capacity (120 W) (group I :  36 pts = 50.7%; group I I :  105 pts = 42.7%); 
a small percentage could perform only 30 W (group I :  4 pts = 5.6%; group I I :  
11 pts = 4.5%) (Fig. 6).
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F ig . 5. S ite  o f the in fa rc tio n
No.of examinations: 246 Ul.l'U
(Ю5)
(36)
5Q 7 F ig . 6. Exercise performance
10
Gr. II No. of examinations 185
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55.1 %
69.5°/o
Gr. I No. of exam inations 59
PEP/LVET Normal va lues:=Q 34lQ 03 О  
values indicating 
impaired LVF>0.37 Ш
( ) = No.of patients
Fig. 7. Phonomechanography
-  Phonomechanography
A PEP/LVET value over 0.37, ind ica ting  an impaired le f t  ven tricu la r 
func tion , was put in  evidence more frequently among patients in  group I I  
(44.9%) than those in  group I  (30.5%) (F ig . 7).
-  Radioisotope examinations
The stroke volume index was diminished in  both groups in  about 40% of 
the patients (group I :  39.2%; group I I :  41.8%). The estimated e jection  fra c ­
t io n  was moderately decreased (35 to 50%) in  h a lf of the patients of both 
groups (group I :  50.0%; group I I :  51.2%). The two parameters ind ica te  a 
moderately impaired l e f t  ventricu lar function in  40-50% of the patien ts.
A severely impaired LVF (EF ^  35%) was shown out only in  a few cases 
(F ig . 8).
NONFATAL MYOCARDIAL INFARCTION IN WOMEN 11
No.of examinations:
263 246
Stroke Volume index Ejection Fraction
normal > A5gr>- /min 
m b.s.
normal decreased low 
>50°/. 35-50°/. <35°/.
□  normal b.s.= body surface
No.of exam inations:78 Щ pathol. ( )=No.of patients
F ig. 8. Radioisotope examinations
113
Indium
-  Biochemical laboratory examinations
In group I ,  we found pathologic values of cholesterol, tr ig ly ce rid e s , 
HDL cholesterol, LDL cholesterol and u ric  acid only in a small percentage 
(32.2; 29.3; 25; 16.7 and 15.4%), respectively. In group I I ,  elevated chol­
estero l (42.0%) and tr ig ly c e rid e  (46.5%) levels were found more common. 
Pathologic HDL (19.7%) and LDL cholesterol (37.3%) values were not uncommon. 
The plasma u ric  acid was elevated in  22% of the patients (F ig . 9 ).
- Risk factors
We analysed the frequency of each r is k  factor and of the combinations 
of r is k  factors in  both groups. There was a considerable d iffe rence  between 
the two groups.
Gr. Il 422 211 193 180 407
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Pathologie Cholesterol Triglycerides HDL cholesterol LDL cholesterol Uric acid
values i>6.5mmol/l >2mmol/l <1mmol/l > A mmol/1 >350m m ol/l
Gr. I 75 41 36 30 78
Fig. 9. R esults o f biochemical labo ra to ry  examinations
In group I  the very important r isk  fa c to r was smoking (80.8% of the 
p a tie n ts ). A quarter o f a l l  pts (25.6%) was heavy smoker (30 to 40 ciga­
re tte s  a day).
The other important r is k  factor was use o f anticoncipients (41%). 
Hyperlipoproteinaemia (32%) and psychical stress (28.2%) occurred in  about 
o n e -th ird  of the pa tien ts . In most patients w ith  hyperlipoproteinaemia we 
observed type I l /a  (16.6%) and type I I I  (11.6% of the 78 pa tien ts). Type 
И /b  occurred only in  three cases (3.8%). The other r is k  factors, such as 
hypertension (26.9%), p o s itiv e  family h is to ry  (16.6%), diabetes (6.4%) and 
elevated uric acid le ve l (5.4%) were less important; 29 patients (37%) were 
obese. Obesity occurred only in  combination w ith  other r is k  factors, such as 
smoking and hypertension, smoking and anticoncip ients or smoking and hyper­
lipoproteinaemia (F ig . 10).
Only 4 pts (5.1%) were without any evident r is k  fac to r, 15 (19.3%) 
had a single risk  fac to r (smoking: 13 = 16.7%) and use of anticoncipients:
2 = 2.6%. The others had 2 or 3, some had even 4 r is k  factors (F ig. 11).
In group I I , the most important r isk  fa c to r was hypertension (48.8%). 
The proportion of smokers was also considerable (45.2%), 5.9% of a l l  pts 
were heavy smokers. Hyperlipoproteinaemia and diabetes were put in  evidence 
more frequently than in  group I (41.2 and 10.9%, respectively) (F ig. 10).
In th is  group we observed mostly the types I l / a  and I l / b  (20.6 and 
13.7%,respectively, o f the pa tien ts). Type I I I  occurred only in  a few cases
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Gr II 422 pts
F ig . 10, Risk fac to rs
F ig . 11. Number of r is k  facto rs
14 BÖSZÖRMÉNYI, E. e t  a l .
Nr.
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F ig . 12/b. The most frequent r is k  fa c to r combinations 
Gr. I I
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(6.9%). Obesity was observed more frequently than in  the young group (181 
pts = 42.8%); 32 pts (10.2%) were considerably obese (B r . i.  > z  1 .3 ).
In a few cases (11 pts = 2.6%) obesity was the single r is k  fa c to r. 
Generally i t  was present in  combination with another 2 or 3 r isk  facto rs , 
such as smoking, hypertension or hyperlipoproteinaemia. IGT (3.1%), stress 
(15.8%) and elevated u ric  acid leve l (23.5%) were not frequent.
From the 166 women aged 41-50 years 20 (12%) used anticoncip ients. 
Some patients (39 = 9.2%) had no evident r isk  fa c to r. Most patients had 1, 2 
or 3 r is k  factors (27.1 and 26.6 and 22.33%,respective ly , and only a few had 
more (F ig. 11).
Combination of r is k  factors
In group I ,  smoking (13 pts = 16.7%) and in  2 (2.6%) patients use of 
anticoncip ients was considered single r isk  fac to rs . The majority of the pa­
tie n ts  had 2 or 3 r is k  facto rs . The most frequent combinations were smoking 
+ anticoncipients (23 pts = 29.5%), smoking + anticoncip ients + hyperlipo­
proteinaemia (12 pts = 15.4%) and smoking + hyperlipoproteinaemia (10 pts = 
12.8%). Other combinations occurred rare ly (F ig. 12/a).
In group I I ,  single r is k  factors were smoking (59 pts = 14.0%), hyper- 
lipoproteinaemias (28 pts = 6.6%) hypertension (21 pts = 5.0%) and, in  6 
cases (1.4%), anticoncip ients. The most important r is k  factor combinations 
were smoking + hyperlipoproteinaemia (40 pts = 9.5%), smoking + hypertension 
(15 pts = 3.6%), smoking + anticoncipients (12 pts = 2.8%), and hypertension 
+ HLP (21 pts = 5.0) (F ig . 12/b).
D iscussion
Our observations ind ica ting  an increasing number of in fa rc tions  among 
women are s im ila r to those reported by other research groups. Considering 
the fact that our patients were liv in g  in d iffe re n t parts of Hungary we can 
suppose that these observations re fle c t the s itu a tio n  in th is  country.
The m ajority of our patients with MI were 41 to 60 years (331 = 66.2%) 
o ld . I t  seems that th is  is  the most dangerous age fo r women to get a MI.
The number of younger patients ( <  40) was also considerable. Some of 
them even younger than 30 years.
In both age groups the majority of the patients were b lu e -c o lla r
workers.
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A quarter of the young, and only 10.6% of the older patien ts was 
w ithout any cardiac complaint before the in fa rc tio n . Some of them had angina 
or arrhythmia, and only a few older patients had heart fa ilu re .
Hard or unusual physical a c t iv ity  was a predisposing fa c to r before 
the in fa rc tion  in  both groups, much more frequently in  young than in  old 
pa tien ts . The non-invasive investigations indicated an impaired le f t  ven­
t r ic u la r  function in  both groups, in  40-50% of the patients but severe LV 
dysfunction was observed only in  a few cases.
Despite th is  phenomenon, the m ajority  of patients from both groups 
had a good exercise capacity.
The most important r is k  facto r o f patients under 40 was smoking, 
which was in 13 cases (16.7%) the only r is k  fac to r, and was put in  evidence 
in  the majority of pa tien ts  with other 1, 2 or 3 r is k  fac to rs . The most 
frequent risk  combination were smoking + hyperlipoproteinaemia and smoking 
+ anticoncipients + hyperlipoproteinaemia. Use of anticoncip ients was also 
a very important r is k  fa c to r but with the exception of 2 cases (2.6%) oc­
curred only in combination with 1, 2 or 3 others. This observations suggests 
th a t in  th is  age group the anticoncip ients represent generally a cardio­
vascular r isk  only in  combination with other factors. Obesity, hypertension 
and hyperlipoproteinaemia were not uncommon, but only in combination. Posi­
t iv e  family h istory and diabetes showed no considerable importance. Stress 
s itu a tio n s  were present in  about one-third of the patients.
In the older age group the important r is k  factors as hypertension, i t  
was followed by smoking and hyperlipoproteinaemia. Each of these occurred 
also as a single r is k  fa c to r, but mostly in  combination w ith 1-4 others. 
Obesity occurred more frequently. In a few cases th is  was even the single 
r is k  facto r, but generally i t  occurred together with others. Diabetes was 
observed in 10.9% of the patients.
Coronary spasm probably plays an important ro le  in  the pathogenesis 
o f myocardial in fa rc tio n  in  young menstruating women taking o ra l contracep­
t iv e  p i l ls  and smoking c igare ttes. A number of investigations /12, 19, 23, 
24, 26/ suggest synergism between ora l contraceptives and c iga re tte  smoking 
in  the pathogenesis o f MI in  young women /5 , 17/. Cigarette smoking alone 
was suggested to be atherogenic in  autopsy studies /1 / and to cause sudden 
death in  women /29 /.
Cigarette smoking can be associated w ith nicotine-induced release of 
norepinephrine /6 / ,  which might th e o re tica lly  cause vasoconstriction, 
probably by a lte ring  the prostacyclin thromboxane Ä£ ra tio  /3 4 /.
NONFATAL MYOCARDIAL INFARCTION IN WOMEN 17
The question arises whether women who had suffered from a myocardial 
in fa rc tio n , despite the overa ll low incidence of th is  disease in  middle-aged 
women, were more heavily burdened by the r isk  factors hypercholesterolaemia, 
hypertension, and smoking than are men with MI. Wilhelmsen e t a l.  /35/ 
found, however, s im ila r d is tr ib u tio n s  of these r is k  factors in  MI patients 
in  both sexes and in  general, among pre- and postmenopausal women, a fact 
that does not support th is  hypothesis.
In te res ting ly  enough, Olsson and Rehnqvist /25 / did not notice any 
difference in  the 3 year prognosis between patients having low ( <L6.7 mol/1) 
and higher (6.7 mmol/1) serum cholesterol leve ls. Treatment w ith metoprolol 
fo r 3 years did not influence the to ta l serum cholesterol leve l (one quarter 
of patients were women).
On the other hand, Leren et a l. /15/ found elevated cholesterol 
levels a fte r several years treatment with propranolol. The HDL cholesterol 
leve l decreased.
Hyperuricaemia seems to have an independent influence on the overa ll 
m orta lity  in  women, although there is  no re la tionsh ip  between serum uric  
acid concentration and incidence of cardiovascular disease, such as MI or 
angina pectoris /4 /.
Treatment of hypertension is  a major objective in  the prevention of 
cardiovascular disease. However, the e ffects of antihypertensive drugs on 
the CHD m orta lity  have been contradictory and in  many respects disappointing 
/ 2 ,  21, 22/ .
Leichen /16 / in  a large population study (Tromsei Heart Study) sug­
gested that the increased leve l of to ta l serum cholesterol in  hypertensives 
probably was present o r ig in a lly ,  and was not aggravated by the antihyper­
tensive treatment.
The lower HDL cholesterol and elevated tirg ly c e rid e  leve ls in  treated, 
compared to untreated hypertensives might have been evoked by drug therapy. 
The unfavourable e ffec ts  of these drugs may in  th is  way counteract the bene­
f i t s  of blood pressure reduction. Probably contro l of blood pressure alone 
is  not enough to reduce the incidence of and m orta lity  from CHD.
Despite the l ip id  changes, the Beta-Blocker Heart Attack T r ia l /15/ 
showed benefic ia l e ffec ts  both on morbidity and m orta lity  by long-term pro­
pranolol treatment.
A possible explanation fo r these co n flic tin g  resu lts  might be that 
these drugs in h ib it  not only lec ith in -cho le s te ro l acyltransferase, resu lting  
in  decreased HDL cho lestero l, but also acyl CoA-cholesterol acyltransferase,
an e ffe c t that might re s u lt in  a decreased deposition of cholesterol esters 
in  the artery walls /3 / .
The investigations ind ica te  a remarkable d ifference between the myo­
c a rd ia l in fa rction  of men and women: high serum cholesterol is  not such a 
strong risk  factor fo r (no n -fa ta l) myocardial in fa rc tio n  in  women as in  men. 
High trig lyce rides are apparently more common in  in fa rc t women /16, 35/.
I t  has also been demonstrated that the CHD r is k  in  hypertensives is  
g re a tly  magnified by d a ily  smoking. I t  has been shown that i t  may be more 
important fo r subjects w ith  mild hypertension to  stop smoking than to put 
them on antihypertensive drugs /22/.
To prevent the MI o f women or to stop the increase of casualties we 
could advise the fo llow ing :
1. Cessation or moderation of smoking.
2. Women who have been using anticoncipients fo r a long period should 
be checked for other r is k  factors. They must know tha t the combination of 
smoking with use of anticoncip ients may be dangerous at every age. The risk  
is  much more increased fo r  women older than 35 years.
3. Treatment o f hypertension and prevention of obesity is  also very 
important.
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INCIDENCE OF RHYTTW DISORDERS IN  HYPERTHYROSIS WITH SPECIAL RESPECT OF
OLD AGE FORM
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Sinus tachycardia and a t r ia l  f ib r i l la t io n  are frequent features in  hyperthyrosis 
while sinus node dysfunction is  regarded as a rare com plication. Bradycardia пну cause 
diagnostic problems mainly in  a typ ic  hyperthyrosis o f the old age. The authors ana­
lysed d is tr ib u t io n  and age re la ted  association o f the rhythm disoreders in  hyper­
thy ros is . In  case o f the appearance o f Sick Sinus Syndrome (SSS), parameters repre­
senting the function  o f sinus node were studied by e lec trophys io log ica l in ves tig a tion s . 
Above the age o f 50 years incidences o f a t r ia l  f ib r i l la t io n  and SSS were s ig n if ic a n t ly  
increased. The abnormal sinus node func tion  proved to  be reve rs ib le  in  a po rtion  of 
the cases. In  o ld  age, in  case o f occurrence o f the symptoms o f SSS, p o s s ib i l i ty  of 
hyperthyrosis also should be considered, especia lly  when in d ica tio n  of permanent pace­
maker is  established.
Keywords : Hyperthyrosis, s ick sinus node syndrome, im plantation o f pacemaker
In t r o d u c t io n
I t  was almost 170 years ago that Parry a ttr ibu ted  great importance to 
the abnormality o f the cardiovascular system in  generating symptoms of 
hyperthyrosis (HT) /2 5 /. HT may exacerbate ex is ting  ischaemic or myocardial 
impairment of other o rig in  of the heart or may cause heart disease in  i t s e l f  
/11, 21/. The nonspecific cardiovascular symptoms (p a lp ita tio n , e ffo r t
dyspnoe, weakness, peripheral vasodilata tion) are reversib le  by attainment 
of the euthyroid state and they may be reproduced in  animal experiment by
Abbreviations: SSS = Sick Sinus Syndrome; HT = hyperthyrosis
O ffp rin t requests should be sent to  A. Mohácsi, H-4012 Debrecen, P.0. Box 19, Hungary
Akadémiai Kiadó, Budapest
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administration of thyroxine /1 5 /. Besides c ircu la to ry  hyperkinesis, arrhyth­
mias form the most important group of the cardiac symptoms of HT. Apart from 
the persisting tachycardia during sleeping the most common type of arrhyth­
mia in  HT is  a t r ia l f ib r i l la t io n ;  less frequently , other arrhythmias, lik e  
paroxysmal supraventricu lar tachycardia, a t r ia l  f lu t te r ,  a t r ia l  tachycardia, 
ven tricu la r and a t r ia l  ex trasys to lia , SSS-linked arrhythmias and transient 
conductiv ity  disturbances may occur /5 / .  The frequency of th is  la s t type ar­
rhythmia is  poorly known. In case of occurrence of the typ ica l c lin ic a l 
symptoms recognition o f the existing endocrine disturbance, simultaneously 
e x is tin g  together w ith rhythm disorders, does not cause any problem, but in 
o ld  age patients the c l in ic a l  symptoms may be absent or misleading (apathie 
form ). Leading or s ing le  symptom can be ju s t the rhythm disorder and/or the 
insu ffic iency  of the pump-function appearing res is tan t to medical treatment. 
Regarding the fac t tha t the beginning of the HT occurs in  old age in  almost 
the th ird  of the cases (30-35 per cent), presence of rhythm disorders ac­
companied by bradycardia may cause diagnostic and therapeutic problems /5 , 
7 /.  The above-mentioned s itu a tio n  prompted us to investigate the incidence 
o f rhythm disorders and th e ir  d is trib u tio n  in  old-age HT, w ith special a t­
te n tio n  to the rhythm disturbances causing bradycardia. We analysed the 
sinus-node function of HT patients who were subjected to e lectrophysio log i- 
ca l investigations because o f SSS c lin ic a l symptoms.
P a t ie n ts  and Methods
The data of 219 cases, c l in ic a l ly  v e r ifie d  and/or id e n t if ie d  by laboratory methods 
were analysed. [Ji^gnoses were based on c lin ic a l appearance, T^ uptake (T U), to ta l serum T^ 
and T values, I  storage curves and, occasionally, TRH-TSH te s t (200 Л g TSH), anti-human 
th y ro g lo b u lin  and anti-microsome antibody determinations, o r th in  needle-biopsy. The patients 
were subdivided in to  two groups: to  a group o f age below 50 years belonged 121 pa tien ts , 12 
male and 109 female, w ith average age o f 29.1 years (17-48 years), while the group o f the age 
above 50 years contained 98 p a tie n ts , 96 female and 2 male ones, w ith average age o f 60.0 
years (50-84 years). The d is t r ib u t io n  o f diagnoses was as fo llo w s : Graves-Basedow1s disease, 
182 cases; autonomous adenoma, 35 cases; Graves' disease associated w ith  Hashimoto's thy­
r o i d i t i s ,  2 cases. The type o f arrhythmia was established a t admission and during disease 
process by electrocardiograph re g is tra t io n .  During the in ve s tig a tion s  only those pa tients were 
inc luded whose anamneses did not show hypertension, ischaemic myocardial disease and/or con­
g e s tive  heart fa ilu re . In  f iv e  cases invasive e lec trophys io log ica l in ves tiga tions  also took 
p lace . The fo llow ing parameters were determined: sinus node recovery time (SNRT), s in o -a tr ia l 
c o n d u c tiv ity  time (SACT). His bundle electrogram, v e n tr ic u la r  and a t r ia l  e ffe c tiv e  re fra c to ry  
periods (AERP, VERP) and a tr io -v e n tr ic u la r  (AV) impulse con d uc tiv ity  c h a ra c te r is tic  curve 
(Wenkebach po in t).
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R es u lts
Table I
Rhythm disturbances in  219 h yp e rth y ro tic  cases
17-49
Number of cases 
years 50-84 years
I . Normal
I I .  Disturbances o f impulse formation
A. Disturbances o f sinus impulse 
formation
12 14
sinus tachycardia 93 39
sinus bradycardia
B. Disturbances o f heterotopic 
impulse formation
7
a t r ia l  f ib r i l la t io n 2 34
paroxysmal a t r ia l  tachy 2 1
premature a t r ia l  beat 
Ш . Disturbances o f impulse conductiv ity
4 3
s inoauricu la r block - 5
f i r s t  degree AV block 5 4
Aberrant v e n tric u la r conductiv ity 5 4
Table I  shows the d is tr ib u tio n  of arrhythmias observed during t re a t­
ing of 219 hyperthyrotic patients. In the group of patients below 50 years 
there were only 12 cases in which impulse formation and conductiv ity d is ­
turbances were not observed. An overwhelming majority of the arrhythmias 
were of sinus tachycardia, 93 cases (76.8 per cent). A tr ia l and paroxysmal 
tachycardia occurred exceptionally. The number of AV conductivity d is tu rb ­
ances as well as ven tricu la r and a tr ia l heterotopies did not change with 
age. In the group of patients with age above 50 years occurrence o f ar­
rhythmias, ra is ing  the suspect of SSS (s in o -a tr ia l block and sinus brady­
cardia) and a t r ia l f ib r i l la t io n ,  was increased. A tr ia l f ib r i l la t io n ,  sinus 
bradycardia, s ino-auricu la r block were observed in 34, 7 and 5 cases, 
respectively. Besides the persistent a t r ia l  f ib r i l la t io n  the arrhythmias 
appeared paroxysmally in  12 cases. Figure 1 shows the age-dependent d is t r i ­
bution of a t r ia l f ib r i l la t io n  and deviations re fe rring  to sinus node dys­
functions. In the subgroup of age above 70 years, the frequency o f a t r ia l
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F ig , 1. Age dependence o f the rhythm disturbances appearing in  the forms of a t r ia l  tachy­
ca rd ia  and sinus-node disease. (Open columns: a t r ia l  tachycard ia, shaded columns: re fe r ­
r in g  sinus-node disease.) When constructing the fig u re  "normal" frequency heart func tion  
in  HT was also taken in to  account.
f i b r i l l a t io n  surpassed 50 per cent of the cases; the number of SSS cases 
also increased, although a t a reduced ra te . Table I I  depicts the data of 
pa tie n ts  who were admitted to e lectrophysio log ica l investigation because 
o f the suspect of sinus-node disease. A d e f in ite , but moderate, pro­
longation of s in o -a tr ia l conductivity was observed in  4 cases w ith  an 
a t r ia l  e ffec tive  re frac to ry  period inhomogenity. In two cases, because 
o f p e rs is ting  pathological sinus-node functions and s ign ifican t symptoms, 
permanent pacemaker im plantation was performed; in  one case, symptoms were 
m anifesting upon adm in istra tion of beta-receptor blocker. These symptoms 
disappeared as dosage had been reduced. In two cases the euthyroid s ta te  
was reached and the anomalies re ferring to  sinus-node dysfunction ceased. 
Prolonged H-V in te rva l re fe rr in g  to conductiv ity  disturbance, was not ob­
served.
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Table I I
E lectrophysio log ica l data o f hyperthyrotic  patients showing symptoms re fe rrinn  to  s ick
sinus syndrome
Patient
No.
Sex Age
(years)
ECG SACT
(120-240)
ms
SNRT
(800-1200)
ms
AV node 
Wenkebach
AH
(50-120)
ms
HV
(35-55)
ms
1 female 61 SA-block 400 5000 180 70 35
2 female 55 SA-block 450 2000 220 75 45
3 female 74 Sinus brady-
cardia
(S .s ta n d s t il l)  260 1800 180 70 50
4 female SA-block 240 1250 200 90 40
5 male SA-block 260 1600 185 90 50
a t r ia l  f ib r ,
D iscuss ion
The occurrence of a t r ia l  f ib r i l la t io n  in  HT is  estimated at 20 per 
cent in  general; AV-conductivity disturbances and SSS are kept in  evidence 
as rare complications; th e ir  prevalence is  changing by publications /5 , 6, 
20, 23, 24/. The occurrence of AV-conductivity disturbances ranges from 5 
to 20 per cent in  the publications, though, Ferrer does not mention HT 
among the possible causes of SSS /10 /. In our investigations, sinus brady­
cardia and s ino-auricu la r block did not occur below 50 years; above 50 
years we observed these arrhythmias in  12 cases. In old age HT we saw the 
sinus node syndrome, frequently. In the cases "normal" frequency heart 
work and an a t r ia l  f ib r i l la t io n  appearing paroxysmatically could be a 
p a r t ia l phenomenon belonging to a pathological sinus-node function. Talwar 
et a l.  observed d e fin ite  prolongation of the sinus-node recovery time and 
s in o -a tr ia l conductiv ity time at the investiga tion  of HT patients sent to 
electrophysiology study w ith bradycardia, but these phenomena regressed 
when the euthyroid state was attained /31 /. In two of our cases the devi­
ations persisted even in  the euthyroid s ta te , only in  three cases they 
proved to be revers ib le . The uneven character o f the re fractory period of 
the atrium referred to i t s  vu ln e ra b ility  in  one case. We found no devi­
ations charac te ris tic  or AV-conductivity damages. In our cases age-depend­
ence of the arrhythmias was obvious: in  younger ages, together w ith frequent 
sinus tachycardia, a tachycardia of paroxysmal character occurred in  ex-
ceptional cases ( in  serious thyro tox icos is ), while above 50 years the number 
o f both the permanent and the paroxysmal type a tr ia l f ib r i l la t io n  was in ­
creased. Arrhythmia together with bradycardia occurred only above 50 years 
o f age.
The exact mechanism through which HT leads to the above types of ar­
rhythmias has not been c la r if ie d .  Although the role of age is  obvious, age 
in  i t s e l f  cannot serve as an explanation as i t  has been shown by the resu lts 
o f 24 h Holter monitoring on healthy subjects /4 / .  Symptoms re fe rr in g  to the 
increase of the sympathetic tonus as well as the advantageous e ffe c t of the 
beta receptor blockers i t  seemed to be obvious to conclude to the change of 
reaction  of the sympathico-adrenal system /3 , 12/. The c l in ic a l observation, 
however, that before and a fte r beta-receptor blocker the frequency and blood 
pressure response of HT patients to work load were iden tica l w ith those of 
the s im ila rly -trea ted  healthy subjects served as evidence against the hyper­
a c t iv i ty  of the sympathetic system /1 2 /. In sp ite  of the presence of the 
noriral catecholamine le v e l, the increase of the beta-receptor density with 
the simultaneous decrease in  number of the alpha receptors, as w e ll as the 
high cAMP level increment upon isoproterenol adm inistration, investigated in  
v i t r o  in  isolated myocardial ce lls , makes very probable the increase of the 
beta-receptor hype rsens itiv ity  towards catecholamines /16, 30/. There is  no 
evidence of the presence of cholinergic hypersensitiv ity  of SSS in  i ts  
pathogenesis e ither /13, 28/. Among the symptoms of the old-age HT the in ­
crease of the number o f angina pectoris is  s tr ik in g . On th is  ground vaso- 
pasm, local ischaemia cannot be excluded in  background /2 / .  In HT, fo r the 
high number of the arrhythmias probably the in tra c e llu la r  changes of the ion 
m ilie u  can be regarded as responsible. Duration of the action p o ten tia l (AP) 
decreased in the ve n tr icu la r heart muscle c e lls  as a resu lt of the shorten­
ing o f the plateau phase at f i r s t  place; the steepness of the d ia s to lic  re- 
po la riza tion  slope rose but the resting threshold potentia l of the membrane, 
the steepness and ve lo c ity  of the ascending branch of AP remained unchanged 
/1 ,  17, 30/. For a l l  these changes during development of the plateau phase 
the potential-dependent Ca^+ channels and the conductance changes o f the K+ 
channels, playing ro le  in  the d ia s to lic  repo la riza tion , could be regarded 
as responsible. However, opposing th is  view, Jaeger et a l. described pro­
longation of the AP in  Purkinje fib res as a re su lt of thyroxine e ffe c t /17 /. 
The above changes can be explained only in  tha t case i f  the facto rs  respon­
s ib le  fo r opening and closing of the Ca^+ channels (phosphorylation and de- 
phosphorylation mechanism) as well as fo r the increase and decrease of the
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K+ conductance are changing simultaneously upon thyroxine e ffe c t. The actual 
change (decrease and increase of the duration of AP and/or e x c ita b i l i ty )  
w i l l  be defined as resultant of the above changes. In spite of the acceler­
ated Na+— K+ ATP-ase function in  HT, fas t increase of the e x tra ce llu la r K+ 
takes place because of the lack of ATP, a l l  th is  resulting in  an increase 
of the e x c ita b il ity  of the ce lls  /9 , 26/. The increase of the in tra c e llu la r  
Ca^+ concentration causes changes of the same d irection /14, 19, 32/. The 
Caz+ antagonist diltiazem  favourably can be used in the treatment o f a r­
rhythmias occurring in HT /22 /. This experimental fact is  also re la ted  to 
the changes ro le  of the Ca^+ channel's.
As to the occurrence of SSS in  old age, i t  is  important to take in to  
consideration the p o s s ib ility  of HT because in  the lack of adequate c l in ic a l 
symptoms too much time may elapse u n t i l  the correct diagnosis is  established 
while myocardial damage may develop. The correct in terp re ta tion  of rhythm 
disturbances and th e ir  adequate treatment may essentia lly  improve the l i f e  
prospect of the patient /8 / .  The reversib le  nature of a rhythm disturbance 
should be taken in to  account in  such a case during establishing the neces­
s ity  of permanent pacemaker implantation.
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The non-invasive d if fe re n t ia l diagnosis o f ischaemic heart disease (IHD) and 
acute myocarditis or secondary cardiomyopathy fo llow ing  myocarditis can be d i f f i c u l t  
on the basis o f the complaints, resting  and exercise ECG and nuclear ca rd io lo g ica l 
te s ts . 92 patients (mean age: 46 years) in  the f i r s t  step and 100 pa tien ts  (mean age: 
44 years) in  the second step a l l  w ith heart troub les, were examined. Besides determ i­
nation of the routine parameters, nuclear haemodynamical and haemorheological measure­
ments were carried out. Then each group of the patients was c la s s ifie d  in to  4 sub­
groups: 1) myocardial in fa rc tio n  /п :9 / ,  2) IHD /5 2 /, 3) myocarditis /2 8 / ,  4) chronic 
cor pulmonale (CCP) /3 /  subgroups in  the f i r s t  group and 1) normal /п :2 0 / ,  2) IHO 
/5 0 /, 3) m yocarditis /1 6 /,  4) chronic cor pulmonale /14 / subgroups in  the second 
group. The patients were re c la ss ifie d  by our m u ltiva ria te  pattern recogn ition  a lgor­
ithm (PRIMA). The average effectiveness o f our method was over 80%, the recogn ition  
a b i l i t ie s  fo r the subgroups (classes) ranged between 71 and 100%. An ana lys is  o f the 
d iscrim ination power of the properties has made i t  evident tha t the haemorheological 
features were more c h a ra c te r is tic  than the haemodynamic ones in  d is tin g u ish ing  the two 
d iffe re n tia l-d ia g n o s tic a lly  c r i t ic a l  groups. Dur re su lts  show tha t our m u ltiva r ia te  
s ta t is t ic a l method can be useful fo r the computer-aided decision in  ca rd io lo g ica l 
d iagnostics.
Keywords: PRIMA, haemorheological parameters, haemodynamical measurements, d i f ­
fe re n tia l d iagnostics.
Abbreviations : AMI: acute myocaridal in fa rc tio n ; CCP: chronic cor 
ishaemic heart disease
O ffp rin t requests should be sent to  K. Tóth, H-7643 Pécs, Ifjúság
pulmonale; IHO: 
u. 13, Hungary
Akadémiai Kiadó, Budapest
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In t r o d u c t io n
The nonivasive, and sometimes even the invasive d if fe re n t ia l diagnos­
t ic s  of ischaemic heart disease (IHD), acute myocardial in fa rc tio n  (AMI) and 
acute v ira l myocarditis can pose a hard problem in  the c lin ic a l practice /1 , 
2, 6, 8-11/. In these diseases, both the acute and chronic phase, the com­
p la in ts  often are s im ila r ,  the resting ECG does not always make d is tin c tio n  
and the stress tes ts  performed in the chronic phase often provide s im ila r 
re su lts . The v irus serology tests performed in  the case of the suspicion of 
myocarditis may be p o s itive  in  a ll  of the mentioned diseases. Even the value 
o f the invasive endomyocardial biopsy is  c r it ic iz e d  by some investigators 
/1 , 2, 6, 9/.
For a better approach to th is  d if fe re n t ia l diagnostic problem, rad io­
isotope haemodynamical and haemorheological investigations were rou tine ly  
carried  out in our cardiopathie patients /1 4 /.
To evaluate the collected resu lts, our m ultivariab le  pattern recog­
n it io n  method /7 / was used to classify the pa tien ts  in to  d iffe re n t diagnos­
t i c  categories.
P a tie n ts  and M ethods
92 patients (mean age: 46 years) in  the f i r s t  and 100 patients (mean age: 44 years) in  
the second step, a l l  admitted w ith  cardiac complaints, were examined. On the basis o f the case 
h is to r ie s , the physical examination and of the performed te s ts  each group could be divided 
in to  4 subgroups. Tables I  and I I  show the age and sex d is tr ib u t io n  o f the pa tients w ith in  the 
d iagnostic  groups.
Table I
Sex d is tr ib u t io n  o f the patients in  the subgroups o f the f i r s t  group
Sex o f Subgroup 1 Subgroup 2 Subgroup 3 Subgroup 4
. .  . (AMI) p a tie n ts
n= mean age
(IHD) (c a rd it is ) (CCP)
n= mean age n= mean age n= mean age
(y rs ) (yrs) (yrs) (y rs )
Male 7 55 37 48 9 38 3 49
Female 2 61 15 53 19 40 0
T o ta l 9 57 52 50 28 39 3 49
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Table I I
Sex d is tr ib u t io n  of the pa tients  in  the subgroups of the second group
Sex o f Subgroup 1 Subgroup 2 Subgroup 3 Subgroup 4
pa tien ts
(normal) (IHD) (c a rd it is ) (CCP)
n= mean age
(y rs )
n= mean age 
(y rs )
n= mean age
(yrs)
n= mean age
(y rs )
Male 10 32 45 57 2 31 12 56
Female 10 30 5 52 14 32 2 50
Tota l 20 31 50 56 16 32 14 55
Resting ECG recording w ith 12 leads, rou tin e  laboratory tests and v irus -se ro logy  tes ts  
were performed. Furthermore, haemodynamical parameters, such as cardiac output, card iac index, 
stroke volume and stroke volume index were determined in  the f i r s t  group by f i r s t  pass isotope 
method using a portable NK-362 g^ ijjma detector (Gamma Factories, Budapest, Hungary). Before the 
intravenous isotope in je c tio n  ( 77Technecium) blood samples were taken fo r the haemorheologic- 
a l assays. In  the f i r s t  group o f patients whole blood and plasma v iscos ity  was determined at 
low shear rates (0.53, 1.35, 2.48, 4.95 1 /s) w h ile  in  the second group a t medium and high 
shear rates (10, 90, 200 1 /s ). Fibrinogen le v e l was quantified  by the Reiner-Cheung method. 
The rheo log ica l measurements were performed a t low shear rates iniContraves Low Shear 100 
viscosim eter, a t medium and high shear ra tes in  Hevimet ca p illa ry  viscosim eter /3 ,  14/.
Table I I I  shows the upper l im its  o f the normal ranges as estimated by our method.
Table I I I
The upper leve ls  o f the normal range o f whole blood and plasma v is c o s it ie s
and plasma fib rinogen  leve l
Shear rates Whole blood v is c o s ity Plasma v is c o s ity
(1 /s ) (mPa s) (mPa s)
0.53 30
1.35 20
2.48 15
4.59 10
90.0 4.5 1.35
Plasma fib rinogen le v e l: 4.0 g/1.
To evaluate our co llected haemodynamical and haemorheological parameters by computer 
ana lys is , the most re levant parameters were selected.
These data served the tra in in g  set fo r  the PRIMA (Pattem Recognition by Independent 
M ulticategory Analysis) supervised pattern recogn ition  techniques /4 , 7 /.  This c lass modelling 
method derives in  learning phase fo r each c lass independent decision ru les th a t subsequently 
can be uaad fo r c la s s if ic a t io n  of samples ( in  our case patients) o f unknown o r ig in .  The de­
c is io n  ru les are based on class distances. C la s s if ic a tio n  can be done by assigning the pa­
t ie n ts  to  th a t class (subgroup) fo r which the c lass distance is  minimal or sm aller than a 
su ita b ly  selected l im it  value, the so-ca lled c lass distance threshold. A fte r  the learning 
phase, we could ca lcu la te  the d iscrim ina ting  power o f the d iffe re n t p roperties which can be
34 TÚTH, K. e t  a l .
used to  characterize the importance o f the given property and to  select the relevant data from 
the po in t o f view o f the given c la s s if ic a tio n .
The e ffic iency  o f c la s s if ic a t io n  is  characterized by the "recognition a b i l i t y " ,  which 
corresponds to the fra c tio n  o f pa tients from the tra in in g  set th a t are c la ss ifie d  c o rre c tly .
The algorithm o f the PRIMA method was programmed in  BASIC fo r ROSY 80-B (R o litro n ) 
microcomputer.
R e s u lts
Figure 1 shows the values of the cardiac output and of whole blood 
v isco s ity  at low shear ra te  in  the f i r s t  group o f patients.
The cardiac output was the lowest in  chronic cor pulmonale. I t  should 
be noted that a l l  the 3 patients were already in  the decompensated phase of 
GCP as confirmed by r ig h t-h e a rt ca theteriza tion . One of them even died in  
the hospita l. In cases o f AMI the nuclear te s t was carried out immediately 
a fte r  the m obilization from bed, mostly on the 5th day of hosp ita liza tion . 
The cardiac output in  these patients was lower than the normal le ve l. In IHD 
and myocarditis, the cardiac output was in  the normal range, but in  myocar­
d i t is  i t  was higher and often showed a hyperkinetic state, though the d i f ­
ference from the IHD pa tien ts  was s ta t is t ic a lly  not s ign ifican t.
The most patho log ica l whole blood v isco s ity  was found in chronic cor 
pulmonale. This parameter was pathologically high in  AMI and IHD as w e ll. In 
myocarditis the whole blood viscosity was s ig n if ic a n t ly  lower than in  AMI 
and IHD (P ^O .O l) and i t  was in the normal range.
The values of whole blood viscosity and haematocrit for the second 
group can be seen in  F ig . 2. The highest values were measured in  CCP due to 
the polyglobulia in  th is  disease. In IHD, also increased whole blood v is ­
cos ity  was found. In the normal controls and in  myocarditis both parameters 
were s ig n ifica n tly  lower than in the other two groups (P <  0.01) and were in  
the normal range.
Figure 3 shows the plasma viscosity and fibrinogen levels of a l l  the 
examined patients. In AMI, IHD and chronic cor pulmonale pathologically 
elevated fibrinogen leve ls  were measured. Due to  the high fibrinogen le ve l, 
plasma viscosity was increased in these pa tien ts , too.
In Table IV the ordered discrim inating powers of the most relevant 
measured parameters are lis te d  in the point o f view of discrim inating be­
tween classes 2 and 3 in  the f i r s t  group of pa tien ts . Haemorheological par­
ameters have the highest values. The resu lts  of haemodynamic test are less 
re lia b le  in  the d if fe re n tia t io n  of these diagnostic categories.
Whole blood Cardiac
v isco s ity  output
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(mPas)
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( l /min) 1
1
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6 0 -
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1
I
I 1
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I I 1 
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1
   
11 1 
1 / /1
5 0 - 1**1 1 11 1 1 / /1
1 1**1 6 - 11 1 I / / I
1 1 * *  1 1 1 XX 1 1 / /1
1 1 * *  1 1 1 XX 1 I / / I
1 1 1**1 1 1 XX 1 I / / I
40 - 1 1**1 5 - 1 XX 1 1 / / I
1 — 1**1 1 1 XX 1 1 / / I
1 1 H 1 1 1**1 1 1 1 XX 1 1 / / I
1 1 il 1 — 1**1 1 — 1 XX 1 1 / / I
1 1 ## 1 1 1 1 1 * *  1 4 - 11 1 IXX 1 1 / /1 1
30- 1 ns 1 1 XX 1 1 **  1 1 1 ns 1 1 XX 1 I / / I —
1 in s  1 1 XX 1 1 ** 1 1 1 « s 1 IXX 1 1 / /1 1 1 1
I 1 ns 1 1 XX 1 1 1**1 1 1 SS 1 1 XX 1 1 / /1 1 * *  1
1 i n n i 1 XX 1 — 1 *  *  1 3- 1 SS 1 1 XX 1 1 / /1 1** 1
1 1 nn 1 1 XX 1 1 1 1 1 X *  1 1 1 s s  1 1 XX 1 1 / / \ 1** 1
20 - 1 К »  1 1 XX 1 1 / /1 1 XX 1 1 I f l f l l 1 XX 1 1 / / I 1** 1
1 1 « fl 1 1 XX 1 \ / / \ 1 * *  1 1 1 ss 1 1 XX 1 l / V I 1**1
1 И. 1 12. 1 i3. 1 1 4. 1 2 - 11. I 12. 1 13. 1 14. 1
1 1 ns 1 1 XX 1 1 / /1 1 X * 1 1 I SS I 1 XX 1 I / / I 1 * *  1
1 1 s» 1 1 XX 1 1 / /1 1**1 1 I »S I 1 XX 1 1 / /1 1 ж *  1
10 - 1 #« 1 1 XX 1 1 / /1 1**1 1 I « f l I 1 XX 1 1 / /1 1 * * 1
1 1 fl«  1 1 XX 1 1 / /1 1**1 1 - ISSI 1 XX 1 I / / I 1 ж *  1
1 1 SS 1 1 X X 1 1 / /1 1 * *  1 1 I »S I 1 XXI 1 / / I 1 * * 1
1 1 SS 1 1 XX 1 1 / /1 1**1 1 I f l»  I 1 XX 1 l /V | 1 * ж  1
1 1 « fl 1 1 XX 1 I / / I 1**1 1 1 « » 1 1 XX 1 1 / / 1 1 X * 1
1. AMI fl n=9
2. I HD X n=52
3. M yocard itis
0
0
C
NIIc\
4. ССР X
00IIc
Fig. 1. The values o f whole blood v isco s ity  and cardiac output in  the f i r s t  group o f pa tien ts
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C
F ig . 2. The values o f whole blood v iscos ity  and haematocrit in  the second group o f pa tien ts
HAEMORHEOLOGICAL ÆASUREMENTS IN THE CARDIOLOGICAL DIAGNOSTICS 37
Plasma
viscos ity
(mPas)
F ibrinogen
level
( g / l  )
I
I
1
1 . 5  -  
I 
I
1
1
1
1
I I I  1 
I I I  1 
I I I  1 
I t  1 6 -  
1 * 1  1
I
1. 4 -  
1
1 1 1 
1 1 1
1 X 1
1 11 
1 1 1
1 * 1  1
1 * 1  1 
I I I  5 -  
1 « 1 1
1
1
1
1
1
1 11
1 l x  1 1 1 1 14 1 1 — 111 1 1 1
1 1 X 1 1 1» 1 1« 1 1 1 1 1 111 1 *  1
1 1 X 1 - 1» 1 1 * 1 4 - 1 1 1 1 111 1 « 1
1 . 3  - 1 X 1 111 1 *  1 1 * 1  1 1 1 1 1 1 I X 1 11 1
I 1 1 X 1 l / l 1 X 1 l * l  1 — 1 X 1 1 I X 1 I t  1
I - l x  1 l / l 1 * 1 1 * 1  1 1 1 1 l x  1 — 1 Ж 1 11 1
I 1 1 1 1 X 1 l / l I X  1 1 * 1  3 - 1 1 1 1 X 1 111 1 X 1 1 » 1
I 1 1 1 X 1 l / l 1 X 1 l » l  1 1 1 I X 1 1 11 I X 1 1 1 1
1.2 - 1 1 1 X 1 l / l I X  1 i l l  1 1 1 I X 1 l / l I X 1 1 1 1
1 1 1 l x  1 l / l I X 1 1 * 1  1 1 1 I X 1 l / l I X 1 I t l
1 И.  I 12.1 13.1 14.1
1CSI
LO И .  I 12.1 13.1 14.1 15.1
1 1 1 l x  1 l / l 1 X 1 I t  1 1 I 1 I X 1 l / l I X  1 11 1
1 1 1 1 X 1 l / l 1 *  1 1 *  1 1 1 1 l x  1 l / l 1 X 1 1 1 1
1.1 - 1 1 1 X 1 l / l 1 X 1 i t  1 1 1 1 I X 1 l / l I X  1 1 *  1
1 1 1 1 X 1 l / l 1 X 1 I t  1 1 - 1 1 I X  1 1 / 1 I X  1 11 1
/ 1 1 1 X 1 l / l 1 X 1 111 1 1 1 1 X 1 l / l 1 X 1 1 1 1
/ 1 1 1 X 1 l / l 1 X 1 1 * 1  1 1 1 1 X 1 l / l l x  1 1 *  1
1 1 1 I X 1 l / l I X  1 1 *  1 1 1 1 1 X 1 l / l 1 X 1 1 1 1
1. Normal n=20
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4. CCP *  n=17
5. AMI tt n=9
Fig. 3, The values o f plasma v is c o s ity  and fib rinogen in  the studied groups
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Table IV
The ordered l i s t  o f d iscrim inating powers between classes 2 and 3 in  the
f i r s t  group o f p a tie n ts
Variables
D iscrim inating
power
1. Whole blood v is e , a t 1.35 1/s 1.568
2. Whole blood v is e , a t 2.48 1/s 1.445
3. Whole blood v is e , a t 4.59 1/s 1.443
4. Whole blood v is e , a t 0.53 1/s 1.427
5. Haematocrit 1.423
6 . Red blood c e l l  count 1.085
7. Plasma p ro te ins 0.736
8. Cardiac index 0.694
9. Cardiac output 0.472
10. Cholesterol 0.430
О 1st c la ss : ♦
1 2nd c la ss : *
1 3 rd c la s s : О
1
1
4 t h c lass : X
4 -
3 -
2 -
1 -
о о 
oo
ooooo
OOOOO *♦ ■ '" * *
oo  о Xo,*% + + j(Jf 
o o o  *  , o * + x *  * * *  
000/Д X * * * * * * * * *
И
* * * * * * * * * * *
*******
I ------> 3
F ig . 4. Class distances o f pa tien ts  o f the f i r s t  group
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The class distances from the 2nd and 3rd classes a fte r  the reclas­
s if ic a t io n  of patients of the f i r s t  group is  graphically presented in  Fig.
4. I t  shows that the 2nd and 3rd classes, which give the most d i f f ic u l t  d i f ­
fe re n tia l diagnostic problem, are situated in  well-separated regions.
Table V shows the average effectiveness and the recognition a b il it ie s  
fo r ind iv idua l classes of the f i r s t  group. The average effectiveness was 
80%, which is  a good resu lt from the point of the c l in ic a l practice.
Table V
The average and in d iv id u a l recognition a b i l i t ie s  in  the f i r s t  group
of patients
Classes No. o f 
pa tie n ts
C orrectly
c la s s ifie d
In co rre c tly
c la s s ifie d
Recognition 
a b i l i t y  
(per cent)
1. 9 9 0 100
2. 52 37 15 71
3. 28 25 3 89
4. 3 3 0 100
Total 92 74 18 80
Figure 5 shows the class distances between the 2nd and 3rd classes
a fte r the re c la ss ifica tio n  of patients of the second group on the basis of 
th e ir  haemorheological parameters. A good separation of the classes is  clear 
Table VI shows the average effectiveness and the recognition a b i l i ­
t ie s  fo r ind iv idua l classes of the second group. The average effectiveness 
did not d if fe r  s ig n if ic a n tly  from the f i r s t ly  examined group, although in 
the second group only haemorheological parameters were taken in to  consider­
ation.
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Fig, 5. Class d istances o f patients o f the second group
Table VI
The average and in d iv id u a l recogn ition  a b il i t ie s  in  the second group 
o f patients
Classes No. of 
patients
C o rre c tly
c la s s if ie d
In co rre c tly
c la ss ifie d
Recognition 
a b i l i t y  
(per cent)
1. 20 17 3 85
2 . 50 45 5 90
3. 16 13 3 81
4. 14 13 1 92
T o ta l 100 88 12 88
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D iscuss ion
The d if fe re n t ia l diagnosis of IHD, of i t s  most serious manifestation 
form, the AMI, and of the acute and chronic v ir a l myocarditis often pose a 
hard problem even nowadays /6 , 8, 10, 13/. Even the previously widely used 
endomyocardial biopsy has been in  widely c r it ic iz e d . Being an invasive 
method, i t  cannot be rou tine ly  used and the h is to lo g ica l results may be 
ambiguous /1 , 2, 6, 9 /.
Therefore, in  our ward a routine ly used new noninvasive laboratory 
method was in it ia te d  to help to solve the mentioned problem. The ro le  of 
haemorheological factors are well-known in  d iffe re n t cardio logica l and 
other vascular diseases /5 , 12, 13, 15/. The rheologica l measurements can 
play an important ro le  in  epidemiological, d if fe re n t ia l diagnostic and 
clinico-pharmacological studies. Our resu lts  suggest that the use of th is  
measurement can be he lp fu l in  th is  d if fe re n t ia l diagnostic problem, too.
The complex evaluation of d iffe re n t tes ts  often poses a serious 
problem because sometimes there are contradictions between them. Our resu lts  
with the application of PRIMA in  d if fe re n t ia l diagnostics ve rify  tha t th is  
method is  useful fo r computer-aided decision in  the c lin ic a l practice and 
is  su itab le  fo r developing expert systems on the basis of new conceptions.
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75 pa tients  w ith Graves' disease (54 w ith  ophthalmopathy) were investiga ted  using 
the tes ts  o f leucocyte adherence in h ib it io n  and immune adsorption w ith  I - la b e lle d  
Staphylococcus Protein A, against human eye muscle "crude" membrane antigen. The re­
s u lts  o f p o s itive  leucocyte adherence in h ib it io n  (10 out of 26 vs. 1 out o f 28, 
P « 0 .0 5 )  and anti-human eye muscle membrane antibody index (mean +_S.D.) (1.89 _+ 1.20 
vs. 0.84 +_ 0.38, P « 0 .0 0 1 ) showed a c o rre la tio n  w ith the patients w ith c l in ic a l ly  ac­
t iv e  eye disease and the HLA-88 antigen in  Graves' ophthalmopathy (P « 0 .0 1 ) .  P os itive  
leucocyte adherence in h ib it io n  was observed in  9 out of 21 cases o f Graves' disease 
w ithout ophthalmopathy, but i t s  prognostic relevance has to  be confirmed in  the devel­
opment o f ophthalmopathy.
Keywords : Leucocyte adherence in h ib it io n ,  antihuman eye nuscle antibody, Graves' 
ophthalmopathy, HLA haplotypes
In t r o d u c t io n
Graves' ophthalmopathy is  an autoimmune disease characterized by c e l l-  
mediated and humoral immune responses against o rb ita l tissue /11, 19, 28/. A 
high frequency of minimal changes in  the eye muscle can be found by u lt ra ­
sonography and computerized tomographic scanning in Graves' disease without 
ophthalmopathy /2 1 /. Early observations showed in  re tro o rb ita l tissues 
receptors capable of binding TSH or i t s  derivatives /33, 34/. Thyroglobulin- 
antithyrog lobu lin  complexes causing a damage in  the human eye muscle were 
also reported /15, 18, 23/. Autoimmune responses against eye muscle antigens 
have been described but i t  is  not known whether the damage re su lts  from
O ffp r in t requests should be sent to  I ld ik ó  Molnár, H-4043 Debrecen, Dorottya u. 2,
Hungary
Akadémiai Kiadó, Budapest
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cell-m ediated immunity, c ircu la tin g  immune complexes or pathogenic a n t i­
bodies /5 , 29, 30/.
Local release of lymphokines by in f i l t r a t in g  ce lls  may also be im­
po rtan t, since these lymphokines may produce many of the well-known patho­
lo g ic a l features of the disease /25 /.
Graves"disease was one of the f i r s t  autoimmune disorders where an as­
soc ia tion  with certa in  HLA haplotypes was reported. The su s c e p tib ility  to 
Graves' ophthalmopathy was strongly associated w ith HLA-B8 haplotypes ra ther 
than w ith  DR3 /7 / .
The aim of our investiga tion  was to  study the role of leucocyte ad­
herence in h ib it io n  (LAI) against human eye muscle membrane antigen and to 
detect the c ircu la tin g  anti-human eye muscle membrane antibody (AEMA index) 
in  Graves' ophthalmopathy. We investigated whether the a c tiv ity  o f the eye 
disease in  Graves' ophthalmopathy influences the cell-mediated and humoral 
immune responses against human eye muscle membrane antigen. F in a lly , we 
wanted to  study the association between the LAI and AEMA index,on the one 
hand,and the HLA haplotypes in  Graves' ophthalmopathy on the other.
P a t ie n ts  and M ethods
F if ty - f iv e  pa tients o f the I l l r d  Dept, o f Medicine of Kenezy's H osp ita l, Debrecen 
(14 males, 61 femalse, from 17 to  77 years (mean age 46 +_ S.D. 13 years), w ith Graves' disease 
were inves tig a te d . F if ty - fo u r  had ophthalmopathy w ith  an average Duration of 6 +_ 2 years. The 
c l in ic a l  diagnosis o f Graves' disease was on the elevated thy ro id  hormone le ve ls , elevated 
th y ro tro ph in  receptor antibodies and d iffuse  hyperplasia o f  the gland on thyro id  scan. Clas­
s if ic a t io n  o f ophthalmopathy was performed according to  the c r i te r ia  o f the American Thyroid 
A ssocia tion /3 1 , 3 2 /. The pa tients  w ith Graves ' disease, who were age- and sex-matched were 
d iv ided in to  two groups based on the presence (group B) o r absence (group A) o f ophthalmo­
pathy. Group A consisted o f 21 pa tien ts : 2 males, 19 females, from 17 to 77 years, mean age 
47 +_ (S .D .) 16 years. Group В consisted o f 54 pa tie n ts : 12 males, 42 females, from 23 to  68 
years, o f  mean age 46 +_ 12 years.
The cell-m ediated immune response against human eye muscle "crude" membrane antigen 
was examined by U r is t ' s leucocyte adherence in h ib it io n  te s t  (LAI te s t)  /2 7 /. There are several 
te s ts  to  de tect cell-m ediated immune responses. Among them the LAI te s t seemed to  be a sensi­
t iv e ,  simple method fo r  using as a rou tine  d iagnostic technigue /4 , 17/. A p o s itive  LAI te s t 
was defined as a value exceeding the upper l im it  o f mean +_ 2 S.D. fo r normal subjects tested 
concurren tly  (-12 .64+^26 .21).
C irc u la tin g  antibodies against human eye musjjg "crude" membrane antigen was tested 
b^ -F a ry n a 's  method using immune adsorption w ith I - la b e lle d  Staphylococcus P rote in  A 
( I-SPA) / 6 / .  The antihuman eye muscle membrane antibody index (AEMA index) was ca lcu la ted 
from data obtained in  the presence o f serum from 25 c o n tro ls . P ositive  te s t was defined as a 
value exceeding th  upper l im i t  o f mean +_ 2 S.D. fo r  normal subjects tested concurrently 
(0.997 + 0 .085).
HLA antigens were studied w ith  lymphocyte c y to to x ic ity  micro-method /2 4 /.
The human eye muscle "crude" membrane antigen was obtained from patients who had not 
su ffe red  from tumour, endocrine or in fe c tio us  diseases w ith in  4-6 h a fte r death. A fte r removal
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o f fa t  and the tendinous parts , the tissue was f in e ly  minced and homogenized. The homogenate 
was centrifuged at 500 x g to  remove debris, and the supernatant was centrifuged a t 3000 x g 
to  obtain the "crude" membrane p e lle t.  The p ro te in  concentration was measured by Lowry's 
method and the concentration 1 mg/ml was used in  the te s t /1 6 /.
A l l  data were analysed by Student's pa ired _t te s t or Welch's d^  te s t ,  and the pro­
portions o f the po s itive  re su lts  by the Chi-square te s t /1 3 /.
R e s u lts
We found a higher frequency of LAI in  group A than in  group B. Nine
out of the 21 in  group A and 11 out of the 54 in  group В were p o s itive  fo r
2 2LAI. A borderline significance was found by the tes t ( j^  = 3.91,
P >-0.05) (F ig. 1).
Elevated AEMA indices were found in  both groups A and В (1.19 +_ 0.48 
and 1.39 +_ 1.05, respectively) (F ig. 2 ). The AEMA index was p o s itive  in  6
□  Negative lai
Positive lai
m opathy m opathy
Graves' d isease
F ig . 1, Leucocyte adherence in h ib it io n  (LAI) against human eye muscle membrane antigen in  
Graves' disease. P os itive  LAI was defined as value >39.78. P ^0 .0 5  by Chi-square te s t
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ophthalm opathy ophtha lm opathy
F ig . 2. The anti-human eye muscle membrane antibody (AEMA) index in  Graves' disease. 
Positive  AEMA index was defined as value >1 .17 . P = N.S. (non-s ign ificant)
P<0.05 □  Negative lai
a c t iv ity  a c tiv ity
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AEMA index
5.0
4.0
P< 0.0001
3.0 -
2.0
1.0
Eye disease 
w ith  
a c tiv ity
-------------------Graves ophthalmopathy
Eye disease 
w ithou t 
a c tiv ity
F ig . 4, The anti-human eye muscle membrane antibody (AEMA) index in  Graves' ophthalmopathy 
w ith the presence and absence o f eye disease a c t iv i t y .  P os itive  AEMA index was defined as 
value > 1 .17 . P <  0.001 by Welch's te s t
cases out of 18 in  group A and 19 out of the AO in  group B. No s ig n if ic a n t
d ifference was found between the two groups.
LAI (F ig. 3) showed a borderline s ign ificance , but the AEMA index
(Fig. A) was found to be s ig n if ic a n tly  higher in  the group with c l in ic a l ly
active eye disease as compared to the group with c lin ic a lly  inac tive  d i-
sease(10 out of 26 vs. 1 out of 28, _)^  ^ = 5.1, P < 0 .0 5  and 1.89^+1.20 vs.
0.8A + 0.38, P -= 0.001 b y j(2 test with Yates' correction and Welch's te s t)
S ign ifican t difference of LAI was observed between HLA-B8+ patients
2 2compared to those who were lacking the antigen (j^ = 8.59, P -<0.01 by ^
test with Yates' correction) (Table I ) .  A borderline significance of AEMA 
index was found between the DR3+ and DR3- patients (P <  0.05 by Welch's d^ 
te s t ) .
< -----------------
F ig . 3. Leucocyte adherence in h ib it io n  (LAI) against human eye muscle membrane antigen in  
Graves' ophthalmopathy w ith the presence and absence o f eye disease a c t iv ity .  P o s itive  LAI 
was defined as value >39.78. P <. 0.05 by Chi-sguare tes t
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Table I
Relationship between the frequences of two HLA antigens and the pos itive  
leucocyte adherence in h ib it io n  or anti-human eye muscle membrane antibody 
index in  Graves' ophthalmopathy
Studied HLA antigens in  
patients w ith  Graves' 
ophthalmopathy
Positive  LAIa AEMA index mean +_ S.O.
HLA-B8+ N = 14 X6 1.80 + 0.95
HLA-B8- N = 24 X1 1.26 + 1.37
DR3+ N = 12 4 XX2.15 + 1.68
DR3- N = 9 0 XX0.91 + 0.37
aa value 1*39.78
X
P < 0 .0 1 , by Chi-square te s t w ith  Yates' co rrec tion
XX
P<0.05, by Welch's ii te s t
D iscu ss io n
Although previous studies showed cell-mediated responses against the 
o rb ita l tissue by the MIF te s t, LAI and te s t fo r  release of leucocyte pro- 
coagulant a c t iv ity  in  Graves' disease, but the ro le  of these changes in  the 
pathogenesis of ophthalmopathy is  s t i l l  questionable /9 , 10/. The incon­
sistencies between the resu lts  obtained w ith the above tests may re f le c t 
d if fe re n t T c e ll functions in  the development of ophthalmopathy /5 / .  In 
ophthalmopathy c irc u la tin g  antibodies against human eye muscle were detected 
by several studies /1 , 14/. The pathogenic ro les of these functions were 
a ttr ib u te d  to antibody-dependent cell-mediated cy to tox ic ity . The antigens 
involved cross-reacted with TSH receptor on fib ro b la s ts  and globulin in  eye 
muscle /2 , 8, 20/.
I t  was shown tha t the MHC class I  antigens on human eye muscle mem­
brane were demonstrated in  Graves' disease, suggesting th e ir ro le  in  the 
development of ophthalmopathy. Positive LAI was more frequently observed in  
patients with HLA-B8 antigen than in  those w ith 0R3 in our cases with 
Graves' ophthalmopathy /3 , 22/. The presence o f these immunologic stigma 
associated with minimal changes in  eye muscle, without c lin ic a l evidence 
ophthalmopathy can be presented by pos itive  LAI. This presumption is  sup­
ported by the fac t that LAI-reactive c e lls  are apparently antigen-specific
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while MIF is  species-specific. The suppression is  correlated w ith  the sup­
pression of adaptive transfer of DTH (delayed T -ce ll hype rsens itiv ity ) /26 /. 
The prognostic value of AEMA and LAI has yet to be confirmed by long-term 
studies. The positive resu lts  of LAI and AEMA index strongly corre la ted with 
the a c t iv ity  of the eye disease, there fore , th is  knowledge may be u tiliz e d  
in  the therapy.
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CORRELATIONS BETWEEN SERUM ALPHA2-HS-GLYCOPROTEIN CONCENTRATION ANO 
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Serum alpha^HS-gLycoprotein (A2HSG) concentrations o f 63 pa tien ts  w ith  systemic 
lupus erythematosus (SLE) were determined, and found to be s ig n if ic a n t ly  low compared 
to  those o f 59 healthy blood donors. The dim inution o f serum A2HSG concentration was 
p roportiona l to  the degree o f a c t iv ity  o f SLE, and was not influenced by secondary in ­
fec tio ns . There was a s ta t is t ic a l ly  s ig n if ic a n t pos itive  c o rre la tio n  between serum 
A2HSG and the C3 complement component le ve ls . A negative co rre la tio n  between serum 
A2HSG and IgG, IgA concentration and anti-DNA a c t iv ity  was observed. Serum A2HSG was 
s ig n if ic a n t ly  low in  cases of pos itive  fo r the fo llow ing  laboratory parameters: a n ti­
nuclear antibodies, c irc u la tin g  immune complexes and LE c e ll phenomenon. We found no 
co rre la tio n  between serum IgM concentration, cryoglobulins, la tex agg lu tina tion  and 
serum A2HSG le ve ls . The unusually good negative co rre la tion  between A2HSG pathogeneti- 
ca l ro le  of th is  g lycoprote in in  SLE. The determination o f A2HSG concentration may be 
o f c l in ic a l importance in  SLE.
Keywords: Alpha^-HS-glycoprotein, systemic lupus erythematosus
A b b re v ia tion s : ALAT: leucine aminotransferase; ANA: antinuclear antibody; ASAT: 
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ENA: extractable nuclear antigen; SLE: systemic lupus erythematosus; VDRL: venereal disease 
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In tro d u c t io n
Alpha2-HS-glycoprotein (A2HSG) is  a g lycoprotein of 49 kd. I t  was 
f i r s t  described by Heremans /11 / and by Schmid and BLirgi /2 7 /. The terminal 
amino acid and the antigen ic id e n tity  of the proteins isolated by these two 
groups of authors was demonstrated by Schultze /2 8 /, who proposed the current 
name of th is  glycoprotein according to the discoverers' in i t ia ls  (H .S.).
Although many properties of A2HSG have been described, i t s  b io log ica l 
ro le  is  s t i l l  unclear. I t  accumulates in  highly mineralized tissues, such as 
bone and dentin. Besides albumin, A2HSG is  one of the major constituents of 
the non-collagenous bone matrix /9 , 30/. I t  may play a ro le  both in  bone 
m inera lization and resorp tion  /5 , 9, 20, 21/. I t s  serum concentration de­
creases in patients w ith Paget's disease of bone /2 / ,  in  those of prote in- 
energy m alnutrition /1 , 26/ and in the hypercalcaemia of m ultip le myeloma 
/ 6 / .  A2HSG is  produced by the liv e r  /30 /. I ts  serum leve l is  decreased in 
a lcoho lic  c irrhos is  of the l iv e r  /12 /. A2HSG is  a negative acute-phase re­
actan t, i t s  plasma concentration decreases in  severe bacteria l in fec tion , 
trauma, some so lid  tumours and myocardial in fa rc tio n  /3 , 4, 14, 25, 29/.
The role of A2HSG in  the defensive mechanism o f the organism has also 
been suggested. Besides opsonic properties A2HSG can increase the phago­
c y t ic  function of human neutrophil granulocytes and monocytes /17, 24/. I t  
binds to Epstein-Вагг v iru s  transformed lymphocytes, thus i t  may play a ro le  
in  the elim ination of these c e lls  /18 /. A2HSG can a ffe c t the lymphocyte pro­
l i fe ra t io n  response in  healthy individuals /19 / and in  patients with lung 
and neck tumours /3 , 4, 7 /.
Apart from one report debating the b io lo g ica l ro le  of A2HSG in  rheu­
matoid a r th r it is  /2 3 /, the behaviour of i t s  serum concentration in auto­
immune disorders has not been studied. Therefore, having p u rifie d  A2HSG
from human serum, we determined the serum concentration of th is  glycoprotein
in  patients with systemic lupus erythematosus (SLE). We correlated these 
values to the a c t iv ity ,  and c lin ic a l course of the disease, and some lab­
ora to ry parameters conventionally measured in  patien ts with th is  disease.
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P a t ie n ts  and Methods
Patien ts. We determined the A2HSG concentration in  265 serum samples from 63 patients 
w ith SLE (59 females, 4 males, aged 43.2 +_ 10.0 years, x + S.O.) and tha t o f 108 serum samples 
from healthy con tro ls  (32 females, 27 males, aged 40.4 10.5 years, x t  S .D .). The diagnosis
o f SLE was based on the ARA c r i te r ia .  The SLE was considered active  when antinuclear a n ti­
bodies (ANA) and c irc u la tin g  immune complexes (CIC) could be detected, the serum concentration 
of the complement component C3 was less than 0.9 g/1 and the anti-DNA a c t iv ity  exceeded 25 
IU/m l. Patients were given prednisolone (Prednisolone, 0-120 mg d a ily ,  o ra lly )  and/or azathio­
prine (Imuran, 0-50 mg/d, o ra l ly ) ,  depending on the a c t iv ity  o f the disease.
Preparation o f A2HSG. A2HSG was iso lated from pooled human serum by the method of 
Matsushima et a l.  /2 2 /,  w ith  some m odifications. In  b r ie f ,  human serum was p rec ip ita ted  by 
ammonium sulphate (37%), and the p rec ip ita te  was p u rif ie d  in  the fo llow ing  steps: DEAE- 
Sephadex A 50 (Pharmacia, Uppsala) and DEAE-cellulose (Reanal, Budapest) ion-exchange chromato­
graphy, gel f i l t r a t io n  on Sephadex G 200 (Pharmacia) column, hydroxylapatite  adsorption 
chromatography (Bio-Gel HTP, Bio-Rad, Richmond) and Blue Sepharose CL-6B (Pharmacia) a f f in i t y  
chromatography.
The p u rity  o f the iso la ted  A2HSG was determined by SDS-PAGE /8 /  and crossed imrnuno- 
e lectrophoresis. The former was done in  acrylamide gel ( to ta l ge l: 7.5%, running ge l: 5% 
acrylamide) s ta in ing  w ith Amidoschwarz. The la t te r  was made in  1% L itex  agarose ge l, on 5x5 cm 
s lid e  glasses. Two u l o f A2HSG preparation was used as antigen and 60 y j l  o f polyvalent horse 
anti-human antiserum (Human, Budapest) and 60 u l o f monospecific rab b it anti-A2HSG antiserum 
(Behringwerke) were used as antibody. The electrophoresis was done in  Veronal-Na-Veronal 
bu ffe r (pH 8.6) at 10 V/cm fo r  1 h in  the f i r s t  d ire c tio n  and a t 1 V/cm, fo r  16 h in  the 
second d ire c tio n . The preparations were stained w ith Amidoschwarz. The crossed electrophoresis 
of our A2HSG preparation gave only one p re c ip ita tio n  lin e  against anti-human polyvalent horse 
serum, vrfiich was id e n tif ie d  by monospecific rabb it anti-human A2HSG antiserum. Our A2HSG pre­
paration proved to  be homogeneous on SDS-PAGE, too.
The determination o f serum A2HSG concentration. The serum le ve l o f A2HSG was deter­
mined by electroimmunodiffusion /1 5 / in  1% Litex agarose ge l on 5x5 cm s lid e  glasses. Twoyul of 
serum was used as antigen and 60 yul o f monospecific ra b b it anti-human A2HSG antiserum' (0.7 
g/1; Behringwerke) incorporated in  the gel were used as antibody. We used our p u rif ie d  A2HSG 
in  d iffe re n t concentrations (0 .2 , 0 .4 , 0.6 and 0.8 g/1) as standard. The e lectrophoresis was 
made in  Veronal-Na-Veronal b u ffe r (pH 8.6) at 1 V/cm fo r 16 h. The preparations were stained 
w ith Amidoschwarz.
Other laboratory determ inations. CIC was determined by p re c ip ita tio n  (4% PEG 6000), 
cryoglobulins were detected by the conventional method (incubation a t 4 C fo r 24 h ). In  the 
ANA and la tex agg lu tina tion  te s ts  the appropriate k its  were used (Sevac and Human, respect­
iv e ly ) .  The LE c e ll phenomenon was detected a fte r  destroying granulocytes mechanically in  
heparinized samples. The determ ination of serum concentrations o f C3, IgA, IgG and IgM was 
made by ra d ia l immunodiffusion (Hyland monospecific antisera  to  C3 and Human antisera to 
immunoglobulins). Serum anti-DNA a c t iv ity  was measured by radioimmunoassay k i t s  (Amersham). 
The serum b il ir u b in  concentration was measured by the diazo reaction . ASAT and ALAT a c t iv i­
t ie s  were determined k in e t ic a lly  (Boehringer). A lka line  phosphatase and prothrombin a c t iv i­
t ie s  were measured by the method o f King and Armstrong and the S inp las tin  te s t,  respective ly .
The s ta t is t ic a l analysis was done w ith S tudent's and paired Student's te s t.
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R e s u lts
The serum A2HSG concentration of the healthy controls is  shown in 
Table I .  We found neither sex differences nor age varia tions among the serum 
A2HSG values of contro ls. The serum A2HSG concentration of patients with SLE 
was s ig n if ic a n tly  lower than that of the controls (F ig. 1). The serum A2HSG 
le v e l o f patients with ac tive  SLE was fu rthe r reduced, compared both to 
con tro ls  and to that of the inactive  SLE group. During the 1-25 year c l in i ­
ca l fo llow-up we observed remission and exacerbation of SLE in  15 and 16 
cases, respectively. Compared to the previous values, we found a s ig n ifica n t 
increment of serum A2HSG concentration during remission and a decrement 
during exacerbation of the disease (Table I I ) .  The serum A2HSG concen­
tra t io n s  of patients w ith permanently active disease hardly d iffe re d  from 
each other, and were sub s ta n tia lly  low during s e ria l determinations. On the 
other hand, the serum leve ls  of patients with permanently inactive  disease 
were much higher, showing no s ig n ifica n t change during s e ria l determi­
nations.
Table I
Serum A2HSG concentration o f healthy in d iv id u a ls  o f d if fe re n t age (g /1 )
Age
( y e a rs )
n A2HSG 
X +_ S . D .
11 -  20 6 0.671 + 0.07
21 -  30 12 0.745 + 0.06
31 -  40 20 0.694 + 0.09
41 -  50 10 0.701 + 0.08
51 -  60 7 0.675 + 0.09
61 -  70 2 0.692 + 0.06
to ta ls 59
n = number o f healthy c o n tro ls
Secondary in fec tions  (usually of pulmonary and urogenita l o rig in ) 
were observed in 16 pa tien ts . The serum A2HSG concentrations of these pa­
t ie n ts  did not d if fe r  from the values of the patients without secondary in ­
fe c tio n  (F ig. 2). The d iffe rence  between the groups of active and inactive 
disease dominated over the changes observed during in fec tion  in  both the 
ac tive  and the inactive groups of patients.
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C ontro ls SLE SLE SLE 
to ta l active  inactive
A2HSG: c* -H S -g lycop ro te in  
SLE: Systemic lupus erythem atosus
F ig . 1, Serum A2HSG concentrations (x +^S.D.) o f healthy con tro ls  (empty bars) and o f 
pa tients with SLE (a c tiv e  SLE : ///!//, inactive  SLE SLE to ta ls : f i l l e d  ba rs).
The number o f observations are represented by the figu res w ith in each bar.
них = P <0 .001
Correlating some conventional laboratory parameters measured in  SLE 
to serum A2HSG leve ls , the serum A2HSG concentration of ANA-positive and 
that of CIC-positive patients were s ig n if ic a n tly  lower than those of the 
ANA- or CIC-negative ones (F ig. 3). This could have been expected from the 
a c t iv ity  c r ite r ia  of SLE mentioned above. However, the serum A2HSG concen­
tra tio n  was s ig n if ic a n tly  reduced in  LE c e ll pos itive  patients compared to 
negative ones. The serum A2HSG concentration did not decrease e ith e r in  
cryog lobulin -positive or in  la tex-pos itive  patien ts s ig n ifica n tly .
On the other hand, we found a s ta t is t ic a l ly  s ign ifican t pos itive  cor­
re la tion  between serum A2HSG concentration and serum C3 (Table I I I ) .  We ob-
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0 .7 0  
0 .65  
0 .6 0  
0  55 
0 .5 0  
0 .4 5  
0 .4 0  
0. 35
A2HSG 
(g / i )
* я *
I-------------------
0 .0 5  -
О --
A c tive  SLE
A2HSG: o<2 - HS-glycoprote in  
SLE: Systemic lupus e ry them atosus 
NS: Not significant d iffe rence
F ig . 2. Serum A2HSG concentrations (x + S.D.) o f SLE pa tients  with ( f i l le d  bars) and 
w ithou t (empty bars) in fe c tio u s  complication. The numbers o f observations are shown 
w ith in  each bar. x = P-< 0.05; xxx = P<Í0.001
Table I I
Serum A2HSG concentration as a function o f the c l in ic a l  course of SLE (g /1 )
A2HSG P
x + S.D.
no change in a c t iv ity :
permanently active 9/34* 0.479 + 0.10 XXX
permanently inactive 23/91 0.620 + 0.10
changes in  a c t iv ity :  
exacerbation 15/30 0.476 + 0.06 X X X
remission 16/32 0.605 + 0.08 X X X
Number of patients per number observations. xxx = P 0.001, compared to  inac­
t iv e  status in  permanently ac tive  and exacerbation group, and to active  sta tus 
in  the remission group.
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A2H5G
( g / i  )
0. 70 
0 .6 5  
0 .6 0  
0. 55 
0. 50 
0 .A 5  - 
0. Д0 
0 .3 5
0 .0 5  I  
0
* * * * * NS
ANA
171/5А
CIC
102/92
LE
111/32
CRYO 
170 !U2
LTX
110/62
A2HSG : <*2 -  HS-glycoprote in
ANA: Antinuclear antibody
CIC: C ircu lating immune complex
LE . Le cell phenomenon
CRYO: Cryoglobulin
LTX : Latex agg lu tina tion
NS : Not s ig n ific a n t d ifference
F ig . 3. Correlations between serum A2HSG concentration (x +_ S.D.) and the presence o f a n ti­
nuclear antibody (ANA), c irc u la tin g  immune complexes (CIC), LE c e ll phenomenon (L E ), cryo­
g lobu lins  (CRYO) and the la tex agg lu tina tion  te s t (LTX). Positive and negative values are 
represented by f i l le d  and empty bars, resp e c tive ly . The numbers o f observations o f negative 
and pos itive  values are shown before and a f te r  slashes under each bar, re s p e c tiv e ly , 
x = P < 0 .0 5 ; XX = P < 0 .0 2 5 ; xxx = P <  0.001; NS = not s ig n ific a n t d iffe re n ce
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Table I I I
Correlation between serum A2H5G levels (q /1 ; x — S.D .) serum C3. IgA. IgG, IaM 
concentrations (g /1 : x - S .D . )  and anti-DNA a c t iv i t y  (IU/ml) 
in  SLE
n regression curve parameters Г Р
C3 254 y = 0.096X + 444.7 0.274 * К К
IgA 178 y = -0.168X + 606.2 -0.255 к # #
IgG 178 y = -О.ОбОх +  648.6 -0.364 # # #
IgM 178 у =  -О.Юбх +  576.0 -0.118 NS
anti-DNA 95 у =  -1.067X +  617.0 -0.547 К * *
n = nuntier o f observa tions; г  = regression c o e ff ic ie n t ;  
P <0 .001 ; NS = not s ig n if ic a n t
served a s ta t is t ic a lly  negative correlation between serum A2HSG levels and 
serum IgA and IgG. S im ila r corre lation was not found with IgM. We detected 
an especially good negative correlation between serum A2HSG level and serum 
anti-DNA a c tiv ity .
Retrospectively, we tr ie d  to find co rre la tio n  between some types of 
autoantibodies and serum A2HSG concentration. The VDRL test was negative in  
each o f our patients stud ied . C irculating lupus anticoagulant a c tiv ity  was 
demonstrated in 3 cases. The serum A2HSG leve ls  o f patients showing th is  
a c t iv i ty  did not d if fe r  from those of without i t .  Immunofluorescence methods 
fo r  antibodies against mitochondria, smooth muscle and extractable nuclear 
antigen (ENA) were done only fo r d if fe re n t ia l diagnostic purposes (a l­
together 5 patien ts). A l l  proved negative. Nine patients proved Coombs­
p o s itiv e . However, the serum A2HSG concentration o f Coombs-positive SLE 
pa tien ts  was reduced only when c lin ic a l and se ro log ica l a c tiv ity  could also 
be demonstrated (data not shown).
D iscussion
We separated A2HSG from human serum and used our preparation fo r the 
determination of serum A2HSG concentration successfu lly in  the present work. 
In contrast to Dickson e t a l ., who reported a progressive age-related de­
crease of serum A2HSG (from  0.74 to 0.64 g/1) in  167 healthy women /1 0 /, we 
found neither age- nor sex-related differences between the 32 female and 27 
male controls we studied.
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The serum A2HSG concentrations of patients with SLE were reduced s ig ­
n if ic a n t ly  compared to healthy contro ls. Low serum A2HSG levels can be due 
to decreased production, increased consumption or e lim ination. A2HSG is  
produced by the liv e r  /30 /. We fa ile d  to  observe any corre la tion  between 
serum A2HSG concentration and the enlargement of the liv e r  or hepatic func­
tio n  tests  (serum b il iru b in  concentration, ASAT, ALAT, alkaline phosphatase 
and prothrombin a c t iv ity )  in  our patien ts. Increased urinary loss also seems 
u n like ly , even in  patients with lupus n e p h ritis  /13 /.
The e ffec t of prednisolone and azathioprine treatment on serum A2HSG 
leve ls cannot be excluded in  th is  study. We could not find any re lia b le  d i f ­
ference among the serum A2HSG concentrations of our patients because of the 
small number of untreated cases expressing a c t iv ity .  However, the serum 
A2HSG concentration of these few patients did not d if fe r  from th a t of the 
treated cases. Corticosteroid treatment resulted in  an increase o f serum 
A2HSG leve ls in  hypercalcaemic patients w ith m ultip le  myeloma /6 / .
Thus, we th ink that diminished serum A2HSG levels are due ra ther to 
increased consumption than to any other cause in  SLE. This is  supported by 
the negative corre la tion  between serum A2HSG leve l and anti-DNA a c t iv ity ,  
which seems very strong compared to the other laboratory parameters used 
in  th is  work. A2HSG has been suggested to bind to DNA /16 /. I t  is  well-known 
tha t a large amount of native DNA is  released in to  the c ircu la tio n  as a con­
sequence of nuclear damage caused by autoantibodies; th is  process can in ­
duce a fu rthe r increase in the anti-DNA a c t iv ity  of the serum. The binding 
of serum A2HSG to native DNA could counteract th is  process. Moreover, A2HSG 
could play a ro le  in  the elim ination of native DNA or DNA-containing immune 
complexes from c ircu la tio n  by enhancing phagocytosis.
Although the presence of autoantibodies against glycoproteins is  un­
usual in  SLE, the occurrence of anti-A2HSG antibodies could provide another 
basis fo r the reduction of serum levels o f th is  glycoprotein. Unfortunately, 
we could not investigate the presence of such antibodies because of the 
small amount of isolated A2HSG. We th ink th is  question needs fu rth e r evalu­
a tion . We could not establish any re la tionsh ip  between serum A2HSG concen­
tra tio n  and other nonspecific autoantibodies (those against c a rd io lip in , 
blood coagulation factors, ENA, mitochondria, smooth muscle c e lls  and 
erythrocyte membrane).
Lebreton et a l.  reported a f a l l  of serum A2HSG levels in  patients 
with in fec tion  /1 4 /. However, we could not fin d  s ig n ifica n t reduction of 
serum A2HSG in  patients with secondary in fec tions . This d ifference can be
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a ttr ib u te d  to that the secondary in fections observed in  our patients were 
less severe than those they reported on (e .g . Staphylococcus or Pseudomonas- 
speticaemia a fte r burns or osteom yelities). Furthermore, the blood samples 
we investigated were taken from patients who had already been treated w ith 
broad-spectrum a n tib io t ic s .
Our data show tha t there is  a considerable corre lation between serum 
A2HSG leve l and the a c t iv ity  of SLE. This is  supported by the d ifference be­
tween the serum leve ls o f patients in the active  phase and those in  the in ­
active  phase of SLE and the a lte ra tion  of serum A2HSG concentration during 
the long-term fo llow-up. The variation of serum A2HSG concentration in d i­
cated well the change o f disease a c t iv ity  both in  relapse and remission. 
Since the behaviour of serum A2HSG has not been studied extensively in  
autoimmune diseases, the s p e c if ic ity  of th is  parameter cannot be determined 
ye t. In our practice ANA, and, especially, anti-DNA a c tiv ity  seem to be the 
most pred ictive among the conventional laboratory parameters in  SLE. Since 
these parameters show the strongest co rre la tion  with serum A2HSG leve ls , we 
assume tha t the la t te r  parameter may also be highly pred ictive. This is  
supported by the fa c t tha t serum A2HSG concentration was consequently less 
than 0.69 g/1 (average o f healthy contro ls) in  samples showing anti-DNA 
a c t iv i ty  higher than 25 IU/ml (c r ite r io n  of SLE a c t iv ity ) .  On the basis of 
our observations, the determination of serum A2HSG may have c l in ic a l im­
portance.
Acknowledgement
We thank Miss M. Németh, Mrs. D. Csömör and Mrs. V. M. Nagy fo r s k ille d  techn ica l as­
s is tance . This work was supported by the grant Eü. Min-MTA OTKA No. 161.
REFERENCES
1. Abidoun, P.O., Ihongbe, J .C ., D a ti, F .: Decreased le ve ls  of alpha HS g lycoprote in  in  
ch ild ren  w ith p ro te in -energy-m a lnu trition . Eur. J . P ed ia t. 144. 368-369 (1985)
2. Asthon, B ., Smith, R .: Plasma oC -HS-glycoprotein concentration in  Paget's disease o f bone: 
i t s  possible s ign ifica n ce . C lin . Sei. 58, 435-438 (1980)
3. Baskies, A.M., Chretien, P .B ., Weiss, 3 .F ., Makuch, R.W., Beveridge, R.A., Catalona, A.B. 
W .J., Spiegel, H .E.: Serum glycoproteins in  cancer p a tie n ts : F irs t report o f co rre la tio n s  
w ith  in  v it ro  and in  v ivo parameters of c e llu la r  immunity. Cancer 45  ^ 3050-3060 (1980)
4. Bradley, W.P., Blasco, A .P ., Weiss, 3 .F ., Alexander, 3 .C ., O r., Silverman, N.A., Chretien, 
P .B .: Corre lations among serum protein-bound carbohydrates, serum glycoproteins, lymphocyte
SERUM ALPHA 2-HS-GLYCOPROTEIN IN  SLE 63
re a c t iv ity ,  and tumour burden in  cancer pa tien ts . Cancer 4Ю, 2264-2272 (1977)
5. Colclasure, G.C., Lloyd, W.S., Lamkin, M., Gonnermann, W., T rox le r, R .F., O ffner, G.O., 
Bürgi, W., Schmid, K ., Nimberg, R.B.: Human serum cO -HS glycoprotein modulates in  v it ro  
bone resorption. 0. C lin . Endocrinol. Metab. 66, 187-Í92 (1988)
6 . Crawford, S.M.: Alpha-2 HS glycoprotein in  the hypercalcemia o f m ultip le  myeloma. Sr. 3. 
Cancer 49, 813-815 (1984)
7. C m ic, D.M., Weiss, J .F .,  Chretien, P.B.: Corre lations among serum g lycopro te ins, in  v it ro  
lymphocyte re a c t iv ity  to  phytohemagglutinin, 1 c e ll le ve ls  and tumour burden in  pa tients 
w ith head and neck squamous carcinomas. Proc. Am. Assoc. Cancer Res. 155 (1977)
8 . Davis, 0 .3 ., O rste in, L . :  Methods in  Immunology and Immunochemistry, Vol. I I .  ed. W il­
liam s, Chase 1969, p. 38
9. Dickson, I .R .,  Poole, A .R ., Veis, A.: Loca lisa tion  o f plasma oOj-HS g lycopro te in  in  
m inera liz ing human bone. Nature 256, 430-432 (1975)
10. Dickson, I .R . ,  Bagga, M., Paterson, C.R.: V aria tions in  the serum concentration and urine 
excretion o f ^"HS-glycoprotein, a bone-related p ro te in  in  normal in d iv id u a ls  and in  pa­
t ie n ts  with osteogenesis imperfecta. C a lc if. Tissue In t .  35, 16-20 (1983)
11. Heremans, 3 .F .: Les Globulines Sériques du Système Gamma. (Arscia, Bruxelles and Masson, 
P a ris ), 1960, pp. 103-105
12. Jezequel, M., Seta, N .S., Corbie, M.M., Feger, 3.M., Durand, G.M.: M od ifica tions o f соп- 
canavalin A patterns of cC -l-ac id  glycoprotein and &-2-HS glycoprotein in  a lco h o lic  l iv e r  
disease. C lin . Chim. Acta 176, 49-58 (1988)
13. Kishore, 8 .K., Gejyo, F .,  Arakawa, M.: Alpha -HS-glycoprotein in  the serum and urine of 
patients with renal diseases. Postgrad. Med. J. 59, 304-307 (1983)
14. Lebreton, 3.P ., Jo is e l, F .,  Raoult, 3 .P ., Lannuzel, B ., Rogez, J .P ., Humbert, G.: Serum 
concentration of human alpha„-HS-glycoprotein during the inflammatory process. 3. C lin . 
Invest. 64, 1118-1129 (1979) L
15. L a u re ll, C.B.: Q uantita tive  estimation of p ro te ins by electrophoresis in  agarose gel con­
ta in in g  antibodies. Anal. Biochem. 13, 45-52 (1966)
16. Lewis, 3.G., André, C.M.: A serum DNA-binding p ro te in  absent in  malignant disease. FEBS 
L e tt. 92, 211-213 (1978)
17. Lewis, 3.G., André, C.M.: Enhancement of human monocyte phagocytic function  by dC^-HS- 
g lycoprote in. Immunology 42, 481-487 (1981)
18. Lewis, 3.G., C rosier, P .S ., André, C.M.: об -HS-glycoprotein binds to lymphocytes trans­
formed by Epstein-Вагг v iru s . FEBS L e tt. 138, 37-39 (1982)
19. Lewis, 3.G., André, C.M.: The e ffe c t o f 0G„-HS-glycoprotein on lymphocyte r e a c t iv ity  to 
phytohemagglutinin. Immunol. Commun. 13, 35-Í7 (1984)
20. Malone, 3 .D ., îe ite lbaum , S .L ., G r if f in ,  G .L ., Senior, R.M., Kahn, A .3 .: Recruitment of 
osteoclast precursors by p u rif ie d  bone matrix constituen ts. 3. C e ll. B io l.  82, 227-230
(1982)
21. Malone, 3.D ., Richards, M.: £</-HS-glycoprotein is  chemotactic fo r mononuclear phagocytes. 
3. C e ll. Physiol. 0 2 ,  118-225^(1987)
22. Matsushima, K., Cheng, M., M ig ita , S.: P u r if ic a tio n  and physiocochemical characte riza tion  
o f human có^-HS-glycoprotein. Biochim. Biophys. Acta 21> 200-205 (1982)
23. №>uyi-Muamba, 3.M., Dequeker, 3 ., Stevens, E .: Alpha^-HS-glycoprotéine dans l 'a r t h r i t ie  
rheumatoide. Sa concentration plasmatique e t son rô le  biologique possible. Rev. Rhum. Mal. 
O steoartic. 49, 515-518 (1982)
64 KALABAY, L . e t  a l .
24. van Oss, C.O., Gilman, C .F ., Bronson, P.M., Border, O.R.: Opsonic properties o f human 
serum alpha-2-HS-glycoprotein. Immunol. Commun. 3_, 329-335 (1974)
25. van Oss, C .J., Bronson, P.M ., Border, O.R.: Changes in  the serum alpha g lycoprote in  d is ­
t r ib u t io n  in  trauma p a tie n ts . 1. Trauma J3, 451-455 (1975)
26. Schelp, F.P., Thanangkul, 0 . ,  Supawan, V ., Pangpaew, P .: CO_-HS-glycoprotein serum leve ls  
in  protein-energy m a ln u tr it io n . B r i t .  0. Nutr. 43^ , 381-385 (1980)
27. Schmid, K ., Bürgi, W.: Preparation and properties o f the human plasma Ba-alpha-w-glyco- 
p ro te in . Biochim. Biophys. Acta 47, 440-453 (1961)
28. Schultze, H.E., Heide, К . ,  Haupt, H.: Charakterisierung eines niedermolekularen 00^~ 
Mukoids aus Humanserum. Naturwiss. 49^ , 15 (1962)
29. Snyder, S., Durham, B.C ., Iskandrian, A.S., Coodley, E .L ., L inha rt, O.W.: Serum lip id s  and 
glycoproteins in  acute myocardial in fa rc tio n . Am. Heart 0. 90, 582-586 (1975)
30. T r i f f i t t ,  O.T., Gebauer, U ., Asthon, B.A., Owen, M .E., Reynolds, 0 .0 .: O rig in  o f plasma 
O^-HS-glycoprotein and i t s  accumulation in bone. Nature 262, 226-227 (1976)
Acta Medica Hungarica, Vol. 47/1-2, pp. 65-76 (1990)
T-LYMPHGCYTE SUBGROUPS AND THE ACTIVITY OF HUMAN NATURAL KILLER (HNK) 
CELLS IN  LOW-GRADE AND HIGH-GRADE MALIGNANT CASES OF NON-HOOGKIN LYMPHOMA
T . BURGER, M ATILD SCHMELCZER, LENKE MOLNÁR, G y. F Á B IÁ N , 
ADÉL SZABÚ, ESZTER TÓVÁRI
2nd D epartm ent o f M e d ic in e , U n iv e r s i ty  M e d ica l S choo l, Pécs, H ungary 
(R e ce ive d : O ctobe r 2 , 1989)
T-lymphocyte subgroups and the percentage and a c t iv ity  o f Human N a tu ra l K i l le r  
(HNK) c e lls  were investigated in  24 pa tien ts  su ffe ring  from low-grade and 24 pa tients  
w ith high-grade malignancies o f non-Hodgkin lymphoma (NHL). T he^ ja tio  o f  CD3, CD4, 
Leu-7, and HNK c e lls  as w e ll as the release by HNK c e lls  of the Cr bound to  ta rge t 
c e lls  were found decreased, depending on the pathologica l stage. The te s ts  were per­
formed w ith OKT-monoclonal sera. A s ig n if ic a n t change was observed in  the re a c t iv ity  
o f bone marrow c e lls  to  monoclonal sera; the change was iden tica l in  characte r w ith 
tha t observed when lymphocytes iso la ted from the peripheral blood were used in  the 
same te s ts . No s ig n if ic a n t changes could be observed in  the qua n tita tive  re la t io n s  of 
imnunoglobulins. Such changes could by no means be expected, on the basis o f the un­
changed number o f T-suppressor lymphocytes (COB). As to the supposed immunological 
re la tio n  in  d e ta il,  the ro le  o f a plasma fa c to r th a t reduces T-lymphocyte form ation is  
assumed to  have primary importance in  th is  phenomenon.
Keywords : Non-Hodgkin lymphoma, T-lymphocyte subgroups, k i l le r -C e l ls ,  monoclonal 
an tibod ies.
Abbreviations: CC: cen tro cy tic ; CB: ce n tro b la s tic ; HNK: human natura l k i l l e r ;  MABs: 
monoclonal antibod ies; NHL: non-Hodgkin lymphoma
O ffp r in t requests should be sent to : T. Burger, H-7621 Pécs, Bern u. 3, Hungary
Akadémiai K ia d ó , Budapest
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In tro d u c t io n
Non-Hodgkin lymphoma (NHL) is  a he te rog en eou s  group o f lym pho id  neo­
p lasm s showing w ide h i s t o lo g ic a l  and c y to m o rp h o lo g ic a l v a r ia t io n .  The d i f ­
fe re n c e s  in  im m u n o lo g ic a l phenotypes are s ig n i f i c a n t ,  and d is o rd e rs  o f  th e  
immune system fa v o u r  th e  developm ent o f  NHL /1 7 ,  21 , 2 8 /.  The damaged con­
d i t i o n  o f the  immune sys te m  shows d i f f e r e n t  d e g re e s , the  accompanying im ­
mune s ta tu s  and i t s  de ve lopm e n t are p o o r ly  know n, and the  pa thog en es is  i s  
f a r  from  be ing c le a r .  S tu d ie s  on t h is  p rob lem  have g ive n  an accoun t o f  an 
in c re a s e d  В lym phocyte  le v e l  assoc ia ted  w ith  a s im u lta n e o u s  re d u c t io n  o f  T - 
c e l l  c o u n t, and o f  a d is tu r b e d  c e l lu la r  a c t i v i t y  r e la te d  to  th e  fu n c t io n  o f  
th e  immune system . T he re  a re  l i t e r a r y  da ta  on q u a n t i ta t iv e  changes in  th e  
r a t i o s  o f  T -lym phocyte  sub g ro ups , and a l l  t h i s  shows correspondence to  th e  
h is t o lo g ic a l ,  typ e  and th e  p a th o lo g ic a l s ta g e  / 1 5 ,  16, 1 8 /. The a c t i v i t y  o f  
human n a tu ra l k i l l e r  (HNK) c e l ls  in  NHL and in  d i f f e r e n t  h is to lo g ic a l  ty p e s  
de se rve s  s p e c ia l a t t e n t i o n  / 1 3 / .
The c la s s i f i c a t io n  in  terms o f h i s t o lo g ic a l  type  acco rd in g  to  th e  
s o - c a l le d  " K ie ls "  s y s te m , a system, in tro d u c e d  n e a r ly  20 years ago /2 1 ,  2 9 / 
has re ve a le d  th a t  th e  c e n t r o b la s t ic  and c e n t r o c y t ic  p a th o lo g ic a l p ic tu r e s  
o r ig in a t e  from  В c e l l s ,  whereas those w ith  t y p i c a l l y  con vo lu ted  and m u l t i -  
lo b u la te d  T - c e l l  lymphomas a re  lo ca ted  in  th e  c o r t i c a l  substance o f  lymph 
nodes. An im m u no log ica l c h a ra c te r iz a t io n  o f  th e s e  c e l ls  may f a i l .  The i n t r o ­
d u c t io n  o f m onoclona l a n t ib o d ie s  (MABs) in  d e te rm in in g  the  phenotypes o f  
NHL has been ve ry  h e lp f u l  / 1 ,  14, 20, 2 4 /.
The aim o f  t h i s  r e p o r t  was to  in v e s t ig a te  th o se  changes in  p a t ie n ts  
w i th  d i f f e r e n t  p a th o lo g ic a l  stages o f NHL, w h ic h  can be d e te c te d  in  th e  
p e r ip h e r a l b lood and th e  bone marrow w ith  MABs. The s ta g in g  system th a t  has 
been s u ita b le  in  c h ro n ic  lym pho id  leukaem ias as im proved by B in e t e t  a l .  / 2 /  
c a n n o t be a p p lie d  in  NHL because o f s ig n i f i c a n t  d if fe re n c e s  in  th e  p a th o ­
g e n e s is  o f t h is  d is e a s e . G e n e ra lly  th e  Ann A rb o r  s ta g in g  / 7 /  in  H odgkin 
d is e a s e  is  a p p lie d  in  NHL, though, even t h i s  can be f a l l i b l e .  The a c t i v i t y  
o f  p e r ip h e ra l b loo d  and bone marrow c e l ls ,  w h ic h  d i f f e r e d  from  norm al when 
te s te d  w ith  MAB, can a d e q u a te ly  supplement th e  ju d g in g  o f th e  p a th o lo g ic a l 
s ta g e .
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P a t ie n ts  and Methods
Tkent y -fou r low grade (CC-CB) and 24 high grade (CB) pa tients  were included in  th is  
study. The patients were tested p a rt ly  p r io r  to  the beginning o f treatment, p a rt ly  before i t s  
con tinua tion . In  addition to  the usual haematological te s tin g , the immunoglobulin leve ls  as 
w e ll as the lymphocyte subgroups were determined in  the blood and in  a pa rt o f the pa tients , 
in  the bone-marrow asp ira te . The fo llow ing  monoclonal sera were used: ORTHO-Pharmaceutical 
Corp., New Jersey: 0KT3, 0KT4, 0KT8 and Becton-Oickinson, U.S.A.: Leu-7. D e ta ils  o f the tests 
were reported elsewhere /5 / .  In  a part o f the patients the a c t iv ity  o f na tu ra l k i l l e r  c e lls  
was determined in both pa tho log ica l groups as practised by Stephenson e t a l.  /1 5 /.
For pathological te s ts  bone-marrow biopsy (spina il ia c a  post, sup.) was performed with 
Jamshidi needle. Evaluation was made p a r t ia lly  from aspirate smears using May-Griinwald' s 
s ta in . S im ila rly  to  tes ts  o f periphera l blood, lymphocytes were iso la ted  from the asp ira te , 
and the percentages o f lymphocyte subgroups were determined w ith MAB-sera.
The pathological te s ts  were based on examination o f the removed lymph node, spleen, 
stomach, or bowel. These inves tiga tions  were performed in  the In s t itu te  o f Pathology, Univer­
s i t y  Medical School, Pécs. For th is  valuable help, we express our thanks here. The K ie l c las­
s if ic a t io n  was used.
A ll o f our NHL pa tients  had В-c e l l tumours.The group of low-grade malignancies as well 
as that of high-grade malignancies contained 24 pa tien ts . The ra t io  o f males to  females war 
14/10 and 13/11, respective ly . The d is tr ib u tio n  by stage of disease was as fo llow s: ( i )  low- 
grade malignancy (CC-CB): I —I I t  12, I I I - IV :  13; ( i i )  high-grade malignancy (CB): I - I I :  10, 
I I I - I V :  14 patients. In  the group o f low-grade malignancy: lymphoplasmacytic: 1, centro- 
b la s tic -c e n tro c y tic , f o l l ic u la r :  11, d iffu se : 11, cen trocy tic : 1. In  the group o f high-grade 
malignancy; immunoblastic: 3, ce n tro b la s tic : 1, B u rk it t 's  lymphoma: 2, lymphoblastic: 4, not 
c la s s if ia b le : 4. (In  the fo llo w in g , the designations CC-CB and CB w i l l  be used.) The treatment 
o f patients in the group o f low-grade malignancies was carried  out according to the MOP pat­
te rn , vdiereas in  tha t of high-grade malignancies i t  was performed according to the "PROMACE" 
and "OVER 50" patterns, a lte rn a tin g  w ith MOP. I t  is  not the purpose of the present paper to 
give an account of the re su lts  o f these studies / 6 , 8/ .  The resu lts  were compared w ith data 
o f con tro l patients 40-60 years o f age who had undergone venipuncture fo r other reasons. These 
d id  not su ffe r from haemotopoietic or oncologic diseases. Most o f them had hypertension. 
L ite ra ry  data and, in  pa rt, data of ind iv idua ls  who were subsequently excluded from the groups 
o f patients and proved to be healthy served as con tro ls  o f the data of bone-marrow te s ts . The 
resu lts  were then evaluated in  terms o f mean, d is tr ib u tio n  and Student's te s ts .
R e s u lts
The CD3- and C D 4 -p o s it iv e  T -lym phocytes were reduced in  number in  the 
p a th o lo g ic a l s tages I I ,  I I I  and IV  o f th e  CC-CB g roup . On th e  o th e r  hand, 
th e  C D 8 -p o s it iv e  c e l ls  were e i th e r  id e n t ic a l  o r  h ig h e r in  number as compared 
to  th e  norm al c o n t r o ls .  The CD4/CD8 r a t io  showed a d e f in i t e  re d u c t io n  in  a l l  
th e  fo u r  p a th o lo g ic a l s ta g e s . A modest re d u c t io n  o f th e  pe rcen ta ge  o f Leu-7 
p o s i t iv e  c e l ls  and a s ig n i f i c a n t ly  low ered a c t i v i t y  o f  HNK c e l ls  were ob­
se rve d . In  the  advanced p a th o lo g ic a l s tag es  th e  E - ro s e tte  c o u n t was de­
creased in  accordance w ith  th e  fo re g o in g , whereas no s ig n i f i c a n t  changes 
co u ld  be observed in  th e  EAC ro s e t te  cou n ts  and a b s o lu te  lym phocy te  cou n ts .
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In  the  group o f  p a t ie n ts  w ith  h ig h -g ra d e  m a lig n a n c ie s  (CB) a s ig ­
n i f i c a n t  re d u c tio n  o f  C D 3 -p o s it iv e  c e l ls  was re v e a le d  in  s ta g e s  I I I  and IV ; 
th e  C D 8 -p o s it iv e  c e l ls  were in c re a se d  in  number in  groups I  and I I .  In  
s ta g e s  I I I  and IV ,  on th e  o th e r  hand, o n ly  a s l i g h t  change was observed . 
The CD4/CD8 r a t io  was d e f i n i t e l y  low . The a c t i v i t y  o f  Leu-7 and HNK c e l ls  
had low ered  va lues  in  a l l  g ro u p s , e s p e c ia l ly  in  p a th o lo g ic a l s tag es  I I I  and 
IV :  E - ro s e tte  fo rm a tio n  was reduced in  th e  t h i r d  and f o u r th  groups o n ly ,  
w hereas the  p ro d u c tio n  o f  EAC ro s e tte s  was l e f t  unchanged. No s ig n i f ic a n t  
d i f f e r e n c e s  cou ld  be ob se rve d  in  th e  a b s o lu te  lym phocy te  c o u n ts . S ig n i f ic a n t  
d i f f e r e n c e s  were found in  CD3, CD4. C08 and HNK c e l l  a c t i v i t i e s  in  b o th  o f 
g ro u p s  CC-CB and CB. The d i f f e r e n c e  was a ls o  s ig n i f i c a n t  in  bo th  p a th o lo g i­
c a l  g roups i f  th e  two I I I  and IV  s tage  groups a re  v iew ed . S ig n i f ic a n t  
changes o f CD3, CD4, CD4/CD8, Leu-7 and HNK a c t i v i t i e s  and in  E - ro s e tte  
fo rm a t io n  were observed in  g ro up s  CC-CB and CB, as r e la te d  to  th e  c o n t ro ls  
(T a b le  I ) .  MAB r e a c t i v i t i e s  a re  expressed in  colum n diagram s in  F ig .  1.
T es ts  fo r  bone-m arrow  lym phocyte subgroups were c a r r ie d  o u t in  15 
case s  o f  group CC-CB, and in  13 cases o f th e  CB g ro u p . A f te r  a m echan ica l 
h o m o g e n iza tio n  o f th e  a s p ir a te s ,  th e  is o la t io n  o f  lym phocytes and from  these  
th e  t e s t s  fo r  subgroups were perfo rm ed as re fe r r e d  to  above. CD3-, CD4- and 
C D 8 -p o s it iv e  c e l ls  showed a marked and s ig n i f i c a n t  r e d u c t io n ,  whereas th e re  
w ere  no s ig n i f ic a n t  d i f f e r e n c e  in  th e  Leu -7 , E - ro s e t te  and E A C -ro se tte  and 
mouse ro s e t te  c o u n ts . T h is  r e fe r r e d  to  eve ry  s ta g e  o f  th e  CC-CB group o f 
p a t ie n t s ,  and s im i la r  r e s u l t s  were ga ined in  th e  CB g roup . However, th e  d i f ­
fe re n c e  was marked and s ig n i f ic a n t  in  bo th  p a th o lo g ic a l fo rm s between s tages  
I  and I I , o n  the one hand, and IV  on the  o th e r  (T a b le  I I ) .
T ab le  I I I  shows th e  im m unog lobu lin  le v e ls .  S ig n i f i c a n t  d if fe re n c e s  
be tw een c la sses  CC-CB, CB and c o n t ro ls  were observed in  c la s s  IgA o n ly .  The 
v a lu e  o f  C4 was lo w er th a n  t h a t  o f  c o n tro ls  in  s ta g e s  I I I  and IV  o f  th e  CB 
g ro u p  o n ly .
T ab le  IV c o n ta in s  d a ta  on th e  c l i n i c a l  m a n ife s ta t io n  o f  th e  d ise a se . 
The m ost ge ne ra l symptom was in vo lve m en t o f  th e  lym phnode, sample (se e , 
s e c t io n  1 ) .  M e d ia s tin a l and g e n e ra liz e d  phenomena o c c u rre d  in  s tag es  I I I  and 
IV .  I n  s e c t io n  2 : an in v o lv e m e n t o f  W a ld e ye r's  r in g  was observed in  the  
advanced stages o n ly ,  and even th e re ,  in  le s s  tha n  a h a l f  o f  th e  cases. 
S p lenom ega ly  (s e c t io n  3 ) (exam ined by p a lp a t io n  o r  w ith  u ltra s o n o g ra p h y ) ,  
had a lo w e r in c id e n c e  in  th e  i n i t i a l  s ta g e s , whereas i t  had a m a jo r i n c i ­
dence in  s tages I I I  and IV .  E x tra ly m p h a tic  process  o f  a h ig h  in c id e n c e  was, 
p r im a r i l y  found in  th e  g ro u p  o f  h ig h -g ra d e  m a lig n a n c ie s  and in  advanced
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Table I
R eactiv ity  w ith  monoclonal sera and rose tte  formation. 
Lymphocytes from the peripheral blood of CC-CB and CB patients 
(mean + S.E.)
Stage CD3 CD4 CD8 CD4/CD8 Leu-7 HNK R-Ros
EAC
Ros.
Absolute Ly-count 
10 /L
CC-CB 45 40.2 30.3 1.3 9 8.5 60.0 19.0 2.0
I  n=5 +4.2 +3.8 +2.8 +0.2 +1.4 +2.7 +3.1 +4.2 +0.4
I I  n=7 55.8 42.2 31.8 1.5 12.0 15.0 50.0 18.0 2.8
6.1 4.1 2.2 0.2 2.1 3.0 7.1 3.4 0.5
I I I  n=5 45.8 26.6 27.7 1.0 13.5 10.1 40.0 21.2 1.3
+4.5 +2.9 +2.8 +0.3 +1.9 +2.0 +4.5 +2.9 +0.2
IV n=7 36.5 30.5 19.6 1.4 7.3 15.5 33.7 23.5 6.2
+4.5 +2.9 +2.0 +0.2 +1.5 +2.9 +5.5 +7.5 +4.5
CB 43.5 38.6 23.5 1.6 11.9 34.6 64.2 24.5 2.7
I  n=5 +2.5 +4.6 +3.9 +0.3 +2.9 +6.1 +6.7 +3.9 +0.2
I I  n=5 42.9 35.7 31.2 1.3 12.4 35.0 57.3 20.0 2.4
+3.1 +3.2 +4.1 +0.2 +2.9 +3.9 +8.1 +4.9 +0.2
IIIn=7 31.8 24.9 19.3 1.3 7.5 11.1 38.6 27.2 1.5
+4.5 +4.1 +3.9 +0.3 +1.5 +2.1 +8.0 +4.1 +0.3
IV n=7 35.7 18.6 16.8 1.1 7.7 4.0 34.0 21.0 2.7
+6.0 +2.9 +4.1 +0.1 +2.1 +1.1 +6.0 +4.1 +0.3
CC-CB
45.7 34.8 27.3 1.3 10.4 12.2 45.9 20.4 3.0
n=24 +2.1 +1.9 +2.3 +0.3 +1.7 +3.1 +4.7 +3.0 +0.4
CB Tota l 38.4 29.4 22.6 1.3 9.9 21.2 48.5 23.1 2.3
n=24 +3.9 +2.9 +3.0 +0.3 +2.9 +4.1 +4.5 +2.7 +0.5
S ignificance 
CC—CB vs.CB
P-<0.05 P<0. 0 1
 
1
ns
.05
ns
P<0.01
ns ns ns
CC-CB
I I I - I V
41.1 28.5 23.6 1.2 10.4 12.7 36.8 22.3 3.7
n=12 +2.9 +2.9 +1.8 +0.2 +2.9 +2.0 +4.1 +4.1 +0.3
CB I I I - IV  33.8 21.7 18.0 1.2 7.6 7.5 36.3 24.1 2.1
n=14 +4.1 +3.1 +1.9 +0.2 +3.1 +1.9 +3.9 +2.9 +0.2
S ignificance 
CC-CB vs CB
PC0.05 P<0,
ns
.05 F40.05
ns
P<0.05
ns ns
P 0.05
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Table I  (co n t.)
Stage C03 CD4 CD8 I3D4/CD8 Leu-7 HNK R-Ros
EAC
Ros.
Absolute Ly-count 
10 /L
C ontro l 61.2 40.5 20.3 2.0 23.6 51.6 64.4 27.1 2.1
n=25 +4.3 +1.4 +1.1 +0.1 +2.4 +16.7 +7.8 +6.6 +0.3
S ig n .co n tr.
VS . PO.Ol P-0.01 ns P-<0.0]. P<0. 01 P<0.01 P<0.01 ns P<0.01
CC-CB-CB
t o i
CB RAI 0-1.ST CB RAI lll-IV.ST CC-CB RAI 0-II.ST CC-CB RAI IMYST CONTROL 
□  S  0Ш ^  H  □
CD3 CDA CD8 A/8 Leu 7 HNK
Fig. 1. Monoclonal antibody re a c tiv ity  and HNK-cell 51CR-delivery in
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Table I I
R eactiv ity  w ith  monoclonal sera and rose tte  formation.
Bone-marrow lymphocytes from CC-C8 and CB patients 
(mean + S .E .)
Bone-
marrow
CD3 CD4 CD8 CD4/CD8 Leu-7
HNK
51
Cr
E-Ros. EAC-Ros Mouse Ros.
4 % 4 % fsz 4 H 4 4
CC-CB 22 A 14.8 11.4 1.3 6.7 N.G. 10.12 9.38 0
I - I I  n=7 +4.5 +6.1 +4.5 +0.4 +2.1
I I I - IV 16.9 13.8 17.3 0.6 3.6 N.G. 6.0 34.5 0
n=8 +4.5 +2.9 +6.4 +0.1 +1.5 +2.5 +12
CB I - I I 35.1 15.4 12.7 1.2 5.8 N.G. 12.5- 33.5- 0
n=5 30.0 13.5 11.0 +6.2 8.0 30.0
I I I - IV 11.6 9.5 9.6 0.9 7.0 3.0 26.0 33.0 0
n=8 +6.2 +6.1 +7.5 +0.4 +2.1 +1.0 +1.5 +2.0
Control 44.2 21.6 20.2 1.1 4.5 6.3 0.1 7.3 0.05
n=10 +3.5 +4.1 +2.2 0.1 +1.8 7.1 12.8
Control VS. P«0.01
ns ns ns ns
CC-CB
CB
P«0.01 P<0.01
N.G. = not given 
ns = not s ig n if ic a n t
p a th o lo g ic a l s ta g e s . The bone-marrow sam ple ( s e c t io n  5) showed a b la s t ic  
in c id e n c e  in  more tha n  25 p e rc e n ts , o f  th e  p a th o lo g ic a l p ic tu re s  w ith  h ig h -  
grade m alignancy and in  advanced cases . Anaemia appeared s im i la r l y  in  
advanced c l i n i c a l  s ta g e s . A p a th o lo g ic a l ,  c e l lu l a r  i n f i l t r a t i o n  o f th e  l i v e r  
was observed in  a h is to lo g ic a l  t e s t in g  o f  l i v e r  b io p s y , where s im i la r l y ,  
th e  advanced s tage  o f  th e  d isease  appeared to  be d e c is iv e .
The d ig e s t iv e  t r a c t  (s e c t io n  8 ) was a f fe c te d  r a r e ly ,  m o s tly  as 
p r im a ry  m a n ife s ta t io n .  I t  cou ld  be tra c e d  in  6 o f  the  14 p a t ie n ts  in  th e  CB 
group in  s tages  I I I  and IV . The in v o lv e m e n t o f  th e  c e n t ra l ne rvous  system 
may p r im a r i ly  be c h a r a c te r is t ic  o f  th e  CB g ro up : we observed i t  in  3 pa­
t ie n t s ,  two o f  whom s u f fe re d  from  B u r k i t t ' s  lymphoma. The lu n g s  and the  
p le u ra  were a f fe c te d  r a r e ly  showing g e n e ra liz e d  p a th o lo g ic a l p ic tu r e s ;  we 
observed i t  in  4 cases. I n f i l t r a t i o n  o f  th e  s k in  was observed in  4 p a t ie n ts .
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Table I I I
Mean iirmunoolobulin le ve l in  stages I - I I  and I I I - I V  CC-CB and CB patients (mean +_ S .E .)
Immuno­
g lo b u lin s
IgG
g / i
IgA
g / i
IgM
g / i
CH-50
mg/dl
C3
mg/dl mg/âl
CC-CB 7.1 2.3 2.0 1.5 73.5 32.5
I - I I  n :10 +2.1 +1.1 +0.3 +0.3 +8.1 +5.3
I I I - I V 8.2 2.5 2.3 0.9 80.5 27.7
n :8 +1.5 +1.1 +0.6 +0.6 +12.1 +5.6
CB I - I I 10.6 3.3 1.0 0.9 60.4 30.6
n :10 +2.1 +0.9 +0.3 +0.2 +10.9 +4.8
I I I - I V 9.6 2.2 1.1 1.5 B1.0 31.6
n :12 +2.1 +0.4 +0.2 +0.3 +11.2 +3.1
C on tro l 11.0 1.1 1.1 1.5 100.0 40.0
n:50 +1.8 +0.7 +0.5 +1.1 +22.0 +9.0
S ig n ific a n c e : ns 
CB-CBCC vs .co n tro l
P<0.05 ns ns ns ns
ns = no t s ig n if ic a n t
Table IV
Organic changes of pa tients w ith  CC-CB and CB lymphomas in  d if fe re n t pathologica l stages
CB-CC No. 24 CB No. 24
I - I I I I I - IV I - I I I I I - I V
1. Lymph nodes region 1-2 
m ed ias tina l: 
genera lised
(n=10)
10
(n=14)
5
5
(n=10)
10
(n=14)
14
14
2 . W aldeyer's ring 0 6 2 6
3. Spleen ( in f i l t r a te d ) 2 10 4 9
4. Extra lym phatic process: 2 4 2 9
5. Bone-marrow:<25% b la s t A 8 0 1 0
>254 b la s t В 2 14 9 14
6 . Blood >10 HB 8 1 2 2
<10 HB 2 13 8 12
7. L iv e r  ( in f i l t r a te d ) : 0 7 1 12
8 . G a s tric  and in te s tin a l t ra c t : 0 1 1 6
9. C e n tra l nervous system: 0 0 1 3
10. Lung and pleura 0 1 0 3
11. Skin 0 1 0 3
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D is c u s s io n
I t  has g e n e ra lly  been accepted t h a t  NHL can be d iv id e d  in t o  two 
g ro u p s : th e  one w ith  lo w -g ra d e , th e  o th e r  w ith  h ig h -g ra d e  m a lign an cy  o f  th e  
d is e a s e . T h is  c la s s i f i c a t io n  is  based on th e  d u ra t io n  o f th e  p a th o lo g ic a l 
p ro ce ss  and th e  d e v e lo p in g  c o m p lic a t io n s ,  i . e . ,  on re c o g n it io n  o f  th e  sev­
e r i t y  o f  o rg a n ic  fu n c t io n a l d is tu rb a n c e s  and th e  tim e  o f t h e i r  appearance . 
C h ro n ic  lym pho id  le ukaem ia , which is  a m a lig n a n t lymphoma, sho u ld  d e f i n i t e l y  
be d is t in g u is h e d  from  th e s e ; i t s  c la s s i f i c a t io n  can be c o n s id e re d  to  be 
s o lv e d  by R a i's  g ro u p in g , in  term s o f  th e  m o d if ic a t io n s  suggested by B in e t  
e t  a l .  / 2 / .  The s ta g in g  o f  o th e r  m a lig n a n t NHLs is  fa r  from  b e in g  c o m p le te , 
as i t  d is re g a rd s  s e v e ra l p a th o lo g ic a l phenomena, those q u a l i f y in g  th e  d u r­
a t io n  o f  th e  p a th o lo g ic a l p rocess and th e  s e v e r i t y  o f th e  d is e a s e  / 7 / .
We made e f f o r t s  to  f in d  q u a n t i t a t iv e  changes from  norm al c o n d it io n s  
by in v e s t ig a t in g  lym phocyte  phenotypes, p r im a r i l y  in  T -lym phocyte  subgroups . 
A marked re d u c t io n  o f  CD3 and CD4 was ob se rve d  in  stages I I - I V ,  w h ile  th e re  
were no s ig n i f i c a n t  changes in  s tages  I I - I V  in  th e  C D 8 -p o s it iv e  ly m p h o c y te s . 
The con s tancy  o f  th e  s u p p re s s o r /c y to to x ic  c e l l  coun t can r e s u l t  fro m  tum ou r- 
g e n e t ic  d is o rd e rs  o f  th e  o c c u rr in g  c e l l  m arke rs  / 1 /  on the  one hand , and i t  
can e x p la in  th e  d is tu rb e d  immune ba la n ce  and th e  enhanced in c l in a t io n  to  
in fe c t io n  on th e  o th e r .  The decrease o f  th e  5 iC r - re le a s in g  c a p a c ity  o f  HNK 
c e l l s ,  and o r th e  re d u c t io n  o f  t h e i r  a b s o lu te  numbers, i s  marked / 2 0 / .  The 
decrease  o f  E ro s e t te s  in  number as w e ll  as th e  inc reased  number o f  B -pheno- 
ty p e  c e l ls  may be in  accordance w ith  В- c e l l  malignoma.
In  th e  group o f  lymphomas o f  h ig h -g ra d e  m alignancy (CB) a s im i la r l y  
s ig n i f i c a n t  decrease o f  CD3, CD4, Leu-7  and HNK c e l ls  can be ob se rve d , 
e s p e c ia l ly  in  th e  advanced p a th o lo g ic a l s ta g e s . On the  o th e r  hand , no s ig ­
n i f i c a n t  q u a n t i ta t iv e  changes were found  in  C D B -pos itive  c e l ls .  U p s e t t in g  o f 
th e  immune ba lance  i s  in d ic a te d  by a s ig n i f i c a n t l y  reduced CD4/CD8 r a t i o .
The b e h a v io u r o f  th e  bone-m arrow lym phocytes -  in  f u l l  acco rdance  
w ith  l i t e r a r y  da ta  -  d i f f e r s  from  th e  q u a n t i t a t iv e  r e la t io n s  o f  th e  lym pho­
c y te  subgroups in  th e  p e r ip h e ra l b lo o d  / 6 ,  8 / .  A lthough th e  t e c h n ic a l  d i f ­
f i c u l t i e s  o f  th e  te s ts  in  a s p ira te s  a re  e v id e n t ,  th e  changes r e la te d  to  the  
no rm a l c o n t ro ls  showed a d i r e c t  r e la t io n .  The re d u c tio n  o f CD3, CD4 and CDB- 
p o s i t iv e  c e l ls  was s ig n i f i c a n t ,  b u t no marked d if fe re n c e s  c o u ld  be observed 
in  th e  re d u c t io n  o f  th e  Leu -7 , E - ro s e t te  and E A C -rosette  c o u n ts . T h is  may be 
r e la te d  to  a m a lig n a n t o r ig in  o f  bone-m arrow  lym phocytes, th o u g h , a l te r n a ­
t i v e l y ,  th e  appearance o f  Leu-7 c e l ls  may be a consequence o f  r e c i r c u la t io n
n e ith e r  can i t  be e x c lu d e d  th a t  bone-marrow lym phocytes may c a r ry  do ub le  
m a rk e rs .
U n fo r tu n a te ly ,  we had no o p p o r tu n ity  to  examine HNK c e l l  a c t i v i t y .  
The nu m e rica l d i f f e r e n c e s  were m arkedly s ig n i f i c a n t  in  th e  advanced p a th o ­
lo g ic a l  s ta g e s .
The im m u n o g lo b u lin  le v e ls  d i f f e r e d  fro m  th e  norm al o n ly  in  th e  IgA 
c la s s ,  and the  CD4 v a lu e  d i f f e r e d  o n ly  in  s ta g e s  I I I  and IV o f CB lymphomas. 
The la c k  o f an in c re a s e d  a n tib o d y  p ro d u c tio n  in  s p i te  o f r e c u r r in g  in f e c ­
t io n s  can be a t t r ib u t e d  to  th e  a c t i v i t y  o f  s u p p re s s in g  c e l ls  (CD8) and th e  
re d u c t io n  o f th e  c o u n t a n d /o r  a c t i v i t y  o f  Leu-7  and HNK c e l ls  th a t  m odu la te  
th e s e  / 4 / .  F u r th e r ,  i t  s h o u ld  be taken in t o  a cco u n t th a t  by the  re d u c t io n  o f 
CD4 lym phocytes in te r le u k in - 2  ( IL - 2 )  p ro d u c t io n ,  to o ,  w i l l  de c rea se , and 
t h a t  t h i s  phenomenon may have a ro le  in  in c re a s in g  HNK a c t i v i t y  / 1 9 / .  P re ­
sum ab ly , IL -2  has -  v ia  in te r fe r o n  gamma -  a d i r e c t  and an in d i r e c t  i n f l u ­
ence on the  a c t i v i t y  o f  HNK c e l ls  /4 ,  1 9 / .  One sh o u ld  reckon w ith  a m u tua l 
r e in fo r c in g  a c t i v i t y  w ith  in te r fe r o n  a lp h a , to o  / 4 / .  The fa c t  t h a t  th e  im ­
m u n o g lo b u lin  le v e ls  a re  n o t f a r  from  b e in g  no rm a l can be a t t r ib u te d  to  th e  
i n e f f e c t i v i t y  o f  th e  q u a n t i t a t iv e ly  norm al c h a ra c te r  o f  th e  CD8 T -lym p h o cy te  
g roup  a d jo in e d  to  th e  re d u c t io n  o f  c e l lu la r  a c t i v i t y  o f  CD4, Leu-7 and HNK. 
O th e rw is e , s ig n i f i c a n t l y  reduced im m u nog lobu lin  le v e ls  cou ld  n o t have been 
o b se rve d .
The s ig n i f i c a n t  re d u c t io n  o f the  T -ly m p h o c y te  group observed in  B- 
c e l l - t y p e  HNL can , p e rh a p s , be e xp la in e d  by a phenomenon observed e x p e r i­
m e n ta lly  / 1 1 / .  The cause o f  t h is  pehnomenon i s  a s ig n i f ic a n t  decrease o f  
T - c e l l  co lon y  fo rm a t io n s .  As observed by H u tc h in s o n  e t  a l . ,  t h is  phenomenon 
i s  r e la te d  to  a plasma f a c t o r  c i r c u la t in g  in  p a t ie n ts  w ith  B -c e l l- t y p e  NHL. 
The same does n o t o c c u r in  p a t ie n ts  w ith  T - c e l l - t y p e  NHL, though, i t  can be 
fou nd  in  o th e r ly m p h o p r o l i fé r a t iv e  c l i n i c a l  p ic tu r e s  / 3 ,  2 3 /. M a lig n a n t В 
c e l l s  m ig h t produce in h ib i t o r y  lym phokin a n d /o r  th e re  m igh t be a c o m p e t it io n  
between f l u i d  and c e l l- b o u n d  IL -2 s  /9 ,  10, 12 , 2 5 , 2 6 / .
The va lue  o f  d a ta  abou t the  o rg a n ic  lo c a l i z a t io n  o f th e  d is e a s e  
(T a b le  IV ) needs c o n f irm a t io n  by e xa m in a tion  o f  f u r t h e r  p a t ie n ts .  The ex ­
te n s io n  o f  the  o rg a n ic  lo c a l i z a t io n  is  in  f u l l  accordance w ith  the  judgem ent 
o f  m a l ig n ity  on th e  c l i n i c a l  p ic tu r e .  More s e ve re  and v i t a l l y  dangerous com­
p l ic a t io n s ,  such as an i n f i l t r a t i o n  o f th e  c e n t r a l  nervous system and seve re  
anaem ia, can p r im a r i ly  be observed in  cases o f  m a lig n a n t CB. The l a t t e r  was
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accompanied by a r a t io  o f  b la s t ic  c e l ls  exce ed ing  25% in  the  bone m arrow o f  
ou r p a t ie n ts .
The problem s co n ce rn in g  the  a e t io lo g y  and pa thogenes is  o f  NHL a re  to  
be s o lv e d . In  s p i te  o f  re c e n t successes, we canno t y e t be s a t i s f ie d ,  n o t 
even w ith  th e  th e ra p e u t ic  r e s u l t s .
A t p re s e n t,  we cannot y e t r e fe r  to  c le a r  agreements between th e  ex­
p re s s io n  o f  c e l l  m arkers and the  m o rp h o lo g ic a l appearance o f c e l l s .  A l l  t h is  
f i t s  to  th e  r e a c t i v i t y  o f  m onoclonal a n t ib o d ie s  w ith  an "e p is to p e "  p r im a r i l y  
on th e  c e l lu la r  s u r fa c e  than w ith  p a th o lo g ic a l m olecu les d e f in in g  th e  t u ­
morous c h a ra c te r  o f  c e l l s . 1*
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ENDOGENOUS INTERFERON ( IF N )  IN  PATIENTS WITH ACUTE HEPATITIS В
A . BORON-KACZMARSKA*, R. ZACHOVAL , V . ZACHOVAL,
F . DEINHARDT
Max von P e tte n k o fe r  I n s t i t u t e  o f  Hygiene and M ed ica l M ic ro b io lo g y ,  
Ludw ig M a x im ilia n  U n iv e r s i ty ,  M unich, West Germany,M ed ica l C l in i c  I I ,  
K lin ik u m  G rosshadern, Ludw ig M a x im ilia n  U n iv e r s i t y ,  M unich, West Germany
(R e ce ive d : November 23 , 1989)
The occurrence of serum in te rfe ron  was studied in  39 patients w ith acute v ir a l  
h e p a tit is  B. A n tiv ira l a c t iv ity  o f in te rfe ron  in  serum was determined by measuring the 
in h ib it io n  o f the CPE o f vesicu la r s to m a titis  v iru s  on bovine kidney c e l ls  (1“ЮВК). 
Among these patients only 5 (12.8%) had detectable serum in terferon le v e l during the 
f i r s t  week of h o sp ita liza tio n . The a n t iv ira l a c t iv i t y  o f the in te rfe ro n -p o s itiv e  sera 
was low (5-10 IU /m l).
Keywords : In te rfe ron , acute v ir a l  h e p a tit is  В
In t r o d u c t io n
Recovery from  acu te  v i r a l  in fe c t io n  in v o lv e s  a c o m p le x ity  o f  h o s t -  
de fense  mechanisms, among them in te r fe r o n  ( IF N ) ,  which a f fe c ts  mechanisms 
such as n o n -s p e c if ic  in f la m m a tio n , a n tig e n  e x p re s s io n , p h a g o c y to s is , a n t i ­
body fo rm a tio n  and c e ll-m e d ia te d  re s is ta n c e  / 7 / .
The r o le  o f  IFN in  human v i r a l  h e p a t i t i s  has n o t been w e l l - d e f in i t e d  
up to d a y . P rev iou s  re p o r ts  in d ic a te d  th a t  p a t ie n ts  w ith  d i f f e r e n t  fo rm s o f  
v i r a l  h e p a t i t i s  were unab le  to  produce IFN / 2 ,  6 , 8 / .  W ith new ly deve loped  
m ethods, however, c e r ta in  a u th o rs  /1 ,  3 , 5 /  found  endogenous in te r f e r o n  in  
p a t ie n ts  w ith  acu te  h e p a t i t i s .  These f in d in g s  have been q u e s tio n e d  by 
o th e rs  / 4 / .
^Fellowship o f Alexander von Humboldt Foundation.
O ffp rin t requests should be sent to  A. Boron-Kaczmarska, C lin ic  of In fe c tio u s  Diseases 
Medical School, 15-540 B ia lystok, Zurawia 14, Poland
Akadémiai Kiadó, Budapest
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The aim o f  th e  s tu d y  presen ted he re  was to  assess the  fre q u e n c y  o f 
o ccu rre n c e  o f  serum IFN in  acu te  h e p a t i t i s  В in  a s e r ie s  o f  p a t ie n ts  ad­
m it te d  to  th e  C l in i c  o f  In fe c t io u s  D iseases in  B ia ly s to k ,  Poland (head : 
P ro fe s s o r  P. B o ro n ).
P a t ie n ts  and M ethods
T hirty-n ine  pa tien ts  su ffe rin g  from acute h e p a tit is  В fo r positive (HBsAg and a n t i-  
HBc-IgM) were included in  the study. None of the pa tien ts  suffered from the severe (fu lm inan t 
h e p a tit is )  c l in ic a l from o f the disease.
A fte r hosp ita l admission sera of the pa tien ts  in  the acute phase o f disease were 
sampled and immediately frozen a t -20 C. From these p a tie n ts  a to ta l of 92 blood samples were 
a va ila b le  fo r analysis. Blood samples were drawn a t the time o f hospita l admission and up to  6 
times during h o sp ita liz a tio n .
Refrigerated sera were sent in  dry ice to  the Max von Pettenkofer In s t itu te ,  Munich, 
FRG (head: Prof. d r. med. F. Deinhardt), in  order to  be tes ted .
Hundred and twenty healthy ind iv idua ls served as a co n tro l group (none o f them showed 
c l in ic a l  signs of any v i r a l  in fe c t io n .)
A n tiv ira l a c t iv i ty  o f sera was determined by measuring the in h ib it io n  o f the cy to - 
pa th ic  e ffe c t (CPE) o f ve s icu la r s tom atitis  v iru s  (VSV) on bovine kidney c e lls  (MDBK).
S eria l twofold d ilu t io n s  o f sera were made in  volumes o f 0.05 ml in  the w ells o£ f l a t -  
bottomed 96-well m ic ro tite r  tra ys  (Nunc, Denmark). MDBK c e lls  a t concentration 0.4 x 10 /m l in
0.05 ml minimal essen tia l medium (MEM) with 10% FCS were added and incubated at 37 C fo r  24 h 
in  a humidified 5% CO^  atmosphere. The resu lting  monolayers were then drained by inve rs ion  of 
the m ic ro tite r  tray  over a s te r i le  pad and 0.05 ml o f a suspension of VSV was added to  each 
w e ll. The f in a l evaluation o f CPE was done a fte r re incubation  o f the m ic ro tite r trays  fo r  48 h 
a t 37 °C.
A n tiv ira l u n its  were calcu lated as the rec ip roca l o f the serum d ilu tio n  in h ib it in g  50% 
o f the CPE. One u n it is  equ iva lent to  approximately one reference un it o f the World Health 
Organization human leukocyte reference IFN В 69/19. The lower l im it  o f detection o f th is  te s t 
was 5 IU/m l. As some o f the sera were tox ic  to  the MDBK c e lls ,  the sera were preabsorbed w ith 
the MOBK targets.
Every serum IF N -pos itive  in  the bioassay was reexamined using an immunoradiometric 
assay fo r  IFN-alpha (SUCROSEP IFN -  alpha, IRMA, Rôhm -  Pharma, West Germany).
R e s u lts
H e a lth y  in d iv id u a ls  had v i r t u a l l y  no IFN in  b lo o d . Among th e  39 pa­
t ie n t s  w ith  acu te  h e p a t i t i s  B ,5  (12.8%) had d e te c ta b le  IFN le v e l  in  serum 
d u r in g  the  f i r s t  week o f  h o s p i ta l iz a t io n .  One p a t ie n t  had IFN up to  th e  
s ix t h  week o f h o s p i t a l iz a t io n .
The a c t i v i t y  o f  IFN and an ti-H B c IgM in  b lo o d  serum in  5 p a t ie n ts  is  
i l l u s t r a t e d  in  T ab le  I .
No c o r r e la t io n  between IFN le v e l and c l i n i c a l  course o f  th e  d ise a se  
was observed , and a l l  IF N -p o s it iv e  p a t ie n ts  w i th  acu te  v i r a l  h e p a t i t i s  В 
re c o v e re d .
Table I
The in te r fe ro n  le v e l  and a n ti-H B c -Iq M  in  b lood  serum o f  p a t ie n ts  w ith  co n firm e d  IFNI a c t i v i t y
Week o f  h o s p i ta l iz a t io n
Patients
I I I I I I IV V VI
IFN
U/ml
a rrti-  
-HBc IgM
IFN
U/ml
a n t i-  
-HBc 1^1
IFN
U/ml
a n t i-  
-HBc IgM
IFN
U/ml
a n ti-  
-HBc IgM
IFN
U/ml
a n ti-  
-HBc IgM
IFM
U/ml
a n t i-  
-HBc IgM
1 10 + ( - ) + ( - ) + ( - ) (♦) ( - ) (+) ( - ) +
2 5 + ( - ) + ( - ) + ( - ) ( - ) ( - ) ( - ) ( - ) ( - )
3 5 + ( - ) + ( - ) + ( - ) ( - ) ( - ) ( - ) ( - ) ( - )
4 5 + ( - ) + ( - ) + ( - ) + ( - ) 4- 5 +
5 10 + ( - ) + ( - ) + ( - ) + ( - ) ( - ) ( - ) ( - )
ENDOGENOUS INTERFERON IN
 PATIENTS W
ITH ACUTE HEPATITIS В
80 BORON-KACZMARSKA, A. e t  a l .
The a n t i v i r a l  a c t i v i t y  o f  th e  IF N -p o s it iv e  se ra  was low  (5 -1 0  IU /m l) .  
E ig h t y - s ix  sampes were n e g a t iv e  fo r  IFN.
The a n t iv i r a l  a c t i v i t y  was c h a ra c te r iz e d  as IF N -a lp h a  by n e u t r a l iz ­
a t io n  w ith  an tib o d y  to  IF N -a lp h a  and by SUCROSEP IF N -a lp h a  IRMA. In c u b a tio n  
w i t h  a n tib o d y  to  IF N -b e ta  and IFM-gamma had no e f f e c t .
D iscussion
IFN is  an e a r ly  d e fe n s e  mechanism a g a in s t  v i r a l  in f e c t io n ,  in d u c in g  
an a n t i v i r a l  s ta te  in  m on on uc le a r c e l ls .
Our s tudy shown t h a t  o n ly  few o f  p a t ie n ts  w ith  acu te  h e p a t i t i s  В 
resp o n d e d  to  the  in f e c t io n  by a c t iv a t io n  o f  t h e i r  IFN system . The IFN 
le v e ls  were low in  th e s e  p a t ie n ts  d u rin g  th e  e a r ly  phase o f  d ise a se  and 
w ere  n o t lo ng e r m easurab le  th e r e a f te r  b u t in  one p a t ie n t  w ith  a more severe  
fro m  o f  h e p a t i t is .
The f a i lu r e  o f  d e te c t in g  c i r c u la t in g  IFN in  m ost p a t ie n ts  w ith  acu te  
h e p a t i t i s  В does n o t e x c lu d e  a p o s s ib le  in v o lv e m e n t o f  th e  IFN system  in  
v i r a l  h e p a t i t is  B, f o r  th e  t e s t s  m ight n o t be s e n s i t iv e  enough. IFN m igh t 
p r e fe r a b ly  a c t in  s i t u ,  a t  th e  t is s u e  in ju r y  o r  IFN m etabo lism  c o u ld  be 
a l t e r e d  in  acute l i v e r  d is e a s e .
Our f in d in g  th a t  a n t i v i r a l  a c t iv i t y  i s  p re s e n t in  a t  le a s t  some pa­
t i e n t s  w ith  acute h e p a t i t i s  В be should encourage re s e a rc h e rs  to  a p p ly  more 
s e n s i t i v e  te s t  system to  e lu c id a te  the  r o le  o f  IFN in  acu te  h e p a t i t i s  B.
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E N D O C R I N O L O G Y
THE FEASUREÆNT OF THE SERUM SEX-HORMONE BINDING GLOBULIN IN  VARIOUS
THYROID DISEASES
J .  FÖLDES, S . VANA, CS. BÁNOS, P . LAKATOS, G. TARJÁN
F i r s t  Departm ent o f  M ed ic in e , Semmelweis U n iv e rs i ty  M ed ica l S c h o o l, 
B udapest, and Vyzkumny I n s t i t u t e  o f  E ndocrino logy  
(u s ta v  e n d o k r in o lo g ic k y ) , Praha
(R ece ived: August 2 , 1989)
Synthesis of "sex-hormone binding g lo b u lin "  (SHBG) is  influenced by thyro id  
hormones and i t s  concentration in  the serum o f femals subjects may be a marker of 
thy ro id  hormone e ffe c t a t the peripheral t issu e  ( l iv e r )  le ve l. Compared to  the leve ls  
found in  euthyroid females (n=46), the mean (+^S.O.) serum SHBG concentration was 
found elevated in overt hyperthyroidism (Graves' disease: n=56; 141.6 +_ 37.6 vs. 
48.3 +_ 16.2; to x ic  nodular g o ite r: n=16; 119.9 _+ 50.7 vs. 48.3 +_ 16.2 nmol/1; 
P ■< 0.001). In  con tras t, i t  was decreased in  manifest hypothyroidism (n=25; 
24.9 +_ 14.8 vs. 48.3 +_ 16.2; P«C 0.001). In  the group of p re c lin ic a l hyperthyroidism  
(n=43), despite suppressed TSH secretion, the serum value of SHBG was normal (47.4 +_ 
16 .8), while i t s  serum leve l approached the lower border o f the normal range in  sub- 
c l in ic a l hypothyroidism (n=10; 33.6 ^  6.1 vs 48 .3^+16.2  nmol/1; P < 0 .0 1 ) .  Data in ­
d icate  tha t the p itu ita ry  responds more s e n s it iv e ly  than the l iv e r  to  a s l ig h t  change 
o f the serum thyro id  hormone le ve l. During th y ro id  hormone replacement fo r  hypothy­
roid ism , measurement o f serum SHBG may provide help to  assess the response o f the 
ta rge t organ to  the given therapy. In  pa tie n ts  w ith  generalized resistance to  thyro id  
hormone, the serum SHBG leve l is  w ith in  the normal range (51.3 +_ 9.8 nm ol/1 ), thus, 
i t s  determ ination supports the diagnosis o f th is  disease.
Keywords : Serum, sex-hormone binding g lo b u lin ; thyro id  diseases
Abbreviations: FT^: free-thyrox ine ; FT^: f гее- t r i iodothyronine; TSH: th y ro id -s tim u la t­
ing hormone; TRH: thyro troph in -re leasing  hormone; SHBG: sex-hormone binding g lo b u lin ; GRTH: 
generalized resistance to thyro id  hormone
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In t r o d u c t io n
"Sex-horm one b in d in g  g lo b u l in "  (SHBG) i s  a g ly c o p ro te in  s y n th e s iz e d  
in  th e  l i v e r ;  i t  se rve s  as a t ra n s p o r t  p r o te in  f o r  te s to s te ro n e  and o e s t ­
r a d io l .  I t s  p ro d u c tio n  i s  s t im u la te d  by o e s t r a d io l  and reduced by t e s t o s t e r ­
one / 8 ,  9 / .  P re v io u s  d a ta  in d ic a te  th a t  t h y r o id  hormones enhance th e  sy n ­
t h e s is  o f  SHBG d i r e c t l y  o r  v ia  in d i r e c t  mechanisms /1 3 /  and th a t  th e  serum 
c o n c e n tra t io n  o f  t h i s  g ly c o p ro te in  is  a m arker o f  th y r o id  hormone e f f e c t  a t  
p e r ip h e r a l  t is s u e  ( l i v e r )  le v e l .  R e ce n tly , a s e n s i t iv e  radio im m unoassay has 
been deve loped f o r  th e  measurement o f serum SHBG. By means o f t h is  method in  
m ost o f  th e  cases w ith  o v e r t  h y p e r th y ro id is m  an e le v a te d , w h ile  in  th e  
m a jo r i t y  o f  p a t ie n ts  w ith  m a n ife s t h y p o th y ro id is m  a decreased, serum SHBG 
le v e l  was d e te c te d  / 1 ,  10 , 1 5 / .
A s tu d y  has been unde rtaken  to  c le a r  th e  fo l lo w in g  q u e s tio n s : 1 ) To 
w hat e x te n t  i s  th e  serum SHBG le v e l abnorm al in  cases w ith  o v e r t  h y p e r­
th y r o id is m  o r h y p o th y ro id is m  and when does th e  serum le v e l r e tu rn  in t o  th e  
no rm a l range a f t e r  an adequate tre a tm e n t;  2 ) To what degree is  serum SHBG 
le v e l  in f lu e n c e d  by s u b c l in ic a l  h y p e r th y ro id is m  o r  h yp o th y ro id is m  and does 
i t s  d e te rm in a t io n  g iv e  any fu r t h e r  in fo rm a t io n  abou t the  p e r ip h e ra l ( l i v e r )  
e f f e c t  o f  th y r o id  hormone in  these la te n t  t h y r o id  d iseases? 3) Does th e  
measurement o f th e  serum SHBG le v e l p ro v id e  any h e lp  in  the  d ia g n o s is  o f  
g e n e ra liz e d  re s is ta n c e  to  th y r o id  hormone?
P a t ie n ts  and M ethods
Untreated female pa tien ts  aged 20 to 60 years, w ith  overt hyperthyroidism (Graves' 
disease: n = 56; to x ic  nodular g o ite r: n = 16) or m anifest hypothyroidism (n =25) were studied 
The re s u lts  were compared w ith  data obtained in  age- and sex-matched euthyroid sub jects. In  
a l l  hyperthyroid cases the serum free-thyroxine (FT ) and free -triiodo thyron ine  (FT ) le ve ls  
exceeded the upper l im i t  o f the normal range, while the serum TSH concentration was less than 
0.1 irtJ/1. On the other hand, in  hypothyroid subjects the serum FT^ leve l was low (9 .3  pmol/1) 
and the TSH concentration was elevated (5.0 mU/1).
The studies were extended to  patients w ith la te n t  hyperthyroidism and hypothyroidism. 
The c l in ic a l  sta te  o f p re c lin ic a l (sub c lin ica l)  hyperthyroidism  can be best observed in  pa­
t ie n ts  w ith functiona l autonomous thyro id  adenoma. The subjects in  th is  group were c l in ic a l ly  
e u thyro id , a "hot" nodule was demonstrated in  th e ir  th y ro id  gland, the basal serum TSH le v e l 
was subnormal and the TSH response to  TRH remained absent despite serum FT^ and FT^ le ve ls  
s t i l l  w ith in  the normal range. These studies were performed in  43 female pa tients w ith  pre­
c l in ic a l  hyperthyroidism.
Ten female subjects were enrolled in to  the group o f subc lin ica l hypothyroidism. In  
these cases the su b c lin ica l hypothyroid sta te  developed a fte r  subtotal thyroidectomy and 
rad io iod ine  therapy, or i t  was the consequence o f Hashimoto's th y ro id it is .  The pa tie n ts  were 
c l in ic a l ly  euthyroid, th e ir  serum TSH concentrations exceeded the upper l im it  o f the normal 
range in  sp ite  o f normal FT^ and FT^ values.
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We investigated the e ffe c t o f an appropriate therapy on the serum SHBG le v e l in  pa­
t ie n ts  w ith hyperthyroidism and hypothyroidism. In  8 hyperthyroid subjects the serum SHBG and 
TSH leve ls  were measured before the onset o f treatment and, again 4, 8 , 12 and 20 weeks a fte r 
methimazol (Metothyrin) therapy was begun. Three months fo llow ing the s ta r t  o f the treatment 
a l l  pa tients  became c l in ic a l ly  euthyro id, w ith serum FT^ and FT  ^ levels w ith in  the normal 
range.
We determined also the serum SHBG leve ls  o f pa tients  receiving th y ro id  hormone re­
placement (Thyranon, Organon or E ltro x in , Glaxo) fo r  hypothyroidism and re fe rred  to  our thy­
ro id  ou t-pa tien t c l in ic .  W ithin th is  group a l l  subjects seemed to be c l in ic a l ly  euthyro id  and 
th e ir  FT^ -  FTj leve ls were w ith in  the wide normal range. These patients were c la s s if ie d  in to  
three subgroups: a) normal serum TSH (n = 22); b) elevated serum TSH ( > 3 .0  mU/1; n = 9); 
c ) suppressed serum TSH concentration ( < 0 . 1  irtJ/1 ; n = 14).
At la s t ,  we measured the serum SHBG le v e l o f 3 female patients w ith  generalized 
resistance to  thyro id  hormone. These subjects were c l in ic a l ly  euthyroid despite elevated to ta l-  
T4 , FT^, to ta l-T ^  and FT^ values; in  one of these cases the serum TSH leve l was normal, while 
in  the remaining two i t  was s l ig h t ly  elevated; an exaggerated TSH response to  TRH load was ob­
served in  each.
Serum SHBG leve l was determined by a sex-hormone binding g lobu lin  immunoradiometric 
assay k i t  (Farmos, F in land). The intraassay c o e ff ic ie n ts  o f va ria tion  (cv) fo r  value in  the 
low range (25 nmol/1, n = 10) was 5.1%, while in  the high range (120 nmol/1, n = 10) i t  was 
3.8%. The interassay cv was 8.5% fo r  a value of 25 nmol/1 and 6.7% fo r a value o f 120 nmol/1. 
Blood fo r SHBG assay was taken a t 8 o 'c lock in  the morning a fte r an overn igh t fa s t.
To measure serum hormone leve ls  the fo llow ing  commercially availab le k i t s  were used: 
to ta l-T ^  (TT ) :  RK-12 (Isotope In s t itu te  of the Hungarian Academy o f Sciences; normal range: 
70-155 nm o l/I); to ta l-T ^  (TT,) : RK-11 (Isotope In s titu te  o f the Hungarian Academy o f Sciences; 
normal range: 1.2-3.0 r m o l/ I j ; free-T^ (FT^) : Amerlex M FT^ (Amersham; normal range: 9.3 -  
24.5 pmol/1); free-T (FT ) :  Amerlex M FT (Amersham; normal range: 3.5 -  8.6 pm ol/1); TSH: 
IRMA-mat TSH (M a llinckrod t; normal range: 0.3 -  3.0 mU/1). For TRH loading te s t 200 ug TRH 
was administered intravenously and the TSH response was considered normal i f  ATSH (maximal- 
basal TSH le ve l)  was is  the range^^rom 2.0 to  25 ntl/1 a fte r  the TRH load. Thyroid scans were 
performed a fte r  adm inistration o f ^Vc-pertechnetate (50 MBq).
Student's two-sample _t te s t was used in  the s ta t is t ic a l analysis. Mean +_ S.D. are 
given in  the te x t and the tab les.
R e s u lts
Table I
Serum SHBG leve l (mean — S.D.) in  euthyroid female subjects and in  age- and sex-matched 
pa tients w ith overt and s u b c lin ic a l hyperthyroidism and hypothyroidism. S ign ificance  of 
deviations from the con tro l group: * *  P c  0.01; * * *  P c  0.001
Diagnosis Serum SHBG
(normal ranqe: 30-90 nmol/1)
Control (n=46)
Overt hyperthyroidism
48.3 + 1.63
a) Graves' disease (n=56) 141.6 + 37 .6***— KK*
b) Toxic nodular go ite r (n=16) 119.9 + 50.7
P re c lin ic a l hyperthyroidism (n=43) 47.4 + 16.2
Manifest hypothyroidism (n=25) 24.9 + 14 .8***
S u b c lin ica l hypothyroidism (n=10) 33.6 + 6 .1 **
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Data in  Tab le  I  d e m on s tra te  th a t  in  m a n ife s t  h y p e rth y ro id is m  (G ra ve s ' 
d is e a s e , to x ic  n o d u la r g o i t e r )  the  mean v a lu e  o f  serum SHBG was s i g n i f i ­
c a n t ly  h ig h e r ,  c o n v e rs e ly ,  in  o v e rt h y p o th y ro id is m  i t  was rem arkab ly  lo w e r 
th a n  in  the  e u th y ro id  g ro u p  (P <  0 .0 0 1 ). The mean serum SHBG le v e ls  were 
id e n t i c a l  in  the  p r e c l in i c a l  h y p e rth y ro id  and c o n t r o l  g roups, w h ile  in  sub - 
c l i n i c a l  hypothyrod ism  th e y  were low er than  in  e u th y ro id  fem ales (P 0 .0 1 ) ,  
b u t  h ig h e r  than in  o v e r t  h y p o th y ro id is m .
Serum SHBG 
nmol / 1
F ig . 1. Ind iv idual serum SHBG le ve ls  of euthyroid (c o n tro l)  females and of age- and sex- 
matched patients with manifest hyperthyroidism (Graves' disease, tox ic  nodular g o ite r)  and 
w ith  p re c lin ic a l hyperthyroidism . Area between the dotted lin e s  indicates the normal range
o f serum SHBG le ve l
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Figure land Fig. 2 i l lu s tra te  the ind iv idua l serum SHBG values in  the 
examined groups. In 49 out of 56 patients w ith Graves' hyperthyroidism and 
in  13 out of 16 subjects with toxic nodular go ite r elevated, while in  19 of 
25 patients with overt hypothyroidism decreased, serum SHBG levels were 
found. In most of the subjects with subc lin ica l hypothyroidism the serum 
SHBG levels were around the lower border of the normal range. At la s t,  in  
a l l  3 patients with generalized resistance to thyro id  hormone the serum 
SHBG concentrations f e l l  w ith in  the normal range.
Table I I  shows the serum SHBG and TSH leve ls of 8 o r ig in a lly  hyper- 
thyro id female patients p rio r to in it ia t io n  of treatment and 4, 8, 12 and 
20 weeks follow ing the beginning of methimazol therapy. I t  is  demonstrated 
that the serum SHBG leve l returned into the normal range sooner than the 
TSH concentration to Metotyhrin treatment.
Figure 3 demonstrates the ind iv idua l serum SHBG levels of those of 
our out-patients who were receiving thyroid replacement fo r hypothyroidism 
at least 6 months and were c l in ic a lly  euthyroid. On the basis of the serum
F ig . 2, Ind iv idua l serum SHBG leve ls  o f female pa tien ts  w ith manifest and su b c lin ica l 
hypothyroidism. Data fo r  3 female subjects with the diagnosis o f generalized resistance
to  thyro id  hormone, as w ell
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Table I I
Changes o f serum SHBG and TSH leve ls  a f te r  in i t ia t io n  o f methimazol 
(Metothyrin) therapy In  8 female hyperthyroid pa tients . Normal and
abnormal cases a t the given time
SHBG TSH
normal high low normal
Before treatment _ 8 8 _
4 weeks a fte r  therapy 3 5 7 1
8 weeks a fte r  therapy 4 4 6 2
12 weeks a fte r  therapy 7 1 4 4
20 weeks a fte r  therapy 8 - 3 5
Serum SHBG 
nm o l/ l
120 
100 
8 0  
60 
Л0 
20 H
TSH TSH norm. TSH
F ig . 3. Ind iv idua l serum SHBG leve ls  o f female pa tien ts  receiving thy ro id  hormone 
replacement fo r primary hypothyroidism and c la s s if ie d  on the basis o f serum TSH 
concentra tion. |=  TSHO.l m/1; TSH ^ 3  mü/1
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TSH c o n c e n tra t io n s ,  these  s u b je c ts  were c la s s i f ie d  in to  3 sub g ro ups . In  9 
o u t o f  45 p a t ie n ts  th e  serum TSH le v e ls  s t i l l  exceeded th e  upper l i m i t  o f  
th e  norm al range (4 .0  -  20 .0  mU/1) and among them serum SHBG le v e ls  r e ­
mained decreased ( <  30 .0  nm o l/1 ) in  4 case s . On the  o th e r  hand , in  r e ­
sponse to  th e  th e ra p y , serum TSH d isa p p e a re d  in  14 s u b je c ts .  Out o f  them 
serum SHBG va lu e s  exceeded th e  upper l i m i t  o f  th e  normal range in  3 cases .
D is c u s s io n
Sex- and a g e -re la te d  d if fe re n c e s  have an e x p l i c i t  in f lu e n c e  on serum 
SHBG le v e l .  P re v io u s  da ta  have de m on stra te d  th a t  the  serum c o n c e n tra t io n  
o f  t h i s  b in d in g  p ro te in  i s  h ig h e r  in  fe m a le s  than  in  males / 1 ,  1 5 / .  For 
sake o f  a b e t te r  com parison and e v a lu a t io n  o f  th e  re s u lts  in  th e  p re s e n t 
s tu d y  o n ly  20 to  60 yea rs  o ld  u n tre a te d  fem a le  p a t ie n ts  were in c lu d e d .  The 
outcome o f  t h i s  in v e s t ig a t io n  re fe rs  o n ly  to  these  s u b je c ts .
In  accordance w ith  p re v io u s  f in d in g s  / 1 ,  10, 15 / our p re s e n t r e s u l t s  
dem onstra te  th a t  in  th e  m a jo r ity  o f  th e  p a t ie n ts  w ith  o v e r t h y p e r th y ro id is m  
th e  serum SHBG le v e l  i s  e le v a te d  and a f t e r  th e  a d m in is t ra t io n  o f  m e th im azo l 
tre a tm e n t i t  shows a d e c lin e .  Our o b s e rv a tio n  d is c lo s e s  th a t  a f t e r  th e  on­
s e t o f  m eth im azo l th e ra p y  th e  s y n th e s is  o f  SHBG in  the  l i v e r  r e tu r n s  to  
norm al sooner tha n  the  TSH s e c re t io n  in  th e  p i t u i t a r y .
In  cases w ith  fu n c t io n a l th y r o id  adenoma to x ic  no du la r g o i t e r  u s u a l ly  
e v o lv e s  in  a g ra d u a l way th rou gh  th e  c l i n i c a l  s ta te  o f p r e c l in ic a l  (s u b -  
c l i n i c a l )  h y p e r th y ro id is m . The l a t t e r  c o n d i t io n  is  regarded as an i n t e r ­
m ed ia te  s ta te .  I t  i s  s t i l l  q u e s t io n a b le  w he the r in  p r e c l in ic a l  h y p e r th y ­
ro id is m  -  b e s id e  th e  hypophys is  -  f u r t h e r  ta r g e t  organs a re  a f fe c te d  by 
changes o f  serum th y r o id  hormone le v e ls  s t i l l  w i th in  the  norm al ran ge  o r  by 
t r a n s ie n t  in c re a s e s  o f  serum T^ o r  T^ le v e ls .  Former s tu d ie s  based on serum 
SHBG assay had n o t y ie ld e d  an u n e q u iv o c a l answer to  t h is  q u e s t io n  / 5 ,  1 6 /.  
A cco rd in g  to  ou r f in d in g s  the  mean le v e l  o f  serum SHBG was no rm a l in  p re ­
c l i n i c a l  h y p e r th y ro id is m  in d ic a t in g  th a t  th e  p i t u i t a r y  is  more s e n s i t iv e  
tha n  th e  l i v e r  to  a s l i g h t  change o f  serum th y r o id  hormone c o n c e n tra t io n .
As shown by p re v io u s  d a ta , th e  serum SHBG le v e l is  decreased in  most 
o f  th e  cases w ith  m a n ife s t h y p o th y ro id is m . T h is  is  c o rro b o ra te d  by our 
f in d in g s .  In  th e  group o f  s u b c l in ic a l  h y p o th y ro id is m  th e  mean v a lu e  o f 
serum SHBG approaches th e  lo w er l i m i t  o f  th e  norm al range. T h is  in d ic a te s  
th a t  th e  l i v e r  as a p e r ip h e ra l o rgan m ig h t be a f fe c te d  by a de crea se  o f
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serum th y r o id  hormone le v e l  w i th in  th e  no rm a l ra n g e , however, in  t h i s  r e ­
s p e c t th e  p i t u i t a r y  i s  a much more s e n s i t iv e  o rg a n .
I t  i s  s t i l l  u n c e r ta in  whether th e  measurement o f  serum SHBG s u p p lie s  
any h e lp  in  e v a lu a t in g  th e  a p p ro p r ia te  t h y r o id  hormone rep lacem ent dose f o r  
h y p o th y ro id is m . Our d a ta  dem onstra te th a t  in  s u b je c ts  whose serum TSH con­
c e n t r a t io n  n o rm a liz e s  in  response to  s u b s t i t u t io n  th e ra p y , d is re g a rd in g  
some e x c e p t io n a l cases serum SHBG le v e l r e tu r n s  in to  th e  normal ra n g e . How­
e v e r ,  in  some c l i n i c a l l y  e u th y ro id  p a t ie n ts  th e  TSH co n te n t rem ained e le v ­
a te d  in  s p i te  o f  serum FT^ and FT^ va lu e s  w i t h in  th e  w ide norm al ra n g e . In  
th e s e  s u b je c t ,  a decreased  serum SHBG le v e l  was found q u ite  o f te n ,  i n d i ­
c a t in g  th a t  " t is s u e " -h y p o th y ro id is m  s t i l l  e x is te d .  Thus, th e  n e c e s s ity  
to  in c re a s e  th e  re p la ce m e n t dose was ra is e d .  C o n v e rs e ly , in  some p a t ie n ts  
TSH s e c re t io n  became a lre a d y  suppressed in  resp on se  to  the  hormone th e ra p y ,  
tho ugh  th e  serum FT^ and FT^ le v e ls  rem ained s t i l l  w i th in  the  w ide no rm a l 
ra n g e . In  th e  m a jo r i t y  o f  these cases a no rm a l serum SHBG le v e l  c o u ld  be 
d is c lo s e d ;  in  some s u b je c ts ,  however, th e  serum SHBG va lues  became e le v a te d ,  
g iv in g  a d d i t io n a l e v id e n c e  to  the  developm ent o f  " t is s u e " - t h y r o to x ic o s is .  
I t  i s  supposed th a t  in  th e se  p a t ie n ts  s u b c l in ic a l  h y p e rth y ro id is m  had de­
v e lo p e d , w h ich may be d e tr im e n ta l in  th e  lo n g - te rm  and i t  needs f u r t h e r  
th e ra p e u t ic a l im p l ic a t io n s .
A t la s t ,  ou r s tu d y  was extended to  s u b je c ts  s u f fe r in g  from  g e n e ra l­
is e d  re s is ta n c e  to  t h y r o id  hormones (GRTH). The d ia g n o s is  o f t h i s  d is e a s e  
i s  d i f f i c u l t ,  because s e n s it iv e  methods f o r  d e m o n s tra tio n  o f p e r ip h e r a l 
t is s u e  responses to  t h y r o id  hormones a re  la c k in g ;  fu r th e rm o re , th e  s e n s i­
t i v i t y  o f  th e  d i f f e r e n t  organs to  T^ and T^ may be d iv e rg e n t / 4 / .  Our r e ­
s u l t s  a re  c o n s is te n t  w i th  p re v io u s  data show ing norm al SHBG le v e ls  d e s p ite  
e le v a te d  T^ and T^ v a lu e s  in  GRTH /1 1 , 1 4 / .  T h is  v a r ie s  due to  th e  change 
o f  serum SHBG le v e l  fou nd  in  h y p e r th y ro id is m , th u s ,  th e  measurement o f  SHBG 
p ro v id e s  h e lp  in  th e  d ia g n o s is  o f  GRTH. However, th e  va lue  o f  t h i s  t e s t  
seems to  be l im i t e d ,  as in  some cases o f  h y p e r th y ro id is m  the  serum SHBG 
le v e l  rem a ins w i th in  th e  norm al range . For t h i s  re a so n , in  suspected cases 
o f  GRTH Sem e e t  a l .  / 1 4 /  combine the  d e te rm in a t io n  o f  the  basa l SHBG le v e l  
w i th  i t s  response to  s h o r t- te rm  T^ a d m in is t ra t io n  w h ile  C e c c a re ll i  e t  a l .  
/ 3 /  a p p ly  a com plem entary in  v i t r o  method by w h ich  i t  i s  dem onstra ted th a t  
th e  no rm a l s u p p re s s iv e  e f f e c t  o f T-j on f ib r o n e c t in  s y n th e s is  is  b lu n te d  in  
f ib r o b la s t s  from  p a t ie n ts  w ith  GRTH. Anyhow, i t  can be s ta te d , and t h i s  has 
been c o rro b o ra te d  by o u r s tu d ie s ,  th a t  SHBG d e te rm in a t io n  serves as a t e s t  
f o r  th e  assessment o f  end -o rgan  ( l i v e r )  s e n s t i v i t i t y  to  th y ro id  hormones 
and i t  may p ro v id e  h e lp  in  th e  d ia g n o s is  o f  GRTH.
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G A S T R O E N T E R O L O G Y
GASTRIC ANO COLORECTAL CANCER IN  THE TROPICAL PART OF AFRICA
(A REVIEW)
G . A . B Ä L IN T
Departm ent o f  Pharm acology; Add is Ababa U n iv e r s i ty ;  G.P.O. Box 6682. 
Add is Ababa, E th io p ia *
(R ece ived : June 10, 1989)
U n til recen tly  the p rac titio n e rs  in  A fr ic a , and also those in  the temperate 
clim ates, had to re ly  on lite ra tu re  w ritte n  in  an environment tha t is  very d if fe re n t 
from the tro p ic a l circumstances. In  the ra p id ly  changing world the physician must be 
well-informed about the differences which e x is t between the medical p ra c tice  o f the 
tro p ic a l and o f the temperate climates. In  th is  a r t ic le  the ch a ra c te ris tics  o f g a s tric  
and co lo recta l cancer in the tro p ic a l (sub-Saharan) part of A frica  are b r ie f ly  re ­
viewed.
Keywords : Gastric cancer; co lo recta l cancer; tro p ics ; Africa
In t r o d u c t io n
G a s tr ic  cancer is  one o f  th e  most common le th a l  m a lig n a n c ie s  a l l  over 
th e  w o r ld .  Men a re  a f fe c te d  about tw ic e  as o f te n  as women.
The mean age u s u a l ly  re p o rte d  i s  55 yea rs  b u t p a t ie n ts  a re  even o ld e r  
in  some N o rth  Am erican s e r ie s .  Only 5 p e r c e n t o f  the  p a t ie n ts  a re  le s s  
than  40 yea rs  o f  age.
Cancer o f  th e  la rg e  bowel acco un ts  f o r  about 20 pe r c e n t o f  a l l  
dea ths  due to  m a lig n a n t d isease  in  th e  U n ite d  S ta te s . Colon is  th e  second 
most common s i t e  f o r  carcinom a in  b o th  m ales and fem a les. U n fo r tu n a te ly ,  
th e  dea th  ra te  f o r  t h is  d isease  has n o t changed in  the  p a s t 40 y e a rs .
*Permanent address: F irs t  Department of Medicine; A lbert Szent-Györgyi Medical Univer­
s i t y ;  Szeged, Hungary
O ffp r in t requests should be sent to  G.P.O. Box 6682, Addis Ababa, E thiopia
Akadémiai K ia d ó , Budapest
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There i s  no doub t th a t  some d iseases  have d i f f e r e n t  p a t te rn s  -  symp­
tom s, in c id e n c e  ra te s ,  e tc .  -  in  the  t r o p ic s  th a n  in  th e  tem perate c lim a te s  
S o c ia l change i s  r e le n t le s s  and ra p id  a l l  ove r A f r ic a .  I t  has a l ­
re a d y  changed th e  c h a ra c te r  o f  some d isea ses  and i t  w i l l  e x p e c te d ly  con­
t in u e  t o  change i t  as th e  t r a d i t i o n a l  and r u r a l  s o c ie ty  is  re p la c e d  by a 
new u rb an  one.
The aim o f  t h i s  a r t i c l e  is  to  b r i e f l y  re v ie w  th e  d if fe re n c e s  re g a rd ­
in g  t o  g a s t r ic  and c o lo r e c ta l  cancer in  th e  t r o p ic a l  p a r t  o f  A f r ic a .
G a s tr ic  cancer
G a s tr ic  carc inom a i s  le s s  common th ro u g h o u t th e  A fr ic a n  c o n t in e n t  
th a n  i t  i s  Europe, though i t  i s  w idespread a l l  o v e r th e  t r o p ic s .
The main prob lem  ( s im i la r l y  to  c o lo r e c ta l  c a n ce r) is  th a t  th e  a v a i l ­
a b le  f ig u r e s  a re  sca rce  and do n o t r e f l e c t  th e  t r u e  in c id e n c e  o f  th e  
d is e a s e .
R e p o rtin g  th e  e x a c t m o rb id ity  and m o r t a l i t y  ra te s  o f  a d ise a se  de­
pends on a s a t is f a c to r y  case h is to r y  (w h ich  i s  v e ry  d i f f i c u l t  to  o b ta in  in  
m ost p a r ts  o f  th e  d e v e lo p in g  w o r ld , where th e  p h y s ic ia n  is  so dependent on 
in t e r p r e t e r s ) ,  on good d ia g n o s t ic  f a c i l i t i e s  (endoscopy is  a c o s t ly  m ethod, 
th e r e fo r e  th e  lo c a l  budget can r a r e ly  a f fo r d  i t ;  mass scree n ing  is  im p r a c t i ­
c a b le  in  A fr ic a n  -  r u r a l  -  c irc u m s ta n c e s ); and f i n a l l y  on autopsy r e p o r ts .  
(To p e rfo rm  post-m ortem  a u to p s ie s  in  a l l  cases seems to  be p r a c t i c a l ly  im ­
p o s s ib le  because o f  th e  la c k  o f  f a m i ly 's  con sen t a n d /o r due to  r e l ig io u s  
p r i n c ip le s . )
There a re , however, c o n s id e ra b le  v a r ia t io n s  in  in c id e n c e  ra te s .  The 
d is e a s e  i s ,  e .g .  more common in  N ig e r ia  (w here i t s  frequency  is  about f i v e  
pe r c e n t  o f  a l l  m a lig n a n c ie s  and th e  m a le /fe m a le  r a t io  is  2 .6 :1 .0 ) ,  th a n  in  
Uganda and Mozambique /1 2 ,  13, 17, 22, 23, 28, 4 2 , 53, 55, 5 6 /.
In  Rwanda and B u ru n d i, and ea s te rn  Z a ire  g a s t r ic  cancer seems to  be 
th e  m ost common tum our in  men, and i t s  fre q u e n c y  is  a ls o  h igh  around M t. 
K i l im a n ja r o ,  in  (some p a r ts  o f )  Western Kenya and in  th e  West Lake p ro v in c e  
o f  T anzan ia  /3 2 ,  3 3 / b u t ,  in t e r e s t in g ly ,  in  Dar-es-Salaam  (T a n z a n ia )
Dolmans e t  a l .  / 2 1 /  found  o n ly  5 cases o f  g a s t r ic  cancer in  446 endos- 
c o p ic a l ly  in v e s t ig a te d  p a t ie n ts ,  between Septem ber 1978 and March 1980. 
Dent / 2 0 /  g iv e s  da ta  f o r  Rhodesian (Zimbabwean) A f r ic a n s .
A p a rt from  a s ig n i f i c a n t  r e la t io n s h ip  to  b lo o d -g ro u p  A, th e re  seems
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to  be no sug ge s tion  o f  a g e n e tic  o r e th n ic  fa c to r  in  th e  a e t io lo g y ;  -  the  
cause most p ro b a b ly  l i e s  in  e n v iro n m e n ta l fa c to rs  / 3 1 / .
R e la t io n  to  d i f f e r e n t  d ie ta r y  s ta p le - fo o d s  has been suggested  b u t no t 
p roved / 7 / .
A lc o h o l,  sm oking, c a rc in o g e n s  in  g r i l l e d  o r smoked meat o r  f i s h ,  
v ita m in  A d e f ic ie n c y ,  p e rn ic io u s  anaemia, e tc .  have a l l  been suggested  as 
s ig n i f i c a n t  fa c to rs  b u t none have been proved y e t to  be im p o r ta n t  / 1 2 / .
The c l i n i c a l  cou rse  o f  th e  d isease  is  v e ry  s im i la r  to  t h a t  in  the  
w e ste rn  w o r ld . The m a le /fe m a le  r a t io  is  about 2 :1  in  most p a r t  o f  A f r ic a .
Most o f  th e  tum ours o r ig in a te  in  th e  p y lo r ic  o r p r e p y lo r ic  re g io n  
/2 8 ,  4 4 /.  Besides th e  u lc e r a t iv e  fo rm , which is  th e  most common, p o ly p o id  
and i n f i l t r a t i v e  typ e s  a ls o  o c c u r. G a s tr ic  cancer is  an adenocarcinom a w ith  
a spectrum  from  w e l l - d i f f e r e n t ia t e d  to  a n a p la s t ic  / 5 0 / .
Two main groups a re  d is t in g u is h a b le  / 4 1 / :  th e  in t e s t in a l  ty p e ,  which 
i s  c h a ra c te r iz e d  by c e l ls  w ith  a tendency to  cohes ion  and fo rm a t io n  o f 
g la n d u la r  s t ru c tu re s  and " is la n d s " ;  and th e  d i f f u s e  ty p e , c h a ra c te r iz e d  by 
s e p a ra te  c e l ls  th a t  i n f i l t r a t e  in d iv id u a l ly .  A h ig h e r ra te  o f  th e  fo rm er 
v a r ie t y  had been re p o r te d  in  areas w ith  h ig h - in c id e n c e  r a te  o f  g a s t r ic  
carc inom a /5 6 / .  I t  was th e re fo re  unexpected th a t  in  n o r th e rn  N ig e r ia ,  which 
i s  a lo w -in c id e n c e  area / 4 4 / ,  o f  65 specimens c la s s i f ie d ,  by u s in g  the  
c r i t e r i a  o f Lauren / 4 1 / ,  40 were in t e s t in a l ,  16 d i f f u s e ,  2 m ixed and 7 un- 
c la s s i f ia b le ;  these  p a t ie n ts  were m o s tly  young, i . e .  a t  an age w h ich  has 
been th o u g h t to  fa v o u r th e  d i f f u s e  le s io n .
Because e a r ly  symptoms a re  o fte n  m in im a l o r n o n e x is te n t in  th e  po ten ­
t i a l l y  c u ra b le  phase, p a t ie n ts  u s u a lly  seek m ed ica l ad v ice  to o  la t e .  Thus, 
d e s p ite  improved d ia g n o s t ic  and s u rg ic a l te ch n iq u e s  and f a c i l i t i e s ,  le s s  
tha n  10 per cen t o f th e  p a t ie n ts  s u rv iv e  5 y e a rs .
C o lo r e c ta l  cancer
T h is  tumour has f o r  lo n g  been known to  be in fre q u e n t  in  A f r ic a n s  in  
A f r ic a ,  an o b s e rv a tio n  th a t  a p p lie s  to  most o f  the  t h ir d - w o r ld  c o u n tr ie s  
/2 6 ,  29, 47 , 49, 54, 6 1 / .
The in fre q u e n c y  o f  c o lo n ic  carcinom a in  Uganda, as compared to  Eu­
ropean c o u n tr ie s ,  was no ted  by T ro w e ll / 5 7 / ,  who remarked th a t  t h i s  a p p lie s  
to  most p a r ts  o f A f r ic a .  T u rne r /5 8 /  in  Mombasa (Kenya) re p o r te d  o n ly  two 
( a d u l t )  cases per year in  a re t ro s p e c t iv e  s tu d y ; Sande found 49 cases in  a
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f iv e - y e a r  p e rio d  in  N a ir o b i ,  Kenya /5 4 / ,  and W h ite  in  Bulawayo (Zimbabwe) 
re p o r te d  th re e  a d u lt  cases  in  a p e rio d  o f th re e  y e a rs  / 6 0 / .
The Kampala Cancer R e g is t ry  (Uganda) re c o rd e d  in  a p e r io d  o f  9 yea rs  
(1 9 5 2 -1 9 6 0 ) 39 cases, i . e .  1 .3  per cen t o f a l l  c a n ce rs  / 1 8 / .
Umerah and O badike  re p o r te d  5 cases d u r in g  one yea r from  Zimbabwe 
/ 5 9 / ,  w h ile  Johnson f a i l e d  to  f in d  a s in g le  case in  Botswana in  a p e r io d  
o f  6 yea rs  /3 7 / .  Bodoe p u b l is h e d  data fo r  Ghana / 5 / .
The re a l in c id e n c e  o f  th e  d isease in  N ig e r ia  is  unknown; a r a t io  
fre q u e n c y  o f 2 .6  pe r c e n t was re p o rte d  from  Ibadan / 2 4 / .
C l in ic a l  s e r ie s  fro m  Enugu, Ibadan, Lagos and Z a r ia  in d ic a te  th a t  
th e  te a c h in g  h o s p ita ls  each manage from  5 to  20 cases a n n u a lly  /1 ,  3, 46, 48/.
So ra re  is  th e  c o n d i t io n  th a t  s in g le  case re p o r ts  have been con­
s id e re d  w o rth w h ile  in  A f r ic a  / 3 8 / .
However, d u r in g  th e  l a s t  decade e v ide nce  o f  a r i s in g  tendency o f 
c o lo n ic  carcinoma has appeared  ( in  A fr ic a n s )  in  A f r ic a  /2 7 ,  43, 51, 6 2 /.
There is  no do ub t t h a t  en v iro nm en ta l f a c to r s  a re  o f  g re a t im portance  
in  c o lo r e c ta l  cancer /3 1 ,  3 6 / .
The very low  in c id e n c e  o f  c o lo n ic  ca rc inom a in  th e  t r o p ic s  i s  p e r­
haps s u rp r is in g  in  th e  v ie w  o f  the  ve ry  h ig h  in c id e n c e  o f p a r a s i t i c  in fe c ­
t io n s  and o th e r in f la m m a to ry  c o n d it io n s  o f  th e  c o lo n .  S ince am oeb ias is  and 
s c h is to s o m ia s is  a re  v e ry  common th rou gh ou t A f r ic a ,  th e y  a re  o b v io u s ly  n o t 
in v o lv e d  in  the  a e t io lo g y  o f  c o lo r e c ta l c a n ce r.
Regions o f th e  w o r ld  w i th  a h igh  r i s k  f o r  carc inom a o f  th e  co lo n  and 
re c tu m  are c h a ra c te r iz e d  by h ig h  soc io -econom ic c o n d it io n s  w ith  d ie ts  r ic h  
in  b e e f and s a tu ra te d  f a t s  b u t  poor in  f ib r e .
I t  seems v e ry  p ro b a b le  th a t  the  d ie t  o f  common peop le  l i v i n g  in  
t r o p i c a l  (sub-S aharan) A f r ic a  is  ve ry  poor in  c a rc in o g e n s . In  th e  more 
d e v e lo p e d  c o u n tr ie s  s a tu ra te d  fa ts  are f r e q u e n t ly  used f o r  f r y in g ;  in  
A f r i c a ,  on the  o th e r  hand , th e  anim al f a t  in ta k e  i s  u s u a l ly  ve ry  lo w , and 
due t o  th e  very h ig h  c a rb o h y d ra te  and f ib r e  c o n te n t  o f  th e  d ie t  ca rc ino gen s  
may be d i lu te d  c o n s id e ra b ly  by the  la rg e  fa e c a l mass. The h ig h  f ib r e  con­
t e n t  o f  the  usua l d ie t  a ls o  may o f f e r  some p r o te c t io n  /1 0 ,  4 0 / .  M oreover, 
th e  d i f f e r e n t  ( c o s id e ra b ly  lo w e r)  in t e s t in a l  b a c t e r ia l  cou n ts  m ig h t a ls o  
a c c o u n t fo r  the  g re a t v a r ia n c e  o f the  ra te  o f  c a rc in o g e n  p ro d u c tio n  /3 5 / .
A s h o rte r i n t e s t i n a l  t r a n s i t - t im e  is  a ls o  t y p ic a l  in  th e  t h i r d -  
w o r ld ;  consequently  th e  c o n ta c t - t im e  between th e  c a rc in o g e n s  and th e  c o lo r ­
e c t a l  mucosa is  s h o r te r .
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Whether or not "h ig h -fib re " d ie t protects against colonic cancer is  
s t i l l  under debate /8 , 9, 14, 15, 30, 39/.
Cleave /11 / has sought a corre la tion between the consumption of re­
fined sugar and colonic cancer without convincing resu lts .
In the h igh -risk  regions there is  also a high prevalence of pre- 
malignant conditions, such as adenomatous polyps, multiple polyposis, 
v illo u s  adenoma and chronic u lcerative c o l i t is  /3 4 /. These conditions are 
uncommon in  the tro p ica l A frica .
The tumour and the c lin ic a l p icture, when i t  occurs, is  s im ila r to 
that observed in the developed countries.
Two-third (or more) of the tumours develop in  the le f t  ha lf (rec to ­
sigmoid) of the colon; the caecum is  also involved, whereas the intermediate 
areas have a much lower incidence rate. (Short trans it-tim e?)
In N igeria, righ t-s ided  colon carcinomas and obstructing tumours are 
more frequent, but treatab le  pre-malignant conditions are less common than 
in  the western world /2 / .
The tumour is  an adenocarcinoma; u lce ra tive , protuberant and i n f i l ­
tra t iv e  growths occur, the la s t being more common in  A frica than in  temper­
ate countries /25 /.
Mucoid and anaplastic forms are apparently also more common in  A fr ica . 
In tenstina l obstruction is  a very rare complication in  Africans /1 6 /.
The mean age at presentation is  lower than in  western countries /2 / ,  
and the h is to ry of the disease is ,  in te re s tin g ly , longer /4 /.
According to Owor /5 2 /, on the whole, patients with carcinoma of 
colon and rectum, are about a decade younger than th e ir counterparts in  
Europe and North America. This statement has been supported by Adenkule /2 / ,  
and by Opiyo and Din /5 1 /, who have reported four cases of colorectal cancer 
from Zambia under the age of 20 years.
Rectal amoebiasis is  the most important diagnostic problem in  the 
trop ics.
A mass in  the r ig h t i l ia c  fossa in a tro p ic a l country is  l ik e ly  to be 
caused by pyomyositis ( in  the ileopsoas muscle), an appendix mass or ab­
scess or, possibly, by a helminthoma; carcinoma of the caecum is  very low 
on the l i s t  of p o s s ib il it ie s . In areas where schistosomiasis is  common, 
peritoneal granulomas ( in  association with an ir re g u la r, hard l iv e r )  can be 
mistaken fo r abdominal and hepatic secondary deposits from a colonic car­
cinoma; those granulomas, however, tend to be uniform in  size and are es­
pec ia lly  dense on the pe lv ic  flo o r.
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A course of metronidazole should be given in i t ia l ly  on the suppo­
s it io n  that the lesion is  caused by amoeba; i f  amoebiasis is  the correct 
diagnosis, some reduction in  the size of the mass should occur in  72 hours. 
Colonic carcinoma and appendix abscess do not respond to that regime /12 /.
The current approach to treatment of colon cancer is  p rim a rily  surgi­
c a l. The chemotherapy o f colorecta l cancer has been reviewed by Moertel /45/.
At la s t but not at leas t, one should be borne in  mind tha t in  trop­
ic a l A frica , a comparatively large number of the patients are in fected by 
H IV -virus. According to  Bernstein, AIDS ( in  some cases) may cause a d i f ­
fe re n t ia l diagnostic problem /6 / .
Another very important statement is  that the unanimously accpeted 
p r in c ip le , namely mass-screening by endoscopy, detection of occult bleeding, 
e tc . as a preventive step against co lo recta l and gastric malignomas /19 /, 
is  out of question in  most of the th ird -w o rld  countries, fo r the loca l 
budget cannot afford the necessary expenses.
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This study was suggested to evaluate the possible ro le  of porphyrins and DNA, 
and th e ir  in te ra c tio n , in  some photosensitive premalignant and malignant dermatoses. 
Twenty-five pa tients w ith photosensitive skin diseases v iz . xeroderma pigmentosum and 
basal c e ll carcinoma, were randomly selected a t the ou tpa tien t c l in ic  o f Dermatology 
in  Mansoura U n ive rs ity  H ospita l. Twenty-five matched normal ind iv idua ls  were used as 
a contro l group. In  basal c e ll  carcinoma pa tien ts , a high increase in  skin DNA and de­
crease in skin to ta l porphyrin , haemoglobin and haem concentrations were observed. In 
xeroderma pigmentosum, a s ig n if ic a n t decrease in  both skin DNA and skin to ta l por­
phyrin were found, a t the same time, there were e levations in  u rinary  to ta l porphyrin, 
PBG and ALA concentrations, and a high decrease in  haemoglobin and haem le ve ls .
Keywords: Porphyrins, nucle ic acid, photosensitive skin disease, Xeroderma p ig ­
mentosum
In t r o d u c t io n
Reactions o f the skin to sun exposure are of pa rticu la r importance in  
Egypt where sunshine is  intensive almost a l l  over the year and i t s  damaging 
e ffec ts  are p rim arily  due to i t s  u ltra v io le t (UV) component /1 / .  Chronic 
exposure to solar rays over decades often resu lts  in  production of ca rc i­
noma of the exposed areas of the skin /25 /.
Sun exposure plays an important ro le  in  the development of basal c e ll 
carcinoma, the most common carcinoma of the skin , and the tumour has i t s
Abbreviations: ALA = & -am inolaevulin ic acid; ALA-D = S -am ino laevu lin ic  acid de- 
hydraseFt PBG = Prophobilinogen ; DNA = Deoxyribonucleic acid
O ffp rin t requests should be sent to  M.M.H. El-Sharabasy, Che. Dept. Mansoura U n iv., 
Faculty o f Science, Egypt
Akadémiai Kiadó, Budapest
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highest incidence over areas most exposed to sun. Some 3/4 of the in i t ia l l y  
presenting lesions occur on the head and neck /14 /.
Xeroderma pigmentosum is  a rare autosomal recessive disease, in 
which patients develop the solar damage, pigmentation abnormalities and 
malignancies in the area of skin exposed to sun ligh t. The disease has UV 
hypersens itiv ity  and abnormal DNA repair /19 /.
The accumulation o f porphyrins in  the skin w ith aging leads to photo­
dynamic carcinogenesis, which resu lts  from b io lo g ica lly  s ig n if ic a n t damage 
to  DNA in  the form of s ing le  strand breaks and s is te r chromatid exchange 
/1 6 /.  Porphyrins, to evoke cutaneous pho tosensitiv ity , must be present 
close enough to the skin surface to absorb the radiant energy transm itted 
through the skin /2 / .
Pathak and Burnett /23 / showed that porphyrins are normally present 
in  trace amounts in  the human skin and tha t in  porphyria these leve ls  are 
increased. By using fluorescence microscopy, i t  was demonstrated tha t por­
phyrins are present in the stratum corneum, in  the Malpighian c e lls  and in 
the dermis.
The present study was designed to evaluate the possible ro le  of por­
phyrins and DNA and th e ir  in te rac tion  in  some patients su ffering from xero­
derma pigmentosum or basal c e ll carcinoma.
M a te r ia ls  and Methods
M aterials
Twenty-five cases o f photosensitive premalignant or malignant skin diseases o f  d i f ­
fe re n t ages (15-50 years) and both sexes were examined. The pa tients were randomly selected 
from outpa tien ts presenting a t the C lin ic  o f Dermatology, Mansoura U n ive rs ity . They were 
c la s s if ie d  in to  two groups:
-  Xeroderma pigmentosum, 10 pa tients and
-  Basal c e ll carcinoma, 15 pa tien ts .
The diagnosis was based on s t r ic t  h is to ry , c l in ic a l examination and h is topatho log ica l 
exam ination. A group of 25 apparently healthy persons were taken as a con tro l group. Skin 
biopsy from the involved sk in , e spec ia lly  the sun-exposed parts , hands, head and neck. Venous 
blood samples and urine samples were co llec ted .
Methods
The follow ing components were assayed:
Tota l porphyrin in  the blood /2 4 / and skin biopsies /3 / .  Erythrocyte protoporphyrin 
and haem /2 0 /. ALA-D a c t iv ity  /3 2 / .  Haemoglobin per cent /1 2 /. DNA in  skin and blood /2 8 /. 
T o ta l p ro te in  in  leucocytes-a modified method o f lowry /2 1 /. Urinary ALA /3 0 /. U rinary PGB 
/2 6 / .  U rinary coproporphyrin and uroporphyrin /2 9 /.  Creatin ine in  the urine /3 1 / .  The s ta t­
i s t i c a l  analyses of the re s u lts  were carried out according to the method described by Burn 
e t  a l .  /5 / .
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This study was suggested to evaluate the possib le ro le  of porphyrins and DNA, 
and th e ir  in te ra c tio n , in  some photosensitive premalignant and malignant dermatoses. 
Twenty-five pa tients  w ith photosensitive skin diseases v iz .  xeroderma pigmentosum and 
basal c e ll carcinoma, were randomly selected a t the ou tpa tien t c l in ic  of Dermatology 
in  Mansoura U n ive rs ity  H osp ita l. Twenty-five matched normal ind iv idua ls  were used as 
a contro l group. In  basal c e l l  carcinoma pa tien ts , a high increase in  skin DNA and de­
crease in skin to ta l porphyrin, haemoglobin and haem concentrations were observed. In 
xeroderma pigmentosum, a s ig n if ic a n t decrease in  both skin DNA and skin to ta l por­
phyrin were found, a t the same time, there were e levations in  u rinary  to ta l porphyrin, 
PBG and ALA concentrations, and a high decrease in  haemoglobin and haem le ve ls .
Keywords: Porphyrins, nucle ic acid, photosensitive skin disease, Xeroderma p ig­
mentosum
In t r o d u c t io n
Reactions of the skin to sun exposure are of pa rticu la r importance in  
Egypt where sunshine is  intensive almost a l l  over the year and i t s  damaging 
e ffects are p rim arily  due to i t s  u ltra v io le t (UV) component /1 / .  Chronic 
exposure to solar rays over decades often resu lts  in  production of ca rc i­
noma of the exposed areas of the skin /25 /.
Sun exposure plays an important role in  the development of basal c e ll 
carcinoma, the most common carcinoma of the skin , and the tumour has i t s
Abbreviations: ALA = & -am inolaevulin ic acid; ALA-D = 8 -am ino laevu lin ic  acid de- 
hydraseFt PBG = Prophobilinogen; DNA = Deoxyribonucleic acid
O ffp rin t re v e s ts  should be sent to  M.M.H. El-Sharabasy, Che. Dept. Mansoura U niv., 
Faculty o f Science, Egypt
Akadémiai Kiadó, Budapest
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highest incidence over areas most exposed to sun. Some 3/4 of the in i t ia l l y  
presenting lesions occur on the head and neck /14 /.
Xeroderma pigmentosum is  a rare autosomal recessive disease, in 
which patients develop the solar damage, pigmentation abnormalities and 
malignancies in the area of skin exposed to sunlight. The disease has UV 
hypersens itiv ity  and abnormal DNA repair /19 /.
The accumulation o f porphyrins in  the skin with aging leads to photo­
dynamic carcinogenesis, which resu lts  from b io lo g ica lly  s ig n if ic a n t damage 
to DNA in  the form of sing le  strand breaks and s is te r chromatid exchange 
/1 6 /. Porphyrins, to evoke cutaneous photosensitiv ity , must be present 
close enough to the skin surface to absorb the radiant energy transm itted 
through the skin /2 / .
Pathak and Burnett /23 / showed that porphyrins are normally present 
in  trace amounts in  the human skin and that in  porphyria these leve ls are 
increased. By using fluorescence microscopy, i t  was demonstrated tha t por­
phyrins are present in  the stratum corneum, in  the Malpighian c e lls  and in 
the dermis.
The present study was designed to evaluate the possible ro le  of por­
phyrins and DNA and th e ir  in te raction  in  some patients su ffering  from xero­
derma pigmentosum or basal c e ll carcinoma.
M a te r ia ls  and Methods
M ate ria ls
Twenty-five cases of photosensitive premalignant or malignant skin diseases o f  d i f ­
fe re n t ages (15-50 years) and both sexes were examined. The patients were randomly selected 
from outpatients presenting a t the C lin ic  of Dermatology, Mansoura U n ive rs ity . They were 
c la s s if ie d  in to  two groups:
-  Xeroderma pigmentosum, 10 pa tients  and
-  Basal c e ll carcinoma, 15 pa tien ts .
The diagnosis was based on s t r ic t  h is to ry , c l in ic a l examination and h is topa tho log ica l 
exam ination. A group o f 25 apparently healthy persons were taken as a con tro l group. Skin 
biopsy from the involved sk in , espec ia lly  the sun-exposed parts , hands, head and neck. Venous 
blood samples and urine samples were co llected .
Methods
The fo llow ing components were assayed:
Total porphyrin in  the blood /2 4 / and skin biopsies /3 / .  Erythrocyte protoporphyrin 
and haem /2 0 /. ALA-D a c t iv ity  /3 2 / .  Haemoglobin per cent /1 2 /.  DNA in  skin and blood /2 8 /. 
T o ta l p ro te in  in leucocytes-a modified method o f lowry /2 1 /. Urinary ALA /3 0 /. U rinary PGB 
/2 6 / .  U rinary coproporphyrin and uroporphyrin /2 9 /. Creatin ine in  the urine /3 1 / .  The s ta t­
i s t i c a l  analyses of the re su lts  were carried out according to the method described by Burn 
e t a l .  /5 / .
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R e s u lts
Some biochemical abnormalities were observed in the blood, skin and 
urine of xeroderma pigmentosum and basal c e ll carcinoma patients as com­
pared to the control values.
I t  is  clear from Table I  taht the blood haemoglobin per cent was 
highly s ig n if ic a n tly  decreased in the xeroderma pigmentosum group while i t  
was s ig n if ic a n tly  decreased in  basal c e ll carcinoma. These decreases were 
generally accompanied by decreased haem leve ls . In the same pa tien ts , there 
were in s ig n ifica n t changes in  to ta l porphyrin, protoporphyrin and ALA-D ac­
t iv i t y .
Table I
Blood haemoglobin (qH), to ta l porphyrins (uq^), % -am inolaevulinic acid
dehydratase (ALA-D. u n its ) ,  protoporphyrin IX (úrnőid) and haem (mol^) 
in  xeroderma pigmentosum (XP) and basal c e l l  carcinoma (BCC) in  com­
parison to the co n tro l group
Item Control XP BCC
Haemoglobin 
Mean ^  S.D. 
Number
P
12.70 + 1.21 
22
10.30 + 1.55 
10
<0.001
10.95 + 1.69 
12
< 0 .0 1
Tota l porphyrin 
Mean +_ S.D. 
Number 
P
27.40 + 6.03 
20
23.90 + 6.58 
10
> 0 .0 5
30.77 +_ 8.05 
12
> 0 .05
ALA-0
Mean +_ S.D.
Number
P
17.07 + 5.95 
22
13.85 + 4.25 
10
>0.05
16.10 + 8.17 
12
> 0 .0 5
Protoporphyrin 
Mean t  S.D. 
Number 
P
(8.73 + 3.58)10~* 
15
(9.78 + 4.90)10” * 
10
>0.05
(7.76 + 2.01)10” * 
9
> 0 .0 5
Haem
Mean +_ S.D.
Nunber
P
(14.65 + 2.47)10”*  
22
(12.21 + 2.04)10”* 
10
< 0 .0 5
(12.30 + 2 .3 9 )1 0 '*  
12
< 0 .0 1
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Table I I
(uq/qm tissue ) in  xeroderma piqmentosum (XP) and basal c e ll  carcinoma (BCC)
in  comparison to the c o n tro l qroup
Item Control XP BCC
Blood DNA
Mean + S.D. 72.52 + 7.45 69.20 + 5.21 72.60 + 5.78
Nuirber 22 10 11
P >0.05 > 0 .05
Skin DNA
Mean + S.D. 311 + 17.53 274 + 33.46 427 + 94.90
Number 25 8 11
P <0.01 <0.001
Skin to ta l porphyrin
Mean + S.D. 0.966 + 0.421 0.695 + 0.170 0.583 + 0.352
Number 25 7 10
p •tO .01 <0.01
Table I I I
Urinary to ta l porphyrin , Porphobilinoqen (PBG). and á-am inolaevulin in  a rid
(ALA) in  mq/om crea tin in e  in  xeroderma piqmentosum (XP) and basal ce ll ca r-
cinoma (BCC) in  comparison to  the c o n tro l qroup
Item Control XP BCC
Tota l porphyrin
Mean +_ S.D. (17.75 + 3.90)10 (31.8 + 13.27)10'3 (18.90 + 12.91)10~3
Number 16 7 10
P <0.001 > 0 .05
PBG
Mean + S.D. 6.11 + 2.83 8.64 + 3.28 6.67 + 4.23
Number 22 7 9
p < 0 .05 >0.05
ALA
Mean + S.O. 2.51 + 0.92 4.09 + 1.70 2.59 + 1.62
Number 22 7 9
P < 0 .01 >0.05
Table I I  reveals tha t blood DNA did not change in e ither the xero­
derma pigmentosum and basal c e ll carcinoma group. However, skin DNA was 
s ig n if ic a n t ly  decreased in  xeroderma pigmentosum and highly s ig n if ic a n tly  
increased in  basal c e ll carcinoma group. Skin to ta l porphyrin was s ig n i f i ­
can tly  decreased in  both groups of patients.
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In xeroderma pigmentosum, the mean concentrations of urinary to ta l 
porphyrin, ALA and PBG were increased, however, there were no considerable 
changes in  these parameters in  basal c e ll carcinoma (Table I I I ) .
D iscuss ion
Oxidized porphyrins are fluorescent and th e ir  importance in  c lin ic a l 
dermatology is  related to the fact that they may accumulate in  the skin and 
th e ir  exposure to certa in  wave length is  followed by cutaneous photosensi­
t iz a tio n  /27 /. Cutaneous photosensitiv ity  may be associated with increased 
porphyrin levels in  the skin , erythrocytes and/or blood plasma /9 /.
In 1935, Korbler /19 / suggested that the accumulation of porphyrins 
in  the skin with aging leads to photocarcinogenesis. Since then, a number 
o f reports have supported the in terp lay between porphyrins and DNA damage 
in  inducing tumours.
As shown by the present resu lts , haemoglobin per cent was decreased 
in  both xeroderma pigmentosum and basal c e ll carcinoma. This decrease may 
be a ttribu ted  to the fa c t tha t the disease is  reported mainly in  patients 
from ru ra l regions; our patients were mainly farmers liv in g  at a low stan­
dard of l i f e ,  they must have been predisposed in  the form of n u tr it io n a l 
deficiency brought about by shortage of intake or by gas tro in tes tin a l up­
sets, which may have been due to in te s tin a l worm in fes ta tion  or schistoso­
miasis /13 /. On the other hand, th e ir anaemia may be a ttr ibu ted  to m ultip le 
neoplasia in xeroderma pigmentosum cases /22 /.
In xeroderma pigmentosum, urinary to ta l porphyrin and the porphyrin 
precursors, ALA and PBG were elevated. These elevations could be understood 
on the lig h t of abnormalities in  the a c t iv it ie s  of most enzymes of the haem 
biosynthestic pathway /1 1 /.
The present study indicates also that both the DNA and to ta l por­
phyrin levels in the skin samples from xeroderma pigmentosum patients where 
decreased. There is  no sa tis facto ry  explanation fo r the decrease of skin 
DNA leve l in  these cases. The decrease of the to ta l porphyrin might be 
understood as a consequence of the in h ib it io n  of the enzyme copro-oxidase, 
as previously suggested by Hegazy et a l. /1 7 /. These authors stated that 
the decrease of to ta l porphyrin in  xeroderma pigmentosum may be due to 
blocking of copro-oxidase and accompanying p a ra lle l changes in  the cor­
responding protoporphyrin/haem ra tio . The in h ib it io n  of copro-oxidase w il l
104 EL-SHARABASY, e t  a l .
re s u lt in  an accumulation of coproporphyrin and uroporphyrin, which are 
both highly hydrophilic and almost completely excreted in  the urine. Ac­
cord ing ly , the urine le v e l of to ta l porphyrin w i l l  be elevated as in  the 
present study.
Our results ind ica te  tha t the photosensitiv ity  in  xeroderma pig­
mentosum cases is  associated w ith a decrease of both DNA and to ta l porphy­
r in  in  the skin. The degree of photosensitiv ity may depend on the type and 
quan tity  of porphyrins in  skin and plasma /1 0 /. So, the estimation of skin 
to ta l porphyrin concentration seems not to be a re lia b le  diagnostic factor 
helping in the c l in ic a l management of the patients. Rather, i t  is  probable 
th a t the estimation of some spec ific  porphyrin isomer(s) (type and quantity 
o f th a t isomer) may be of d iagnostic value in  these patients.
Epstein et a l.  /1 5 / reported that the in h ib it io n  of DNA, RNA and 
p ro te in  synthesis and m itos is  formation occurred w ith in  the f i r s t  hour 
a fte r  ir r id a tio n  and persisted for several hours therea fte r. In 1968, 
Cleaver /6 / reported tha t skin fib rob lasts  from xeroderma pigmentosum pa­
t ie n ts  are unable to repa ir normally a fte r exposure to a certa in  type 0V 
l ig h t  because th is  l ig h t  induced damage in th e ir  DNA. This DNA repa ir de­
fe c t is  most l ik e ly  due to a lack or in s u ff ic ie n t amount of DNA endo­
nuclease, which is  an essentia l enzyme that in h ib its  the repair of UV - 
damaged DNA /7 /.
In basal c e ll carcinoma patients, there are no considerable changes 
in  the urinary to ta l porphyrin, ALA and PBG while a s ig n ifica n t increase 
in  cutaneous DNA is  observed in  addition to a decrease in  the to ta l por­
phyrin concentration in  the skin . This find ing is  in  accordance with the 
find ings  of Bohm and S and rilte r /4 /  and Collste et a l.  /8 / as regards the 
increase in  DNA in  so lid  tumours and i t s  value in  serving diagnostic pur­
poses. However, the decrease in  the skin to ta l porphyrin may be understood 
on the basis of the p o s s ib il ity  that porphyrins pa rtic ipa te  in  the induc­
tio n  o f ac tin ic  damage.
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A C TIV ITIE S  OF SERUM CATHEPSIN (B , H AND L ) AND METALLOPROTEINASE 
(M V 7-A S E ) IN  PATIENTS WITH GASTROINTESTINAL AND BRONCHIAL 
MALIGNANT TUMOURS
ARANKA LÁSZLÓ1, I .  S0HÁR2, S. KARÁCSONYI3, A. PETRI3 ,
I .  TRÓJÁN3
1 2  3Pediatric Department, Biochemical In s t itu te , Department of Surgery, 
Albert Szent-Györgyi University Medical School, Szeged
(Received: October 23, 1989)
Serum lysosomal cysteine protéinases cathepsin B, H, L and m etalloproteinase 
(PMP7-ase) a c t iv it ie s  o f 14 patients su ffe rin g  from gas tro in te s tin a l and bronchia l 
carcinomas were investiga ted . The serum cathepsin В and H a c t iv it ie s  were s ig n i f i ­
cantly diminished in  the carcinoma group as compared to the con tro ls , w h ile  the ac­
t i v i t y  o f cathepsin L and o f PMP7-ase was normal.
Keywords : Serum, cathepsin B, H, L, m etalloproteinase, pa tients , g a s tro in te s t i­
na l, bronchial carcinomas
In t r o d u c t io n
A lysosomal cysteine proteinase, cathepsin В has been reported to be 
involved is  p ro life ra tio n  and metastatic potentia l of malignant experi­
mental tumours /3 / and human mammary and cerv ica l carcinomas /2 / .
Elevated pro te inase-like peptidase a c t iv it ie s  (collagenase, cathepsin 
B, cathepsin В + L, cathepsin H and D) were observed in  homogenates of 
gastric  cancer tissue, suggesting an important role of these enzymes in  
tumour invasion /5 / .
A c tiv it ie s  of serum cysteine proteinases and metalloproteinase were 
investigated in the present study in  gastro in tes tina l and brocnhical can­
cerous patients of the Department of Surgery (Szeged).
O ffp rin t requests should be sent to  Aranka László, P ed ia tric  Department, H-6701,
P.0. Box 471, Hungary
Akadémiai Kiadó, Budapest
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M a t e r ia l  and M ethods
Serum cathepsin 8, H, L and metalloproteinase (MMP7-ase) a c t iv it ie s  o f 14 pa tien ts  
having g a s tro in tes tina l (h e p a tic , g a s tr ic , pancreatic, re c ta l)  and bronchial cancer confirmed 
by h is to lo g ic a l examinations were analysed.
Serum cathepsin B, H, L and NMP7-ase were determined f lu o r im e tr ic a lly  using syn thetic  
peptide substrates (4-methyl-7-coumaryl-amide = MCA) / 1 / .  PMP7-ase hydrolyses succ in y l- 
a lanyl-alanyl-prolyl-phenylalanyl-(Suc-A la-A la-Pro-Phe-M CA) substrate / 4 / .
R e su lts
Serum cathepsin В and H a c tiv it ie s  were s ig n if ic a n tly  diminished in  
the tumorous group as compared to controls (Table I ) ,  while the cathepsin L 
and MMP7-ase a c t iv it ie s  were approximately equal in  both groups.
Table I
A c t iv it ie s  of serum cyste ine proteinase (cathepsin B, H, L) and metalloproteinase (MMP7-ase)
Enzyme
Tumours group Control group
mean
mU/ml + S.D. t  probe
mean
mU/ml + S.D.
Cathepsin В 3.66 4.1 P <  0.001 20.65 11.84
Cathepsin H 79.64 29.99 P <  0.001 104.8 6.5
Cathepsin L 1.6 1.03 P > 0 .0 5 1.89 0.98
M etalloproteinase 7.26 4.33 P > 0 .0 5 7.55 3.29
U = micromol x min
D iscuss io n
Watanabe et a l.  /6 /  published th e ir  re su lts  a fte r we had fin ished 
our investigations; they found higher cathepsin В and L a c t iv it ie s  in  the 
tumorous tissue than in  the surrounding tumourfree one, ind ica ting  tha t 
the elevated cathepsin a c tiv ité s  are related to p ro life ra tio n  and envolve- 
ment of gastric cancer.
Independently o f Watanabe's group we measured the a c tiv ity  of cys­
t in e  proteinases and MMP7-ase in  serum samples from tumorous patients not 
d ire c t ly  from the cancer tissue.
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The lower enzyme a c t iv it ie s  in  the tumorous pa tien ts ' sera may re­
f le c t  increased u t i l iz a t io n  fo r the ce llu la r a c t iv ity  and fo r tissue de­
struc tion .
Further cysteine proteinase and metalloproteinase investigations 
should be made a fte r resection of d iffe re n t tumours to evaluate the ro le  
of the above-mentioned enzymes in  the p ro life ra tio n  and metastatic capacity 
of gas tro in tes tina l and bronchial carcinomas.
Furthermore, i t  is  known that alfa-2-macroglobulin can in h ib it  lyso­
somal cysteine proteinases. The lower proteinase a c t iv it ie s  in  serum can 
also be produced by higher concentration of proteinase in h ib ito rs  found in  
serum.
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Hexachlorobenzene
Proceedings of an In terna tiona l Symposium. (IARC, S c ien tific  Publications
No. 77.)
Eds: C.R. MORRIS and J.R .P . CABRAL 1987 
Price: 50.00 Í
This volume contains the proceedings o f an international symposium on 
hexachlorobenzene (HCB), held in Lyon, France 24-28 June 1985. HCB is  used 
as a fungicide in  various regions of the world. Being present in  some 
pesticides and in d u s tr ia l wastes i t  is  also important as a source of im­
p u ritie s . HCB is  h igh ly resistant to degradation and easily dispersed in  
the environment, as is  illu s tra te d  by the epidemic poisoning that occurred 
in Turkey during the 1950s. The book contains a co llection  of in te rp re ta tive  
overviews of the occurrence, chemical p roperties and manufacturing, as well 
as the d is tr ib u tio n  of HCB the environment. I t  summarizes the persistence 
and pathways of HCB from the technosphere in to  the athmosphere. Several 
health e ffec ts  of HCB are described in  the chapter "Human Observations". 
HCB is  one member of a small group of polyhalogenated aromatic hydrocarbons 
that are capable of causing cutaneous porphyria in  humans.
In Turkey the porphyria was accompanied by neurotoxic symptoms, v iz . 
sensory motor neuropathy and myotonia. There are some evidences based on 
epidemiological data suggesting that HCB exposure or poisoning may associ­
ate with an elevated incidence of primary l iv e r  cancer. This volume of the 
IARC Monographs concludes tha t there is  s t i l l  a considerable burden of HCB 
in  human population as well as in our environment. Even with the obvious 
technological advances, several questions remain unsolved. Their so lu tion  
would require highly innovative research, new c r i t ic a l  approaches to  de­
velop in te rna tiona l cooperations. A re g is te r would be useful to assess 
world research in  th is  f ie ld .  This volume of the WHO IARC Monographs seems 
to be the f i r s t  step in  th is  d irection.
ANNA TOMPA
Some Halogenated Hydrocarbons and Pesticide Exposures 
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to 
Humans. Vol. 41. WHO, IARC, Lyon, France 1986 
Price : Sw.Fr. 6 5 .-
This volume of IARC Monographs deals w ith  11 of halogenated a lip h a tic  
hydrocarbons, b is (2 -ch lo ro -l-m ethy l)e ther, polybrominated biophenyls and 
am itro l. Some of these compounds have already been evaluated by the IARC 
and th e ir  l i s t  is  published in  th is  volume again. The importance of ha l­
ogenated alkanes is  due to the large quan tity  o f the annual production in  
the developed countries. Therefore, IARC analysed th is  group of chemicals 
with special in te res t and reevaluated th e ir  carcinogenecity, based on the 
very recent data base.
Because of the extreme to x ic ity  o f some polychlorinated dibenzo-di- 
oxins and polychlorinated dibenzofurans, h igh ly  selective and sp e c ific  ana-
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ly s is  is  required to detect even low levels of these compounds in  order to 
minimize occupational exposure. These compounds have a considerably high 
odour threshold and th is  may cause problem in  th e ir  everyday use and ex­
p la in s  the re la tive ly  high number of in tox ica tion s .
Evaluation of these chemicals was not easy fo r the Working Group. A l l  
short-te rm  test systems were taken in to  consideration, although, some of 
them were not reproducible between laboratories.
Case control studies offered an a lte rna tive  approach to cohort 
s tud ies fo r assessing the corre la tion between certa in exposures and the 
sporadic appearance of rare diseases. In these studies the increased r is k  
has been associated mainly with chlorophenoxy herbicides and with ch lo ro - 
phenols. Four compounds were found to have su ffic ie n t evidence of the 
carc inogen ic ity in  experimental animals, but none of them showed any e v i­
dence of human carcinogen ic ity. Most of these chemicals were suspect o f in ­
creasing other environmental contaminants' to x ic ity  and of exh ib iting  syn­
e rg is t ic  e ffects. Looking at th e ir inhalation and skin to x ic ity , i t  is  con­
cluded that chlorophenoxy herbicides have only lim ited  evidence of the car­
c inogen ic ity  of occupational exposure to humans.
ANNA TOMPA
Some Naturally Occurring and Synthetic Food Components, 
Furocoumarins and U ltra v io le t Radiation 
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals 
to Humans. Vol. 40. WHO, IARC, Lyon, France 1986 
P rice : Sw.Fr. 65 .-
This volume of IARC Monographs contains 20 items from na tu ra lly  oc­
cu rrin g  and man-made food and food additives or other compounds which may 
have been used in therapy with UV rad ia tion .
Diets have an increasing role as facto rs  causing cancer in  humans and 
some compounds taken together with food may influence the endogenous fo r ­
mation of d iffe ren t carcinogens (nitroso-compounds). Therefore, in  the 
fu tu re  the composition o f the human meals w i l l  have a prominent importance 
in  cancer research and cancer prevention. This fact underlines the im port­
ance o f th is  volume, which gives a detailed l i s t  of the current data re ­
la te d  to th is  top ic.
The importance of analysing the carcinogenicity of the natura l and 
syntheth ic food is  not new in  the IARC Monographs. Since 1969, the Agency 
has evaluated more than 30 food additives and food contaminants and more 
than 20 naturally occurring edible m aterials, and gave evidence of carcino­
g e n ic ity  fo r both animals and men fo r more than 30 food add itives .
In th is  volume the Agency considers na tu ra lly  occurring tox ins : 
bracken fern and some of i t s  constituents v iz . c i t r in in ,  patu lin  and rugu- 
lo s in .  Among the food additives benyzl acetate, butylated hydroxyanisole 
(BHA), butylated hydroxytoluene (BHT) and potassium bromate were evaluated. 
In  these two groups three compounds were found carcinogenic to experimental 
animals: bracken fern , BHA and potassium bromate. However, there is  no su f­
f ic ie n t  evidence fo r the carcinogenicity o f these substances to humans.
The th ird  group o f compounds dealt w ith  in  th is  volume comprises 
seven heterocyclic amines in  food: these appear during pyrolysis of d i f ­
fe re n t heterocyclic amino acids. They are formed from heated proteins con­
s is t in g  two classes of N-heterocyclic primary amines of e ither carbolines
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or imidazoquinolines. A f in a l conclusion of these compounds' carcinogenic 
po ten tia l has not been made yet because sa tis fac to ry  human data f a i l .  The 
f in a l group of the compounds dealt w ith includes a number of furocoumarins 
which are used c l in ic a l ly  together with UV-treatment. C itrus o ils ,  such as 
bergamot o i l ,  contain psoralen, which is  used not only in  food but also in  
d iffe re n t suntanning products. In the absence o f UV-light, furocoumarins 
have no s ig n ifica n t therapeutic or genotoxic e ffe c t. This is  important not 
only fo r the therapeutist but also fo r users of bergamot-oil-scented cos­
metics, or fo r any other p rac tica l use of thes products.
ANNA TOMPA
The Relevance of N-nitroso Compounds to  Human Cancer.
Exposures and Mechanisms
IARC S c ie n tif ic  Publications No. 84. WHO, IARC, Lyon France 1987 
Eds: H. BAR1SCH, I .  O'NEILL and R. SCHULTE-HERMANN 
P rice : 50.00 £.
IARC S c ie n tif ic  Publications serve the programme conducted by the 
WHO to study po ten tia l carcinogens in  human environment. They intended also 
to contribute to the dissemination of a u tho rita tive  information on d i f ­
ferent aspects of cancer research.
This volume contains the Proceedings of the Ninth International Meet­
ing on N-nitroso Compounds held in Baden (A ustria ) in  1986. I t  is  dealing 
with the carcinogenic and mutagenic e ffects of d iffe re n t N-nitroso com­
pounds, considering th e ir  mechanism of action at the molecular and b io­
chemical le ve l. There is  a detailed description of th e ir  metabolism in  vivo 
as well as th e ir  reaction with macromolecules in  v it ro .  The volume also 
contains methods fo r detection of N-nitroso compounds in  gastric ju ice , and 
in  food and drinks.
The b io log ica l e ffects  of N-nitroso compounds are described in  
Chapter 5 in  d iffe re n t in  vivo and in  v itro  experimental models. Chapter 6 
deals with endogenous formation of nitrosamines from the n itr ite -re a c tiv e  
compounds in  vivo; th is  process was analysed also a fte r alcohol intake and 
a fte r high cysteine intake, which modulates the process.
The measurement of v o la t ile  n itroso compounds in  the a ir ,  in food or 
in  d iffe re n t drugs give some evidence about the leve l of environmental 
exposure.
The role of the n itroso compounds in the tobacco and in bete l-quid , 
which can cause cancer, is  discussed in  Chapter 9. Methods fo r analysis of 
spec ific  markers which have been detected in  some tobacco smokers is  also 
included. ■ “T -postlabe ling  assay is  used fo r determining the d iffe re n t ad­
duct formations. By adding proline to the bete l-qu id  mixture and then ana­
lysing the saliva of chewers i t  has been demonstrated that some of these 
nitrosamines are formed during chewing.
In the la s t Chapter of the volume papers are presented on the c l i n i ­
cal and epidemiological studies, convincing the reader of the relevance of 
the experimental data to humans.
Some of the conclusions of human studies are re a lly  important. For 
example they emphasize the importance of maternal and paternal exposure to 
N-nitroso compounds in  the increase of childhood brain cancer in th e ir  o f f ­
springs. Although i t  was already known that food intake and the qua lity  of 
the food can influence the incidence of gas tric  cancer, the benefic ia l e f-
114 BOOK REVIEWS
fe e t of c itru s  f r u i t  consumption and tha t fib res  can reduce g as tric  cancer 
incidence is  a new discovery.
Besides these examples, the Proceedings present a number of recently 
developed and sensitive methods fo r measuring b io log ica lly  active doses of 
N-nitroso compounds and give stra teg ies to the ir application in  human 
studies in  cancer prevention.
ANNA TOMPA
THE NINTH ANNUAL MEETING OF 
THE SOCIETY OF MAGNETIC RESONANCE 
IN  MEDICINE
SCIENTIFIC MEETING AND EXHIBITION 
August 18-24, 1990 w il l  be held in  New York C ity , U.S.A.
For more information contact SMRM,
1918 University Ave., Suite 3C 
Berkeley, CA 94704, U.S.A.
Telephone (415) 841-1899. Fax (416) 841-2340.
I f  you require fu rthe r d e ta ils , please c a ll our business o ff ic e  at 
(415) 841-1899 or fax (415) 841-2340
3 rd  INTERNATIONAL CONGRESS ON TRACE ELEMENTS IN MEDICINE AND BIOLOGY
CHROMIUM AND TRACE ELEMENTS IN  ENDOCRINOLOGY
15 - 18 January 1991
The French Society fo r Study and Research on Essential Trace Elements 
organizes i ts  Third Congress on Trace Elements in Medicine and Biology 
at Les Deux Alpes (France), January 15-18, 1991.
For add itiona l inform ation contact:
A r le tte  ALCARAZ -  Laboratoire de Biochimie С -  CHRU de Grenoble, 
BP 217 X, 38043 GRENOBLE CEDEX.
T é l: 76.42.81.21, extension 4465
6TH WORLD CONGRESS IN  ULTRASOUND. 1 - 6  SEPTEMBER 1991
The 6th World Congress in  Ultrasound w i l l  be held in  Copenhagen, 
from September the 1 s t to  6 th 1991.
The congress is  sponsored by the World Federation fo r Ultrasound 
in  Medicine & Biology.
C o n g re s s  S e c r e t a r i a t :
Spad ille  Congress S ervice, Sommervej 3,
DK-3100 Hornbaek, Denmark
Phone: + 452202496 T e le fax: + 452200160.
A fte r May 89:
Phone: + 4542202496 T e le fax : + 4542200160.
2nd In te rna tiona l Congress on 
THE IfMJNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS
- Mechanisms and Therapeutic Approaches
Munich, West Germany 
March 6th -  9th, 1991
THE DEADLINE FOR ABSTRACTS IS OCTOBER 20th, 1990
F o r  f u r t h e r  i n f o r m a t i o n ,  p l e a s e  c o n t a c t  t h e :
Local Organizing Secretary 
dr. Eugen F a is t
Ludw ig-M axim ilians-Universität Munich 
Klinikum Grosshadern 
Dept, o f Surgery 
Postfach 70 12 60 
8000 Munich 70, FRG 
T e l.: (089) 70 95- 34 41 
34 36
Fax.: (089) 70 95- 7 00 44 18
W O R LD  H EALTH  O R G A N IZA TIO N
IN TE R N A TIO N A L A G ENC Y FOR RESEARCH ON CANCER
O U R S E  O N  M O L E C U L A R  B I O L O G Y
F O R  C A N C E R  E P I D E M I O L O G I S T S
IARC, LYON, FRANCE -  18-27 SEPTEMBER 1990
The course is intended for cancer epidemiologists who feel the need to understand 
more of the modem developments in molecular biology, and to foresee the impact that 
these may have on epidemiological research in the future.
The aims o f the course are:
• to present the key concepts in the rapidly evolving fields of molecular biology and the biology of viruses
in the context of the biology of cancer
• to prompt discussion of their relevance to cancer etiology and to etiologically-oriented epidemiological
research
• to consider future lines of development in the area of ‘molecular epidemiology’
The course w ill cover:
• general principles of cellular biology
• general principles and techniques of molecular biology
• viruses and human cancer (human papilloma virus, Epstein-Barr virus and hepatitis В virus)
• oncogenes, recombinant DNA, tumour suppressor genes
• multistage mechanisms of carcinogenesis
• DNA adducts and repair in humans
• linked polymorphisms and inherited conditions
• detection and analysis of somatic mutations in humans
• metabolic activation of carcinogens in human tissues
The potential applications of molecular biology techniques to epidemiological studies will be discussed.
The course programme is coordinated by John Cairns (Harvard School o f Public Health, Boston, M A, USA) and 
Ruggero Montesano (IARC, Lyon, France) The teaching faculty also includes:
Monica Hollstein (IARC, Lyon, France)
Bo Lambert (Department o f C linical Genetics, Karolinska Institute,Stockholm)
Gilbert Lenoir (IARC, Lyon, France)
Jim Mullins (Department of Microbiology and Immunology, Stanford University Medical School, CA, USA) 
Nubia Munoz (IARC, Lyon, France)
Bruce Ponder (CRC Human Cancer Genetics Research Group, University of Cambridge, UK)
Rodolfo Saracci (IARC, Lyon, France)
Bakary Sylla (IARC, Lyon, France)
Natalie Teich (Imperial Cancer Research Fund Laboratories, London)
Chris Wild (IARC, Lyon, France)
Roland Wolf (ICRF laboratory of Molecular Pharmacology and Drug Metabolism, Edinburgh, UK)
The working language o f the course will be English, and participants will be expected to have a reasonable 
knowledge of spoken English.
No charge will be made for the course but participants w ill be expected to find their own support for travel and 
accommodation. Limited funds are available for participants requiring some assistance.
F u rthe r in fo rm ation  and app lica tion  form s may be obtained from :
The Unit of Education and Training, International Agency for Research on Cancer 
150, cours Albert Thomas -  69372 Lyon Cedex 08 -  France
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RADIOLOGY POSTGRADUATE EDUCATION
Enclosed are the announcements for the fo llow ing courses which we fe e l 
w i l l  be of in te res t to the readers of your publication.
CT, MR, In  Body Im ag ing :
May 22-25, 1990
A Com prehensive Course:
Monterey, CA
Roentgen R e v is ite d :
June 17-27, 1990 Munich, Salzburg, Vienna
M ic ro s u rg e ry  F o r C e re b ro v a s c u la r D isease
July 13-15, 1990 San Francisco, CA
P e d ia t r ic  N e u ro ra d io lo g y
October 13-14, 1990 Washington, D.C.
Head and Neck Im ag ing :
October 14, 1990
Update 1990
San Francisco, CA
C l in ic a l  M agne tic  Resonance Im aging
October 15-19, 1990 San Francisco, CA
V a s c u la r U ltra s o u n d : S ta te  o f  the  A r t
October 20-21, 1990 San Francisco, CA
D ia g n o s t ic  R a d io lo gy  Sem inars
November 5-9, 1990 Manui, HI
F o r  f u r t h e r  i n f o r m a t i o n  p l e a s e  c o n t a c t :
Radiology Postgraduate Education, U n ivers ity  o f C a lifo rn ia
521 Parnassus Avenue, Room C-324
San Francisco, CA 94143
Phone: (415)476-5731
Fax: (415)476-9213

HEVIZOS®
o in tm en t Antiviral chemotherapeutic
For top ica l use in Herpes virus in fections.
The active substance o f HEVIZOS in h ib its  viral g row th  by in terfering w ith  the 
D N A  synthesis in viral cells. Most of the  app lied  dose is localised in the  skin and 
does not exert a system ic effect.
Active substance
80 mg of 3 -/2 -d e o x y -ß -D -rib o fu ra n o z il/-5 - is o p ro p y l-u ra c il in 10 g of 
w ater-so lub le  suspension ointment.
Indications
For the local treatm ent o f recurrent herpes simplex, herpes zoster and herpes 
progenita lis infections.
Contraindications 
N one know n to  date.
Application
A p p ly  HEVIZOS in a th in  layer to the a ffected area 3 to  5 times daily. D uration of 
the  treatment is 3 to  5 days w hich may be raised to 6 to  12 days in exceptional
cases.
Adverse reaction
M ild  transient burn ing sensation.
How supplied
10 g o f o in tm ent in tube  and cardboard box w ith  package insert.
Produced by
BIOGAL Pharmaceutical Works, Debrecen/Hungary
Cavinton improves cerebral metabolism
— Increases the oxygen-utilization of the 
brain tissue
— Increases the anoxia- tolerance of the 
brain cells
— Shifts to aerobic way the glucose me­
tabolism
— Inhibits phosphodiesterase activity
— Stimulates adenylcyclase activity in­
creasing cAMP concentration of the 
brain cells
— Increases ATP concentration
Cavinton improves microcirculation
— Inhibits adenosine uptake of the RBC
— Inhibits platelet aggregation
— Decreases high blood viscosity
— Increases RBC deformability
— Promotes the 0 2 transfer to the tissues
— Stimulates glucose penetration through 
the blood-brain barrier
Cavinton increases cerebral blood flow
— Increases selectively and intensively 
the CBF
— No steal-effect
— Inverse steal-effect
— Does not cause bradycardia or hypo­
tension
— Increases vasodilatation induced by 
hypoxia
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NEUROLOGY
SOMATOSENSORY EVOKEO PÜTEN1IALS ELICITED HY STIMULATION ОТ THE 
POSTERIOR TIBIAL NLRVE IN PATIENTS WITH MULTIPLE SOLI ROSIS
J.L. CZOPF, L. KELLÉNYI and J . CZOPF
Department of Neurology and In s t itu te  of Physiology, University of Pécs, 
Medical School, Pécs, Hungary
(Received: June 5, 1990)
Normal con tro l somatosensory evoked p o te n tia l data (e l ic ite d  by s tim ula tion  o f the 
pos te rio r t ib ia l  nerve), o f 20 healthy subjects were compared to the e lec trophys io log ica l 
data o f 20 pa tients w ith the diagnosis o f d e f in ite  or probable m ultip le  s c le ro s is . The 
demyelinating process a ffe c ts  a l l  segments o f the response, causing increase in  la tency and 
decrease in  amplitudes as w ell as lack o f the p o te n tia ls  during the disease. Based on the 
l i te ra tu re ,  the neuro log ica l lo c a liz a tio n  values o f TPSEP are summarized. Due to  i t s  o u t­
standing s e n s it iv ity  in  these cases, the procedure as advised by the authors should be used 
in  demyelinating processes and in  other sp ina l cord disease o f d iffe re n t a e tio lo g y .
Keywords: m u ltip le  sc le ros is , c l in ic a l  electrophysiology, evoked p o te n tia l, p o s te r io r 
t ib ia l  nerve.
In troduction
M ultip le  sclerosis (MS) is  a common organic neurological disease, 
a ffe c tin g  mostly young adults and re su ltin g  in  stepwise progression to 
early  d is a b il ity .  In the c l in ic a l diagnosis of m u lt ip lic ity  ( i .e .  fo c i in  
white matter) the evoked po ten tia l (EP) technique has gained an important 
ro le  in  the la s t two decades. EPs are e le c tr ic  changes of brain a c t iv ity  of 
low in te n s ity  e lic ite d  by re p e tit ive  external s t im u li.  In 1947, Dawson /1 2 / 
succeeded fo r the f i r s t  time in  reg is te ring  somatosensory EPs by e le c tr ic  
s tim u la tion  of the lower limb nerve which he recorded as "co rtica l response"
Abbreviations: MS = M u ltip le  sc le ro s is ; EP = evoked p o te n tia l; TPSEP = somatosensory 
evoked po ten tia ls  e l ic ite d  by stim ula tion  o f the pos te rio r t i b ia l  nerve; SEP = somatosensory 
evoked p o ten tia l
O ffp r in t requests should be sent to  J .L . Czopf, H-7623 Pécs, P.O.Box 99, Hungary
Akadémiai Kiadó, Budapest
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In 1963, Liberson et a l. /31 / recorded potentia ls over the spinal 
cord, evoked by e le c tr ic  stim ulation. -  Following the investiga tions of 
Cracco et a l. /9 /  -  the procedure has become a routine procedure in  the 
c l in ic a l e lectrophysio log ica l diagnosis. Ih is  method, by monitoring the 
propagation of the stimulus along the somatosensory system, enables the 
c lin ic a l neuro log ist to  localize pathologic functions and detect c l in ic a l ly  
s ile n t  foc i.
PAÏIENTS AND MEÏHODS
Data from 20 hea lthy adult persons were compared to  those from 20 MS p a tie n ts . A l l  
the patients had a d e f in ite  or probable form o f the disease; three o f them were o f completely 
normal sensory fu n c tio n , the others showed moderate signs o f motor or deep sensory d is ­
turbance of sp ina l cord o r ig in .  Degrees o f c l in ic a l  c e r ta in ty  have been established according 
to  Bauer's c r i te r ia  /4 / .
S tim u la tion . The posterio r t ib ia l  nerve was stim ulated behind the medial ankle w ith 
s u p e rfic ia l e lectrodes. A constant current generator produced square pulses o f 0.5 ms dur­
a tion  and 1/s frequency. A fte r determining the sensory threshold, an in te n s ity  -  somewhat 
higher than the motor th resho ld  -  was induced, which e lic ite d  a tw itch  in  the sho rt f le xo rs  
o f the ha llux. (Th is  va lue was 2-5 times higher than the sensory th resho ld .) Both lower ex­
trem itie s  were examined in  each case.
R e g is tra tio n . The po ten tia ls  were re g is te re d  a t points C3 and C4 -  being the active  
s ite s  and at po in t CO -  being the reference p o in t - ,  according to  the 10-20 electrodes a r­
rangement system. Frequency transmission o f the a m p lifie r  was 50-2000 Hz. The sampling 
frequency o f the averager (Kell-512-D-81-2), was 2 kHz. 512 ind iv idua l responses were aver­
aged, and every r e g is t ra t io n  was repeated a t le a s t tw ice . Taking in to  account the d iffe rences 
in  the length o f the ex trem ities , co rrec tions  were performed in  la tency measurement.
Evaluation o f the response. The absolute la tency values o f waves in  the c o r t ic a l 
po ten tia l measured w ith in  the f i r s t  120 ms (P1-N1-P2-N2-P3-N3-P4), the amplitudes from peak 
to  peak of the in d iv id u a l segments were evaluated. The mean value, standard dev ia tions o f the 
normal material and the so-ca lled  confidence e ll ip s e s  ( i . e .  the d is tr ib u tio n  f ie ld  o f normal 
w ith  2 SD p ro b a b ility )  were calculated, l im i t  values (low and high extremes) were also de­
termined and used to  d if fe re n t ia te  the normal from pa tho log ica l response.
RESULTS
Figure 1 and Table I  show s ta t is t ic a l  data fo r the normal re­
sponses. The abnormal TPSEP values in  a l l  cases of MS re fle c t les ion in  the 
a fferent sensory system. In cases w ith  sp ina l cord lesions TPSEP may be 
absent (Fig. 2 ). As shown in Fig. 3, an increase in  latency, a decrease in  
amplitude, and lack o f certain components were observed. Pathological a lte r ­
ations were also frequent in patients devoid of detectable c l in ic a l sensory 
symptoms (documentation of subc lin ica l le s io n ). In three patien ts the 
neurological sensory findings were normal in  every respect -  and in  two out
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SEP
Slim. ■' left post, 
tibial nerve
Reg СД -Co
Fig. 1. Upper p a rt: The normal TPSEP. (The s ing le  EPs o f 9 normal subjects were superimposed 
fo r demonstrating the in te r in d iv id u a l s ta b i l i t y  o f the response). Lower pa rt: The "confidence 
e llip s e s "  o f the peaks ( i . e .  the f ie ld  which contains the normal value at 95.4% p ro b a b ility )
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SEP
ms
F in . 2, Upper p a rt: normal TPSEP. Middle: TPSEP o f a 46 years old man. (C lin ic a lly  d e f in ite  MS 
w ith  generalized symptomatology. No c o rt ic a l response could be recorded.) Lower p a rt:  The 
response o f a 56 years o ld  man. (C lin ic a lly  d e f in ite  MS w ith optospinal symptomatology, and 
m ild sensory d e f ic i t .  Note the prolonged la tency o f a l l  components.)
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Table I
SEP (S tim .: n . t ib ia l is  p o s t.)  Latency (ms)
PI N1 P2 N2 P3 N3 P4
Mean 29.7 35.75 44.3 55.73 67.2 84.86 101.4
C3-Co SD 2.08 2.06 1.76 2.11 2.70 4.41 4.51
Lim .v.
27-
-33
33.5-
-40
42-
-47
53-
-61
63.5
-73
77-
-90
96-
-105
Mean 30.0 36.0 44.63 56.03 67.88 82.68 100.08
C4-Co SD 1.93 2.01 1.01 2.57 3.49 5.65 5.59
Lim .v.
27-
-34
33.5-
-41
42-
-48
51-
-62
63.5-
-75
74-
-94
92-
-106.5
SEP
Amplitudes yjV)
P l-N l N1-P2 P2-N2 N2-P3 P3-N3 N3-P4
Le ft
Mean 6.3 12.3 11.2 10.4 10.0 9.4
SD 2.9
2.6-12
5.4 5.3 5.7 5.6 3.2
СЗ-Со
Lim .v. 4.6-22.4 4.0-23.2 4.6-22.8 3.6-22 4.0-12
Mean 6.8 14.2 12.6 10.9 10.1 9.5
Right
C4-CO
SD 3.2 7.2 6.8 7.0 6.6 4.0
Lim .v. 2.2-14.1 5-30.4 4.4-28.8 2.0-27.2 2.8-24.4 4.0-12.4
Lim .v. = l im it  values (low  and high extremes)
of the three cases severe a lte ra tions  were observed in  the EPs (su b c lin ica l 
lesions). With repeated examinations the responses may well serve in  long­
term monitoring of stero id treatment (F ig. 4).
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Frequency of pathological changes of fhe somatosensory 
ep components.
50
F ig . 3. Upper pa rt: the normal TPSEP. Lower p a rt: the frequency (in%) o f the d if fe re n t  a l te r ­
a tions o f the evoked p o te n tia ls
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F ig . 4, Upper pa rt: Normal TPSEP. Middle: The record o f  a 24 years old women. (C lin ic a lly  
d e f in ite  MS w ith generalized symptomatology.) No response is  detectable. Lower p a rt: The 
response o f the same p a tie n t a fte r  6 weeks s te ro id  therapy. The components can be id e n t if ie d ,
th e ir  latencies are increased
Discussion
The proposed value of the components in  lo ca liza tio n  - based on the 
l ite ra tu re  - are summarized in Table I I .  The po ten tia l of the plexus 
ischiadicus appears to be w ithin 11-21 ms; transmission of the sensory 
impulse in  the sp ina l cord lasts 21-27 ms. Potentia ls of the nucleus 
g ra c il is  and the lemniscus medialis are re flec ted  by the waves between 24 
and 31 ms, those of the thalamus about 30 ms, the c o rtic a l response appears 
between 30 and 75 ms /1 , 15, 21, 25, 26, 28, 29, 32, 33, 34, 38, 42, 43, 
44, 46, 48, 52, 54 , 55/. Because of the optimal recording p o s s ib ility  of 
the vector of the c o r t ic a l generator o f the lower limb, the EPs e lic ite d  by 
the stim ulation of the posterior t ib ia l  nerve is  of higher voltage on the 
side of the s tim ula tion  /1 0 /. I t  seems possible tha t the stim ulation of the
Table I I
The probable o r ig in  o f the SEP components 
P osterior column
Plexus 
and roots Lumbal Thoraic Cervical N.g ra c il is  Lemn.med. Thalamus G y.centr.ant. G y.centr.post. P a r ié t.дуг.
PHILLIPS e t a l.  1980 N1 N2
'------ -------y*---------- V_----------------------^ ---------------------- ------------y*----------*
LUEDERS e t a l.  1980 N 24 N 26 -  P 27 N 30 P 35
-V
KAKIGI e t a l.  1981 P 29 N 27 -  P 28 -  N 31 P 36
LEANDRI e t a l.  1982 Pli-N17-P21 N24(conus) P 27 N 31
ABBRUZZESE 1982 N17 -  18 P21 -  N23
LASTIMOSA 1982 P 24 -V27 N 33 -  P 37 -  N 45 -  P 55
KAKIGI 1983 P 28-N 31 N 32(c)
--------------/
P 36
SEYAL e t a l.  1983 P 28 P 31 N 3*4 P 38 N 38
LUEDERS 1983 N24 P27 N 30
MAUGIERE et a l.  1983 N 16 N 20 P 27-45
YAMADA e t a l.  19B3 N 29 N 32 N 34-60
SMALL e t a l.  1984 N21
- V
N 27 -  29 P 33
TSUJI e t a l.  1984 N18-N20 N18-N20 N 24 P 27 TN 30
___/
P 38 N 46
QESMEDT e t a l.  1985 N20-F21-P26 P 30
N33(c) N37(c) N33(c) N33(c)
P58(b) N75(1) P58(b) N75(1) P38(i)P58(b)
N75(i)
GILMORE e t a l.  1985 (N5) N14 N20
SEYAL e t a l.  1985 P22(-N22) °22
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posterior t ib ia l  nerve is  mainly transm itted through the posterior fa s c ic le , 
wherease tha t o f the sural nerve is  through the spinothalamic system /4 2 /.
An increase in  the speed of conduction at the centra l areas was observed 
when the proximal part of the t ib ia l  nerves was stimulated /37 /. The con­
duction ve loc ity  a t d iffe re n t segments can be calculated on the basis of 
latency differences corresponding to d if fe re n t levels of the a ffe ren t 
system or by using the resu lts  of s tim u la tions a t various heights /6 , 19/ 
v iz . cauda equina: 34 m/s (38), "whole" sp ina l core: 65.8 m/s /2 3 /, 45-65 
m/s /6 / ,  64 m/s /2 2 /, lower thoracic pa rt: 49 m/s upper thoracic pa rt: 
100 m/s /37 /.
SEP analysis may also be he lp fu l in  lo ca liza tio n  of vascular d is ­
eases /5 , 8, 13, 14, 20, 51/, i t  can be properly used fo r in traopera tive  
monitoring, and has been widely used in  the analysis of root and periphera l 
nerve lesions and myelopathies and degenerative diseases /2 , 17, 47, 53, 
56/, but the most f r u i t f u l  f ie ld  of i t s  app lica tion  is  MS.
I t  was Namerov /36 / who succeeded fo r  the f i r s t  time in  e l ic i t in g  
somatosensory EPs and observed a lte red recovery function of the sensory 
system. Baker e t a l. /3 /  found pathological EP a lte ra tions in  more than 
two-thirds of th e ir  MS patients. Since the early  seventies th is  procedure 
has become a routine method /7 , 45/. According to Walsh et a l. /50 / the SEP 
was altered in  a higher proportion than the v isua l evoked po ten tia ls ; only 
one patient was found (out of 56) w ith normal response.
Jörg /24 / summarized the a lte ra tio n s  observed in  h is MS patients 
(fo llow ing stim ulations of the median nerve, the posterior t ib ia l  nerve and 
segmental s tim u la tio n /: (1) an increase in  the latencies of the c o r t ic a l 
SEP components, (2) an increase in  the d iffe rence  between the po ten tia ls  
registered at the le f t  and r ig h t sides, (3) an increase in the cen tra l con­
duction time; (4) and increase in  the inter-peak latency of the subcortica l 
p o ten tia l; (5) an increase in  the re fra c to ry  period; (6) disseminated 
a lte ra tions  in  the segmental SEP. According to our data the reduction of 
amplitude (or lack) or components is  frequent as w ell.
Responses e lic ite d  by s tim ula ting  the lower limb nerves were more 
often pathological than the po ten tia ls  evoked by stim ulating the upper 
ones /7 , 18, 39, 40, 45, 54/. The prolonged latencies of the po ten tia ls  
usually do not disappear in  the course of the pathological process, however, 
in  rare cases, they might return to normal /16, 17, 22/. Davis e t a l.  /11/ 
concluded - on the basis of analysing mainly spinal cases - tha t su b c lin i-  
cal lesions were detected in  high proportions.
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Among EPs the response e lic ite d  by the stim ulation of the t ib ia l  
nerve is  of outstanding s ign ificance . When patients with MS are examined, 
i t  is  the most sens itive  e lectrophysio log ica l parameter, which can mainly 
be used fo r detecting sp ina l cord lesions.
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The non-specific  peroxidase (donor: H ^ -o x id o re du c ta se , EC 1.11.1.7) a c t iv i t y  o f red 
blood c e lls  in  pa tien ts  w ith  m u ltip le  sc le ros is , pa tie n ts  w ith other neuro log ica l diseases, 
and healthy con tro l in d iv id u a ls  was investiga ted . To th is  end, a simple method was developed. 
No s ig n if ic a n t d iffe rence  was found in  the non-specific  peroxidase a c t iv ity  o f red blood c e lls  
from pa tien ts  w ith m u ltip le  sc le ros is  and con tro ls .
Keywords: m u ltip le  sc le ro s is , red blood c e lls ,  non-specific  peroxidase a c t iv ity .
In troduction
Red blood c e lls  (RBC) of patients w ith m ultip le  sclerosis (MS) show 
several abnormalities. I t  has been reported that there is  an increase in 
the osmotic and mechanical f r a g i l i t y  of MS RBC /3 , 5, 13/. Also, these 
c e lls  show decreased electrophoretic m ob ility  /17 /, and an abnormal cor­
re la tio n  between the leve ls of lino lea te  and arachidonate has been found 
/4 / .  A decreased adherence of MS RBC to myelin basic protein has also been 
reported /10 /.
Glutathione peroxidase is  believed to be a key enzyme in  the main­
tenance of the in te g r ity  of RBC membranes /9 /  and plays a major ro le  in  the
X
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disposal of peroxides from liv in g  ce lls  /1 1 /. I t  has previously been pro­
posed that abnormal l i p id  peroxidation may play a ro le  in  the pathogenesis 
o f MS /8 , 12/. Several authors have found a m ild , but s ig n ific a n t, e ry th ro ­
cyte glutathione peroxidase deficiency in  MS /6 , 14-16/, while others 
fa ile d  to detect any s ig n if ic a n t change in  the a c t iv ity  of th is  enzyme 
/ 1 , 7/.
These observations prompted us to study the non-specific peroxidase 
a c t iv i ty  of RBC in  p a tien ts  with MS, patients w ith  other neurological d is ­
eases (OND) and in  healthy control (HC) in d iv id u a ls . A simple method has 
been developed to measure the non-specific peroxidase a c t iv ity  of red blood 
c e lls ,  using hydrogen peroxide (E^op and o-phenylenediamine (OPD) as sub­
stra tes  in  a co lo rim e tric  reaction.
MATERIALS AND METHODS
T h irty  e ight MS p a tie n ts  (22 F, 16 M, mean age 43 years, range 25-64; mean duration 
o f  disease 12 years, range 1 -2 6 ), 31 patients w ith  OND (18 F, 13 M, mean age 45 years, range 
18-73), and 21 HC in d iv id u a ls  (13 F, 8 M, mean age 35 years, range 24-81) were included in  the 
study. Two of the cases in  the MS group were la te r  autopsy-proven, 20 f u l f i l le d  the c r i te r ia  
o f  d e f in ite ,  6 o f probable and 10 o f possible MS / 2 / .  Two o f the MS patients received s te ro id  
treatm ent, while the o thers were on vitamin В treatm ent, o r were given no drugs at the time 
th e ir  blood samples were c o lle c te d . The 0N0 group included pa tients w ith epilepsy ( fo u r ) ,  
G u illa in -B a rre  syndrome (one ), cerebrovascular syndromes (e ighteen), Parkinson's disease 
(one ), amyotrophic la te ra l s c le ro s is  (one), and others ( s ix ) .
F if ty  u l  o f blood was drawn by f in g e rt ip  puncture during the morning hours a f te r  a 
l ig h t  breakfast, and was immediately d ilu ted , and washed 3 times in  10 ml of phosphate-buf­
fe red  sa line (PBS; 10 mM phosphate, 150 mM sodium c h lo r id e , pH 7 .2 ). The c e lls  i*iere co llec ted  
by cen trifuga tion  at 200 x g fo r  10 min. The c e ll dens ity  was adjusted to 1 x 10 RBC per ml of 
PBS, the c e lls  were ce n trifu g e d , the supernatant was asp ira ted  and replaced w ith the same 
volume o f d is t i l le d  water. A fte r  haemolysis, the samples were stored in  1 ml volumes a t -20 C.
The defrosted samples were d ilu ted  1:5 in  d is t i l le d  water, g iv ing a haemolysate 
equ iva lent to 2 x 10 RBC per m l. One hundred u l  o f haemolysate was a l l ie d ,  in  ^ r ip l ic a te ^ ,  
in to  the v e ils  of a 9 6 -w ÿ l m ic ro t it jÿ ' tfa y . A lso, 100 ^ul o f 0.5x10 , 1.0x10 , 1.5x10 ,
2.0x10 , 2.5x10 \  З.ОхЮ or t.O xlfl u g o f horseradish peroxidase (HRPO, type I ,  EC 
1 .1 1 .1 .7 , spec ific  a c t iv i t y  95 U/mg, Sigma) per ml o f d is t i l le d  water, was used in  t r ip l ic a te s  
as a standard in  separate w e lls . The reaction was s ta rte d  by adding 100yul o f freshly-prepared 
c o lo r im e tr ic  reagent (0 .2  M c i t r i c  acid-phosphate b u ffe r ,  pH 5 .0 , containing 1 mg/ml o f OPD, 
and 0.022% H,,0,,) to  each ^ 7 1  w ith  samples prewarmed to  37 C. A fte r 7 min o f incubation at 
37 C, the reaction was term inated by adding 50y i l  o f 1 M su lphu ric  acid. The o p tic a l dens ities  
were measured at 492 nm in  a Specord (GDR) spectrophotometer equipped w ith a m icrocuvette. The 
a c t iv i t y  detected in  100 y j 1 o f  c e ll  lysate (equ iva len t to  2x10 RBC) was expressed as the 
amount o f HRPO producing c o lo r im e tr ic  reaction o f the same in te n s ity  as tha t detected in  the 
c e l l  lysa te . In order to  reduce the e rro r of the method, samples o f 15 subjects (5 from each 
group) were assayed sim ultaneously on the same tra y .
The amount o f H^O  ^ s u f f ic ie n t  to ensure sa tu ra tio n  o f the enzyme, and the time during 
which the re la tionsh ip  between the amount of oxydized OPD and the reaction time is  l in e a r ,  was 
determined in  pre lim inary experiments. In in tra -  and in terassay re p ro d u c ib ility  experiments 
the average standard e rro r  o f the mean was 1.6% and 10.7% o f the mean value, respec tive ly .
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Non specific peroxidase activity
(pe r 2 *1 0 4 R B C ) = * 1 0 "4 pg HRPO
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Fig. 1. D is tr ib u tio n  of non -spec ific  peroxidase a c t iv ity  in  red blood c e lls  (RBC) o f m u ltip le  
sc le ros is  (MS) pa tien ts , pa tie n ts  w ith  other neurological diseases (OND), and healthy con tro l 
(HC) in d iv id u a ls . Results are expressed as the amount o f horseradish peroxidase (HRPO) pro­
ducing co lo rim e tr ic  reaction  o f the in te n s ity  detected in  2x1c/1 RBC.4 
Bars represent the mean +_ S.D.
RESULTS AND DISCUSSION
The d is tr ib u tio n  of non-specific peroxidase a c t iv ity  in  RBC of 
patients and controls is  shown in Fig. 1. The mean peroxidase a c t iv ity  
measured ( ±  standard devia tion) in  38 patients w ith MS, 31 with OND and 
21 HC ind iv idua ls  was equivalent to the a c t iv ity  o f: 2.6+0.7 x lO ^; 
2.9_+l x 10 ^ ; and 2.6+0.6 x 10 ^yug of HRPO in  2x10^ RBC, respectively.
The method used in  th is  study is  very s im ila r to that in  the enzyme- 
linked immunosorbent assay (ELISA). The hydrogen peroxide is  degraded by 
H2 Ü2 -oxidoreductase and the 0PD is  converted in to  i t s  oxidized form, re­
su lting  in  a co lo rim e tric  reaction. Experiments w ith p u rifie d  catalase
showed tha t although H2 O2  is  read ily  degraded by th is  enzyme, no c o lo r i­
metric reaction develops in  the presence of 0PD (data not shown). Further­
more, when increasing amounts of catalase were added to the reaction mix­
ture 7 min p rio r to the addition of HRPO, a competitive in h ib it io n  of 
co lo rim e tric  reaction was observed. Since fo r a 30% in h ib it io n , a catalase/ 
HRPO ra t io  of 2000 was necessary, i t  is  un like ly  tha t the RBC catalase and
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peroxidase in te rfe re  w ith  each other at a s ig n if ic a n t leve l in  our assay 
system.
E arlie r studies have reported decreased glutathione peroxidase 
a c t iv i ty  in RBC of m u ltip le  sclerosis patients /6 , 14-16/, however a causa­
t iv e  ro le  has not been established. Other studies fa ile d  to detect a g lu ta­
th ione peroxidase defic iency in  MS /1 , 7 /. Our work does not reveal a 
defic iency in  the non-specific  peroxidase a c t iv ity  of RBC in  MS.
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TISSUE CHARACTERIZATION BY TRANSVAGINAL COLOUR DOPPLER FOR THE 
EVALUATION OF GYNAECOLOGICAL ÍUMÜIJRS
F irs t of two parts: review of the lite ra tu re
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This is  the f i r s t  review published in  Hungary about the usefulness o f transvaginal 
co lour Doppler (TVCO) in  gynaecology. The h is to ry  o f "u ltrasound tissue  cha ra c te riza tion ", 
the conventional and colour Doppler methods are discussed as w e ll as the pathomorphological 
basis o f abnormal Doppler s ig n a ls . The summary u f tumourangiogenesis, o f neovascularization 
and i t s  m anifestation in  Doppler spectrum are given. The d iffe rences between normal and 
pa tho log ica l Doppler s igna ls in  female small pe lv is  are shown. I t  is  concluded th a t the 
rou tine  app lica tion  o f TVCD w i l l  reduce the ra te  o f fa ls e  p o s itive  resu lts  and " lu xu ry" 
operations from screening procedures.
Keywords : colour Doppler ultrasound, colour flow  mapping, transvaginal sonography, 
gynaecological malignancy, tissue  cha racte riza tion .
Introduction
The term "tissue characterization" covers a range of meanings from 
q u a lita tive  assessment to s c ie n t if ic  measurement /10 /. Many attempts have 
been made in  the past 20 years to derive more quantita tive  information 
re la tin g  to tissue s truc tu re  from the returned ultrasound beam. Various 
acoustical properties of tissues - absorption, speed, dispersion, density, 
com pressib ility , bulk modulus, scattering ch a ra c te ris tics , attenuation - 
might be probed by "u ltrason ic  te leh is to logy" (a term coined by Chivers and 
H i l l  /9 / ) .
Abbreviations : TAF = tumour-angiogenesis fa c to r; TVCD = transvaginal colour Doppler
O ffp rin t requests should be sent to  B. Juhász, Department o f O bstetrics and Gynae­
cology, U n ivers ity  Medical School o f Debrecen, H-4012 Debrecen, Nagyerdei k r t .  98, Hungary
Akadémiai Kiadó, Budapest
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Of pa rticu la r appeal was the p o s s ib ility  tha t information re la ting  
to  sp e c ific  histology was already availab le  in  the returned echoes and, at 
le a s t p o te n tia lly , s p e c ific  predictors of tissue type might be defined 
merely by more elaborate signal analysis. An index of quan tita tive  tissue 
echogenicity was developed fo r the diagnosis of l iv e r  disease /71 /.
Others used a simple e lectron ic  system adaptable to a standard 
echograph with the aim of obtaining an index of echogenicity /1 4 /. A 
fu r th e r  team /31/ undertook to develop a system fo r obtaining information 
from В-mode ultrasonography, which converts information in to  d ig i ta l  values 
and processes them in  a microcomputer to produce an acoustic in te n s ity  
histogram. Display inform ation on the histogram pattern includes echo 
in te n s ity  and echo frequency in  the region of in te re s t. The curve of a t­
tenuation rate derived from the histogram was used to d is tingu ish  between 
l iv e r  c irrhos is  and the tissue  of normal or fa tty  l iv e r .
Other conceptual developments tha t have taken place since then have 
been noninvasive detection of blood flow by Doppler /7 2 /, tissue motion 
/6 8 / and image texture /43 / as possible ind ica tors of h isto logy and path­
ology.
There are at leas t seven cha rac te ris tics  that can be measured by 
ultrasound:
1) the attenuation of ultrasound /45, 73/
2) the speed of ultrasound /25/
3) the acoustic impedance /29/
4) the scattering cha rac te ris tics  /11/
5) the non linearity  of signal propagation /42/
6) the motion of tissue /68 /
7) blood flow can be detected and quantified by techniques based on 
the Doppler e ffec t /4 , 5, 72, 75/.
Despite a l l  th is  e f fo r t ,  only image inspection and Doppler tech­
niques have shown progress toward the concept of te leh is to logy , and i t  is  
re a lly  only through them tha t tissue characterization has achieved routine 
c l in ic a l  application.
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Tissue characterization by conventional floppier equipments
The presence o f abnormal flow  spectra around the periphery o f malignant tumours was 
documented in  cases o f breast cancers /4 , 72/. The re s u lts  were confirmed by severa l groups 
/32 , 34, 44, 46, 53, 54, 61-64/.
The abnormal flow  s igna ls  consisted o f an increase in  s ignal amplitude when compared 
w ith the con tra la te ra l normal side (corresponding to a greater number o f moving c e lls  w ith in  
the beam), an increase in  peak s y s to lic  flow ; a c h a ra c te r is t ic  d is tr ib u t io n  o f the Doppler 
spectrum, showing a predominance o f high-power, low-frequency element; high d ia s to l ic  s h if t  
( in  some tumours the s y s to lic /d ia s to l ic  va ria tio n  is  absent).
The major d i f f ic u l t y  w ith  both continuous-wave Doppler (CWO) and pulsed-wave Doppler 
(PWD) is  the need fo r operator expertise  and time to  search the periphery o f the tumour and 
detect one o f the lim ite d  number o f loca lized  abnormal vessels or shunts. Colour Doppler, by 
showing a two-dimensional d isp lay  o f vascu la rity , can expedite the examination by d isp lay ing 
simultaneously the presence o f the vessels, which can then be in terrogated fo r  q u a n tita tive  
ana lysis by pulsed Doppler.
Tissue characterization by colour Doppler
Most colour Doppler machines have been developed fo r cardiac u ltrasound; they are 
in s e n s itiv e  fo r detecting neovascular flow . I t  is  not enough to merely demonstrate a vessel 
in  the v ic in i t y  o f a tumour, the diagnostic features o f tumour vascu la rity  are the high ve l­
o c it ie s  and low impedance. Considerable m odifica tion in  s igna l processing was necessary to 
optim ize the colour Doppler machines fo r detecting neovascular flow  c h a ra c te r is tic s . Neverthe­
less, some o f the more se n s itive  machines already show th is  p o s s ib il ity  (Aloka SSD-350, Aloka 
SSD-860, Sonotron Vingmed CFM 700).
Using an u ltra so n ic  dynamic flow  imager i t  was possible to  d isp lay neovascularization 
in  a ra b b it VX2 carcinoma and also to v isua lize  areas o f m u ltid ire c tio n a l flow  presumably due 
to complex a r te r ia l patterns and arteriovenous shunts /5 0 /.
Blood flow in several types o f tumours was assessed w ith colour Doppler echography, 
and invasive moles were considered to be the best in d ic a tio n  o f response to chemotherapy /5 1 /.
Taylor e t a l.  /6 2 / ,  then Hata e t a l.  /2 6 , 27/ were the f i r s t  to  pub lish  Doppler 
u ltrasound studies in p e lv ic  diseases o f women, moreover the la t te r  group used transabdominal 
colour Doppler equipment (p rev ious ly  only the Doppler ultrasound id e n tif ic a tio n  and assessment 
o f deep-lying vessels o f the normal /58 —60/ and pregnant /6 ,  69/ female p e lv is  were made. In 
a l l  cases o f endometrial carcinoma, ovarian carcinoma and trophob lastic  disease ty p ic a lly  
abnormal flows were observed /2 6 , 27/, but a l l  cases o f ce rv ica l carcinoma w ith  abnormal flows 
were o f stage I l / b  or ove r. I t  was concluded that Doppler ultrasound is  a p e rtin e n t d iagnostic 
to o l th a t can be used to  observe changes in  tumour v a scu la rity  in  gynaecologic malignancies 
before and a fte r  treatment.
Colour Doppler sonography has some advantages in  comparison w ith o ther methods.
i )  The v isu a liza tio n  o f blood flow  in  the region o f in te re s t makes the o rien ta tio n  
much easier and makes the search fo r disturbed flow  in  sm all, non -v is ib le  vessels possible. 
This feature  is  of utmost importance in  the examination o f tumours where the d is tr ib u t io n  of 
blood vessels is  never known in  advance. I t  is  th is  search a b i l i t y  which makes i t  p o te n tia lly  
so powerful in  solving some o f the diagnositc problems unsolved so fa r .
i i )  The most im portant advantage o f th is  d iagnositc  to o l is  the d isp lay o f blood flow 
over the whole female p e lv is  as compared with the one lin e  o f s igh t ava ila b le  w ith  conven­
t io n a l pulsed Doppler. By th is  means the technique is  simple to  perform, easy to  in te rp ré té  
and qu ick.
i i i )  The more accurate placement of pulsed Doppler beam has made the re p ro d u c ib ility  
o f Doppler measurements increased.
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Kurjak et a l. /25, 36-40/, and Zalud and Kurjak /77/ were the f i r s t  
to  re p o rt that transvagina l colour flow imaging can be used in  the assess­
ment o f pelvic c irc u la t io n , and to d iffe re n tia te  between benign and malig­
nant pe lv ic  tumour.
With transvaginal co lour Doppler i t  was shown /3 / that the absence 
o f intratumoural neovascularization and a normal (high) p u ls a t i l i ty  index 
can be used to exclude the presence of invasive primary ovarian cancer, 
thus, po ten tia lly  reducing the rate of fa lse  pos itive  resu lts  from the 
screening procedure using conventional ultrasonography while maintaining 
the detection rate of the disease. The early recognition of ovarian cancer 
is  the only approach to  achieve a reduction in  the spec ific  m o rta lity . 
Transvaginal colour flow mapping may be used to  id e n tify  p o te n tia lly  malig­
nant ovarian masses and help in  elucidating the early stages of tumouri- 
genesis. The routine a p p lica tio n  of th is  new technique w i l l  enable us to 
develop a screening programme based on ultrasonography.
In a prelim inary re p o rt /28/ i t  has been confirmed that transvaginal 
co lou r Doppler is  expected to  be an important d iagnostic method fo r assess­
ing  blood flow in  phys io log ic  and pathologic conditions of the pe lv is . 
A transoesophageal probe was used in these stud ies.
What is  the feature th a t provides the abnormal Doppler signals? This 
pathomorphological e n t ity  is  the tumour-neoangiogenesis = neovasculari­
za tion  .
Neovascularization
Many influences in vo lv in g  the neoplasm and host modify the growth 
ra te  o f cancers. One o f the most important conditions is  an adequate 
vascular supply of the tumour.
During experiments w ith  heterologous tumour tran sp la n ta tio n  in  guinea p ig  eyes, i t  
was observed that a few im p lan ts , which apparently d id  not vascularize fa ile d  to  grow fo r 
a lm ost 2 years. However, when the  same tumours were reimplanted in to  th e ir  o r ig in a l host, 
they vascularized and grew p ro g re ss ive ly  /23 /.
Others suggested th a t an a t t r ib u te  of tumour c e lls  is  th e ir  capacity to  e l i c i t  con- 
t in u o s ly  the growth of new c a p i l la r y  endothelium in  v ivo  / 2 / .
Folkamn et a l.  /1 6 / demonstrated that the growth o f tumours which have been im­
p lan ted  in  any one of several d if fe re n t  organs and maintained by a long-term perfusion stops 
when the tumour reaches a diameter o f  3-4 mm.
Further growth o f tumour tissue  in  in  v it r o  organ cu ltu re s  cannot be sustained w ith ­
out neovascularization o f the tumour /2 2 /.
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Neovascularisation does not require d ire c t  contact w ith tumour c e lls  since vessels 
have been e lic ite d  from the hamster cheek pouch by tumours contained in  a m ill ip o re  f i l t e r  
/12, 24/.
Folkman e t a l.  /1 7 / have shown th a t a d if fu s ib le  fac to r, m itogenic fo r  ca p illa ry  
endothelium, can be iso la ted  from animal and human tumour c e lls .  This fa c to r c a lle d  "tumour- 
angiogenesis fa c to r" (TAF) and the concept o f "anti-angiogenesis" was proposed to  ind icate  
th a t blcckade o f TAF might prevent s o lid  tumours from growing beyond a diameter of 
2-3 m  /1 8 /.
When small fragments o f anaplastic Brown-Pearce carcinoma were implanted d ire c t ly  on 
the i r i s  in  susceptible ra b b its , the fragments always vascularized. A c h a ra c te r is t ic  growth 
p a tte rn , consisting o f prevascular, vascular, and la te  phase was observed, which terminated 
w ith destruction  o f the eye w ith in  2 weeks. The beginning o f exponential volume increase was 
shown to  coincide w ith vascu la riza tion  o f the im plant.
In  con tra s t, - im plants placed in  the a n te r io r  chamber, at a distance from the i r is ,  
did not become vascularized. A fte r i n i t i a l  growth in to  spheroids, they remained arrested at a 
small s ize , comparable to  prevascular i r i s  im plants, fo r  periods as long as 6 weeks. Although 
dormant in  terms o f expansion, these avascular tumours contained a population o f v iab le  and 
m ito t ic a lly  active tumour c e lls .  When reimplanted on the i r i s ,  vascu la riza tion  was followed 
by a rap id , invasive growth. These observations suggest that neovascularization is  a necess­
ary cond ition  fo r malignant growth o f s o lid  tumour /2 2 /.
Recent studies /19 / with transgenic mice have shown th a t fo r at 
least one type of cancer angiogenesis occurs during the tra n s it io n  from 
hyperplasia to neoplasia, and the induction of angiogenesis is  an important 
step in  carcinogenesis.
Both animal and human tumour c e lls  have been shown to produce angio­
genesis factors /8 , 13, 15, 49, 55, 57, 70, 76/.
Other workers have recently id e n tif ie d  and cloned a new p la te le t 
derived substance tha t stimulates endothelia l c e ll growth and Chemotaxis 
in  v it ro ,  and angiogenesis in vivo /3 0 /.
The id e n tif ic a tio n  of TAFs raised an in teresting  p o s s ib il i ty  cancer 
growth was blocked by in h ib it in g  the angiogenesis. Indeed, an "an ti-ang io ­
genesis" factor has been extracted from ca rtilage , a tissue th a t normally 
lacks vascularization . Infusion of th is  component of ca rtila g e  reduces the 
growth rate of experimental neoplasms in  animals /41 /. I t  was also demon­
stra ted /66/ tha t heparin released by mast ce lls  (accumulated a t a tumour 
s ite  before the ingrowth of new c a p illa ry  sprouts but that mast c e lls  alone 
could not in i t ia te  angiogenesis) increased the migration of c a p illa ry  endo­
th e l ia l ce lls  in  v it ro  and enhanced the in tens ity  of angiogenesis induced 
by tumour extract in  vivo (but heparin alone could not in i t ia t e  angio­
genesis) .
In contrast, protamine (a heparin antagonist) blocked the a b i l i ty  of 
mast c e lls  and heparin to stimulate m igration of c a p illa ry  endothelial 
c e lls  in  v itro  and inh ib ited  tumour angiogenesis and subsequent tumour 
growth when i t  was applied lo ca lly  but i t  had no e ffe c t on established 
c a p illa r ie s  tha t were not p ro life ra tin g .
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Another in h ib ito r  o f angiogenesis, which is  produced by c e lls  when 
they are capable of expressing an active cancer-suppressing gene, has also 
been discovered /48 /. The loss of th is  in h ib ito r  a c t iv ity  occurs concomi­
ta n t ly  w ith  expression of both angiogenesis and tumourigenesis.
Summary o f  th e  c o n n e c tio n  between tumour g ro w th  and n e o v a s c u la r iz a t io n
Rapid ce llu la r p ro life ra t io n  of and increased metabolic demand by, 
cancer c e lls  ca ll fo r an increased supply of n u tr ie n ts  and oxygen. This in ­
creased demand is  met w ith by simple d iffus ion  o f tissue f lu id  in  the in ­
i t i a l  pa rt of tumour growth. However, with continued growth th is  proves 
inadequate as the cen tra l p a rt of the tumour becomes distant from the 
source of supply, the re fo re , the need fo r a well-developed tumour vascu­
la tu re  o f i ts  own arises. This is  in it ia te d  by production of tumour angio­
genesis fac to r(s ) -  by the tumour ce lls . TAF appears to induce m itosis and 
m igra tion  of endothelial c e l ls  from the surrounding small vessels. These 
vessels soon canalize and grow towards the tumour, forming a complex net­
work o f tumour vasculature. Vascularization of tumours is  shown to be as­
sociated with an increase in  growth rate and acqu is ition  of metastatic 
p o te n tia l.  Tumour volume doubling time and tumour c e ll loss facto r de­
crease as the tumour va scu la rity  increases. The fra c tio n  of ce lls  in  the S 
phase and growth frac tion  are higher, having higher vascu larity . Thus, high 
va scu la r ity  is  associated w ith  rapid growth. The new vessels must be formed 
very e a rly  on in  the development of the tumour and therefore are early 
markers of a tumour.
C h a r a c te r is t ic s  o f  n e o v a s c u la r iz a t io n
The orig ina l descrip tion  of artériographie neovascularity or "tumour 
v a scu la r ity "  is  credited to  Strickland /56 /. He described a tumour vessel 
as one th a t was "deployed seemingly without purpose, keeps to no set course 
and shown no progressive d im inution in ca lib e r". Several benign and malig­
nant tumours were examined /2 0 / to evaluate the h is to lo g ic  picture as shown 
on angiograms as neovascularity. Newly-formed vessels are large ca p illa r ie s  
(ra th e r large endothelial lin e d  c a p illa ry - lik e  channels), or sinusoids, and 
n e ith e r contain smooth muscle in  the ir walls, only some fibrous connective
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tissue. "Puddling", " lak ing " and "s ta in ing" represent the c o lle c tio n  of 
contrast medium in  small ca p illa r ie s  or sinusoids. Smooth muscle neither 
regenerates nor p ro life ra te s  to any s ig n if ic a n t degree in  adults.
I f  normal smooth muscle can be found in  the walls of a rte r ie s  with 
a normal arch itecture, then one may assume tha t the artery is  not new and 
i t  does not represent neovascularity.
Another vascular a lte ra tio n  in malignancy is  the presence of a rte r io ­
venous shunting represented angiographically by early venous opac ifica tio n . 
Arteriovenous shunting may re su lt from a large, foca l, d ire c t communication 
/47 /, or may re f le c t m u ltip le  microscopic communications in  the abnormal 
tumour m icrocircu la tion  /33, 67/. "Pooling" or "laking" re s u lt from tumour 
vessels terminating in  amorphous spaces w ith in  the tumour parenchyma with 
or w ithout associated necrosis. A tumour "s ta in " or "blush" re f le c ts  the 
accumulation of contrast material in  microscopic spaces. Since the vessels 
are collapsed in  a h is to lo g ic  section, i t  is  d i f f ic u l t  to know how large 
these spaces are in  v ivo . Shubik /52/ contrasted the appearance of a liv in g  
tumour -  in  which the vessels may occupy more than 50% of the tumour 
volume -  with the collapse of the vascular bed in  the dying host and the 
dramatic decrease in  tumour vessel size in  the fixed specimen.
The m a n ife s ta t io n  o f  n e o v a s c u la r iz a t io n  in  D o pp le r spe c tru m
Since most of the resistance to flow resides at the le ve l of the 
muscular a rte rio le s , vessels de fic ien t in  these muscular elements present 
diminished peripheral resistance to flow and thereby receive a larger 
volume flow than vessels w ith a high impedance. The abnormal, th in-walled 
vessels would e xh ib it low-impedance signals with l i t t l e  s y s to lic -d ia s to lic  
va ria tion . Because of th e ir  lack of normal muscle components, the amount of 
vasoconstriction by sympathetic stim ulation cannot be increase - th is  is  
the basis fo r d if fe re n tia t io n  between benign and malignant tumour vascular­
i t y  by th e ir  response to  epinephrine /1 / .
The Doppler detection of the haemodynamics of flow through these 
spaces is  thus a more spec ific  tumour marker than the mere vascular mor­
phology shown by imaging studies alone /63 /.
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Differences between normal and patho log ica l Doppler signals 
in  female small pe lv is
Normal waveforms
The use of Doppler ultrasound in  the c l in ic a l  assessment various 
diseases suggested tha t each artery appears to  have i t s  own cha rac te ris tic  
Doppler waveform, which may be modified by disease. Taylor et a l. /58 / and 
Taylor and Burns /60/ have demonstrated ch a ra c te r is tic  waveforms fo r i l ia c ,  
u te rin e  and ovarian vessels and also the changes in  these waveforms associ­
ated w ith  hormonal changes during menstrual cycle and/or early pregnancy.
I t  should be noted tha t AORTA, COMMON ILIAC and EXTERNAL ILIAC 
a r te r ie s  a l l  show s im ila r  waveforms of plug flow , which is  v ir tu a lly  a 
square wavefront. The waveforms outline the envelope of the spectrum with 
"no f i l l i n g  in ", that is ,  not "spectral broadening". In early d iasto le , 
there is  a reversed component due to reversed flow  from the high impedance 
vasculature of the legs during diastole.
In contrast, INTERNAL ILIAC waveform shows complete spectral broad­
ening. In other words, there is  parabolic flow w ith  a l l  ve loc itie s  present 
from zero at the wall to  a maximum in the mid-stream. A cha rac te ris tic  of 
the in te rn a l i l ia c  waveform is  a d ia s to lic  hump. I t  is  important to re­
cognize th is  ch a ra c te ris tic  waveform since the in te rn a l i l ia c  artery is  
seen most frequently ju s t  in fe r io r  to the ovary and is  easily detected in  
the v ic in i ty  of the ovary. I f  the edge of the vessel is  sampled with pulsed 
Doppler, a waveform is  seen which looks very s im ila r  to the resting ovarian 
s ig n a l.
The UTERINE waveform varies by the sta te  o f pregnancy. In the non- 
g ravid  the waveform is  o f high impedance with l i t t l e  or no d ia s to lic  flow. 
Both ascending and descending branches of the u te rine  artery can be located 
even in  the non-pregnant p a tie n t.
The OVARIAN vessels can be sampled by the Doppler beam u t i l iz in g  a 
small sample volume and lo ca tin g  the cursor in  the infundibu lopelv ic l ig a ­
ment ju s t  la te ra l to the ovary. In normal in d iv id u a ls  i t  was noted tha t the 
ovarian signals appeared to  change with time over the menstrual period. I t  
means, enhanced flow was documented with an increased d ia s to lic  component 
during the formation and a c t iv i t y  of the corpus luteum. At the f i r s t  week 
both ovaries show a high impedance flow with v ir tu a l absence of d ia s to lic  
flow . In  the artery of the inactive ovary these high impedance signals
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pe rs is t during the cycle. At ovulation in  the artery of the active  ovary 
there is  a marked d ia s to lic  component as w ell as increased peak v e lo c it ie s . 
Compared w ith those of the inactive ovary, these signals are very easy to 
e l i c i t .  These changes p e rs is t and become more marked by middle lu te a l phase 
but regress to a high impedance signal by the day of next menstruation.
Pathological waveforms
Features of neovascularity determine types of Doppler s igna ls.
ARTERIOVENOUS SHUNTS give rise  to h igh -ve loc ity  flow because of the 
pressure gradients. These shunts are remarkable on account of the extreme 
ve lo c itie s  that may occur in  them. Pressure energy is  converted to k in e tic  
energy to give the high ve loc itie s  which can be detected by a doppler 
device. These small vessels around the periphery of a tumour have blood 
ve lo c itie s  (70-700 cm/s) many times exceeding those in the normal aorta 
/63, 64/. I t  is  un like ly  that these high v e lo c itie s  could be supported in 
vessels smaller than 1.5 mm in  diameter. Although vessels of th is  magnitude 
can be seen angiographically on the periphery of many tumours, such large 
vessels are seldom seen h is to lo g ica lly  even when sp e c ific a lly  sought, 
because of collapse and shrinkage of tumour vessels during f ix a t io n .
ENDOTHELIAL LINED LARGE CAPILLARY-LIKE CHANNELS or SINUSOIDAL SPACES 
make a flow accross a moderate pressure gradient in to  a very low impedance 
vascular place possible. The type of signal orig inated from th is  s inusoida l 
channels exh ib its  l i t t l e  s y s to lic /d ia s to lic  va ria tion  with re la t iv e ly  high 
ve lo c ity  in  addition to th e ir  very low impedance - th is  makes these signals 
h ighly abnormal.
For th is  reason, the several p u ls a t i l i t y  and resistance indexes 
alone may be in s u ff ic ie n t to characterize such tumour signals since s im i­
la r ly  low p u ls a t i l i ty  and resistance is  found in  normal parenchymal flow 
but w ithout high ve lo c ity . Moderately high Doppler sh ifts  ind ica te  that 
some c e lls  are moving rap id ly , but the complete broadening and even the 
concentration of energies at the lower v e lo c it ie s  (ind ica ting  by the white­
ness of the trac ing) suggests that many red blood ce lls  are moving slow ly, 
so tha t the peripheral flow in  these sinusoida l spaces may be qu ite  slug­
gish, accounting fo r the prolonged opac ifica tio n  interpreted as "dense 
parenchymal s ta in ing" on angiograms.
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Remarks
Angiogenesis, the growth of new c a p illa ry  blood vessels, does not 
occur normally in the postnata l l i f e  of males, but in  women new vessels are 
produced in  the vascu lariza tion  of the corpus luteum each month, and, of 
course, during pregnancy. Neovascularization is  also a component in  patho­
lo g ic a l processes, such as wound healing, inflammatory and ce rta in  immune 
responses and continuous growth of so lid  neoplasms.
For the above-mentioned corpus luteum formation we screen premeno­
pausal women fo r early ovarian cancer only during the f i r s t  week of the 
menstrual cycle and take care to avoid the time of ovulation and the pres­
ence o f corpus luteum and pregnancy.
Campbell et a l.  /7 /  reported the re s u lts  of a conventional trans- 
abdominal ultrasound screening fo r ovaria l carcinoma, and they concluded 
th a t i t  was not possible to  d iffe re n tia te  between ultrasonic appearance of 
e a rly  malignant and benign tumours. The odds against a pos itive  screen 
re s u lt  ind ica ting  the presence of primary ovarian cancer were only 1:67.
The routine app lica tio n  of transvaginal colour Doppler w i l l  enable us 
to determine the extent to  which women w ith hydrosalpinx, tumour-like con­
d it io n s  or benign tumours can be id e n tifie d  and save unnecessary operations, 
but a low resistance index can be used as a mark of malignity, even i f  the 
ovary is  normal in  size and there are no other suspicious signs.
In th is  way one can reduce the rate o f fa lse  positive resu lts  and 
" lu xu ry " operations from screening procedure using conventional u lt r a ­
sonography while maintain the detection ra te  o f ovarian cancer.
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TISSUE CHARACTERIZATION BY TRANSVAGINAL COLOUR DOPPLER FOR THE 
EVALUATION OF GYNAECOLOGICAL TUMOURS
Second of two parts: c l in ic a l experiences
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Transvaginal colour Doppler was used to evaluate the blood flow patterns in  p e lv ic  
vessels in  a group o f 315 pa tien ts  including 168 w ith  u te rin e  tumours and 147 w ith  adnexal 
masses. Neovascularization o f malignant tumour tissue  was successfully displayed by colour 
Doppler in  the vases o f endometrial and ovarian cancers but no abnormal blood supply was ob­
served in  the cases o f ea rly  ce rv ica l cancers. A comparison between the c h a ra c te r is tic s  o f 
blood flow  w ith in  benign and malignant lesions showed lower resistance index in  cases o f 
malignancy. The s e n s it iv ity ,  s p e c if ity ,  pos itive  p re d ic tiv e  value, negative p re d ic tiv e  value 
and the d iagnostic accuracy o f th is  new method in  the recogn ition  o f endometrial and ovarian 
cancers are higher than 95%. By the help o f transvag ina l co lour Doppler (together w ith  the 
c la ss ica l methods as colposcopy, cytology e tc .)  i t  w i l l  be possible to estab lish  o f complex 
screening programmes fo r a l l  types o f gynaecological cancers.
Keywords : colour Doppler ultrasound, colour flow  mapping, transvaginal sonography, 
gynaecological malignancy, tissue  characte riza tion .
In t r o d u c t io n
We have shown /5 /  tha t image inspection and Doppler techniques are 
in  progress toward the concept of tissue characterization by ultrasound. 
Colour Doppler and transvaginal sonography are the most exc iting  recent 
developments in  the f ie ld  of obs te trica l and gynaecological diagnostic 
u ltrason ic techniques /6 -11 /.
Abbrevia tions: NPV = negative p raed ictive  va lue; PPV = pos itive  p raed ic tive  value; 
RI = resistance index
O ffp r in t requests should be sent to  B. Juhász, Department o f O bstetrics and Gynae­
cology, U n ive rs ity  Medical School o f Debrecen H-4012 Debrecen, Nagyerdei k r t .  98, Hungary
Akadémiai Kiadd, Budapest
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In the present work we investigated the vascularity of female pe lv ic 
tumours by obtained co lour Doppler s igna ls , using a transvaginal probe.
S u b je c ts  and M ethods
PAÏIENTS
In a group o f 168 p a tie n ts  w ith proven u te rin e  tumours transvaginal co lour Doppler 
s tu d ie s  were performed before operation at the U ltra son ic  In s t itu te  U nivers ity  o f Zagreb. The 
ultrasonographer was informed about the re su lt o f transabdominal ultrasound and date o f the 
la s t  menstrual period, but he was not about c l in ic a l  fin d in g s  and ind ications fo r  treatm ent.
Table I
Types o f operations because o f u te rin e  tumours (n=168)
H I S T O L O G Y O P E R A T I O N S
Conisatio TAH Wertheim op.
Adenoca. endom. 7 2
Leiomyosarcoma u t . 
C a .ce rv .u t.s t."0 " 4
1
(16 malignant)
C a .ce rv .u t.s t.I/b 2
Adenomyosis u t. 21
(152 benign)
Myoma u t. 131
The type o f operations in  re la tio n  to  the pa tho log ica l diagnosis is  l is te d  in
Tabel I .
Laparotomies were performed on 147 other p a tie n ts  w ith adnexal masses, among them 22 
cases w ith  primary cancer, 2 m etasta tic  ovarian cancer and 123 w ith benign les ions o r tumour­
l ik e  cond itions.
TRANSVAGINAL COLOUR DOPPLER (TV-CD)
Patients with empty bladder were examined in  litho thom y position w ith a 5 MHz tran s - 
v a g in a l colour and pulsed-wave Doppler (TV-CD + PWD) probe (Aloka colour Doppler SSD-860, 
Aloka Co., Japan). The probe was covered with a coupling gel and inserted in  a condom, which 
was coated with gel and inse rted  in to  the vagina. Premenopausal women were scanned during the 
f i r s t  week o f the menstrual cyc le  to  exclude changes in  in traovarian blood flow  th a t are 
known to  occtjr during corpus luteum formation. The s p a tia l peak temporal average in te n s ity  
was 80 mW/cm , which is  w e ll w ith in  the highest l im i t  recommended by the Food and Drug Ad­
m in is tra t io n  of the U.S.A. In  the 2-0 Doppler mode, the flow  directed toward the transducer 
was displayed in  shades o f red , the flow  d irected away from the transducer was in  shades of 
b lu e , and the ve loc ity  o f flo w  was coded by the b rightness o f colour. Frequency d ispersion 
was determined as the variance o f the signal by the a u toco rre la to r. I t  was added to  the ve lo ­
c i t y  s igna l as an a lte rna te  hue such as green, which made the turbu lent blood flow  appear not 
as a pure red or blue, but as a d is t in c t iv e  speckled yellow  or cyan (mosaic appearance). The 
maximum v e lo c ity  of the flow  which exceeded the Nyquist l im i t  was presented as co lour a lia s -
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ing. Pulse re p e tit io n  frequencies o f th is  apparatus ranged from 2 to 32 kHz. Blood flow  
v e lo c it ie s  were displayed w ith in  a 90 sector at depths ranging from 2 to 20 cm. In  the 2-D 
and PWD modes, v e lo c it ie s  from 10 to 150 cm/s can be measured. Wall f i l t e r s  (100 Hz) were 
used to e lim ina te  low frequency signals o rig in a tin g  from no ise. In  addition to colour Doppler, 
the machine is  equipped w ith a conventional PWD system, which can be used simultaneously w ith 
В-mode imaging superimposed w ith  colours as in  "duplex"-systems.
Colour Doppler was used f i r s t  to  v isu a lize  c irc u la tio n  in  major vessels, then a 
systematic evaluation o f the u te rine , ovarian and tumour tissue  was done. The ovaries were 
often easier to  id e n tify  in  premenopausal women, owing to  the presence of f o l l ic le s .  A fte r 
menopause, the ovaries tended to decrease in  size and became more uniform ly echogenic, but 
th e ir  p o s itio n  was in va ria b ly  found or confirmed by reference to the uterus and the i l ia c  
vasculature.
Blood flow  ch a ra c te ris tic s  were fu rth e r analysed by PWD. A sample volume on the lin e  
o f the PWD beam was placed a t the region o f in te re s t,  where the colour flow  was c le a r ly  noted. 
Prominent areas o f vascu la riza tion  (probably re f le c t in g  neovascularization) usua lly  appeared 
as continuosuly f lu c tu a tin g  colour rather than the co lour seen with normal a r te r ie s . The 
angle o f the transducer was moved to obtain the maximum waveform amplitude and c la r i t y ,  then 
the p ic tu re  was frozen and the resistance index (R I) was calcu lated e le c tro n ic a lly  from a 
smooth lin e  f i t t e d  to the average waveform over 3-5 card iac cycles, according to the form ula: 
RI = (A-B)/A, where A equals the peak s y s to lic  Doppler s h i f t  frequency, В the maximum end 
d ia s to lic  Doppler s h i f t  frequency. The lowest RI was used fo r flow  ve lo c ity  waveform charac­
te r iz a t io n . Sonographic find ings  and RI-s were compared w ith  operative and h is topa tho log ica l 
diagnoses. S tudent's t - te s t  was used fo r s ta t is t ic a l ana lys is  o f the obtained R I-s fo r  d is ­
t in c t io n  between benign and malignant les ions. Data were then analysed, based on the p r in ­
c ip les  o f te s t in te rp re ta tio n  (see Table I I )  as published by Griner et a l.  / 3 / .  S e n s it iv ity  
addresses the p ro b a b ility  o f a te s t being p o s itive  i f  the disease is  present. S p e c if ic ity  
ind ica tes the lik e lih o o d  o f the re su lt being normal in  the absence of the disease. P o s itive  
p re d ic tive  value (PPV) expresses the p ro b a b ility  th a t the disease is  present when the te s t is  
p o s itiv e . Negative p re d ic tive  value (NPV) ind icates the p ro b a b ility  tha t disease is  not pre­
sent in  a case g iv ing  a negative te s t.  The d iagnostic  accuracy (DgAcc) was ca lcu la ted  to 
determine the percentage o f co rrect te s t re su lts  whether p o s itiv e  or negative.
Table I I
Indices fo r a te s t in te rp re ta tio n
S e n s it iv ity  = true pos itive  /  ( tru e  p o s it iv e  + fa lse  negative) 
S p e c if ic ity  = true  negative /  ( tru e  negative + fa lse  pos itive ) 
PPV = true  pos itive  /  ( tru e  p o s it iv e  + fa lse  p os itive ) 
NPV = true  negative /  (tru e  negative + fa lse  negative) 
DgAcc = correct re s u lts / to ta l p a tie n ts  tested
HIST0PATH0L0GY AND CLASSIFICATION
The extent o f malignant disease was estimated by the surgeon and the f in a l diagnosis 
was based on the h is to logy rep o rt. A ll  abnormal tissues were c la ss ifie d  according to  the 
c r i te r ia  recommended by the World Health Organisation /1 2 / .
The stage o f each primary cancer was determined from the operation records according 
to the revised recommendation o f the In te rn a tio n a l Federation o f Gynaecologists and Obste­
tr ic ia n s  /1 3 /.
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R e s u lts
There were 16 cases of malignant and 152 cases of benign uterine 
tumour. Colour flow inside the endometrium and/or myometrium was detected 
in  8 out of the 9 endometrial carcinomas. The peripheral impedance was 
always low (RI < 0 .5 ) ,  mean RI _+ S.E. = 0.38 _+ 0.06.
Table I I I
Blood flow  patterns of benipn and malignant u te rine  tum urs
H I S T O L O G Y C O L O R
present
FLOW
not present
Adenoca. endom. 8 1
Leiomyosarcoma u t. 1
C a.ce rv .u t. 6
Adenomyosis u t . 21
Myoma u t. 28 103
Table I I I  shows tha t in  1 case out o f 9 endometrial cancer, in  the 
only 1 case of leiomyosarcoma u te r i and in  a l l  of 6 early cerv ica l cancers 
(4 w ith  stage "0" and 2 w ith stage I /b )  we fa ile d  to detect any patho log i­
ca l blood flow.
In a l l  of 21 adenomyosis and in  103 cases of myoma u te r i,  we fa ile d  
to detect abnormality of blood flow. In 28 out of 131 fib ro ids  we saw flow 
ins ide  the myometrium (mostly around the order of the fib ro id )  but RI was 
always higher than 0.5 (mean RI +_ S.E. = 0.73 +_ 0.08). When the RIs were 
compared in  cases of myoma u te r i and carcinoma endometrii, s ig n if ic a n t ly  
lower RIs were obtained in  cases of endometrial cancer ( t  = 6.9; P < 0 .0 1 ) .
I f  we leave the cerv ica l cancers out o f consideration (because our 
attempts to v isua lize  blood flow w ith in  them were completely unsuccessful 
but we have an excellent p o s s ib ility  fo r  screening of cervical cancer by a 
combination of Papnicolau smear with colposcopy) (see Table IV) the sensi­
t i v i t y ,  s p e c if ic ity ,  PPV, NPV and OgAcc show good resu lts  in  the p red ic tion  
of the d ig n ity  of the uterine  tumours (Table V).
Table VI shows tha t colour flow was detected inside the malignant 
adnexal masses, except in  1 case (stage I I I ,  endometrial cancer w ith méta­
stasés in  both ovaries), and no flow or flow w ith high RI was detected in  
a l l  benign lesions, again except 1 case (hvdrosalpinx covered by w ell-vas- 
cu la rized  omentum).
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Table IV
Resistance indices (RI) detected in  benign and malignant
u te rine tumours (except c e rv ic a l cancers)
Malignant Beniqn
RI < 0.5 8 0
RI > 0.5 0 28
(Remark: those cases from Table I I I  when colour flow was 
present)
Table V
The c a p a b ility  o f TV-СО in  d if fe re n t ia t in p  o f benign and malignant 
u te rine  tumour (except ce rv ica l cancer) (n-162)
Blood flow  patterns
S e n s it iv ity
S p e c if ic ity
PPV
NPV
DgAcc
80%
100%
100%
98.7%
98.8%
and benipn adnexaland resistance
Table VI 
ind ices (R I) o f maliqnant
masses (n = 147)
HISTOLOGY Number
o f pa tients
COLOR
present
FLOW
not present
RI (+S.D.)
Cystadenoca ov. 20 20 0 0.34 (+ 0.09)
M etast.ov.ca. 2 1 I х 0.275C+ 0.035)
Granulo sa ce ll tu . 2 2 0 0.35 (+ 0.10)
Dermoid cyst В 0 8
Cysta ov.sim pl. 57 11 46 0.68 (+ 0.12)
Hydrosalpinx 16 1 15 0.71
Cystadenoma ov. 15 4 11 0.65 (+ 0.13)
Endometriosis ov. 19 0 19
Abscessus 5 0 5
Pseudooyst 1
^XX 0 0.41**
Adhaesions 2 0 2
the only one fa lse  negative case 
**the  only one fa lse  p o s itive  case 
explanations see in  te x t)
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Table V II
The c a p a b ility  of TV-CD in  d if fe re n t ia t in g  benign and 
malignant adnexal masses
S e n s it iv ity 95 ,8!
S p e c if ic ity 99 .2*
PPV 95 . 8!
NPV 99 .2'
DgAcc 98 .6'-
The e fficacy of colour Doppler is  exce llen t (Table V II) .
Undoubtedly, the most important fa c t is  tha t 4 out of the 23 true 
p o s it iv e  cases were recognized with early stages (3 with stage I /a ,  1 with 
stage I I )  without any symptom, c lin ic a l sign or sp e c ific  ultrasound fin d in g  
on the transabdominal ultrasonography (only 2 o f them had s lig h tly  enlarged 
ova ries ). Only the p o s itive  transvaginal colour Doppler test (Tabel V I I I )  
served as ind ica tion  of the operation.
Table V II I
D is tr ib u tio n  o f patients w ith ovarian cancer by stages
Stage Number 
o f p a tie n ts
I / a i 3
I l / a 1
I I I+ IV 20
D iscu ss io n
Many c lin ic a l problems remain in  d if fe re n t ia t in g  benign and malig­
nant tumours. The increasing number of imaging techniques have led to 
improved detection of space-occupying lesions but created many more 
problems requiring so lu tion . The major c l in ic a l  problem is  now character­
iz a tio n  of such masses.
Ultrasound imaging when ca re fu lly  done and interpeted by an ex­
perienced operator is  one of the better techniques fo r tissue character­
iz a tio n . One feature of malignancy that is  w e ll known to ra d io lo g is ts , 
however, is  the b iza rr vascular morphology th a t characterizes many malig­
nant tumours. Flow in  these abnormal channels gives r ise  to cha rac te ris tics
tha t can be detected by Doppler techniques. Colour Doppler in  the same 
vaginal probe produces a superb simultaneous v isua liza tion  of s tru c tu ra l 
and flow information about the female pe lv is  and offers new in s ig h ts  in  
dynamic studies of blood flow w ith in  tumour masses /6-11, 14/.
Our resu lts  show tha t the absence o f intratumoural neovascularisation 
or flow with a high RI can be used to exclude the presence o f invasive 
endometrial and ovarian cancer. Tumour vascu la rity  can successfully be used 
fo r characterization of these tumours. S e n s it iv ity , s p e c if ic ity , PPV, NPV 
and DgAcc are acceptably high.
Hata et a l. /4 /  fa ile d  to detect colour Doppler signals in  early 
ce rv ica l cancers. The vascularity of the u te rine  cervix might not be so 
affected by the neoplasm at the early stage of cervical carcinoma and/or 
the newly-formed vessels are too small, thus the velocity and volume flow 
are below the reso lu tion  power of the equipment.
The goal of transvaginal colour Doppler should be id e n t if ic a t io n  of 
tumours in  not enlarged ovaries /2 /.  This excellent method may be used to 
screen fo r ovarian and endometrial cancer; furthermore, the assessment of 
vascular changes and the peripheral resistance to blood flow may reduce the 
number of conventional ultrasound scans and other invasive procedures that 
are required nowadays to give a d e fin ite  diagnosis /1 /.
These developments, together w ith appropriate tra in ing  and q ua lity  
con tro l programmes w i l l  fa c i l i ta te  the establishment of screening c lin ic s  
fo r gynaecological cancers.
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C I R C U L A T I O N
THE EFFECT OF VASODILATOR THERAPY ON THE LIMB CIRCULATION 
IN HYPERTENSION
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The e ffe c t o f vasod ila to r drugs on limb c irc u la t io n  was investigated in  59 hyper­
tensive pa tients . F o rty -s ix  o f them suffered from o b lite ra t iv e  a r te r ia l disease, too. The drugs 
administered were: hydra laz ine, n itro g lyce rin e  and sodium n itrop russ ide . Isotope d ilu t io n  
method was employed to assess limb blood flow before and a f te r  acute treatment. Limb vascular 
resistance was ca lcu la ted from the limb blood flow  and the mean blood pressure.
A marked increase in  limb blood flow and decrease in  vascular resistance fo llo w in g  
vasod ila tor treatment were observed in  hypertensive p a tie n ts  su ffe ring  from o b lite ra t iv e  
a r te r ia l disease. No d iffe re n ce  was found between the various vasodila tors inves tiga ted . 
Normotensive pa tients w ith  a r te r ia l disease exh ib ited  the same response to a lesser degree. 
In  exceptional cases, where blood pressure dropped a b ru p tly , limb blood flow  decreased and 
limb vascular resistance increased.
The data show th a t vasod ila tor therapy in  hypertension resu lts  in  dim inished limb 
vascular resistance and improved limb c irc u la tio n  in  pa tie n ts  w ith o b lite ra t iv e  a r te r ia l  
disease.
Keywords : vaso d ila to rs , o b lite ra tiv e  a r te r ia l disease, hypertension, limb c irc u la t io n .
In t r o d u c t io n
The strategy of antihypertensive therapy in  cases of impaired 
peripheral - limb - c ircu la tio n  has been controversia l fo r decades. Over­
estimation of the s ign ificance  of perfusion pressure in limb a r te r ia l c i r ­
cu la tion  discouraged c lin ic ia n s  from using e ffec tive  antihypertensive
Abbreviations: LBP = limb blood flow ; LVR = lim b vascular resistance; MBP = mean 
a r te r ia l blood pressure
O ffp r in t requests should be sent to  A. Váradi, 1st C lin ic  o f Medicine, Semmelweis 
U n ive rs ity  Medical School, H-1083 Budapest, Korányi Sándor u. 2 /a, Hungary
Akadémiai Kiadó, Budapest
agents in  the therapy of such patien ts, because the decrease o f blood 
pressure in  patients w ith peripheral a r te r ia l stenosis was regarded as 
harmful fo r  the loca l c irc u la tio n . The depression of the pa tho log ica lly  
elevated peripheral vascular resistance w ith  antihypertensive agents, 
however, seemed to be bene fic ia l fo r the limb c ircu la tio n . We planned 
the re fo re  to study the changes of the limb c ircu la tio n  in  hypertensive 
p a tie n ts  under short-term antihypertensive therapy. On theore tica l grounds, 
we chose drugs with periphera l vasodila ting property to depress systemic 
a r te r ia l  pressure.
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P a t ie n ts  and m ethods
F ifty -n in e  hypertensive p a tie n ts , 11 women and 48 men were examined a fte r  having ob­
ta ined  th e ir  consent. The mean age o f the pa tients was 57.3 ys (17-82). F orty -s ix  o f the pa­
t ie n ts  su ffe red  from o b lite ra t iv e  periphera l a r te r ia l disease, too. The pa tients  had in te r ­
m itte n t c laud ica tion  or re s t pa in . The o b lite ra t iv e  a r te r ia l  disease was established by 
s e r ia l angiography and Doppler's sonographic technique. In  13 hypertensive p a tie n ts  the 
p e rip h e ra l c irc u la tio n  was in ta c t .  Three types o f vaso d ila to rs  were chosen to achieve acute 
decrease o f  systemic blood pressure: 39 pa tients were trea ted  w ith hydralazine as an i . v .  
bo lus , n itro g ly c e r in e  was administered to 10 and sodium n itrop russ ide  to another 10 p a tie n ts , 
in  form o f continuous i . v .  in fu s io n , 1-3 ug/kg/m in.
Before drug adm in is tra tion  a n u a fte r  the decrease o f systemic blood pressure limb 
blood flo w  was assessed according to  the venous isotope d ilu t io n  p rin c ip le  /1 5 /. B r ie f ly ,  two 
needles were inserted in to  the femoral vein a t a d istance o f 2 cm from each o th e r. Labelled 
albumin iod ine  was infused through the d is ta l needle w ith  a constant flow  ra te  and samples 
were taken through the proximal one. The d ilu t io n  o f ra d io a c t iv ity  in  th is  set-up is  a func­
t io n  o f  blood flow in  the femoral vein which represents the to ta l a r te r ia l flow , being the 
so le  o u tflo w  tra c t o f the lower lim b .
Limb blood flow  (LBF) can be calcu lated as fo llo w s  /1 4 /:
LBF = I  (
a c t . const. 
act .sample-V/2
-  1) ml/min
where I  = the flow  of isotope through the d is ta l needle (ml/min) 
a c t. c o n s t.= a c t iv ity  of the isotope infused (cpm)
act .sample = a c t iv ity  o f the sample taken through the proximal needle while in fu s in g  isotope 
through the d is ta l one (cpm)
V = blank, a c t iv ity  o f a sample, taken 1 min a f te r  the isotope in fus ion  has been 
stopped. On repeated measurements th is  fa c to r  to  be subtracted is  the mean o f 
the blanks before and a fte r  the actual measurement: (Vl+V2)/2.
On the basis o f limb blood flow  and mean systemic a r te r ia l pressure (MBP), lim b vas­
c u la r  res is tance  (LVR) can be ca lcu la ted  as fo llow s:
LVR
80000 X MBP -5---------  d in  sec cmLBF
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MBP being P
d iast
syst
-  P
d ias t
(Wiggers)
R e s u lts
Table I
E ffe c t o f vasod ila tors on a r te r ia l c irc u la tio n  o f the limb in  hypertensive 
pa tients  w ith obstruc tive  a r te r ia l disease. ~x± S.D. Level o f s ig n ifica n ce  
is  marked w ith as te risks -1-
No. of
Drug
MBP(mmHg) LBF(ml/min) LVR(dinseccm ')
pts before a fte r before a fte r before a fte r
137 108*** 149 244*** 75560 35410***
21 hydralazine +18.8 +13.3 +74.3 +89.3 +21703 +.19031
131 107*** 197 301** 54748 31313***
10 n itro g lyce rin e +23.3 +20.1 +46.6 +132 +13732 + 9790
10
128 g7**x 162 272* 70265 38105***
n itroprusside
sodium +12.6 +12.0 +51.2 +158.5 +25175 +21592
MBP: mean blood pressure; LBF: limb blood flow ; LVR: limb vascular res is tance
*P < 0 .0 5 ; * * P < 0 .0 1 ; ***P < 0 .001
Table I shows the data measured before and a fte r drug adm inistration 
in  hypertensive patien ts, su ffe ring  from obstructive a r te r ia l disease. The 
decrease in  systemic blood pressure was a predictable e ffe c t of drugs with 
vasodila tor a c t iv ity .  Increase in  limb blood flow and decrease in  limb 
vascular resistance pointed to a favourable e ffec t of vasodila tor therapy 
on the diseased limb c irc u la tio n , even w ith the f a l l  of perfusion pressure. 
Table I I  represents the haemodynamic data of hypertensive pa tien ts  without 
peripheral a r te r ia l disease. On adm inistration of hydralazine a tendency 
of increase in  LBF was observed in  these patien ts, but i t  did not reach the 
leve l of s ign ificance. The marked decrease in  LVR is  another change that 
points to the vasodilating e ffe c t.
Exceptionally, some hypertensive patients exhibited a very marked, 
abrupt drop in  blood pressure under hydralazine medication. Table I I I  re­
presents the data of th is  group showing a d e fin ite  decrease in  LBF and a 
s lig h t upward tendency of LVR.
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Table I I
w ith in ta c t vessels. X + S.D. Level of s ig n ifica n ce  is marked w ith asterisks
(see footnote to Table I )
No. o f MBP(mmHg) LBF(ml/min) LVR(dinseccm )
pts before a f te r before a fte r before a fte r
13 138 105** 468.5 511.9 25077 18782***
+12.1 +11.7 +133.5 +198.0 +7845 +7912—
Table I I I
on c irc u la tio n of the lim b . x ± S .0. Level o f s ig n ifica n ce is  marked w ith asterisks
(see footnote to  Table I )
No. o f MBP(mmHg) LBF(ml/min) LVR(dinseccm J')
pts before a f te r before a f te r before a fte r
110.0 83 .4**
VV
400.6 261.4 26376 27620
5
+12.8 +8.8 +183.0 +59.2 +12520 +9899
D iscuss io n
Since, according to  a generally accepted concept about the leading 
ro le  of perfusion pressure in  maintaining adequate limb c ircu la tio n  of 
pa tie n ts  with peripheral a r te r ia l disease, a decrease of blood pressure is  
harmful /7 / ,  therapy should be directed to augment the blood pressure /5 , 
8 /. Our present data showed, in  agreement w ith some e a r lie r  studies /6 , 9, 
10, 11, 17/ that most of the hypertensive pa tien ts  had elevated limb vascu­
la r  resistance due to a continuous peripheral vasoconstriction caused by a 
continuous sympatho-adrenergic dominance /9 , 10, 18/. Drugs with peripheral 
vasod ila ting  property (re la x in g  the smooth muscle of vessel w a ll) w i l l  
d im in ish systemic vascular resistance and, i f  so, produce a favourable 
change in  peripheral c irc u la t io n  even in  cases w ith  low perfusion pressure. 
Another possible danger o f vasodilator treatment of patients with ex- 
t re m ita l obstructive a r te r ia l  disease is  the danger of steal phenomenon /1 , 
3 /. Some authors observed no increase in  limb blood flow with hypertension, 
lim b vascular resistance being higher in  hypertensive patients than in  
normotensive subjects /4 , 6, 11, 12, 17/. We fa ile d  to find  experimental 
signs of steal phenomenon and did not observe any pathological change in 
lim b c ircu la tio n  on adm in is tra tion  of vasoactive drugs.
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Our data show tha t vasodilator therapy in  hypertension re su lts  in 
diminished vascular resistance and improved limb c ircu la tion  in  patients 
with o b lite ra tiv e  a r te r ia l disease.
Three more questions have remained to be answered:
i )  Can the bene fic ia l short-term e ffe c t of vasodilators be extra ­
polated to a long-term benefit of vasodila tor therapy? To answer th is  ques­
tio n , studies of at leas t 2-3 month duration should be completed.
i i )  How should be avoided a fu rth e r impairment of the limb c ircu ­
la tio n  i f  the danger of abrupt f a l l  in  blood pressure could cause a de­
crease in  limb blood flow , as shown on Table I I I?  We must suggest that 
patients of such type of response should not be treated with th is  so rt of 
antihypertensive agents.
i i i )  Which type of vasodilator agent should be chosen fo r  antihyper­
tensive therapy in  cases of obstructive a r te r ia l disease?
The three types of vasodilators in  our experiment showed no s ig ­
n if ic a n t differences in  respect of increase in  LBF. We consider a l l  the 
three su itab le , sodium nitroprusside, however, cannot be used fo r  long-term 
therapy. N itrogylcerine and hydralazine are accepted fo r long term therapy, 
so on the basis of the data above th e ir  use as antihypertensive drugs is  
ju s t if ie d  in  patients w ith obstructive a r te r ia l disease.
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GAST ROENT EROL OGY
ULTRASONOGRAPHY AND WATER CONTENT OF THE LIVER IN 
CHRONIC DIFFUSE LIVER DISEASE
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(Received: A pril 17, 1990)
Water content in  the l iv e r  in vivo was determined in  89 patients (33 w ith  normal 
l iv e r  and 56 w ith chronic l iv e r  disease), simultaneously w ith  ultrasonography and h is to -  
pa tho log ica l examination. A pa rt o f each biopsy specimen was used fo r th is  purpose. The d i f ­
ference between wet and dry weights was calcu lated from the pre- and p o s t- ly o p h iliz a tio n  
weights. According to the a ttenuation type o f u ltra s o n ic  images, the patients were d iv ided 
in to  two groups, v iz . ,  pa tie n ts  o f low attenuation type ( i . e .  patients w ith type I  b r ig h t 
l iv e r )  and those o f high a ttenua tion  type ( i . e .  w ith  type I I  b righ  l iv e r ) .  As to  water con­
te n t, no s ig n if ic a n t d iffe rence  was observed between the two groups. No co rre la tion  was found 
between l iv e r  water content and histopathology e ith e r. I t  is  concluded that knowledge o f co r­
re la tio n  between numerous parameters is  needed to c la r i f y  the reason of a ttenua tion  d i f ­
ferences.
Keywords : l iv e r ,  ultrasonography, water content, d if fu s e  liv e r  disease.
In t ro d u c t io n
The normal echopattern of the l iv e r  - as suggested by some authors 
/2 , 5/ - is  caused by a series of a lte rna te  collagen-water in te rfaces.
Chronic d iffuse  l iv e r  diseases cause well-recognizable changes in 
the l iv e r  texture, characterized by high-amplitude echos /16, 18/ and a 
dense echopattern known as "brigh t l iv e r "  /10, 11, 13/. These signs are not 
sp e c ific  fo r a ce rta in  l iv e r  pathology; normal echopattern may occur in 
pathological cases as well /11, 13, 25/. Numerous authors have described 
also attenuation values lower or higher than normal in ce rta in  l iv e r
O ffp r in t requests should be sent to  Agnes Szebeni, H-1071 Budapest, G o rk ij fasor 
9 /11 , Hungary
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diseases /3 , 14, 15, 17, 22, 26/. In previous studies /19, 20/ we d i f ­
fe ren tia ted  two groups o f patients with ch a ra c te ris tic  u ltrason ic  signs of 
chronic d iffuse l iv e r  disease: one w ith low attenuation characterized by 
b r ig h t l iv e r  (throughout in  the organ) ( ty p e - I b righ t l iv e r  as designated 
by us) and another w ith  high attenuation th a t can be recognized on the 
basis of mainly s u p e rfic ia l appearance o f b rig h t liv e r  pattern ( ty p e -II 
b r ig h t l iv e r ) .  Some authors /8 , 21/ have suggested that the increased liv e r  
attenuation is  caused by collagen f ib ro s is ;  others /3 , 17, 22/ a ttr ib u te  
i t  to  fa t.  Decrease of l iv e r  attenuation is  in terpreted as being due to the 
water content of the l iv e r  /15 /.
In th is  study in  vivo water content determination of the l iv e r  was 
made in  patients w ith normal ultrasonography, as well as in  pa tien ts  with 
chronic d iffuse l iv e r  disease displaying typ e -I or type -II b r ig h t l iv e r  
pa tte rn  on the u ltrason ic  scan.
M a te r ia ls  and m ethods
Ultrasonography. A h igh -reso lu tion  rea l-tim e  scanner (Siemens Sonoline-SL2) was used. 
We took in to  account the ga llb ladde r and the r ig h t  rena l parenchyma as reference organs. 
Echogenic ity and attenuation o f the l iv e r  were evaluated only i f  the ga llb ladder was echofree 
and the r ig h t  renal parenchyma showed a homogeneous echopattern.
89 patients were d iv ided  in to  three groups.
1. 33 patients w ith  normal u ltrason ic  echopattern o f the liv e r  (F ig . 1 ).
F iq . 1 . Normal l iv e r  te x tu re . Echo amplitude d is t r ib u t io n  and echodensity are s im ila r  
those o f the renal parenchyma
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F ig . 2. Type-I b r ig h t l iv e r .  Note the h igh -leve l echos and dense echopattern througnout 
the liio le  thickness o f the l iv e r .  Renal parenchyma e x h ib its  normal echogenicity and 
echodensity. The d iffe rence  between echopattern o f the l iv e r  and renal parenchyma
is  obvious
F ig , 3, ly p e -II  b r ig h t l iv e r .  Note the h igh -leve l echos and dense echopattern near the 
l iv e r  surface and th e ir  absence in  the deeper reg ion . Ihe renal parenchyma is  normal. 
Behind the r ig h t  kidney considerable amounts o f echos are seen
166 SZEBENI ÁGNES e t a l.
2. 24 patients w ith  ty p e -I b righ t l iv e r ,  i . e .  low attenuation pa tte rn  (F ig . 2).
3. 32 patients w ith  ty p e - I I  b righ t l iv e r ,  i . e .  high attenuation pa ttern  (F ig . 3). 
D is tribu tion  o f the two types was determined and compared with p rev iously  examined
p a tie n t groups.
The maximum l iv e r  th ickness was measured, and the averages fo r typ e -I and I I  b righ t 
l iv e r s  were compared.
Water content. The water content o f the l iv e r  o f the 89 patients was determined in  
b iopsy material obtained m ostly by b lin d  percutaneous l iv e r  biopsy performed w ith  Menghini 
needles; in  a minor part d ire c t  l iv e r  biopsy was made during surgery. The ultrasonography 
always preceded the biopsy. A p o rtio n  of the biopsy m ate ria l (appr. 10 mg wet weight) was im­
m ediate ly measured on a S a rto riu s  balance 1207 MP2. This m ateria l was then ly o p h iliz e d  in  a 
Jane tzk i LGR 05 apparatus a t -10 C and 70 to 80 to r r  fo r  2x5 h, i .e .  u n t i l  constant weight. 
Repeated measurements showed steady values o f the dry weight. Water content was ca lcu la ted  as 
fo llo w s :
water content % - 100x(wet w t.-d ry  w t.)/w e t wt.
The remaining part o f  the biopsy m ateria l was u t i l iz e d  fo r h is to lo g ic a l examination 
and evaluated according to  in te rn a tio n a l c r i te r ia  /1 ,  4, 6, 9, 12, 23/.
F inal diagnosis was established by de ta iled  c l in ic a l  examination o f the pa tien ts .
R e s u lts
Table I
D is tr ib u tion  o f type I  and type I I  b r ig h t l iv e rs  in  patients w ith 
chronic d iffuse  l iv e r  disease
Time in te rva l U ltrason ic No. o f Type-I Type-II
o f scannings scanner pa tien ts b irgh t l iv e rs  %
1976-1979 K retztechn ik 144 41% 59%
b is ta b le
1980-1981 B riie l-K jae r 
compound gray-scale
55 45% 55%
1984-1986 Siemens 
H-R re a l- tim e
89 43% 57%
Table I  shows the d is tr ib u tio n  in  per cent of type I  and I I  b righ t 
l iv e rs  in  three groups formed according to  the date and technique of the 
examination. For evaluation of u ltrasonic scans the above-mentioned c r i ­
te r ia  were considered in  each group. The f i r s t  group was studied between 
1976 and 1979 with a Kretz bistable equipment, the second between 1980 and 
1981 with a Bruel Kjaer compound gray scale scanner, and the th ird ,  the 
actua l group between 1984 and 1986, w ith a h igh-resolution rea l-tim e 
scanner. As seen in  Table I  the d is tr ib u tio n  of the two brigh t l iv e r  types 
shows no s ig n ifica n t d iffe rence  in the studied patient groups. Neither the
date of examination, nor the type of equipment influenced the d is tr ib u tio n  
considerably.
lo  elim inate the p o s s ib ility  that high attenuation pattern of b r ig h t 
l iv e r  is  caused only by increased liv e r  thickness, i .e .  the longer propa­
gation time of ultrasound, the maximum liv e r  thickness values were measured. 
In the present study the average maximum thickness fo r the 24 type I b rig h t 
l iv e rs  was 11.5+1.5 cm (mean + S.D.), while tha t fo r  the 32 type I I  bright 
liv e rs  was 11.9+1.8 cm (mean _+ S.D.). Accordingly, no s ig n ifica n t d i f f e r ­
ence exis ts  between the maximal average thickness of type I  and I I  b righ t 
l iv e rs .
The water contents of the 33 normal, 24 type I  and 32 type I I  b rig h t 
l iv e rs  are shown in  Table I I .  No s ig n if ic a n t d ifference was observed.
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Table I I
Water content o f the l iv e r  in  89 pa tients w ith d if fe re n t  u ltrason ic  patterns
U ltrason ic pattern 
o f the liv e r
Number o f 
patients
Water content o f 
the l iv e r  (x+S.D.%)
normal 33 40.9 + 12.5 \
type I
b rig h t l iv e r 24 47.0 + 21.5 H
type I I  
b righ t l iv e r 32 48.9 + 16.4 %
Table I I I
C orre la tion  between h is to lo g y , ultrasonography, and water content of the l iv e r
(89 pa tien ts)
L iver Number o f 
h is to logy pa tien ts
U ltrason ic pattern 
normal type I  type I I
Water content in  
per cent (x+S.D.)
normal 27 20 3 4 40.3 + 13.4
A lcoho lic
h e p a tit is  6 5 1 49.3 + 24.1
Fatty  l iv e r  39 9 11 19 46.6 + 17.2
C irrhos is  12 2 3 7 51.2 + 17.2
Others ( to x ic , 
e tc .)  5 2 2 1 45.5 +_ 21.6
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Table I I I  shows the water content o f the l iv e r  in  re la tionsh ip  to 
ultrasonography and histomorphology. There was no corre la tion  between these 
parameters.
D is c u s s io n
Water content of the l iv e r  and i t s  corre la tion  to acoustic par­
ameters was determined in  v itro  by Bamber and H i l l  /3 /  in  a postmortem 
study. From the numerous biochemical and acoustic parameters water content 
and attenuation c o e ffic ie n t of normal and cancerous liv e rs  were in v e s ti­
gated and correlated w ith each other. A negative co rre la tion  was demon­
s tra te d  between the water content and the attenuation c o e ffic ie n t of the 
l iv e r .  On the contrary, fa t  content and attenuation c o e ffic ie n t of the 
l iv e r  showed a pos itive  co rre la tion  /3 / .  Cloostermans fa ile d  to corre la te  
attenuation and water content but found a re la tionsh ip  between water con­
te n t and re f le c t iv i ty  in  fresh ly  excised l iv e rs  o rig ina ting  from autopsy /8/
No lite ra ry  data are available on in  vivo water content determi­
na tion  of the l iv e r .  In th is  study a simple method was developed using 
l iv e r  tissue obtained w ith biopsy. Ind ica tion  of l iv e r  biopsy was always 
based on c lin ic a l decision. I f  h is to logy of the liv e r  was needed to 
es tab lish  the diagnosis, one part of the m ateria l was used fo r water con­
te n t determination.
I t  has been published that attenuation values in  pa tien ts  with 
chron ic d iffuse l iv e r  disease might be lower or higher than normal /3 , 14, 
17, 22, 26/. These find ings are in  accordance with our experiences, namely, 
p a tie n ts  with chronic d iffu se  l iv e r  diseases exh ib iting  b rig h t l iv e r  by 
u ltrasound, can be c la s s if ie d  in to  two groups according to attenuation. 
An expert examiner using standard c r i te r ia  is  able to d if fe re n tia te  brigh t 
l iv e r s  of low-attenuation (type I )  from those of high-attenuation (type I I )  
/2 0 / .  Maklad et a l . ,  examining attenuation values in  normal l iv e rs  and in 
a group of patients w ith l iv e r  diseases, concluded that an increased water 
content of the l iv e r  is  responsible fo r  the lower attenuation in  patients 
w ith  tissue necrosis, and the higher attenuation values are due to de­
creased water content in  patients w ith l iv e r  c irrhos is  /1 5 /. Bamber and 
H i l l  also found, in  an in  v it ro  study, a negative corre la tion  between water 
content and attenuation co e ffic ie n t /3 / .  Our results do not agree with 
these findings but are in  accordance w ith  those published by Cloostermans
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et a l.  I l l . We found tha t in  vivo water content determined in  l iv e r  biopsy 
material of patients with b righ t l iv e r  patterns showed a large ind iv idua l 
v a r ia b il i ty ,  but no s ig n if ic a n t difference could be observed between the 
low ( I )  and high ( I I )  attenuation types.
In a few cases we attempted to d if fe re n tia te  between free and bound 
water in  biopsy specimens obtained at surgery by the NMR measurement of 
s p in - la tt ic e  re laxation  time. No difference was observed between the groups 
Nevertheless, the small number of measurements did not allow re lia b le  
evaluation.
Unfortunately, a specimen from liv e r  biopsy does not represent the 
l iv e r  as a whole. In th is  study, in which parts of the same specimen were 
used fo r histology and fo r water content determination, presence or absence 
of fa tty  l iv e r  or c ir rh o s is , or some other chronic d iffuse l iv e r  disease 
was diagnosed w ith high accuracy and co rre la tion  between water content and 
u ltrason ic pattern could be analysed re lia b ly . The in  v itro  find ings of 
Bamber and H i l l  /3 /  eventually provide some explanation of our resu lts . 
These authors fa ile d  to observe any co rre la tion  between attenuation coef­
f ic ie n ts  when p lo tted  versus fa t content a fte r  correction fo r va ria tions in 
water content. Presumably, changes of numerous parameters must be studied 
and correlated in  a more complex manner to explain low or high attenuation 
type of u ltrasonic b rig h t l iv e r  pattern /2 4 /.
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SUCCESSFUL TREATMENT OF INTRACTABLE GASTRIC ULCERS WITH ACETAZOLAMIDE
A. ERDEI, I .  GYŐRI, A. GEDEON and ILDIKÚ SZABÓ
Department of Medicine, Central Laboratory Bugát Pál Hospita l, 
Gyöngyös, Hungary
(Received: September 21, 1990)
An open-controlled t r i a l  performed in  g a s tr ic  u lce r cases re s is ta n t to  previous 
C imetidine, antacids, vitam in A and po lyv iny lbu ty le the r therapy applied fo r at leas t 4 weeks. 
A group o f 21 pa tien ts  treated w ith acetazolamide was compared w ith 16 pa tien ts  treated with 
c im etid ine (c o n tro ls ). The period o f management was 3 weeks. The number o f healed patients 
(P = 0.009), the surfaces o f u lce rs  a fte r  treatment (P = 0.0166) and the duration o f com­
p la in ts  (P = 0.0003) d iffe re d  favourably and s ig n if ic a n t ly  in  the acetazolamide group as 
compared to the cim etid ine group. In  the acetazolamide group, however, several side e ffec ts  
( in  11 cases metabolic ac idos is , in  9 cases t in g lin g  o f ex trem ities) were reg is te red . Side 
e ffe c ts  were not seen in  the con tro l group. I t  is  supposed tha t in  the treatment o f g a s tric  
u lcers a compound w ith less carbonic anhydrase in h ib it io n  but w ith the same or more cytopro- 
te c tiv e  e ffe c t would have wider c l in ic a l perspectives than acetazolamide alone.
Keywords : carbonic anhydrase, metabolic ac idos is , u lce r, therapy, side e ffe c ts .
In t r o d u c t io n
antagonits are e ffec tive  drugs against duodenal u lcer disease, 
though, the resu lts  in  the conservative treatment of gas tric  ulcers are 
controvers ia l. That is  why we examined the p o s s ib ility  of acetazolamide's 
(Ac) application.
A bbrevia tions: Ac = acetazolamide, CA = carbonic anhydrase, d = day
O ffp r in t requests should be sent to  A. E rde i, H-3201 Gyöngyös, H osp ita l, Dept. In t .  
Med., Dózsa s t r .  20-22, Hungary
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The carbonic anhydrase enzyme (CA) catalyses the re a c tio n : H O+CO^  H^CO .^
fundamental change is  from a nonpolar gas w ith the lin e a r s tru c tu re  П -  C = 0 to  an acid or 
i t s  conjugate bases w ith the coplanar con figura tion . CA concentration is  high in  mammals' 
stomach p a rie ta l c e lls ,  red blood c e lls ,  sa liva ry  glands, kidney and eye /1 4 /. The e a rly  data 
about the ro le  of CA in  the g a s tr ic  secretion were co n tro ve rs ia l /1 , 4, 5, 8 /.  This enzyme 
appears to  be important in  c o n tro ll in g  g a s tric  acid synthesis in  p a rie ta l c e lls  and in  
re g u la tin g  the bicarbonate secre tion  by surface e p ith e l ia l c e lls .  Some data suggest a pro­
te c t iv e  function  fo r CA in  the g a s tr ic  mucosa /2 , 10/. Ac is  a th ia d ia zo le , a potent CA in ­
h ib i t o r .  I t  is  absorbed from the in te s t in a l tra c t completely, and has about 100 min as plasma 
h a l f - l i f e .  The decay o f Ac from enzyme s ite s  is  slow; a fte r  one week Ac is  s t i l l  found in  the 
organs, though, in a low concentra tion . A high dose o f Ac blocks g a s tric  acid secre tion /8 / .  
The o ra l or intravenous dose necessary to  in h ib it  g a s tr ic  acid secretion in  human beings is  
about 50 mg/kg. When CA in h ib ito rs  are used, complete suppression o f CO,, hydratation cannot 
be expected, i .e .  the ra te  o f uncatalysed reaction is  enough to  provide a moderate reaction  
/1 3 -1 5 /.  Gastric haemorrhagic u lc e rs  were induced by hypovolaemic shock and indomethacin in  
ra ts  ; h igh doses of Ac enhanced g a s tr ic  u lc e ra tio n , assumed to  in h ib it io n  both CA enzyme and 
mucus secre tion /2 , 10, 11 /. Other studies have proved th a t Ac p ro tects against e thano l-, 
a s p ir in -  or histamine-induced g a s tr ic  lesions and increases the degree o f g a s tr ic  cytopro- 
te c t io n  /6 ,  19/.
Recent data have shown tha t the gastroprotective e ffec t of Ac may 
be re la ted  to i t s  su lfh yd ry l content and not to CA in h ib it io n  /1 2 /. Eth- 
oxzolamide causes a complete CA in h ib it io n  but does not prevent ethanol- 
induced lesions. B ism u th io l-I, a th iad iazo l w ith su lfhyd ry ls , is  a weak 
in h ib ito r  of CA. I t  reduced the lesion area induced by ethanol. The acute 
g a s tr ic  mucosal protection by Ac and i t s  deriva tives  might be re la ted to 
th e ir  content of su lfhyd ry ls  in  the oxidized or reduced state and not to 
th e ir  CA-inhibiting a c t iv i ty  in  the stomach /12, 21/.
Despite i t s  side e ffe c ts , Ac has already been applied fo r trea ting  
u lce r disease with good re s u lts . However, there are no w e ll-con tro lled  
clinicopharmacological s tud ies. Our purpose was to  evaluate the e ffe c t of 
Ac on therapy-resistant benign gastric  u lcers, and monitoring the side 
e ffe c ts  of the therapy.
P a t ie n ts ,  methods
We treated endoscop ica lly -con tro lled  benign g a s tr ic  u lce rs  re s is ta n t to  an a t least 
4-week pretreatment in d ica tin g  th a t  the s ize o f u lce r had diminished by less than 20%, or 
remained unchanged or even grew, despite continuous medication. Their pretreatment was 
c a rr ie d  out w ith Cimetidine 1 g /day, antacids o f an average o f dose 50 mEq/d, Vitamin A 
2x50 000 U weekly /9 / ,  1 tab lespoonfu l o f Shostakovsky1 s balsam (Medexport, Moscow) before 
bedtime (a po lyv iny lb u ty le th e r, which provides a p ro tec tive  b a rr ie r  on mucosa). Our study was 
a p rospec tive , open, c o n tro lle d , randomized examination. P a tien ts  w ith renal or cardiac in ­
s u f f ic ie n c y ,  hepatic c ir rh o s is , re s p ira to ry  diseases, chron ic alcoholism , and/or diabetes 
m e llitu s  were excluded. Gastroscopy was performed on three occasions, w ith  an Olympus GIF D4 
upper panendoscope 1) before the i n i t i a l  treatm ent, 2) a t the beginning o f the three-week 
programme, 3) and w ith in  2 days a f te r  fin is h in g  i t .  We took biopsy samples at lea s t fou r from 
the m argin, one from the bottom, and some from the surrounding areas o f the u lce r. A l l  o f the
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samples were evaluated h is to lo g ic a lly .  The size o f the u lc e r was measured with an open biopsy 
forceps, computing the surfaces o f c ir c le ,  e llip s e  or quadrangle. The therapy was known by 
the endoscopists. The period o f management was 3 weeks, not more because o f the expectable 
side e ffe c ts  o f Ac.
The symptoms and the side e ffe c ts  also were reg is te re d . We used Ac monotherapy fo r  
three weeks, g iv ing  25 mg/kg body mass d a ily  doses in  fou r pa rts  (Fonurit ta b le t,  manufac­
tured by Chinoin, Budapest). In  the f i r s t  week of treatm ent we examined three times, and in  
the 2nd and 3rd weeks weekly tw ice , the acid-base re la t io n s , c a p illa ry  pO^, pCO^, serum Na , 
К , Cl , BUN and c rea tin in e  values. We registered the serum b i l i r u b in ,  AST, ALT, a lc a lic  
phosphatase, glucose^ Ca+ , P le v e ls , ECG, spirometry, c re a tin in e  clearence and the p a tie n ts ' 
complaints. Urine Na , К and Cl were measured every day in  4 o f the cases.
The con tro l group members received 1 g o f C im etid ine (H is to d il ta b le t,  R ich te r, 
Budapest), antacids o f an average o f 45 mEq bu ffe r capac ity  per day and vitam in A 50 000 U 
tw ice weekly. In the co n tro l group, laboratory examinations were performed at the beginning 
and a t the end o f the treatm ent. Spasmolytic (papaverinum) was allowed to take in  time o f 
pain in  both groups. S ta tis tica l analvsis was made w ith  the 2 - t a i l  F isher's  exact te s t fo r 
evaluating the proportion o f healed patients in  both groups. Student's t - te s t  was used to 
compare the duration o f complaints and extent o f u lce rs .
R e s u lts
The t r ia l  was carried  out in  a period o f 36 months. Twenty-one pa­
tie n ts  (male 16, female 5) average age 47 received Ac. With 2 patients the 
therapy was discontinued due to hyperkalaemia and urethro-prostatitis. One of 
the patients did not improve, the other was completely cured despite that the 
therapy lasted only one week. By the end o f the th ird  week, the u lcer had 
healed in  15 cases and improved in  4. In 16 members of the contro l group 
(average age, 52; male 12, female 4) in  three weeks of treatment 5 healed,
8 improved, 3 showed no changes (Table I ) .  The average extension of u lcers
2 2in  the Ac group diminished from 143.5 mm to  7.6 mm while in  the con tro l
2 2group from 120.8 mm to 32.1 mm . 2 - ta i l  F ishe r's  exact test proved s ig ­
n if ic a n t as regards the number of recovered pa tien ts  (P = 0.009, includ ing 
the 2 withdrawn cases). The extent of the u lcers before treatment did not 
d if fe r  s ig n if ic a n tly  (P = 0.564), a fte r treatment s ig n ifica n t d ifferences 
were realized in  the two groups (P = 0.0166). The pa tien ts ' pain in  the Ac 
group lasted an average of 4.4 days (S.D. 2 .8 ), in  the control group 11.4 
days (S.D. 5.9). The value of Student's t - te s t  was 0.0003 (Table I I ) .
In the Ac group 9 patients complained of tin g lin g  of extrem ities , 
2 of diarrhoea, 1 o f temporary visual disturbances. We observed acidosis 
in  11 patients of the Ac group. Five of them were normal anion gap hyper- 
chloraemic metabolic acidosis, 2 mixed hyperchloraemic-high anion gap 
metabolic acidosis. Four were mixed metabolic acidosis and resp ira to ry  
acidosis with metabolic dominance. We measured in  some cases other tran -
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Table I
Results of the t r i a l
Medication Response o f pa tie n ts Total
Healed T . Did not Improved
improve
Acetazolamide 16 4 1 21
Control 5 8 3 16
Table I I
Change o f u lce rs ' extent and du ra tion  of pain
Acetazolamide group Control group
----------------------------- 2-----
U lcers ' extent (mm )
before a fte r 
treatment
Duration of 
pain 
(days)
U lcers ' extent 
before a fte r  
treatment
Duration o f 
pain 
(days)
50 0 2 78 13 15
51 0 2 106 29 12
191 0 10 81 0 7
313 0 4 153 31 11
315 0 7 60 0 5
48 0 3 83 32 12
54 0 6 80 80 21
80 0 3 28 0 8
155 0 3 51 13 15
79 0 3 314 80 8
131 0 5 106 106 21
314 30 3 190 31 9
190 0 2 81 0 3
154 29 7 28 49 21
52 0 1 52 0 4
79 0 2 441 53 10
438 80 5
29 0 1
51 0 3
156* no data 11
87* 0* 3
Not included in  the s ta t is t ic a l  analysis
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s ien t mixed acid-base disorders during the treatment (e.g. metabolic 
acidosis with resp ira tory a lka los is ) but the characteris tics o f the d is ­
turbances were as described above /1 6 /. Below pH 7.25 (5 cases) 50-100 
mEq/day NaHCO-j was administered per os. In the course of the Ac therapy, 
excretion of potassium increased, though the d ie t was the same. In 4 cases 
before therapy the excretion of potassium was 33.1 mEq/day, on the average, 
during the f i r s t  3 days of the Ac therapy 38.2 mEq (115.4%) and an average 
of 36.0 mEq/day between the 4th and 21st days (108.8%). This equals to 
67.5 mEq loss in  3 weeks compared to the pretreatment excretion leve l. 
However, hypokalaemia was not seen at a l l ;  fo r that very reason, we did not 
give K+ s a lt.  Excretion of Na+ before therapy was 106.5 mEq/d, during Ac 
medication 131.4 mEq/day on the average (123.4%). We registered once a mild 
hypernatraemia (146 mEq/1). The Cl excretion before the Ac therapy was 
80.3 mEq/day and during i t  87.3 mEq/day (108.7%). Hyperchloraemia was found 
in  5 cases. Diuresis grew by 46% (mean: 805 ml/day before Ac and 1177 
ml/day a fte r Ac). Creatinine clearence showed temporary decrease in  four 
cases (max.: 22%); a fte r 3-4 days the values returned to the e a r lie r  leve l. 
The blood urea nitrogen rose w ith an average 37% but remained ins ide the 
normal range. The other parameters showed no change. The side e ffe c ts  and 
complaints disappeared by the end of the treatment.
The contro l (cim etid ine) group showed no side e ffec ts . There were 
s ix  smokers in  each of the Ac and the con tro l group.
Members of the Ac group and those of the control group spent an 
average of 10.8 days and 8.6 days, respective ly , in  hosp ita l. In the Ac 
group 3 patients used temporarily spasmolytics and 2 pa tien ts  minor 
tra n q u illa n ts  (diazepam and meprobamat). In the control group 8 persons 
used spasmolytics, and one of them used tra n q u illa n t (diazepam).
We examined 4 patients fo r Helicobacter p y lo ri in  the Ac group; 
bacteria were found 3 of them before and a fte r  the treatment.
D is c u s s io n
Under c l in ic a l conditions, good e ffec ts  of Ac have been reported as 
regards the treatment of peptic u lcers. G a il i t is  et a l. /7 /  treated 125 
peptic u lcer patients w ith 1 g/day Ac and found a decrease o f acid se­
cre tion  and a good c lin ic a l response, and tin g lin g  of ex trem ities , meta­
b o lic  acidosis, e le c tro ly te  loss as side e ffec ts . We obtained s im ila r
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re s u lts , but our pa tien ts  did not complain o f loss of appetite. Puscas /17 / 
reported on treatment o f 148 patients (96 duodenal and 52 gastric  u lce rs ); 
a fte r  24 days 94% of duodenal and 91% of g a s tr ic  ulcers were found healed. 
They found paraesthesia in  the limbs in  35%, moderate asthenia and drowsi­
ness in  17% of the cases; no other c l in ic a l ly  important side e ffects  were 
recorded. In another paper /18 / Puscas re la ted  th e ir  experiences of his 
group in  the treatment w ith  the Ac-containing drug U lcos ilvan il to  more 
than 2500 gastroduodenal u lcer patients. They registered the in h ib ito ry  
e ffe c t of th e ir medicine both to basal and stim ulated acid secretion. We 
fa ile d  to find  in  th e ir  studies detailed analysis of the e ffects on the 
acid-base and e le c tro lite  household. Our purpose was to gain some data on 
the te r r ito ry  mentioned above, and to study the e fficacy  of Ac alone, fo r 
the medicine "U lc o s ilv a n il"  used by Puscas and his co-workers contained 
-  in  addition to Ac -  potassium bicarbonicum, sodium bicarbonicum, sodium 
c itr icu m , magnesium oxydatum and aluminium hydroxydatum. Probably, the 
la t te r  components modified the e ffect of Ac.
S o lt /20 /, too, reported good e ffec ts  o f Ac in  the management of 
pep tic  ulcers. We found good responses to the Ac treatment both in  the 
c l in ic a l  symptoms and the endoscopic appearance of gas tric  ulcers, although 
we had to supplement Ac monotherapy with sodium bicarbonicum in  5 cases. 
The e ffe c t of CA in h ib it io n  on the kidney is  important. CA is  present 
w ith in  the ce lls  of both the proximal and d is ta l tubules. When Ac is  used, 
the absolute proximal bicarbonate reabsorption is  found to vary with load, 
but the fraction  reabsorbed is  subnormal. When the f i lte re d  bicarbonate 
load is  gradually reduced by progressive metabolic acidaemia, a decreasing 
amount of bicarbonate is  escaping d is ta lly . When the d is ta l tubule is  able 
to  handle the delivered bicarbonate, the acidosis w i l l  not worsen /3 / .  In 
the d is ta l nephron the H+ and NH^  output is  repressed under Ac medication. 
According to physio log ical experiments on rodents the to x ic ity  of Ac proved 
to  be s im ila r to NaCl ( le th a l dose 50: 3-6 g per kg). When rodents and dogs 
were given Ac fo r several months the animals to lera ted the drug w e ll. 
During chronic adm in istra tion  of Ac normal anion gap metabolic acidosis 
occurs and some ten per cent loss in whole body Na+, K+ content may be 
observed, while these disturbances do not increase under continuous medi­
ca tio n , and steady sta te  sets in . These io n ic  patterns were observed fo r 
experiments lasting  up to  16 months. Due to the blocking of CA of red blood 
c e lls ,  respiratory acidosis may develop. On humans, side e ffects (anxiety, 
t in g lin g ,  breathlessness) appeared with a s ing le  dose over 114 mg/kg 
/8 , 14/.
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We observed in  the Ac group several side e ffec ts , most frequently 
metabolic acidosis. The acid-base disturbance and e lec tro ly te  loss showed 
no progress. We had to discontinue the management only in  one pa tien t fo r 
tha t reason. Our patients found the subjective side e ffec ts , which were 
accompanied by simultaneous rapid pain r e l ie f ,  to le rab le . However, we found 
side e ffects  more frequently than Puscas. A ll side e ffects  disappeared 
a fte r the treatment was fin ished.
In conclusion, our view is  that ac should not be the f ir s t -s te p  
management. We suppose tha t a compound w ith  less CA in h ib it io n  but with 
the same or more cytoprotective e ffec t would have wider c l in ic a l perspec­
tives  than Ac in  the treatment of gastric  u lcers.
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P A T H OP H Y S I OL OGY
EFFECTS OF HYPOTHYROIDISM AND HYPERTHYROIDISM ON THERMOGENIC RESPONSES 
TO SELECTIVE AND NONSELECTIVE BETA-ADRENERGIC AGONISTS IN RATS
I .  ILYÉS* and M .J. STOCK
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Department of Physiology, St. George's Hospital Medical School, London
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Oxygen consumption (VO^) and m itochondrial guanosine diphosphate (GDP) binding o f 
in te rscapu la r brown adipose tissue  (BAT) were measured in  hypothyroid, hyperthyroid and 
euthyroid ra ts  a fte r  stim ula tions w ith  se lec tive  and nonselective beta-adrenoceptor agonists: 
BRL 35135A (BRL) and Isoprénaline (ISO). Resting V0^, V0^ increment and m itochondrial GDP 
binding a fte r  beta-adrenergic s tim u la tions were lower in  hypothyroid ra ts  than in  the euthy­
ro id  group. The reduced responses vere more marked fo r ISO than fo r  BRL. Restion VO^  and VO^  
increment a fte r  beta-adrenergic s tim u la tions were higher in  hyperthyroid ra ts  than in  the 
eurthyro id  group; the increment was more marked fo r BRL than fo r  ISO. In  hyperthyroidism, 
m itochondrial GDP binding a fte r  BRL and a fte r  ISO was in  the same magnitude; i t  was higher in  
the hyperthyroid than in  the euthyro id group a fte r BRL but not a fte r  ISO. The d if fe re n t 
thermogenic responses a fte r  ISO and BRL s tim ulations suggest th a t BRL is  acting on a beta- 
adrenoceptor d if fe r in g  from the beta-1 and beta-2 adrenoceptors responsible fo r the e ffe c ts  
o f ISO. A c tiva tion  o f thermogenesis v ia  the beta-3 adrenoceptor seems to be less dependent 
on the permissive leve ls  o f th y ro id  hormones than a c tiva tio n  v ia  beta-1 and/or beta-2 adreno­
ceptors. The beta-3 adrenoceptor may be more sensitive  to  increased leve ls  o f thy ro id  
hormones.
Keywords: thermogenesis, oxygen consumption, m itochondria l guanosine diphosphate 
b ind ing, beta-agonists, hypothyroidism, hyperthyroidism.
Abbrevia tions: BAT = brown adipose tissu e ; BRL = BRL 35135A; DIT -  d ie t induced 
thermogenesis; GDP = guanosine diphosphate; ISO = Isopréna line ; NA = noradrenaline; NST = 
nonshivering thermogenesis; VO^  = oxygen consumption
O ffp r in t requests should be sent to  I .  I ly é s , P aed ia tric  Department o f U n ive rs ity  
Medical School, H-4012 Debrecen P.0. Box 32, Hungary
Akadémiai Kiadd, Budapest
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In t r o d u c t io n
Brown adipose tissue  (BAT) is  the main e ffec to r of cold-induced non- 
shivering thermogenesis (NST) and diet-induced thermogenesis (DIT) in  
rodents /17/. BAT is  con tro lled  by the sympathetic release of noradrenaline 
(NA), which acts on beta-adrenoceptors on brown adipocytes to  stimulate 
heat production via a unique mitochondrial proton conductance pathway that 
uncouples oxidative phosphorilation /12, 14/.
I t  is  generally accepted tha t thyro id  hormones play a permissive 
ro le  in sympathetic-mediated thermogenesis /5 / ,  acting via modulation of 
catecholamine s e n s it iv ity  by regulating beta-adrenoceptor number and 
adenylate cyclase a c t iv i ty  in  sensitive tissues /2 , 8, 19, 25/.
Radioligand and other studies indicated tha t BAT adrenoceptors con­
s is t  of both the beta-1 and beta-2 subtypes /19, 20/. The use o f a new and 
novel group of beta-adrenergic agonists, however, has shown th a t BAT beta- 
adrenoceptors might not conform to the beta-l/be ta -2  c la s s if ic a tio n  /1 /. 
These agonists stim ula te  brown adipocyte lip o ly s is  much more se lec tive ly  
than heart rate and tracheal re laxation. Since the heart and the trachea 
mainly contain beta-1 adrenoceptors and beta-2 adrenoceptors, respective ly, 
these results suggested tha t the novel agonists activated BAT via a beta- 
adrenoceptor tha t was d iffe re n t from the beta-1 and beta-2 subtypes. The 
presence of th is  "a ty p ic a l"  beta-adrenoceptor on BAT was confirmed in  other 
studies /6 , 10/ and i t  has been designated as beta-3 adrenoceptor.
However, i t  is  not known how thyro id  hormone status a ffec ts  the 
beta-3 adrenoceptors and the thermogenic response to so-called beta-3 
agonists. BRL 35135A (BRL) is  a novel beta adrenergic (beta-3) agonist 
(F ig . 1) which s e le c tive ly  stimulates BAT and thermogenesis /6 / .  The aim of
Cl
R= CH
BRL 35135 A
R=H
BRL 37344
F ig . 1. BRL 35135A and i t s  ac tive  metabolite
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the present study was to investigate the e ffe c t of BRL on thermogenic re­
sponses in euthyroid, hypothyroid and hyperthyroid ra ts  and to compare i t s  
thermogenic e ffects  of BRL to those of Isoprénaline (ISO), which is  a non- 
se lective  beta-agonist acting via beta-1 and beta-2 adrenoceptors.
M a te r ia ls  and M ethods
Male Sprague-Dawley ra ts  (Charles River, UK) were caged in  pa irs  in  a metabolic room 
maintained at 24 C w ith a 12 h lig h t/d a rk  cycle. They were maintained in  a stock d ie t (PRD; 
Christopher H i l l  Group, UK). Hypothyroidism was induced by p rov id ing drinking-water contain­
ing 0.04% (w/v) methimazole (Sigma) /1 5 /; hyperthyroidism was induced by add ition  o f 0.03% 
thyro id  powder (Sigma) to  the d ie t /9 / .
Oxygen consumption (VO ) was measured in  closed c ir c u i t  respirometers /2 3 /. Data o f 
VO неге |ÿa^lected w ith an o n -line  microcomputer and computed to  express the values as a ml 
O^/min/kg ’ (STBD) in  every f iv e  min. A 90 min period o f measurement was done before any 
treatment was given to  the ra ts , and VD  ^ was measured fo r  2 h a fte r  treatments. To define 
responses to drugs V0^ was measured in  the 20-B0 min period a f te r  treatment and increment was 
expressed as a d iffe rence  between average VO^  in  th is  period and the basal res ting  V0 . BRL 
and ISO were used in  so-ca lled  e ffe c tiv e  and maximal thermogenic doses (BRL: 2 yug/Rg and 
200^ug/kg and 400yjg /kg , resp e c tive ly ) on the basis o f our previous experiments.
Serum thyro id  hormone leve ls  were not measured, since the a lte ra tio n  in  res tin g  V0^ 
o f the treated groups was s im ila r  to  tha t found by o thers in  hypo- and hyperthyroidism 
/15 , 16/.
On the day o f GDP binding measurement a fte r  80 min the maximal e ffe c tiv e  doses o f 
beta-agonists the ra ts  were k i l le d  by ce rv ica l d is lo c a tio n , and in terscapular BAT was d is ­
sected and weighed.
Mitochondria were prepared from separate BAT samples according to the method de­
scribed by Slinde e t a l .  /2 2 /. The procedure was ca rr ie d  out a t 0-4 C. The tissue  was 
homogenized in  15 ml o f 0.2 M sucrose bu ffe r using a В Braun homogenizer. The homogenate was 
centrifuged (Beckman 032-21) at 3500 g to separate tissue  fragments. The supernatant was then 
spun at 11000 g and the m itochondria l p e lle t was resuspended in  0.7-0 .5  ml sucrose b u ffe r , to 
give a f in a l p ro te in  concentration o f about 2 mg/preparation.
M itochondrial GDP binding was carried  out as described by Brooks e t a l.  / 3 / .  The 
binding o f H-GDP to iso la ted  mitochondria was measured in  the presence o f unlabelled GDP at 
a concentration o f 2 u^M (approximately equivalent to  the KD o f the binding s ite  and at 200yuM 
(maximum displacement concentration) to  measure nonspecific  b ind ing . To measure the e x tra - 
m itochondria l space C-sucrose was used. GDP binding was expressed as pmol/mg m itochondria l 
p ro te in . The pro te in  content o f m itochondrial samples was determined by the Bio-Rad method.
The s ta t is t ic a l s ign ificance  o f d ifferences was computed w ith Student's t - te s t .
R e s u lts
1. E ffect of methimazole and thyroid powder treatment on body and BAT 
weight
The growth rate of the methimazole-treated ra ts was s ig n if ic a n tly  
lower than tha t of the contro l ones. The in terscapular BAT from hypothyroid 
ra ts  increased in  weight: the BAT weight corrected fo r body size (re la tiv e
Table I
Body mass and ВДТ mass during methimazole and th y ro id  powder treatment (X ±S .E .M .)
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Parameters Methimazole Control t - te s t Thyroid
powder Control t - te s t
I n i t i a l  body mass
(g)
112.9 + 2.0 113.2 + 1 .9 NS 128.4 + 1.4 127.1 + 1.2 NS
F in a l body mass
(g)
193.3 + 7.0 319.9 + 6.4 +++ 286.4 + 7.5 297.1 + 4.3 NS
BAT mass (mg) 215.8 _+ 6.2 277.5 +14.0 +++ 354.2 +25.0 295.8 +18.0 NS
R e la tive  BAI mass 
(mg/g body mass)
1.09^ 0.18 0.85+ 0.15 +++ 1.24+, 0.08 1.02+ 0.07 +
n = 16; NS = non s ig n if ic a n t;
+P < 0 .0 5  1 .
V vs con tro l
+++P <0 .001  J
BAT weight) was s ig n if ic a n t ly  increased in  the hypothyroid group. The body 
weight and BAT weight o f the thyro id -trea ted  group did not d i f fe r  s ig n i f i ­
ca n tly  from those in  the contro l ra ts . However, the re la tive  BAT weight in 
hyperthyroid ra ts s ig n if ic a n t ly  exceeded that in  the con tro l group 
(Table I ) .
2. E ffect of methimazole and thyro id  powder treatment on basal oxygen con­
sumption
Resting V02 of hypothyroid ra ts  was decreased gradually in  the 
course of the methimazole treatment and i t  was approximately 75% of the V02 
measured in euthyroid group a fte r 2-3 weeks of the treatment. Thyroid 
treatment increased the res ting  V02 which was elevated approximately 70-75% 
a fte r  2-3 weeks of the treatment in  the hyperthyroid group, compared to V02 
in  the control group (Table I I ) .
Table I I
Resting 0_ consumption during methimazole and th y ro id  powder treatment (m l/m in /kc0-75;
-  S.E.M.)
Treatment and time C ontro l groups Treated groups t - te s t
Methimazole
2nd week 14.83 + 0.40 10.35 _+ 0.16 P 0.001
3rd week 14.63 + 0.65 9.19 + 0.30 P 0.001
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Table I I  (c e n t.)
Treatment and time Control groups Treated groups t - te s t
Thyroid powder 
2nd week 
3rd week
14.04 + 0.28 
12.50 + 0.22
20.55 + 0.44 
18.12 + 0.22
P ^ ' 0 .0 0 1  
P <  0.001
n = 15 or 16
3. Changes in  V0o fo llow ing adm inistration of BRL and ISO
VO2  s ig n if ic a n tly  increased a fte r in jec tions  of e ithe r BRL or ISO in  
the euthyroid, hypothyroid and hyperthyroid groups. Increments a fte r  e ffec­
tiv e  and maximal thermogenic doses of GRL and ISO are summarized in  Fig. 2.
2  д д  5 0 p g  2 0 0 p g  £ 0 0 p g  2 p g  5 0 p g  2 0 0 д д  £ 0 0  p g
X ± | 0 M  xl00 52
X euthyroid________
20 3 9 2 7  1 5 0  1 2 9  1 9 0  1 6 7
F ig . 2, Increase o f VO2 o f euthyro id , hypothyroid and hyperthyroid ra ts  a f te r  d if fe re n t  
thermogenic doses o f BRL or ISO (n=8)
Increments in VO2  were d if fe re n t according to the thyro id  function of the 
animals and the administered drugs. The VC^  responses to beta-agonists were 
in  the hypothyroid ra ts  lower than in  the euthyroid ones. The reduction of 
response was more marked fo r  ISO than BRL. The increments were 20% and 27% 
o f the control response a fte r  ISO, and 52% and 35% a fte r BRL, using e ffec ­
t iv e  and maximal thermogenic doses of the drugs.
In hyperthyroid group, despite the increased basal VO2 , a fte r  ad­
m in is tra tio n  of beta-agonists, VO2  elevated fu rth e r and the increments were 
h igher than those in  co n tro l ra ts . This increased response was more marked 
fo r  BRL than fo r ISO. The increments were 150% and 190% of the contro l 
response a fte r BRL, and 129% and 167% a fte r ISO, respective ly, using e ffec­
t iv e  and maximal thermogenic doses of the drugs.
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F ig . 3. Increment o f VO o f eu thyro id , hypothyroid and hyperthyroid ra ts  a fte r  maximal 
thermogenic doses o f BRL or ISO (n=8), ь"P -<0.001; + P<D.05
Figure 3 contains the percentage increments in  VO2  a fte r maximal 
thermogenic doses of BRL and ISO in euthyroid, hypothyroid and hyperthyroid 
ra ts . This parameter in  the hypothyroid group was s ig n if ic a n tly  decreased 
a f te r  administration o f beta-agonists. However, the reduction of response 
was more marked fo r ISO than fo r BRL. Whereas, the percentage increments in  
hyperthyroidism were s im ila r  a fte r BRL and ISO, the authyroid-hyperthyroid 
d iffe rence  in th is  parameter was more marked a fte r  BRL than a fte r  ISO.
THERMOGENIC RESPONSES TO BETA-ADRENERGIC AGONISTS IN RATS 185
4, Mitochondrial GDP binding a fte r maximal thermogenic doses of BRL and 
ISO
(3H) GDP binding (pmol/mg protein) 
О  Euthyroid (n =16)
□  Hypothyroid (n =12 or 13)
В  Hyperthyroid (n=8)
The results of m itochondrial GDP binding are shown in  Fig. 4. The 
sp e c ific  GDP bindings induced by beta-agonists were lower in  the hypo­
thyro id  ra ts than in  the euthyroid group; they were higher a fte r BRI than 
a fte r  ISO. The bindings of mitochondria from hyperthyroid ra ts were higher 
than those in  euthyroid animals a fte r BRL but not a fte r ISO, although the 
response to BRL and ISO in  hyperthyroidism were in  the same magnitude.
Discussion
In the present study hypothyroidism resulted in a remarkable re­
duction in growth rate and BAT mass, but BAT mass corrected fo r body weight 
was larger in  the hypothyroid group than in  the contro l one. Enlargement of 
BAT in  hypothyroidism was already observed by e a r lie r  workers /4 , 11, 15, 
26/, and i t  was also pointed out that the hypertrophic BAT of hypothyroid 
ra ts  has a lim ited  physio log ical ro le (incapacity  to respond to NA nor­
F in . 4. BAT m itochondrial GDP binding o f euthyroid, hypothyroid and hyperthyroid ra ts  a fte r  
maximal thermogenic doses o f BRL or ISO, ***P<0.001; + P < 0 .0 5
m a lly ). The re la tive  BAT weight was also s l ig h t ly  increased in  hyperthyroid 
ra ts  was thought to be e n tire ly  due to deposition of l ip id  in  the tissue 
/1 3 /.
Despite the equally increased re la tiv e  BAT weight a fte r methimazole 
and thyro id  powder treatment resting VC^  was remarkably d if fe re n t, proving 
the existence of a hypothyroid and a hyperthyroid status. A lte ra tions  in 
re s tin g  VO2  of the treated groups were s im ila r to that found by others in  
hypo- and hyperthyroidism /15, 16/.
A fter adm inistration of beta-agonists VC^  in  whole animals was in ­
creased in  a l l  groups. However, VC^  response to beta-agonists was lower in 
hypothyroid than in  the euthyroid group. Other workers /7 , 15, 26/ showed 
th a t the thermogenic e ffe c t of NA on BAT decreased in  hypothyroid ra ts  and 
mice. On the other hand, VO2  responses to beta-agonists were improved in  
hyperthyroid rats as compared to the euthyroid group. An increased NA- 
stim ulated V02 response in  hyperthyroidism has also been shown /15 /.
The reduced VO2  response in  hypothyroid ra ts  was more marked fo r ISO 
than fo r  BRL. Although VO2  responses in  hyperthyroidism were s im ila r a fte r 
ISO and BRL, the increment to BRL was more marked than to ISO. The resu lts  
o f measurement of BAT mitochondrial GDP binding agree w ith the data of VO2  
measurements. The basal binding was not measured but the d ifference in  GDP 
binding between hypothyroid and euthyroid groups was more marked a fte r  ISO 
than a fte r  BRL. These re su lts  also prove tha t a hypothyroid status can make 
more e ffec tive  impression on the mechanism responsible fo r the thermogenic 
e ffe c t of ISO than fo r th a t of BRL. BAT m itochondrial GOP binding a fte r  the 
maximal thermogenic doses o f BRL and ISO in  euthyroid and hyperthyroid rats 
did not d if fe r  s ig n if ic a n t ly ,  ve rify ing  tha t BAT thermogenic response to 
BRL in  hyperthyroidism reaches the thermogenic capacity ot ISO.
How to explain the resu lts  of the present study?
The reduced VO2  response in  hypothyroidism and the marked increment 
in  VO2  in  hyperthyroid ra ts  to beta-agonists as well as resu lts  of the 
measurement of m itochondrial GDP binding can be explained with modulating 
catecholamine s e n s it iv ity  due to a lte ra tions  of the thyroid hormone status. 
I t  is  well-known that hyperthyroidism is  associated with an increase in  a 
receptor density in  heart, white adipose tissue and BAT /2 , 19/, whereas a 
decreased receptor number in  ra t brown adipocytes has also been found by 
others /21, 24/.
BAT adrenoceptors have been c la ss ifie d  not only as a mixed beta-1/ 
beta-2 but as a beta-3 subtype, too /1 , 18, 20/ and i t  is  not known how
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thyro id  hormone status a ffects  the beta-3 adrenoceptor or the thermogenic 
responses to a so-called beta-3 agonist, such as BRL. The present results 
suggest that hypothyroidism can exert a more expressed influence on beta-1 
and beta-2 adrenoceptors than on beta-3 adrenoceptors responsible fo r the 
thermogenic e ffe c t of BRL. I t  seems that ac tiva tion  of thermogenesis via 
the beta-3 adrenoceptor is  less dependent on permissive leve ls of thyroid 
hormones than ac tiva tion  via beta-1 or beta-2 adrenoceptors. Furthermore, 
our resu lts suggest tha t the beta-3 adrenoceptor may be more sens itive  to 
increased leve ls of thyro id  hormones, since hyperthyroidism produced a 
greater potentia tion  of BRL responses than of ISO responses.
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I MMUNOLOGY
KILLER-CELL ACTIVITY IN ALCOHOL-ORIGINATED DISEASES 
OF THE LIVER, AND THE EFFECT OF ALCOHOL ON IHE 
K-CELL FUNCTIONS UNDER IN VITRO CONDITIONS
R. SCHNABEL, M. BOKOR, GY. MALATINSZKY, T. GARAM
2nd Department of Medicine of the Károly Robert Hospital 
and P o lic lin ic ,  Budapest
(Received: A p ril 5, 1990)
Non-specific c e l l  immunity and, w ith in  i t ,  the change in  К-c e l l a c t iv i t y ,  can be 
relevant in  alcohol-induced diseases o f the l i v e r . I t  was examined fo r th is  reason how 
alcohol in  i t s  d if fe re n t  concentrations influences the a c t iv i ty  o f К-c e lls  under in  v it r o  
cond itions. Furthermore, the cy to tox ic  capacity o f К-c e l ls  was defined in  22 chronic a l­
coholics and 112 pa tien ts  w ith  alcohol induced hepatopathies. The la t te r  were d iv ided in to  
subgroups. Cytotoxic capacity o f lymphocytes in  the periphera l blood was determined in  a te s t 
against human red blood c e lls .  123 healthy volunteers made up the con tro l group. A high con­
cen tra tion  o f a lcohol was needed to impede К-c e ll capacity  under in  v it r o  cond itions. I t  is  
supposed tha t the gradual growth in  К-c e l l a c t iv i ty  reg is te red  in  cases o f alcohol-induced 
hepatopathy may po in t -  though only in d ire c t ly  -  to  the development o f an antibody-dependent 
c e llu la r  cy to tox ic  reac tion .
Keywords : l iv e r  immunology, alcohol-induced l iv e r  disease, K i l le r - c e l l ,  ADCC.
In t r o d u c t io n
Both experts and lays have long been speculating on the reason for 
the va ria tion  in s u s c e p tib ility  to alcohol. Ihe enormous ind iv idua l v a r i­
ations in  both the acute symptoms and chronic consequences are well known. 
In some ind iv idua ls  heavy drinking habits carried on system atically fo r 
decades induce no l iv e r  aliments, while in  others shorter a lcoho liza tion  
period - la s ting  a few months - can cause serious hepatic lesions. The 
healthy organism can metabolize 160-180 g of alcohol/day. Alcohol addicts
Abbrevia tions: ADDC = antibody dependent c e llu la r  c y to to x ic ity ;  LSP = l iv e r  s p e c ific  
membrane lip o p ro te in
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w i l l  generally metabolize even more, since chronic alcohol abuse causes 
enzyme induction, increasing enzyme capacity. Today we consider tha t high 
a lcohol-content beverages develop a disease fas te r than those of a lower 
a lcohol-content. Under equal conditions, women are more prone to alcohol- 
induced diseases of the l iv e r ,  and usually show faste r progression than 
men, while  advanced forms o f the diseases occur more frequently in  females 
than in  males.
Besides many other fac to rs , i t  is  possible that in  some sp e c ific  
cases the immune system and, w ith in  i t ,  the non-specific c e ll immunity, 
can p lay a leading ro le  in  a lcoho lic  l iv e r  diseases. This can be explained 
by the fa c t that in the course of alcohol-induced l iv e r  c e ll damage, l iv e r  
c e l l  plasma membrane fragments of antigen properties may come in to  contact 
w ith  lymphocytes and, f in a l ly ,  through a series of complicated processes, 
may re s u lt  in  production of auto-antibodies. The lipop ro te in  re lated to  the 
l iv e r  c e l l  plasmamembrane ( l iv e r -s p e c if ic  membrane lipop ro te in : LSP) was 
iso la te d  by Meyer zum BUschenfelde/13/. The d is tr ib u tio n  of LSP on l iv e r  
paranchyma ce lls  is  d iffu se . LSP can appear p a ra lle l on the membranes of 
hepatocytes and the plasma membrane /8 /.  The LSP is  basica lly an antigen 
complex, many factors of which e.g. the hepatic le c t in , sometimes referred 
to  as asialoglycoprotein /12 , 24/ have been recognized. Anti-LSP autoan ti­
bodies were f i r s t  traced by Hopf et a l. who used an immunofluorescence 
method. The autoantibodies were v is ib le  on the membrane of l iv e r  c e lls  in 
the form of linear IgG deposits /9 /.  The anti-LSP is  connected to the 
antigen-determinant area o f the liv e r  c e ll membrane by means of i t s  Fab 
p a rt, while i t  binds to the k i l le r  (K )-c e ll w ith i t s  Fc fragment, the 
actua l cause of cy to lys is . The appearance of the anti-LSP autoantibody 
subsequently means the development of the conditions for an antibody- 
dependent ce llu la r cy to tox ic  (AOCC) reaction directed against the l iv e r  
c e l l  /2 1 /,  with the k i l le r - c e l l  as i ts  e ffe c to r c e ll.  The a c t iv ity  of К 
c e lls  is  p a r t ia lly  gene tica lly  determined, although th e ir  cyto tox ic  ca­
pa c ity  -  when activated - may increase during an ADCC reaction. With a l l  
the above in  mind, the determination of К-c e l l  a c t iv ity  could be a useful 
in d ire c t  parameter to ind ica te  a hypothetical ADCC reaction against the 
l iv e r  c e l l .
A fte r considering the above theore tica l presuppositions and data 
from medical lite ra tu re , we made e ffo rts  to fin d  an answer to the fo llow ing 
questions :
1) How does alcohol influence the K i l le r - c e l l  a c t iv ity  under in  
v i t r o  conditions?
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2) Is there a characte ris tic  change in  К-c e ll a c tiv ity  in  the case 
of alcohol-induced l iv e r  diseases?
Materials and Methods
We have studied antibody-mediated cy to to x ic  capacity  in  an antihuman red blood c e ll 
te s t .  The cy to tox ic  capacity te s t was developed by Garam and Bakács fo llow ing  Urbaniak's 
basic methodology /5 , 23 /. The te s t is  modelled on the enzymekinetic structure  o f Zeijlemaker 
et a l . ,  as well as Thorn and Hanney /22, 26/. According to  th is  model, the cy to to x ic  capacity 
o f lymphocytes also depends on the number o f ta rg e t c e lls ,  in  consequence, the cy to to x ic  
mechanism is  s im ila r to  c e rta in  enzyme reactions.
The lymphocytes were separated from 20 ml heparinized blood. We separated mononuclear 
c e lls  according to Bdyum, fo llow ing  the F ico ll-U rom iro  gradient cen trifuga tion  method /3 / .  
We used as ta rge t c e lls  human "0" (RI, R2) red blood c e lls .  Target c e lls  were washed, in ­
cubated at room temperature w ith 2% papain fo r 10 min, then were labe lled fo r  120 min at 
37 C w ith 200 uCi Cr isotope (Na-chromate, Amersham, England). Following the incubation 
period , the c e lls  and the required concentrations were set in  RPMI-FCS n u tr it iv e  s o lu tio n . 
Anti-D  immunoglobulin (N ationa l In s t itu te  o f Haematology, Budapest) was used as antibody in 
1 :120g f in a l d ilu t io n .  From the target c e lls  were prepared a d ilu t io n  set o f 1x10 to 
14x10 /ml concentration. From these d ilu tio n s  50 yul u n its  were put in to  the V-shaped w e ll o f 
a m icrodisch. Also 50 yul u n its  o f the 2x10 /ml concentra tion lymphocytes were added to  each 
c u ltu re , then 50 u l  an ti-D  serum o f the above-mentioned concentration, and f in a l ly  the end 
volume was augmented to 200 yul by^the addition o f 50 yul medium. The tes t un its  were incubated 
fo r 18 h in  a thermostator o f 37 C in an atmosphere conta in ing 5% C0^. Alcohol was added in 
50yul volumes, at 0.5-1.0-5.0-10.0% concentration to  the in  v it r o  testing u n its .
The ca lcu la tio n  o f cyto tox ic  capacity : F ir s t  the spec ific  release per cent was
ca lcu la ted by the fo llow ing  formula:
O verfloating "cpm" -  spontaneous release "cpm"
--------------------------------------------------------------------------------------------  X 100
Tota l b u i l t - in  a c t iv ity  "cpm" -  spontaneous release "cpm"
From here, the cy to to x ic  capacity, expressed by the maximal number of ta rget c e lls  destroyed 
by a u n it o f lymphocytes, can be calculated by th is  form ula:
No o f sa tu ra ting  target c e lls  x re la te d  sp e c ific  release \
100
The number o f sa tu ra ting  ta rge t c e lls  refers to the sm allest possible number o f ta rg e t c e lls  
by which we can s t i l l  measure the maximum o f lymphocyte a c t iv ity .  In a l l  lymphocyte and 
ta rge t c e ll  combinations, we used two p a ra lle l te s tin g  u n its  and the average o f the two was 
used in  ca lcu la tio n s . In each case, we observed the d ire c t  e ffe c t o f alcohol on red blood 
c e lls ,  but in  none o f the concentrations could we re g is te r  a ly t ic  e ffe c t.  We ran a l l  our 
ca lcu la tions  on a programme obtained from the U n ive rs ity  o f C a lifo rn ia  Los Angeles Biomedical 
Department.
Student's two-sample t - te s t  was used fo r  ca lcu la tio n  o f s ign ificance  between the 
two groups.
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Patients and Controls
К-c e l l a c t iv ity  was determined in  two groups o f pa tients  and a group o f healthy 
vo lun tee rs .
1. P a tien ts ' group 1. Twenty two chronic a lc o h o lic s  (21 male and 1 female), none o f 
vtiom was su ffe rin g  from l iv e r  disease, and a l l  being on voluntary therapy to  break the 
d r in k in g  h a b it. Average age 38.0 (from 17 to 51) years.
2. P a tien ts ' group 2, 112 (64 male and 48 female) pa tients su ffe ring  from a lco h o l- 
induced hepatic ailments. The p a tie n ts  f i r s t  underwent a thorough medical check-up: anamnesis, 
determ ina tion  o f physical s ta tu s ; laboratory tes ts  in c lu d in g  SGOT, SGPT, a lka line  phosphatase, 
protrhom bin, cho les te ro l, cho linesterase, GammaGT, e lec trophores is , immunoelectrophoresis, 
a n t i-n u c le a r  fa c to r, AFP, HBsAg, complete urine a n a lys is , complete blood count, sedimen­
ta t io n  ra te ; more recen tly , i t  has become possible to  determine serum-conjugated b i le  acid 
concentra tion  as w ell as p roco lla g e n -III-p e p tid e  le v e l;  abdominal ultrasound, and in  more 
than h a lf  o f the cases, h is to lo g y . In  some cases a d d itio n a l gastroscopy, isotope liv e r-s p le e n  
s c in tig ra p h y  and computer tomography were performed. The fa t ty  l iv e r  diagnosis was in  a l l  
cases supported by h is to logy. In  acute a lcoho lic  h e p a t it is ,  l iv e r  biopsy was conducted in  11 
cases out o f the 25. Where biopsy was impossible, a lcoho l abuse in  the anamnesis and a 
syndrome consis ting  o f high fe ve r, jaundice, anorexia, vomiting and diarrhoea helped in 
s e tt in g  up the diagnosis. V irus marker (HAV, HBV) te s ts  were negative. Leukocytosis was 
always traceable in  the blood coun t. Laboratory te s ts  were characterized by increase in  serum 
transaminase, GammaGT and a lk a lin e  phosphatase. U ltrasound found lst-degree d iffu s e  l iv e r  
le s io n . 40 out o f the 70 l iv e r  c ir rh o s is  cases were examined h is to lo g ic a lly . Due to  absolute 
or r e la t iv e  con tra ind ica tions, b iopsies were not conducted in  advanced, vascu la rly  decom­
pensated and parenchymatous cases. In  these cases the d iagnosis was based on ty p ic a l c l in ic a l  
p a tte rn s , the presence o f the above-mentioned symptoms o f decompensation, the la bo ra to ry  
te s ts  d e ta ile d  above, as w e ll as a 2nd-stage d iffu s e  l iv e r  lesion found by u ltrasound.
The 112 patients were d iv ided  in to  three groups, v iz . :
acute a lcoho lic  h e p a tit is : 25 cases 
fa t ty  l iv e r :  17 cases
hepatic c ir rh o s is : 70 cases
Follow ing the revised Child scheme /4 / ,  3 subgroups were distinguished w ith in  the hepatic 
c ir rh o s is  group. Child developed a score system based on the 3-leve l va ria tio n s  o f 5 
parameters, which represents e f f ic ie n t ly  the graveness o f the p a tie n t's  c l in ic a l s ta te . We 
have summed up the revised Child  scheme in Table I .  C h ild 's  group "A" is  represented by the 
35 m ildes t c lin ic a l-s ta te  p a tie n ts , in  C h ild 's  group "B" we have the 21 pa tien ts  w ith  a 
c l in ic a l  s ta te  o f medium s e v e rity , and in  C h ild 's  group "C" 14 cases o f the most serious 
c l in ic a l  s ta te . Important data concerning groups and subgroups are shown in  Table I I .
3. The k i l le r - c e l l  a c t iv i t y  o f 123 (55 male, 6B female) healthy volunteers was the 
c o n tro l.  Average age: 56.6 years. This group, too , was subjected to a thorough examination, 
in c lu d in g  anamnesis, determ ination o f physical s ta tus , and laboratory tests (complete blood 
count, u rine  ana lys is , blood sugar le v e l, SGOT, SGPT, GammaGT, a lka line  phosphatase, serum 
b i l i r u b in ,  cho linesterase). Only ind iv idua ls  found hea lthy  in  the above te s tin g  were in ­
cluded in  the con tro l group.
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Table I
The revised C h ild  scheme
poin ts 1 2 3
b i l i r u b in  umol/1 < 2 5 25-50 >50
albumin g/1 >35 30-35 < 3 0
encephalopathy none s u b c lin ic a l EEG + l iv e r  coma 
( I - IV )
ascites none responsive to 
medication or 
su rg ica l therapy
re s is ta n t to 
therapy
s ta te  o f nourishment normal muscle atrophy cachexia
Evaluation: 3 to  7 points = stage "A"
8 to  10 po in ts  = stage "B"
above 10 po in ts  = stage "C"
Table I I
Main data o f alcohol-induced l iv e r  disease groups
L i v e r
Acute a lcoho lic  
h e p a tit is
d i s e
Fatty
l iv e r
! a s e s
L ive r c ir rh o s is Chronic
a lcoho lic
non -live r
disease
Healthy
co n tro l
A
C hild
В C
No. o f cases 25 17 35 21 14 22 123
Male 14 9 25 11 5 21 55
Female 11 8 10 10 9 1 68
Average age 37.3 52.2 65.0 60.3 47.3 38.0 56.6
Age brackets 29-54 31-76 38-71 44-71 37-49 17-54 16-94
R e s u lts
K il le r - c e l l  a c t iv ity  of the healthy contro l group
We determined the average К-c e ll a c t iv ity  w ith in  the contro l group 
also on the basis of breakdown by sex and age (18-40, 41-65, 66+ years). 
Since we wish to publish the de ta ils  of our find ings in  another paper, we 
re s tr ic t  ourselves to g iv ing only the most relevant connections in  the 
present a r t ic le .  The К-c e ll a c t iv ity  (both on the whole and in the age 
groups) was higher in  the female group than in  s im ila r male groups, although
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the differences were not s ig n if ic a n t. Highest К-c e ll a c t iv ity  values were 
found in  the group between 41 and 65 years of age, but the d ifferences from 
the values obtained in  the other age brackets were not s ig n if ic a n t.
E ffe c t of alcohol on k i l le r - c e l l  a c t iv ity  under in  v itro  conditions
We found tha t under in  v itro  conditions K il le r - c e l l  a c t iv ity  needed 
high concentrations o f alcohol (5.0-10.0%) to be impeded. We did not find  
trace influence a ffe c tin g  К-c e ll a c t iv ity  in  the case of lower concen­
tra t io n s  (0.1-0.5-1.0%). Our resu lts  are shown in  Fig. 1. I t  is  discern­
ib le  from there that the alcohol concentration found in  rea l l i f e  s itu ­
a tions (in  vivo) did not a lte r  the cyto tox ic  capacity of К-c e lls  under in 
v i t r o  conditions. Both the 5.0 and 10.1% alcohol concentrations, which 
caused considerable decrease in  К-c e ll capacity, would by no means appear 
under normal ( in  v ivo) circumstances, since even lower concentrations than 
those can prove le th a l.
F ig . 1. К-c e ll a c t iv ity  a lte ra t in g  e ffe c t o f a lcohol measured in ^’0" Rh-positive human red 
blood c e ll cytotoxic capacity te s t under in v it r o  cond itions . 2x10 /ml lymphocytes were used
in the te s t
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K il le r - c e l l  a c t iv ity  of chronic a lcoholics and patients with a lco h o l- in ­
duced l iv e r  diseases
The average K il le r - c e l l  a c t iv ity  of chronic alcoholics (pa tien ts  
with no hepatic ailments was 1 .97xl06j f l . 19xl06. This resu lt does not d i f fe r  
from the К-c e ll a c t iv ity  average measured in  the control group: 1.95x10 +_ 
+1.43x10 . In acute a lcoholic h e p a tit is , К-c e ll a c t iv ity  decreased 
(1 .65xlO°+Q.93x10°) in respect to both the contro l and the chronic group, 
although not s ig n if ic a n tly .
Fig. 2. Cytotoxic capacity^of periphera l lymphocytes against human red blood c e lls  (C=average 
of cy to tox ic  capacity x 10 j^S .D .) o f chronic a lcoho lics  (group No. 1; n=22) and p a tie n ts  o f 
alcohol o rig ina ted  l iv e r  diseases. Group No. 2 is  acute a lcoho lic  h e p a tit is  (n=25). Group 
No. 3 = fa t ty  l iv e r  (n=17). Group No. A the to ta l No. o f hepatic c irrh o s is  (n=70). Group 
No. 5 hepatic c ir rh o s is  -  C h ild 's  "A" (n=35). Group No. 6 h e p a tit ic  c irrh o s is  - C h ild 's  "B" 
(n=21). Group No. 7 hepatic c ir rh o s is  -  C h ild 's  "C" (n=14). Group No. 8: healthy c o n tro l
(n=123)
group 1 V S 4 p
Significance
< 0 .01
d iffe rences 
group 2 vs 6 Р <0.001
group 1 vs 6 p <0.001 group 3 V S 6 P <  0.001
group 2 vs 4 p <0.001 group 4 vs 8 P <0.001
group 2 vs 5 p < 0 .01 group 5 vs 6 P <  0.001
group 5 vs 7 p <0.01 group 6 vs 7 P <  0.001
group 6 vs 8 p <0.001
No s ig n if ic a n t d iffe rence  between groups 1, 2, 3, 5, 7, and 8.
196 SCHNABEL, R. e t  a l .
In fu rthe r groups of liver-disease pa tien ts , we registered an in ­
creasing К-c e ll a c t iv i ty  pa ra lle l to the seriousness of the illn e s s . In 
th is  way, e .g ., in  the group of fa tty  l iv e r  2.11x10^+]. 19x10^ , and in  hepatic 
c irrh o s is  2.77xlO°+1.6xlOö were the reg istered average values of K -ce ll 
a c t iv ity .  The increase in  К-c e ll a c t iv ity  in  a l l  hepatic c irrhos is  cases 
is  strongly s ig n if ic a n t (P <0.001), compared to the control or acute a l­
coholic hepa titis  groups. We also found in te res ting , results w ith in  the sub- 
groupings - established by following C h ild 's  score system - of the c i r ­
rhosis group. In the leas t severe stage, C h ild 's  subgroup "A", the K -ce ll 
a c t iv ity  (2.19x10^+1.03x10^) was equal to tha t of the c l in ic a lly  most 
s im ila r cha rac te ris tics , the fa tty  l iv e r  group. The K-cell a c t iv ity  of the 
medium-gravity c l in ic a l  state Child "B" c ir rh o s is  patients increased s ig ­
n if ic a n t ly  (3.89x10 +1. 69x10 ). This value is  s ig n ifica n tly  higher 
(P -с  0.001) than in  any other group examined. The K-cell capacity of 
C h ild 's  "C" stage pa tien ts  fa lls  sharply (1.47x10^+0.90x10^). For an 
easier survey of the find ings we have summed them up in  Fig. 2; in  which 
the significance of d ifferences between groups is  also shwon.
D is c u s s io n
Alcohol causes a very s ig n if ic a n t change in  the immune system, 
although many of i t s  e ffec ts  are s t i l l  unclear.
The in  v it ro  study of Glassman e t a l.  registered alcohol-induced 
abnormal Chemotaxis and functioning of granulocytes /6 /. The function of 
macrophages decreased in  the presence c f alcohol /6 / .  In a lcoholic hepa­
t i t i s  and c irrh o s is  Con-A-induced lymphocyte p ro life ra tio n  decreased /14, 
25/. Some in  vivo studies show that the to ta l number of T lymphocytes of 
the peripheral blood does not change in  a lcoho lic  l iv e r  diseases /25 /, 
while according to others a certain decrease can be registered /1 0 /. Con­
siderably dissenting resu lts  between T lymphocyte subgroups have also been 
demonstrated. T-helper ce lls  s ig n if ic a n tly  increased in number in  a l l  a l­
coholic l iv e r  diseases, whereas T-supressing lymphocyte growth was only 
registered in  a lcoho lic  c irrhosis /25 /. A c tis  et a l. studied the cyto tox ic  
a c t iv ity  of periphera l blood lymphocytes on autologous hepatocytes of pa­
tie n ts  with alcohol-induced liv e r disease. From the 10 hepatic c irrh o s is  
and acute a lcoho lic  h e p a tit is  patients the cyto tox ic  a c tiv ity  increased in  
9 cases. On the other hand, from the 8 cases of fa tty  l iv e r  and/or l iv e r
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disease accompanied by minor h is to lo g ica l a lte ra tions , an increase in  cyto­
tox ic  a c t iv ity  was observed in  only one case /1 /.  Within the framework of 
the same study, the authors tested which were the ways leading to the 
lesion of l iv e r  c e lls : they found tha t in  those six a lcoho lic  h epa titis  
cases in  which high cy to tox ic  a c t iv ity  was registered, les ion of ce lls  
recurred in  the m ajority ( f iv e  out of s ix ) of the cases and i t  was not tied 
to T -ce lls . On the basis of these find ings, the pathogenetic ro le  of non­
sp e c ific  ce llu la r c y to to x ic ity  and auto-immunity in the development and 
progression of the disease might be questioned, consequently, a ttention  
turned towards natural cy to tox ic  c e lls  and the c e ll lesion re su ltin g  from 
them. These ce lls  are capable of k i l l in g  target ce lls  w ithout p r io r  im­
munization /22, 24/.
The non-specific cell-mediated immunity has two e ffe c tin g  mechanisms:
(a) lymphocytes may cause c y to to x ic ity  d ire c tly , w ithout spec ific  
antibody, th is  is  why i t  is  referred to as natural c e ll - mediated cyto­
to x ic ity  (NCMC), where the executing c e ll is  the natural k i l l e r  (NK)-cell 
/7 , 11, 16, 17, 19/. Müller e t a l. proved a diminishing of NK-cell a c t iv ity  
in  hepatic c irrhos is  cases /1 5 /. Since the most important function NK-cells 
is  to destroy tumour c e lls , i t  seems obvious, although a b i t  fa r-fe tched, 
to estab lish a re la tionsh ip  between the high incidence of malignant l iv e r  
disease in  these hepatic c irrh o s is  cases and low NK-cell a c t iv i ty  reg is­
tered in  the same /15 /.
(b) The condition fo r  the other e ffec ting  mechanism of non-specific 
cell-mediated immunity is  the presence of spec ific  antibodies, which are 
needed fo r the destruction of target c e lls . This mechanism is  termed a n ti­
body-dependent c e llu la r  c y to to x ic ity  (ADCC). The e ffec to r c e lls  of the AGCC 
reaction as mentioned above, are the k i l le r  (K )-ce lls .
The aim of our study was to gather data on the e ffe c t of alcohol on 
K il le r - c e lls  under in  v it ro  conditions, and furthermore, to study the 
change of К-c e ll a c t iv ity  in  groups of patients with l iv e r  diseases of 
a lcoho lic  o rig in . We found tha t К-c e ll a c t iv ity  was impeded only under high 
in  v it ro  alcohol concentration. I t  is  an in teresting  re su lt o f the tests 
tha t К-c e ll a c t iv ity  shows a tendency to decrease in the acute a lcoholic 
h e p a tit is  group. I t  is  possible tha t acute, toxic and large dosis of a l­
cohol intake resulted in  th is  group in  diminishing a c t iv ity .  This hypo­
thesis may also account fo r why no К-c e ll capacity change took place in 
case of a long-term, even alcohol intake (the chronic a lcoho lic , non -live r- 
disease patient group). From Fig. 2 i t  is  also evident tha t p a ra lle l to
growing of seriousness o f c l in ic a l diagnosis, the average of К-c e ll ac­
t i v i t y  increases s te a d ily  u n t i l  Child 's stage "B" c irrh o s is . There was 
bare ly any difference between Child 's stage "A" c irrh o s is  and fa tty  l iv e r  
groups. This is  understandable, since there is  a p o s s ib ility  i f  dynamic 
re la tionsh ip  between the m ildest form of c ir rh o s is  and the more serious 
form of fa tty  l iv e r ,  which could occasionally run together with inflam ­
mation and f ib ro s is . The gravest Child 's stage "C" group shows very low 
К- c e l l  a c tiv ity  value, which could be explained, on the one hand, by the 
general deterioration process the body is  undergoing when a l l  b io log ica l 
functions, including c e l l  functions, f a i l .  On the other hand, i t  is  also 
possible that at th is  stage the AÜCC reaction, being completely over, the 
process burns out.
Our resu lts -  K i l le r - c e l l  capacity growths registered in  more 
serious cases of alcohol-induced liv e r  diseases - seem to support the pres- 
sumption that the p o s s ib il i ty  of an ADCC reaction developing in the course 
o f the disease has to be taken in to  consideration. Although our findings 
are natura lly  only an in d ire c t proof of the AOCC reaction taking place, 
they prompt us to v e r ify  w ith  further tes ting  the presence of theore tica l 
a n t i- l iv e r  c e ll-s p e c if ic  ADCC reaction. The in d iv id u a l proof of an ADCC 
reaction  can perspectively lay  the foundation fo r  an aimed immune therapy 
and could lead to the introduction of new therapeutica l procedures.
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Red blood c e l l  f i l t e r a b i l i t y  as an appropria te  method fo r evaluating red blood c e ll 
de fo rm ab ility  was studied w ith d iffe re n t suspending media o f erythrocytes. Comparison o f 
autologous plasma and b u ffe r suspensions o f healthy sub jec ts ' erythrocytes showed no s ig n i f i ­
cant d iffe rence  in  f i l t e r a b i l i t y .  Albumin alone resu lted  in  a dose-dependent increase, while 
fib rinogen caused a decrease in  red c e ll f i l t e r a b i l i t y .  In the presence o f fib rino g e n , 
albumin showed con trove rs ia l e ffe c ts . The re s u lts  suggest that measurements o f red blood 
c e lls  in  th e ir  o r ig in a l surroundings give more accurate information about the m icroc ircu ­
la tio n  because plasma components may have a c ru c ia l in fluence on erythrocyte d e fo rm a b ility .
Keywords : e ryth rocyte  de fo rm ab ility , absolute and re la tiv e  f i l t e r a b i l i t y ,  healthy 
population, albumin, fib rinogen .
In t r o d u c t io n
At a given blood pressure the tissue blood supply Is determined by 
the diameters of the involved vessels and the rheological properties of the 
blood. ROD is  one of the factors of haemorheology. Damaging of th is  physio­
lo g ica l parameter of RBCs shortens the life -sp a n  of the c e lls , increases 
whole-blood v isco s ity  and worsens m icroc ircu la tion  /4 , 21, 22/.
RCD is  determined f i r s t  of a l l  by the c e l l 's  conditions (the geo­
m etrical state of the c e ll,  the membrane viscoe lastic  properties and the 
in tra c e llu la r  v isco s ity ) /4 / ,  and influenced also by plasma parameters e.g.
Abbrevia tions: CP = number o f clogging p a r t ic le s ;  PBS = phosphate-buffered s a lin e ; 
RBC = red blood c e l l ;  RCD = red c e ll de fo rm a b ility ; Tc = red c e ll tra n s it time
O ffp r in t requests should be sent to : P. Tamás, H-7624 Pécs, Édesanyák u. 17, Hungary
Akadémiai Kiadó, Budapest
albumin /1 4 /, fibrinogen /7 , 18/ and pH /1 , 22/. Therefore, i t  seems to be 
ju s t i f ie d  to d is tingu ish absolute and re la t iv e  RBC deform ability (RCD de­
termined in  buffer and autologous plasma, respec tive ly ). The app lication of 
th is  d is t in c t io n  is  supported by discordant find ings , e.g. in pre-eclampsia 
when the RCD depends on the suspension medium of RBCs /1 , 9, 10, 16/.
The aim of our study was to evaluate the absolute and re la tiv e  RCD 
in  a healthy population and to measure the separate and jo in t  e ffec ts  of 
albumin and fibrinogen on RCD.
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Materials and Methods
19 ml o f venous blood anticoagulated by K -EDTA, obtained from 40 (19-40 years) 
healthy vo lunteers (17 male and 23 females) were cen trifuged  at 2000 g fo r 15 min. E ry th ro ­
cytes were aspirated from the centre o f the packed c e l l  volume and washed twice w ith  PBS 
(pH: 7 .4 ; 290 m0sm/kg) containing 2 g/1 of bovine albumin (SIGMA, frac tion  V) and 5 mMol/1 
glucose. The c e lls  were suspended in  30 cases in  PBS and autologous plasma and in  f iv e  occa­
sions in  1:1 and 1:4 mixtures o f plasma and PBS as w e ll. In  5 cases the RBCs were suspended 
in  PBS containing 0, 10, 20, 40 and 70 g/1 bovine albumin, in  another 5 cases in  PBS con­
ta in in g  40 g/1 albumin, 1 /g/1 human fibrinogen (SIGMA) or both or none. E ry th ro c r its  o f 
a liq u o ts  were adjusted to ^10% before incubation a t 37 C fo r  30 minutes. Leukocyte contami­
nation varied from 0.5x10 to 3x10 /1  in  the samples under v isua l con tro l.
RCD was assessed by measuring RBC f i l t e r a b i l i t y  w ith  a S t. George's f i lt r o m e te r  
(Mikron GMK, Budapest). The determ ination of the suspension's flow  dynamics through the pores 
o f a Nucleopore f i l t e r  models the m ic roc ircu la tion  regarding c e ll concentration, shear force 
and pore diameter. As in  diameter the erythrocytes exceed the f i l t e r  pores (7 -8 ^um vs 5 urn) 
only c e lls  w ith  appropriate de fo rm ab ility  are capable o f passing the pores e a s ily . Red c e lls  
w ith  decreased a b i l i t y  to  change th e ir  shape in  response to  the external force w i l l  meet 
d i f f i c u l t ie s  in  trave rs ing  the pores or w i l l  be even entrapped. The data given by the 
f i l t r o m e te r ,  the e ry th ro c r it  and the number o f open pores a t the beginning o f the measurement 
gave the fo llow ing  ch a ra c te ris tic s  o f RCD when appropria te software and microcomputer 
ш ге  used.
Tc: red c e ll t ra n s it  time ( re la t iv e  to the medium tra n s it  time o f one c e ll through 
a pore 11.5 in  length and 5yum in  diameter).
CP: number o f clogging p a rt ic le s  (number o f blocked pores a fte r f i l t r a t io n  o f 1 ml 
o f suspension i f  one pore is  blocked only by one c e l l ;  10 /m l)  /8 / .
Measurements were ca rried  out in  duplicates at room temperature w ith in  3 h a fte r  
blood sampling. Upon counting the f i l t e r a b i l i t y  parameters, th e ir  means were taken fo r 
s ta t is t ic s .  For the comparison o f plasma and PBS suspensions Student's paired t - t e s t , fo r  the 
others W ilcoxon's te s t was used. Level o f s ign ificance  was taken at P 0.05.
Results
When RBCs were suspended in  th e ir  own plasma the Tc was 7.13^0.69 
(mean _+ S.D .), in  PBS i t  was 6.99 _+ 0.65. The CP (106/m l) equalled in  
plasma 1.055 _+ 0.210 and in  PBS i t  was 1.103 _+ 0.246. Similar resu lts  were 
obtained when the plasma was changed fo r bu ffe r (Fig. 1). No s ig n ific a n t d i f -
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F ig .  1 . Red œ i l  t r a n s i t  tim e  (T c ) and number o f  c lo g g in g  p a r t ic le s  (CP) v a lu e s  (mean j* S .D .)  
in  a u to lo g o u s  p lasm a, b u f fe r  and in  t h e i r  1 :1  and 1 :4  m ix tu re s  (n = 5 )
Albumin cone. (g / l )
f i g -  2 . I n d iv id u a l  red  c e l l  t r a n s i t e  tim e  (T c )  and number o f  c lo g g in g  p a r t ic le s  (CP) va lu e s  
w ith  in c re a s in g  a lbum in  c o n c e n tra t io n  o f  th e  b u f fe r  medium
ference was found between plasma and PBS ;or mixed suspensions in  any case 
and parameter.
Increasing albumin concentration caused a decrease in  Tc. Except 
fo r  the value w ith albumin 10 g / l  (6.72 _+ 0.48), the values w ith  consecu­
t iv e  albumin concentrations (6.66 _+ 0.90, 6.08 +_ 0.90 and 5.90 +_ 0.75) were 
s ig n if ic a n tly  d iffe re n t from the con tro l (7.21 ±  0.79) obtained without 
albumin. The CP found in  albumin free PBS was 1.061 _+ 0.051, w ith  increas­
ing albumin concentration i t  was 1.050 _+ 0.072, 0.956 +_ 0.081, 0.840 +_ 0.042 
and 0.781 0.063. Samples w ith 40 and 70 g / l  albumin concentrations were
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F ig .  3 . D ire c t io n s  o f  changes o f  th e  in d iv id u a l  red  c e l l  t r a n s i t  t im e  (T c ) and number o f  
c lo g g in g  p a r t ic le s  (CP) v a lu e s  o b ta in e d  in  p ro te in  f r e e  PBS, in  th e  presence o f  40 g /1  
a lb u m in  ( A ) ,  1 g /1  f ib r in o g e n  ( F ) ,  o r  b o th  (A+F)
s ig n if ic a n t ly  d iffe re n t from the contro l. In d iv idua l values fo r Tc and CP 
are shown in Fig. 2, respective ly . Further s ig n if ic a n t differences can be 
found between data regarding both parameters.
One g/1 fibrinogen in  the media (Fig. 3, F) resulted in  a s ig n ific a n t 
increase of Tc (from 6.73 +_ 0.75 to 7.85 +_ 0.54). 40 g/1 albumin (A) caused 
again a s ig n ifica n t decrease (5.90 ^  0.78) while the presence of both 
p ro te ins in  equal concentrations (A+F, 7.10 +_ 0.77) the Tc did not d if fe r  
s ig n if ic a n t ly  from the co n tro l value. As regards CP albumin alone caused a 
s ig n if ic a n t enhancement (from 1.049 _+ 0.192 to 0.862 _+ 0.122), fibrinogen 
alone (1.112 +_ 0.248) d id  not, but in  the presence of albumin (1.266 _+ 
_+ 0.149) did resu lt in  a s ig n if ic a n t decrease in  f i l t e r a b i l i t y .
D iscuss io n
ROD could be defined and measured as a re la t iv e ly  absolute value 
in  a given system i f  c e lls  were examined in  b u ffe r a fte r a washing pro­
cedure. This value, however, may be remarkably affected by the c e lls ' 
environment. Therefore, i t  might be considered th a t the measurement of ROD
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in autologus plasma should give a more relevant information to the micro- 
c irc u la tio n  than measurements performed in  any other medium.
RCD measurements in the presence of fibrinogen, and espec ia lly  in 
plasma, may raise a doubt whether changes in  RCD indeed or other e ffec ts  
o rig ina te  from the medium are responsible fo r the changes in  f i l t e r -  
a b i l i t y .  One of such e ffec ts  might be the changes in the medium's viscos­
ity .  In our system the count of re la tiv e  (medium/suspension) flow  values 
allow the exclusion of th is  e ffe c t. On the other hand, fib rinogen  (and 
also g lobulins) may in te rfe re  with the suspension's flow because of RBC 
aggregation /3 , 6, 17, 23/. However, th is  phenomenon occurs w ith  a con­
tinuous slowing down of flow , at very low shear force (under 0.05-0.2 Pa), 
p ra c tic a lly  at the stop of the flow /2 , 5, 13, 20/. Because in  our in s tru ­
ment the applied d riv ing  force was 400 Pa the shear force was about 45 Pa 
in the pores /19 /. Beyond th a t, the f i r s t  few seconds of the flow , when 
RBC aggregates might have formed, were excluded from the measurements and 
in i t ia l  flow rates were determined only in  a mathematical way.
Also our data support that a lte ra tions  in  f i l t e r a b i l i t y  were caused 
by RCD changes. Namely, we would have obtained a worse f i l t e r a b i l i t y  in 
plasma than in buffer i f  e ffec ts  of fibrinogen and globulins had caused 
RBC aggregations. We fa ile d  to find  s ig n if ic a n t difference in  f i l t e r a b i l -  
i t y  by the exchange of plasma medium to bu ffe r.
Albumin enhances the disaggregation of rouleaux formations, but only 
in  the presence of fibrinogen /15 /. In our experiments albumin resulted 
in a dose-dependent enhancement in f i l t e r a b i l i t y  of RBCs in  the lack of 
fibrinogen. This e ffe c t existed in  the same extent in  hyperosmolar PBS 
(unpublished data). Our observations are inconsistent w ith re su lts  of 
Koyama and Kikuchi /12, 14/, who found a s ig n ific a n t worpening in  RCD by 
increasing concentration of plasma or albumin alone in  the incubation 
medium; the worsening was especially high, when ce lls  were suspended in 
hyperosmolar environment. The discordant observations can be explained 
p a rtly  by methodical d ifferences.
Our data suggest that albumin alone increases, fibrinogen decreases 
the RCD on the whole, though, in the presence of fibrinogen albumin acts 
con trove rs ia lly : most of red ce lls  become more f le x ib le  (lower Tc) but 
the remainder c e lls  tend to be more r ig id  (higher CP). Regarding the Tc 
values they oppose each o the r's  e ffec ts  apparently, such as in  th ixotropy 
/11 /. In the l ig h t  of our findings w ith albumin and that both proteins 
adhere to the surface of erythrocytes /12, 18/, i t  may ind ica te  a com­
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p e t it io n  when the adherence of albumin and fib rinogen molecules may have 
an opposite resu lt on RCD. At the same time, the ra te  of pore clogging was 
s ig n if ic a n t ly  higher w ith  both proteins than w ith  fibrinogen alone. This 
observation could be explained by the presence of d iffe re n t c e ll popu­
la t io n s  in  the examined samples.
Our data d i f fe r  from tha t of Rampling and S irs /18 /, who experi­
enced a decreased RCD by repeated washings of the RBCs which could have 
been protected by fib rinogen . I t  should be noted, however, tha t th e ir  
method was basically d if fe re n t from ours. On the other hand, our findings 
are in  accordance w ith the opinion of Dormandy /7 /  that increasing f ib ­
rinogen concentration decreases the e ffec tive  RCD.
Our results w ith  PBS as medium were not s ig n if ic a n tly  d iffe re n t 
from tha t with plasma medium but différend from the resu lts with the PBS 
contain ing both pro te ins. These findings, even though the used fibrinogen 
concentration was lower than the physiological le v e l, may indicate d i f ­
fe re n t RBC - environment in teractions in  bu ffe r and plasma and/or the in ­
fluence of other plasma fac to rs  accordingly. Investiga tion  of de ta ils  of 
RCD - environment connections needs fu rther experiments.
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PHYSIOLOGICAL VALOES OF GLUCOSE-6-PIIOSPHATE-OEHYOROGENASE (G -6-P O )
IN CHORIONIC V IL L I
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The p h y s io lo g ic a l a c t i v i t y  v a lu e s  o f  g lu c o s e -6 -p h o s p h a te  dehydrogenase (G -6-PD ) 
fro m  c h o r io n ic  v i l l i  hom ogenized in  T r i to n  X was e v a lu a te d . The f ro z e n , n o n - c u l t iv a te d  
c h o r io n ic  samples were o b ta in e d  from  a r t i f i c i a l  a b o r t io n  in  an e a r ly  p e r io d  o f  g e s ta t io n  
(6 -1 1  w e e ks). The mean G-6-PD a c t i v i t y  was 0 .4 3  U/mg p r o te in .  The G-6-PD enzyme a c t i v i t y  
showed no c o r r e la t io n  w ith  th e  week o f  g e s ta t io n .
Keywords: g lu c o s e -6 -p h o s p h a te  dehyd rogenase, c h o r io n ic  v i l l i ,  e a r ly  g e s ta t io n a l
p e r io d .
In t r o d u c t io n
Glucose-6-phosphate dehydrogenase (G-6-P0) catalyses the oxidation 
of D-glucose-6-phosphate to D-glucono-delta-lactone-6-phosphate by NADP+ 
(or NAD+). The enzyme was discovered by Warburg and C hristian, in i t ia l l y  
in  horse erythrocytes /1 /  and subsequently in  other mammalian erythrocytes 
/2 / .  The p rinc ipa l function of the hexose monophosphate shunt in  human 
erythrocytes is  the generation of NADPH and lim ited  amounts of 5-phosphori- 
bosyl pyrophosphate. NADPH is  used fo r several functions, the most im­
portant being the coenzyme function fo r g lutathione reductase, the enzyme 
tha t maintains glutathione in i t s  reduced form. In addition, NADPH appears 
to be needed fo r the optimal function ing of catalase /3 / .  The pentose 
phosphate shunt provides the NADPH necessary fo r the fa tty  acid synthesis, 
which is  related to the oxidative pa rt of the shunt where the enzymes
O f fp r in t  re q u e s ts  s h o u ld  be s e n t to  A ranka L á s z ló , S z e n t-G y ö rg y i U n iv e r s i t y  
M e d ic a l S c h o o l, P a e d ia tr ic  D ep a rtm e n t, H-6720 Szeged, P .0 . Box 471, Hungary
Akadémiai Kiadó, Budapest
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G-6-PD and 6-phosphogluconate dehydrogenase produce the NADPH. G-6-PD was 
p u r if ie d  by Kanji e t a l.  /4 /  from pig l iv e r .  This e:nzyme exists as an ac­
t iv e  dimer of molecular weight of 133,000 dalton and an inactive monomer 
o f 67,500. G-6-PD is  h igh ly  spec ific  fo r NADP+ and glucose 6-phosphate, 
lo c a liz in g  mostly w ith in  the soluble portion o f the cytoplasm.
Cultured fib ro b la s ts  may represent a mosaicism of two c e ll types. 
The product of the normal G-6-P0 a lle le  is  designated the В form. A va rian t 
e lectrophoretic  form G-6-PD type А,- is  common mostly in  blacks /5 , 6 /.
K inetic characte riza tion  of the in h ib it io n  e ffec t of n icke l on 
G-6-PD and glutathione reductase (GR) was investigated by Cartana e t a l. 
/ 7 / .  The e ffect of n ic ke l on G-6-PD a c t iv ity  was consistent with a mixed- 
type in h ib it io n  pattern .
Schuster et a l.  /8 /  mathematically modellized the metabolic path­
ways o f G-6-PD enzyme defic iency, the energy and redox metabolism of G-6-PD 
d e fic ie n t erythrocytes the donors of which showed an increased s e n s it iv ity  
to  energetic load.
Since data about the physiological values of G-6-PD a c t iv ity  from 
the chorionic v i l l i  have not been published so fa r ,  we have determined th is  
enzyme a c tiv ity  from chorion ic v i l l i .
M a te r ia ls  and M ethods
The a c t i v i t y  o f  G -6-PD measured in  T r i to n  X (0 .1 % ) homogenized c h o r io n ic  t is s u e  
o b ta in e d  from  th e  f i r s t  t r im e s te r  (6 -11  weeks) o f  g e s ta t io n s  in te r ru p te d  by  a r t i f i c i a l  
a b o r t io n .  P u r if ie d  c h o r io n ic  v i l l i  were s e le c te d  und e r d is s e c t io n  m icroscope by s e p a ra t io n  
fro m  m a te rn a l d e c id u a . The t is s u e  samples were o b ta in e d  a t  le g a l  te rm in a t io n  o f  p regnancy 
p e rfo rm e d  fo r  soc ioeconom ic in d ic a t io n s  w ith  re g u la r  co n s e n t o f  th e  m others. The g e s ta t io n a l  
age was c a lc u la te d  from  th e  f i r s t  day o f  th e  la s t  m e n s tru a l p e r io d .  The t is s u e s  were f i n a l l y  
m inced  in  10 volumes o f  ic e c o ld  b u f fe r  (50 ml TRIS-HC1 1% T r i t o n  X -100 , pH 7 .4 )  and homogen­
iz e d  a t  th re e  20 sec b u r s ts  (U lt r a - T u r r e x  h o m o g e n iz e r) . The homogenate was c e n t r i fu g e d  a t  
1 0 5 ,00 0  g fo r  60 min and th e  s u p e rn a ta n t ( c y to s o l ic  f r a c t i o n )  was used fo r  enzyme a s s a y .
Enzym atic a c t i v i t i e s  w ere measured as d e s c r ib e d  by  K a n ji  e t  a l .  / 4 / .  The change in  
a bso rb a nce  a t  340 nm (1  cm l i g h t  p a th )  was fo llo w e d  w ith  a V a r ia n  DMS 70 s p e c tro p h o to m e te r. 
The r e a c t io n  m ix tu re  had th e  fo l lo w in g  c o m p o s iito n : 2 .5  ml o f  0 .1  M t r ie th a n o la m in e  b u f fe r  
(pH 7 . 6 ) ,  0 .1  ml o f  0 .035  M g lu c o s e -6 -p h o s p h a te , 0 .1  ml 0 .011  M NADP and 0 .2  ml o f  0 .1  M 
m agnesium  c h lo r id e .  The r e a c t io n  was i n i t i a t e d  by th e  a d d i t io n  o f  0 .1  ml o f  p ro p e r ly  d i lu t e d  
enzym e.
One u n i t  o f  G-6-PD i s  d e f in e d  as th a t  amount o f  enzyme w h ich  c a ta ly s e s  th e  fo rm a tio n  
o f  one m icrom o le /m in  o f  NADPH u n d e r th e  c o n d it io n s  d e s c r ib e d  above .
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After storage at -70°C the mean G-6-PÜ a c t iv ity  was 1.43 U/mg 
pro te in , SD +_ 1.75; the mean of gestational weeks was 9.4 SO ±  1.86; the 
mean prote in concentration of the chorionic v i l l i  homogenized in  Triton was 
2.99 SD +_ 1.78 (Table I ) .  The G-6-PD enzyme a c t iv it ie s  showed no cor­
re la tion  with the week of gestation ( r  = -0.27, P > 0 .0 5 ).
Table I
P h y s io lo g ic a l a c t i v i t ie s  o f  G-6-PD enzyme from  
homogenate o f c h o r io n ic  v i l l i
week o f  g e s ta t io n s
X
SD
9 .4
+ 1 .06
p r o te in  c o n c e n tra t io n
X
SO
2 .9 9
+_ 1 .7 8  my/ml
G-6-PD X 1 .4 3  U/mg
n = 22 SD
p ro te in  
+ 1 .75
C o r r e la t io n  c o e f f i c ie n t  = r
G-6-PD and g e s ta t io n a l  weeks г  = -0 .2 7  P > 0 .0 5
D iscu ss io n
Salgó and Pál /9 / determined the reference range fo r 10 enzymes 
(a lka line  phosphatase, ALAT, ASAT, GGT, CK, LDH, e tc .)  in amniotic f lu id  
and maternal samples at 14-42 weeks of gestation . The determination of 
gamma-glutamy1-transferase, heat-stable a lka line  phosphatase and creatine 
kinase was found to be of appreciable d iagnostic significance in  the 
c l in ic a l practice.
In th is  study, our team f i r s t ly  evaluated the physiological ac­
t iv i t y  values of G-6-PD from in  Triton X-homogenized chorionic v i l l i .  The 
frozen, поп-cu ltiva te d  chroionic v i l l i  were obtained in an early ges­
ta tio n a l period.
Previously, the a c t iv ity  of the G-6-PD had been analysed from the 
amniotic f lu id  in  the la s t trimester /10, 11, 12/; the mean a c t iv ity  of 
G-6-PD enzyme was 0.8 U /l (extreme range: 0 -2 .9 ). The a c t iv ity  of the 
lacta te  dehydrogenase was 82.4 U /l (56.7-132); tha t of the above-mentioned 
enzymes was higher than tha t of G-6-PD.
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In the next fu tu re  we w i l l  investiga te  the physio log ical a c t iv ity  
o f the G-6-PD during the second and the th ird  trim ester of gestation . Ihe 
change of the a c t iv ity  o f G-6-PD enzyme might be in te res ting  among patho­
lo g ic a l circumstances l ik e  toxaemia, in trau te rine  fe ta l re ta rda tion  and 
fe ta l  d istress.
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B OOK  R E V I E W S
"Cardiac lymph c ircu la tion  and cardiac disorders" 
S o lt i , F., Je lű n e k , H.
Akadémiai Kiadó, Budapest, 1989, pp. 1-187, with 160 fig s
This is  an exce llen t and up-to-date review on the co rre la tion  of 
cardiac lymph c irc u la tio n  and some cardiac disorders based mainly on ex­
perimental data and c l in ic a l observations of the authors obtained from 
several decades' study. The d iffe re n t forms and consequences of impeded 
cardiac lymph c irc u la tio n  are thoroughly discussed. Mechanical cardiac 
lymphatic in su ffic iency  can be induced by obstructing cardiac lymph flow , 
e .g ., by some inflammatory process in  pa tien ts  or by lig a tio n  of the 
cardiac vessels and regional lymph nodes in  experimental conditions. The 
dynamic insu ffic iency  can be produced by overloading the transport ca­
pacity of the cardiac lymph vessels, e .g ., by increase of heart frequency, 
etc. or by increasing loca l lymph production provoked by elevated venous 
pressure in  experiments. Due to the lymphatic blockade, the p ro te in  (and 
f lu id )  transport from the cardiac in te rs t it iu m  w i l l  be deteriorated with 
the consequences of pro te in  accumulation in  the myocardium and coronary 
vessels w a ll. These consequences are investigated by h is to lo g ica l and 
electrophysio logical (ECG) methods, and by measuring coronary blood flow .
The most important conclusion of the authors is  that cardiac 
lymphatic blockade or insu ffic iency induces pro te in  (plasma) accumulation 
in the wall of small coronary a rte ries , re su ltin g  in  a decreased coronary 
blood flow and i t s  ea rly  and late consequences. The early complications are 
focal necrosis, la te  complications coronary stenosis and cardiac s le ro s is .
The in te rre la tio n s  between acute myocardial in fa rc tion  and a r­
rhythmias with lymphostasis are also discussed.
The documentation is  excellent. The aspect of the treatment of the 
book is  c r i t ic a l .  Unfortunate ly, repe titions  occur frequently and a quanti­
ta tive  analysis of the la te  complications due to lymphostatis is  missing.
The book is  a good guide in to  the pathophysiology of the heart 
function and may be very useful fo r c lin ic ia n s  and physiologists dealing 
with some special problems of cardiology.
MIKLÓS PAPP
"In tr in s ic  Asthma"
Proceedings of the 4th International Symposium held at Davos from 
September 18-20, 1988
Edited by M. Schmitz-Schumann, G. Menz, U. Costabel and C.P. Page.
Birkhäuser Verlag, Basel-Boston-Berlin, 1989, 378 pages,
Price : SFr 96.0
For decades, asthma was considered to be an exchesively a lle rg ic  
disease. When IgE and spec ific  antibodies were f i r s t  detected and measured 
only patients with proven exogenic a lle rg ic  asthma were considered'real 
asthmatics. Later, i t  became apparent th a t status asthmaticus, serious
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forms of asthma or deaths from asthma often the resulted from asthmatic 
illn e sse s  showing no evidence of a lle rg ic  cause. Thus, many c lin ic ia n s  
returned to the tra d it io n a l c la s s ific a tio n  of tronch ia l asthma, i .e .  in to  
e x tr in s ic  (exogen ic-a lle rg ic) asthma and in t r in s ic  (postin fectious) asthma.
C lin ica l research in te re s t is  cu rren tly  focused on bronchial hyper- 
responsiveness, which, as a common feature o f a l l  forms of asthma in te r ­
fe res w ith the old asthma categories. This becomes evident when genetic 
fa c to rs  are being investigated as a possible cause of bronchial hyper- 
responsiveness.
In th is  book the pathogenesis and pathophysiology of in t r in s ic  
asthma are discussed by excellent lec tu re rs  in  depth in comparison w ith 
other forms of asthma. The assumed v ira l o r ig in , as well as the d if fe re n t 
c e l l  populations of immune system involved in  respiratory in fe c tio n , and 
th e ir  mediators, are considered. Regulatory peptides, toxic rad ica ls , the 
neuronal components of bronchial asthma and the specific  biochemical 
les ions being related to in tr in s ic  asthma are also dealt w ith. In the 33 
series of lectures there are also included exhaustive discussions of the 
ro le  of humoral immune facto rs , aspects of in tr in s ic  asthma therapy, 
a lte rn a tiv e  methods of s te ro id  treatment such as cytosta tics, leukotrienes 
and lipoxygenase in h ib ito rs , РАН-antagonists, phosphodiesterase in h ib it io n ,  
up-to-date anti-histam ines and s ta b iliz e rs  fo r  immune-competent c e lls .
The book contains the most important, la te s t theore tica l and prac­
t ic a l  information in  the f ie ld  of in tr in s ic  bronchial asthma.
ANDOR LEÖVEY
"Generalized epilepsy" 
Neurobiological approaches 
Avoli, M., Gloor, P., Kostopoulos, G., Naquet, R. 
Birkhauser, Boston, 1990, pp. 1-481 
Price: SFr 198.0
This book contains selected papers o f the Symposium on Generalized 
Epilepsy held in  Montreal, 1988. The prominent ed ito rs and authors are of 
the opinion tha t, in  contrast to p a r t ia l ep ilepsies, the neurobio logical 
background of generalized epilepsy (GE) has not been s a t is fa c to r ily  
cleared up as yet, although, there are s ig n if ic a n t and promising s c ie n t i f ic  
re s u lts  hopeful fo r use in  the near fu ture in  c l in ic a l practice.
The book s ta rts  w ith  a comprehensive thorough h is to r ic a l review of 
the theories and the models of GE, from Hippocrates to the up-to-date hypo­
theses .
In Chapter 1, tha t introducing the c l in ic a l features of GE, un­
fo rtu n a te ly , not the ac tua lly  accepted c la s s if ic a tio n  of epilepsy is  used.
A very in te resting  paper of Andermann summarizes the unanswered questions 
o f the GE, such as genetica l determination, age dependence, benign nature, 
p la s t ic i t y ,  myoclonus, simple and combined absences, connections between 
absences and ton ic -c lon ic  seizures, p a rtic u la r features of the West and 
the Lennox syndromes, e tc . The common o r ig in  of sleep spindles and of the 
spike and wave complex is  evidenced in  th is  chapter by a relevant study of 
Kellaway. Chapter 2 deals with the basic c e llu la r  and neurotransmitter 
mechanisms of GE. The re p e tit iv e  f ir in g  of the Betz ce lls  is  con tro lled  by 
three slow potassium currents (two of them calcium-dependent, the th ird  one
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sodium-dependent). In the e x tra ce llu la r f lu id ,  among others io n ic  changes 
measured with se lective  microelectrodes are demonstrated. Neurotransmitter 
mechanisms of GE are based on n-methyl-D-aspartate and GABA stud ies; some 
new excitant amino acids have been iso la ted which may play an important 
ro le  in  the pathomechanism. New epilepsy models based on the connection 
with the transm itte r mechanism e x is t, e.g. the in tra c o rtic a l GABA in fus ion 
and the in  v it ro  postsynaptic po ten tia l studies in  s lices . Chapter 3 demon­
stra tes the thalamic and c o rtic a l mechanisms of GE. The ro le  of the 
thalamic relay c e lls , the theory of the thalamic pacemaker and the re la tio n  
of the thalamic "GE-specific" and "non-specific" parts are discussed. Con­
siderable e ffo r ts  have been made fo r a neurophysiological d is t in c t io n  be­
tween p a r t ia l and generalized epilepsies in  animal models and on the basis 
of the pharmacological experiences at c e llu la r  and synaptic le ve l as well 
as chronic neuronal e x c ita b il i ty .  The study of Mirsky and Duncan on 
behaviour in  GE is  one of tfie most in te res ting  papers in  the volume; i t  is  
of great p rac tica l value. Chapter 4 is  connected with the neurobiology of 
photosensitive GE. Exciting cha rac te ris tics  of th is  mechanism might be the 
foca l features seen quite frequently, the p a rtic ip a tio n  of the f ro n ta l lobe 
and the decrease of dopamine release in  the cortex. An exce llen t example 
fo r the u t i l iz a t io n  of the resu lts  of basic research is  the paper of 
W ilkins et a l.  on "e p ile p tic "  and "non-ep ilep tic" pho tose ns itiv ity  and 
th e ir  connection w ith headache and possible harmful e ffec ts  of certa in  
common visual environmental patterns. The top ic of Chapter 5 is  the GTCS in 
GE. Based on experimental models the s ign ificance of the calcium channels, 
the ro le  of the substantia nigra and of the mesencephalon are demonstrated. 
Chapter 6 reviews a top ic of outstanding p rac tica l importance: the resu lts  
of metabolic and neurochemical studies of GE. The most modern method fo r 
them is  positron-emission tomography (PET). Ic ta l hypermetabolism and 
p o s tic ta l hypometabolism are cha rac te ris tic  of both p a rtia l and generalized 
mechanisms, so up now no spec ific  d ifferences have been found between the 
two main kinds of epilepsies. The app lica tion  of PET revealed the function 
of the GABA-benzodiazepine complex during the ep ilep tifo rm  discharges. The 
la s t chapter's theme is  the mechanism of action of the anticonvulsant 
agents in GE. The c e llu la r  e ffects  develop through the calcium channels. 
A summarizing review deals with the importance and perspectives of valpro­
ate, another valuable paper in te rp re ts  the c e llu la r  e lectrophysio log ica l 
background of the e p ile p tic  symptoms occurring as a consequence of w ith­
drawal of sedative durgs.
The ed ito rs and authors mode an excellent work. The volume contains 
a l l  the important resu lts  of the neurobiological research of GE. I t  is  a 
very useful survey not only fo r researchers but - in  my opinion - i t  is  
even more valuable fo r  ep ilep to log is ts  s tr iv in g  to trea t th e ir  pa tien ts  on 
the basis of the up-to-date knowledges achieved in  th is  f ie ld .
F in a lly , a subjective comment: neurobiological approaches of p a r tic ­
u la r physio log ica l, psychological and environmental factors g rea tly  in ­
volved in the c l in ic a l p ic ture  of epilepsies - especially o f GE - s t i l l  
remain to be released up.
PÉTER RAJNA
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"Obstetric genetics" 
Zoltán Papp
Akadémiai Kiadó, Budapest, 1990
During the la s t two decades, two major forces in  c lin ic a l studies 
on human reproduction have been the management of in f e r t i l i t y  and the 
early  detection of fe ta l abnormalities. With th is  fascinating book, 
O bste tric  Genetics, the well-known expert, Zoltán Papp is  a pioneer in  
basic and c lin ic a l genetics in  Hungary. Following the Hungarian ed ition  of 
the book in 1986 the English version proves tha t the book is  f i l l i n g  a gap 
in  the border area of c l in ic a l  genetics and obs te trics  not only in  Hungary, 
but in  in te rna tiona l means, too. Prevention and detection of fe ta l ab­
norm alities may be fe as ib le  with the help o f combined use of basic theor­
e t ic a l knowledge and c l in ic a l  application o f re su lts  of antenatal care and 
prenatal diagnosis, and in  th is  way to apply fe ta l therapy among the most 
recent p o s s ib ilit ie s  o f antenatal care.
The book contains 80 chapters, each w ith several entries. The f i r s t  
eleven chapters deal w ith  basic genetic knowledge tha t brings c l in ic a l 
genetics and obste trics  nearer to each other and is  needed for a l l  the ex­
perts  interested in  o b s te tr ic  genetics. The next 9 chapters are devoted to 
the membranes and amniotic f lu id .  The emphasis is  put on the information 
th a t can be obtained from examination of the amniotic f lu id  and from the 
ex fo lia ted  amniotic f lu id  c e lls . The fo llow ing  "o b s te tr ica l"  chapters de­
scribe the methods of fe ta l examinations (amniofetography, ultrasound, 
fetoscopy, amniocentesis, CVS, fe ta l blood sampling).
Further on, besides the description of prenatal therapy and pro­
cedures fo r pregnancy term ination, very important e th ica l and legal ques­
tions  are discussed concerning the general aspects of decision making 
regarding the fa te  of pregnancy. These problems and the psychological 
aspects of prenatal diagnosis are not s t r ic t ly  involved in  the top ic of 
o b s te tr ic  genetics, but are extremely important from the view of a couple 
w ith  increased genetic r is k .  That is  why we agree with the author when he 
involves these topics and t r ie s  to hand over h is  personal experience, too.
The second h a lf o f the book is  devoted to  the d iffe re n t genetic, 
metabolic, morphologic disorders, which also involve the questions of 
in te rse xu a lity  and gonadal dysgenesis. There are some fu rther chapters 
which do not belong c lose ly  to genetics ( in tra u te r in e  in fections, fe ta l 
haemolytic disease, d ia b e tic  embryopathy), but these disorders may, or 
ra the r should be involved because patients w ith such problems usually turn 
to  genetic counselling.
In conclusion, th is  book can be h igh ly recommended to obste tric ians, 
paed ia tric ians, medical students and to a l l  the experts interested in  the 
f ie ld  of obste tric  genetics. With the English e d itio n  th is  book may become 
accepted as an invaluable and accurate reference book.
IMRE CSABA
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"C lin ica l observations and therapy of lung cancer" 
Ungar, I . ,  Böszörményi, M., Hanovszky, M., and Németh, Gy. 
Akadémiai Kiadó, Budapest, 1989 
Price: 140,- Ft
Carcinoma of the lung s t i l l  remains a leading cause of death among 
the cancer patients in  Hungary, especially among the smoker women. A l­
though surgical therapy, chemotherapy and ir ra d ia tio n  have considerably 
improved in  the past decades, therapy remains unsatisfacto ry. The lim ited  
success of surgical therapy have forced the development of new approaches 
in  treatment protocols. Combinations of these therapies seem to be promis­
ing fo r the m ajority of the patients with advanced disease.
The authors of th is  book present th e ir  own experiencies in  the 
progress of lung cancer treatment, prevention and re h a b ilita tio n . The book 
contains some s ta tis t ic a l analysis about the appearance and m orta lity  of 
lung cancer and the present state oi therapeutical t r ia ls  in  Hungary. The 
authors give short reviews of the a tio logy, h isto logy and biology of th is  
disease. The most in te re s tin g  part of the book consists of case-reports 
which describe the c l in ic a l  course and therapy of patients in  d e ta il.  The 
descrip tive  sty le  of the presentation helps the reader to th ink over the 
cases and to draw the necessary conclusions.
In addition, the book helps the c lin ic ia n  to bu ild  up the optimal 
s tra teg ies fo r lung cancer therapy.
ANNA TOMPA
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Acta Medica Hungarica 
Hungarian Academy of Sciences 
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H-1363 Budapest
Dear S ir
As 1992 approaches, th is  Society is  keen to do a l l  i t  can to promote closer 
lia is o n  in  medicine in  Europe.
Our Journal of the Royal Society of Medicine carried in July an e d ito r ia l 
from Mr Ian Burn, who is  Senior Vice President and Chairman of the Society's 
recently established European Committee, and we wonder whether you would be 
prepared to publish th is  e ithe r in  the form of a le tte r  to your journal 
from Mr Burn or as an e d ito r ia l or in  any other way that you th ink  appro­
p ria te . I enclose a copy of Mr Burn's e d ito r ia l.
We are w ritin g  s im ila r ly  to other journa ls , as we would lik e  our colleagues 
in  Europe to know tha t we are open to new ideas which w i l l  bring European 
and B r it is h  medical men and women closer together. We would also lik e  to 
receive news from European countries which we might publish in  our Journal.
Yours fa ith fu l ly
R o b e rt N. Thomson
Robert N Thomson 
Executive Director
Akadémiai Kiadd, Budapest
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E d i t o r ia ls
I n t o  Europe
Last Year's Annual Report of the Royal Society of Medicine referred to the 
S ocie ty 's  new educational te lev is ion  channel. The launch film  on 30th May 
1989 contained a message from Her Majesty The Queen, which went as fo llow s:
'A s  y o u r P a tro n , I  send you eve ry  good w is h  f o r  th e  in a u g u ra t io n  o f  th e  
S o c ie ty  ' s new te le v is o n  cha nn e l on 3 0 th  May. I  c o n g ra tu la te  you on t h is  
e x c i t i n g  te c h n o lo g ic a l ach ie vem en t, w h ich  w i l l ,  I  hope, b e n e f i t  p e o p le  
th ro u g h o u t t h i s  c o u n try  and in  Europe, now and in  y e a rs  to  com e.'
The reference to Europe emphasizes the Socie ty 's  commitment to involve i t ­
s e lf  much more ac tive ly  on the European scene than h ithe rto . The Single 
European Act scheduled fo r  1992 is  approaching fa s t and, as again stated in  
the Annual Report, the Society fu l ly  intends to prepare i t s e l f  fo r th is  
major event.
At present the Society has formal contacts w ith only three European 
so c ie tie s , namely the Danish Medical Society, the Royal Academy of Medicine 
in  Ire land and the Swedish Society of Medicine. This contrasts w ith the ex­
tensive and close lin k s  now forged with our colleagues in  the United States 
of America, where the Royal Society of Medicine Foundation Inc was estab­
lished  23 years ago and has o ffic e  accommodation at the Metropolitan Club, 
New York. I ts  Anglo-American V is itin g  Professorship scheme and the regular 
Anglo-American conferences have become important elements in the Society 's 
a f fa ir s .  Evidence of the success of our re la tionsh ips  with the USA is  the 
substan tia l A f f i l ia te  membership there, cu rre n tly  around the 3000 mark. As 
Fellows of the Society w i l l  know, in recent yeras there have been a number 
of developments in  the context of medical p rac tice  which re f le c t the Euro­
pean trend. During the la s t decade a number of successful European medical 
soc ie ties  and journals have been established, w ith p a rtic ipa tion  by a l l  
countries w ith in  the Continent. Many B r it is h  medical societies now hold 
jo in t  meetings w ith colleagues in  various parts o f Europe. Occasional meet­
ings o f certa in  Sections o f the Society have already taken place in  venues 
on the Continent. There has also been an increasing number of in v ite d  
speakers to Section meetings from European academic centres.
We have the basis and stimulus fo r making some major new moves now. The 
O ffice rs  of the Society have had prelim inary discussions and certa in  i n i t i ­
a tives  are thought possible. These include encouraging more Sections to 
hold meetings in  Europe or to meet jo in t ly  w ith  European colleagues at the 
RSM, encouraging European pa rtic ipa tion  in  the a c t iv it ie s  of our Forums, 
and extending the Society 's te lev is ion  a c t iv i t ie s  to other European 
countries.
We would hope also to extend our formal l in k s  w ith other academic bodies 
w ith in  Europe.
There may also be scope fo r encouraging lin k s  between our lib ra ry  and 
s im ila r  lib ra r ie s  on the Continent. The Royal Society of Medicine also 
would hope to ass is t in  exchange mechanisms fo r  European colleagues, of a l l  
grades. Hopefully, these and lik e  a c t iv it ie s  w i l l  encourage e lig ib le  co l­
leagues from the mainland of Europe to apply fo r  Fellowship and A f f i l ia te  
membership of the Society.
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To enable the matter to be pursued fu rth e r, the O fficers have proposed 
and Council have approved the setting up of a European Committee to  con­
sider how the Society 's objectives may be promoted in  Europe, and the estab­
lishment of a small named European O ffice to  act as a focal po in t fo r 
European a c t iv ity  at the Society. The European Committee w i l l  meet f re ­
quently and would welcome any relevant suggestions and comments from member 
of the Society, many of whom trave l frequently to the mainland of Europe 
where they have th e ir  own contacts and re s p o n s ib ilit ie s . I f  you have such 
an in te re s t, your help and ideas would be g rea tly  appreciated.
Ia n  Burn
Chairman, European Committee 
Royal Society of Medicine 
1 Wimpole S treet, London
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DIPLOMA
IN
ENDOCRINOLOGY (PATHOLOGY) 
Regulations and Syllabus
Akadémiai Kiadd, Budapest
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ROYAL POSTGRADUATE MEDICAL SCHOOL 
DIPLOMA IN ENDOCRINOLOGY
REGULATIONS AND SYLLABUS
1. Q ualifica tions fo r  Admission
1.1 The Course fo r the diploma is  open to graduates in  Medicine or Science 
whose previous tra in in g  and experience have, in  the opinion o f the 
School, q u a lified  them fo r re g is tra tio n  as students fo r the Diploma.
1.2 Candidates fo r the Diploma in  Endocrinology (Pathology) must be ex­
perienced in  l ig h t  and/or electron m icroscopical morphology and have 
basic tra in ing  in  biochemistry and h is to logy .
2. Course of Study
2.1 Students are required to attend an approved fu ll- t im e  course extending
over a period of not less than one academic year.
2.2 The course fo r Pathology students w i l l  consist of
(a) a period of about 8-9 weeks of lec tu res seminars and p ra c tica l 
classes based on current advances in  laboratory techniques. The 
fo llow ing top ics w i l l  be included: immunohistochemistry; ra is ing  
antibodies; monoclonal antibody technology; advanced histopath- 
ology; techniques fo r the lo c a lis a tio n  of regulatory peptides at 
l ig h t  microscopical le ve l; immunolabelling fo r electron micros­
copy; electron microscopical immunocytochemistry of regulatory 
peptides; recent advances in  q u a n tif ica tio n .
(b) regular attendance a t guest lectures and other a c t iv it ie s  in  the 
School. These include Histopathology guest seminars (weekly during 
term-time), lectures on regulatory peptides presented a t other 
teaching courses (averaging one per fo r tn ig h t) , and the weekly 
Medical S ta ff Round.
(c) regular Departmental meetings which include seminars on current 
research top ics, discussion groups on and th e ir  characterisa tion , 
updates on technology, research reports from other research 
groups, national and in te rna tion a l meetings and research in  
progress photographic sessions. Case report, meetings w ith d is ­
cussions on in te res ting  pathology form an in tegra l part o f the 
teaching programme. Informal guest lectures are frequently held. 
Active p a rtic ip a tio n  in  a l l  of these a c t iv it ie s  w il l  be encouraged
(d) an extended period of p ractica l work on approved projects in  the 
f ie ld  of endocrine pathology. This work w i l l  be carried out in  co­
operating labora tories e ither w ith in  the school or outside and 
w i l l  commence from the date of re g is tra tio n . Projects w i l l  be on 
defined aspects of regulatory peptide pathology/biology and are 
lik e ly  to be in  one of the fo llow ing  broad areas: systematic 
survey of regulatory peptides, involvement of peptides in  diseases
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of the gastro in tes tina l tra c t, resp ira to ry  system, cardiovascular 
system, central and peripheral nervous systems; peptide biosyn­
theses - abnormalities in  disease sta tes, hybrid isation h is to ­
chemistry and pro-peptide trans la tion ; factors a ffecting  grown of 
tumour c e lls ; markers fo r use in neoplastic d iffe re n tia tio n  and 
diagnosis (e.g. neuron-specific enolase, chromogranin A); mixed 
endocrine tumours -  morphology, biology and e ffects .
3. Scheme of Examination
3.1 Each student w i l l  be assessed by means of
(a) set coursework re lated to the course of lectures. Such coursework 
should normally be completed by 30 A p r il of the year in  which the 
lectures were presented.
p lu s  (b) a w ritten  report on the approved p ro jec t which must be submitted 
to the examiners by the 30th June of the year in  which the candi­
date completes the course.
p lu s  (c) an oral examination on the approved p ro jec t.
p lu s  (d) a w ritten  paper of not more than three hours duration on the sub­
je c t as a whole.
(e) or a d isserta tion  which must be w ritte n  in  English and must a ffo rd  
evidence of serious study by the candidates and of his a b i l i t y  to 
discuss c r i t ic a l ly  a d i f f ic u l t  problem in  the f i le d  of endocrine 
biochemistry or pathology.
3.2 The subject of the d isse rta tion  must be approved by the School by 
30th March in  the year in  which the course of study is  completed. 
Candidates must submit th e ir  d isserta tions w ith in  one year of complet­
ing the course of study.
3.3 Successful candidates w i l l  be awarded the "Diploma in Endocrinology 
(Pathology)". A "D is tin c tio n " grade w i l l  be given to candidates who 
show exceptional m erit.
3.4 The Board of Examiners w i l l  be appointed by the Academic Board of 
Royal Postgraduate Medical School and w i l l  contain at leas t one 
examiner external to the School.
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UNIVERSITY OF LONDON 
ROYAL POSTGRADUATE MEDICAL SCHOOL 
OUTLINE PROGRAWE OF COURSES SCHEDULED FOR 1991
in the series
CURRENT ADVANCES IN LABORATORY TECHNIQUES
Further d e ta ils  and application forms are available from: 
Professor Ju lia  M. Polak 
Histochemistry Unit
or the appropriate course organiser at the 
Wolfson Conference Centre 
Royal Postgraduate Medical School 
Hammersmith Hospital, Du Cane Road 
London W12 ONN, U.K.
we re g re t we cannot accept telephone enquiries
MODERN I(“HINOCYTOCHEMISTRY
7-11 OCTOBER 1991
Course organisers: J u lia  M. Polak and Susan Van Noorden (Histochemistry)
IN SITU HYBRIDISATION
21-25 OCTOBER 1991
Course Organisers: Ju lia  M. Polak, G iorgio Terenghi and Sally Gibson
(Histochemistry)
MONOCLONAL ANTIBODY TECHNIQUES
18-22 NOVEMBER 1991
Course organisers: Mary A. R itte r, Heather Ladyman and Russel Hargreaves
(Department of Immunology)
(Closing date: 31st March 1991)
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IMAGE ANALYSIS AND MORPHOMETRY IN  MEDICINE AND BIOLOGY
4-8 DECEMBER 1991
Course organisers: Ju lia  M. Polak, Oavid R. Springall (H istochemistry) 
and Richard Wootton (Medical Physics)
MOLECULAR BIOLOGY
Course organiser: Steve Legon, Lecturer in  Molecular Biology 
(Oept. of Chemical Pathology)
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6TH WORLD CONGRESS IN  OLTRASOUND 
1-6  SEPTEMBER 1991
The 6th World Congress in  Ultrasound w i l l  be held in  Copenhagen, 
from September the 1st to  6th 1991
The congress is  sponsored by the World Federation fo r 
Ultrasound in  Medicine & Biology
Jens Jdrgen Кje r ,  M.D. 
Herlev Hospital 
Department of Ultrasound 
DK-2730 Herlev 
Denmark
Congress Secretaria t: 6th World Congress in  Ultrasound 
Spadille Congress Service 
Sommervej 3 
DK-3100 Hornbaek 
Denmark
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INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
World Health Organization 
Lyon - France
FELLOWSHIPS FOR RESEARCH TRAINING IN CANCER 
1991-1992
A p p lic a t io n s  f o r  t r a in in g  fe l lo w s h ip s  in  1991-1992 a re  in v i t e d  from  
ju n io r  s c ie n t is t s  w is h in g  to  be t r a in e d  in  tho se  asp ec ts  o f  c a n c e r re ­
sea rch  re la te d  to  th e  A g e ncy 's  own programmes: e p id e m io lo g y , b i o s t a t i s t i c s ,  
e n v iro n m e n ta l and v i r a l  c a rc in o g e n e s is  and mechanisms o f  c a rc in o g e n e s is .
Applicants should be engaged in  research in  medical or a l l ie d  sciences 
and intend to pursue a career in  cancer research.
Fellowships are awarded fo r one year and are tenable at the Agency or in 
another suitable in s t itu t io n  abroad. Fellows w i l l ,  in  general, be selected 
from applicants with some postdoctoral research experience re la ted  to cancer 
in  medicine or the natural sciences. Applicants requiring basic tra in in g  in 
cancer epidemiology w i l l  also be considered. They must have an adequate 
knowledge, both w ritten  and spoken, of the language of the country in  which 
th e ir  fellowship is  tenable.
Applications cannot be accepted from people already holding fellowships 
enabling them to study abroad.
Stipends w i l l  vary according to the cost of l iv in g  in  the country of 
study. The cost of tra ve l fo r the applicant, and in  certa in  circumstances, 
tha t of one dependent, w i l l  be met.
VISITING SCIENTIST AWARD 
I 99 ]-1 99 2
T h is  award i s  in te n d e d  f o r  e s ta b lis h e d  can ce r re se a rch  w o rk e rs  w ith  a 
minimum o f  f iv e  y e a rs  p o s td o c to ra l e x p e r ie n c e  who w ish  to  spend up to  one 
y e a r a t  IARC w o rk in g  on th e  im p le m e n ta tio n  o f  a c o l la b o r a t iv e  rese a rch  
p r o je c t  re la te d  to  th e  A ge ncy 's  own programmes: e p id e m io lo g y , b i o s t a t i s t i c s ,  
e n v iro n m e n ta l and v i r a l  c a rc in o g e n e s is  and mechanisms o f  c a rc in o g e n e s is .
Applicants must belong to the s ta ff of a un ive rs ity  or a research in s t i ­
tu tio n . They must provide a w ritten  assurance that they w i l l  have a 
position  to return to at the end of the period of award.
Candidates should submit th e ir  applications a fte r consulta tion w ith an 
IARC s c ie n tif ic  s ta f f  member. Applications w i l l  be reviewed by the Fellow­
ships Selection Committee each year.
There w i l l  be an annual renumeration and the cost of trave l w i l l  be met.
230 CONGRESSES, FELLOWSHIPS, COURSES
Fellowship app lica tio n  forms and more de ta iled  information are
available from:
Chairman o f the Fellowships Selection Committee 
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER 
150 cours Albert-Thomas, 69372 Lyon Cedex 08 
France
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THE TENTH ANNUAL SCIENTIFIC MEETING AND EXHIBITION 
of the
SOCIETY OF MAGNETIC RESONANCE IN MEDICINt
w il l  be held August 10-16, 1991, 
in  San Francisco, C a lifo rn ia , USA
For more information, contact SMRM,
1918 University Avenue, Suite 3C, Berkeley, CA 
94704 USA.
Telephone: (415) 841-1899.
Fax: (415) 841-2340.
PROSIAGLANDINS, LEUKOTRIENES AND LIPOXINS '91
Washington, OC 
May 13-17, 1991
Xlth Washington 
In ternationa l Spring Symposium
c/o Dr. J.M. Bailey
Department of Biochemistry & Molecular Biology 
The George Washington U niversity School of Medicine 
and Health Sciences 
2300 Eye Street, N.W.
Washington, DC 20037 
U.S.A.
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The Society o f Magnetic Resonance in  Medicine 
TENTH ANNUAL
SCIENTIFIC MEETING AND EXHIBITION 
AUGUST 10 -16 , 1991
The San Francisco H ilton  and Towers
San Francisco,
C a lifo rn ia , USA
Young I n v e s t ig a t o r 1s Award C o m p e tit io n
The Society of Magnetic Resonance in  Medicine announces the compe­
t i t i o n  fo r  the Young In ve s tig a to r's  Award in  Magnetic Resonance in  Biology 
and Medicine. The competition is  open to young sc ien tis ts  at the under­
graduate, graduate, and postgraduate leve ls  in  academia, industry, or 
research in s titu tio n s . Applicants must be less than 38 years of age on 
January 1, 1991, and have had no more than the equivalent of f iv e  years' 
fu l l - t im e  postdoctoral research experience, as documented by a curriculum 
v ita e  and le t te r  of confirm ation from th e ir  supervisor, mentor, or depart­
ment head.
To enter the com petition, the applicant must submit a single manu­
s c r ip t  describing o r ig in a l work in  the f ie ld  o f MR in  biology and medicine. 
The app lican t must be the sole or primary author of th is  work. The manu­
s c r ip t  may not have been published p rio r to  the submission deadline. The 
Young Inves tiga to r's  Award Committee w i l l  se lec t up to fiv e  f in a l is ts ,  who 
w i l l  make oral presentations at the Annual Meeting. The winner w i l l  be 
selected on the basis of the s c ie n tif ic  q u a lity  and o r ig in a lity  of h is  or 
her w r it te n  and oral presentations and w i l l  be named before the close of 
the Annual Meeting. The winner is  awarded 21,500, and a l l  other f in a l is ts  
are awarded 2500.
MAIL TO:
SMRM Business O ffice , 1918 University Avenue, Suite 3C
Berkeley, CA 94704, U.S.A.
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CADMIUM IN THE HUMAN ENVIRONMENT 
TGXICITY AND CARCINOGENECITY
An In te r n a t io n a l  Symposium 
G argnano, I t a l y  
25-27 Septem ber 1991
In ternationa l Agency fo r Research on Cancer
In te rna tiona l Union of Pure and Applied Chemistry 
In s t itu te  of Occupational Health, University of Brescia
In ternationa l Agency fo r Research on Cancer 
150, cours A lbe rt Ihomas
F-69372 Lyon Cedex OB
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X l l l t h  I n t e r n a t io n a l  Congress o f  Lym phology 
S eptem ber 2 9 th — O ctober 5 th ,  1991 
a t th e  MERIDIEN MONTPARNASSE H o te l,  PARIS -  FRANCE
MAIN TOPICS
-  Anatomy of lymphatic system
- Surgery and lymphatic system (oncology, reconstructive 
and microsurgery)
- Physiology and rheology of lymphatic system
- M icroc ircu la tion  and lymphatic system
- Dermatology and lymphatic system
- Immunology and lymphatic system
- Transplantation and lymphatic system
- Lymphatic system imaging (conventional radiology, CAT, NMR, 
rad ionuc lides.. .  )
- Oncology and lymphatic system
- Pharmacology, pharmacokinetics and lymphatic system
- Lymphedema
- Venous, a r te r ie s  and lymphatic system
- AIDS and lymphatic system
- Others
The Congress Secretaria t:
DIXIT In te rna tiona l: Tel (1)47 88 53 47 Fax: (1)47 88 56 63
Telex: 611 989
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THE PFIZER AWARD FELLOWSHIP
Dear Sir/Madam,
As part of our continuing e ffo r ts  to support innovative research in  the 
f ie ld  of cardiology, P fizer is  o ffe ring  the:
P f iz e r  Award F e llo w s h ip : to  be g iv e n  to  an in v e s t ig a to r  p re s e n t in g  a h ig h  
q u a l i t y  re s e a rc h  p r o je c t  on c a lc iu m  and membrane t ra n s p o r t  m echanism s.
Applications w i l l  be considered by the award committee of the I n te r n a t io n a l  
S o c ie ty  o f  H y p e rte n s io n .
The award fellowship w i l l  be conferred at the 14th. S c ie n tif ic  Meeting of 
the In te rna tiona l Society of Hypertension, Madrid, Spain, June 14th-19th 
1992.
The award i s  US# 20,000 p e r ye a r f o r  2 y e a rs . A research proposal together 
with curriculum v itae and 2 le tte rs  of recommendation should be mailed to 
the
Secretary of The In te rna tiona l Society of Hypertension
Dr. Hans Ibsen
Medical Department C
Glostrup Hospital
DK-2600 Glostrup
Denmark
One of the le tte rs  of recommendation should be from the ch ie f of the labora­
tory in  which the planned research is  to be carried out.
Deadline of submission: March, 31st, 1992.
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V ia  Lamarmora 45, 5 0 1 2 1  F ire n z e
J A P A N
K IN O K U N IY A  C O M P A N Y  LTD.
J o u rn a l Department, P.O. Box 55 
Chitose, T o kyo  1 5 6
M A R U Z E N  C O M P A N Y  LTD., B oo k  Department 
P.O. Box 5050 Tokyo In te rna tiona l, T o k y o  1 0 0 -3 1  
N A U K A  LTD., Im port Departm ent 
2 -3 0 -1 9  M inam i Ikebukuro, T osh im a-ku , T o kyo  171
K O R E A
C H U LP A N M U L , P h e n ja n  
N O R W A Y
S .A . Narvesens L itte ra turjeneste  
Box 6125, Etterstad 
1 00 0  Oslo
P O L A N D
W EG IERSKI INSTYTUT K U LTU R Y
M arszalkowska 80, 0 0 - 5 1 7  W a rs z a w a
CKP I W, ul. Tow arow a 28, 0 0 - 9 5 8  W a rsza w a
R O U M A N I A
D. E. P., B u c u re s t i
ILE X IM , Calea G riv ite i 64  66, B u c u re s t i  
S O V I E T  U N I O N
SOYUZPECHAT —  IM P O R T, M o s c o w  
and the  post o ffices in each to w n  
M E ZH D U N A R O D N A Y A  K N IG A , M o s c o w  G -2 0 0
S P A I N
D IA Z  DE SANTOS Lagasca 95, M a d r id  6  
S W E D E N
ESSELTE TIDSKR IFTSC ENTRALEN 
Box 62, 101 2 0  S to c k h o lm
S W I T Z E R L A N D
KARGER LI BRI AG, Petersgraben 31, 4 0 1 1  B a s e l 
U S A
EBSCO SUBSC RIPTIO N SERVICES
P.O. Box 1943, B irm in g h a m , A la b a m a  3 5 2 0 1
F. W. FAXON CO M P A N Y , INC.
1 5 S ou thw est Park, W e s tw o o d  M a ss . 0 2 0 9 0  
M A JO R  SCIENTIFIC S U B SC R IPTIO N S  
1851 D ip lom at. P.O Box 8 19 07 4 ,
P a lla s . Tx. 7 5 3 8 1 -9 0 7 4  
REDM O RE PUBLIC A TIO N S, Inc.
2 2  C o rtland t Street, N ew  York, N.Y. 1007
Y U G O S L A V I A
JU G O SLO V EN S K A  K N JIG A , Terazije 27, B e o g ra d  
FO R U M , Vojvode M i§ica 1 . 2 1 0 0 0  N o v i  S a d
Index: 26.015
